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/($'723529,'($³758($1')$,5´9,(:2)60(3$7(17$66(76" 
Janice Denoncourt 
ABSTRACT 
 The most important high technology intellectual property (IP) rights in terms of 
innovation are patents,1 a form of intangible property right.  Even though these corporate 
assets drive 21st century technological innovation, patent-backed lending to UK SMEs 
remains underdeveloped.  One reason is that the value of their internally generated patents is 
under-reported in traditional financial statements due to the application of International 
Accounting Standard 38 Intangibles.  The accounting problem is exacerbated by the fact that 
SMEs are exePSWIURPFRPSDQ\ODZUHTXLUHPHQWVWRSUHVHQWDGLUHFWRUV¶6WUDWHJLF5HSRUWLQ
their annual return to Companies House.  The astonishing lack of quantitative and qualitative 
public information about corporate IP assets makes it difficult to assess their strategic value 
³WKHSDWHQWYDOXHVWRU\´DQGGLUHFWRUV¶VWHZDUGVKLSRIWKRVHDVVHWV:KLOHWKLVPD\restrict 
access to debt finance, this thesis argues there is a wider corporate governance issue.  More 
relevant, accurate and timely corporate IP information (mostly known to internal 
management) is needed to triangulate intangibles financial data through cross verification 
with corporate narrative disclosure.  The multidisciplinary insights into the transparency 
corporate problem and how directors fulfil exisWLQJREOLJDWLRQVWRSURYLGH³WUXHDQGIDLU´,3
information under UK law provide an academic audience with a deeper level of legal analysis 
concerning the intersection between: (1) the patent ecosystem; (2) accounting for intangibles; 
(3) patent-backed debt finance; and (3) corporate disclosure.  Knowledge is advanced with an 
original business triage style Essential, Desirable & Optional narrative corporate disclosure 
model. 
  
                                                 
1
 Torremans, P. Holyoak & Torremans Intellectual Property Law (7th ed.) Oxford University Press, p45 
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1  Introduction and methodology 
 
 
 The human species, according to the best theory I can form of it, is composed of two 
 distinct races, the men who borrow and the men who lend. 
 
      Charles Lamb (1775-1834) in Essays of Elia:  
      The Two Races of Men (1823) 
 
 The most important high technology intellectual property (IP) rights in terms of 
innovation are patents,2 a form of intangible property right.  Even though patents are 
corporate assets that drive technological 21st century innovation, patent-backed debt finance 
is underdeveloped and underused in the UK and elsewhere.  This method of finance simply 
involves using a patent or a portfolio of patent rights as security for a loan.  This thesis argues 
that there is a market failure in recognising IP as an asset in financial accounts and in 
corporate narrative reporting.  However, a transformation of the patent-backed debt finance 
ecosystem may be close to the tipping point3 as public announcements of patent-backed 
lending initiatives around the world are published, making it an increasingly alluring finance 
option. 
 An early example of a patent-backed loan relates to Lewis Waterman4, an American 
small business owner who invented a superior fountain pen that made inkwells and dip pens 
obsolete, while he worked as an insurance agent. Waterman is said to have vowed to invent a 
better writing instrument when an inferior pen leaked on an important insurance contract, 
causing a delay which led to him losing the client.5  In 1884, he borrowed $5,000 USD 
                                                 
2
 Torremans, P. Holyoak & Torremans Intellectual Property Law (7th ed.) Oxford University Press, p45 
3
 The tipping point is the critical point in an evolving situation that leads to a new and irreversible development. 
4
 Lewis Edson Waterman (November 18, 1837 ± May 1, 1901) was the inventor of the capillary feed fountain 
pen and founder of the famous Waterman Pen Company.  He was inducted into the US National Inventors Hall 
of Fame in 2006.    
5
 US Inventors Hall of Fame Biography of Lewis Edison Waterman, at 
http://www.invent.org/Hall_Of_Fame/308.html 
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backed by his fountain pen patent6 to start the Ideal Pen Company in New York. This is the 
first known reported example of patent-backed debt finance.  Five years later in 1899 he 
opened a factory in Montreal, Canada.  When he died in 1901, his nephew Frank D 
Waterman took over the company, renamed it the L E Waterman Company and proceeded to 
increase sales to 350,000 pens per annum.  The fountain pens were widely used until the 
Great Depression made them a luxury item.7  Even today, 130 years later, the Waterman 
Paris8 company continues to design and sell luxury writing instruments, inks and refills and 
the Waterman brand is globally renowned.    
 The point of this century old example is to illustrate the crucial role banks loans have 
already played with respect to patent-backed debt finance.  Nevertheless, it remains an uphill 
battle for small to medium-size (SME) businesses to access debt finance and as a result, many 
early stage patented technologies firms fail due to under-capitalisation. In light of the global 
financial crisis9 and subsequent downturn in the UK economy, there is now an even more 
pressing need to facilitate the use of patents as the underlying asset in a loan transaction.  
Imperfect access to debt finance funding is an important barrier to commercialising 
innovation as, compared with larger companies, SMEs at the beginning of the business life 
cycle frequently lack the internal financial resources to support commercialization.10    
 The scale of RXUPRGHUQHFRQRP\¶Vvalue dependency on intangibles has been 
recognised in many reports commissioned by the UK government, including the 2006 
Gowers Review of Intellectual Property11and the Digital Economy Report (2011).12  The shift 
                                                 
6US Patent 293,545 Fountain Pen, 12 February 1884.  
7
 After World War II the invention of the disposable ballpoint pen dominated. 
8
 Since 2000 Waterman Paris has been a wholly owned subsidiary of the American group Newell Rubbermaid. 
9
 Claessens, S., Kose, M.A., Laeven, L.,Valencia, F. Financial Crises: Causes, Consequences, and Policy 
Responses (February 2014) International Monetary Fund; Kirkpatrick, G. µ7he Corporate Governance Lessons 
IURPWKH)LQDQFLDO&ULVLV¶Financial Market Trends 1 at 4. 
10
 Options for an EU Instrument for Patent Valorisation (2012) Prepared by the Expert Group on IP 
Valorisation, European Union, p18 
11
 Gower, A. Review of Intellectual Property (December 2006) HM Treasury on behalf of the Controller of Her 
0DMHVW\¶V6WDWLRQHU\2IILFH p3 
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to intangible assets, including patents, copyright, trade marks, designs and several others, as 
the major driver of value in corporations is clear.  In March 2014 the Department of Business, 
Innovation & Skills (BIS) confirmed that: 
 
 «,QYHVWPHQWLQµLQWDQJLEOH¶DVVHWVKDVLQFUHDVHGE\PRUHWKDQWRELOOLRQ
from 2009 to 2011 and nearly half of this investment was protected by formal 
,QWHOOHFWXDO3URSHUW\5LJKWV«'DWDVKRZVLQYHVWPHQWLQLQWHOOHFWXDOSURSHUW\DQG
µLQWDQJLEOH¶DVVHWVLVJURZLQJDQGFRQWLQXHVWRRXWVWULSLQYHVWPHQWLQWDQJLEOHDVVHWV
such as buildings and machinery, which fell slightly from £93 billion to £89.8 billion. 
The figures signal the growing value UK businesses attach to knowledge, innovation 
and creativity.13  
 
 Traditionally, the nature of assets used as security in loan transactions mainly 
included land, plant, stock, inventories and receivables.  Gold, jewelry and other tangible 
assets including antiques and works of art are used as security.  While the ratio of the value of 
intangible assets to the value of tangible assets owned by companies has steadily increased 
from the late 1970s to date,14 fast forward to 2014 and we see that innovating SMEs still 
struggle to secure loans using their patents,15  a valuable form of personal property available 
for use as security.  Whereas large corporations have used their IP and patent assets to raise 
loan capital, few innovating SMEs have followed the same trend.16  More than 99% per cent 
of UK companies are SMEs and do not issue publicly trade-able securities, making them 
                                                                                                                                                        
12
 Hargreaves, I. Digital Opportunity: A Review of IP and Growth (May 2011) Independent report 
commissioned by the UK Prime Minister, p3 
13
 µNew figures published today show that UK business is building success through knowledge and creative 
DVVHWV¶1 March 2014) Department Business, Innovation and Skills at 
https://www.gov.uk/government/news/uk-knowledge-investment-continues-to-grow 
14
 .UDPHU:-DQG3DWHO&%µ6HFXULWLVDWLRQRILQWHOOHFWXDOSURSHUW\LQWKH86PDUNHW0DUVKDOO-XQH
Gerstein & Borun, Chicago, IL 
15
 Patents are considered personal property as established in s 30(1) PA 1977 
16
 'RQHJDQ&µ,QGXVWU\UHSRUW± IP finDQFHWKHDVVHWFODVVWKDWIHOOWRHDUWK¶0D\DWhttp://www.iam-
media.com/industryreports/detail.aspx?g=9b5ac3a7-9514-4a99-85d8-a17b4f39bcd0 
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reliant on credit from banks to grow their businesses.  Whilst in quoted (publicly listed on a 
stock exchange offering shares to the public) and large private companies, the value of 
intangible patent assets is recognised in their market value, for unquoted SMEs there is no 
comparable mechanism for them to measure and demonstrate the value of the patent assets 
inherent in their business to use as security or collateral17 or for bank loans.18   
 Fortunately, important and meaningful recent developments in IP and patent-backed 
finance have recently provided impetus to consolidate knowledge with respect to this under-
exploited yet promising financing method.  In the UK, research focusing specifically on 
patent-backed debt finance has been published in the independent Banking on IP? Report 
(2013).19  Speaking at the Alliance for IP Conference in London on 17 October 2013, the then 
Business Secretary Vince Cable said: 
 
 SMEs are the lifeblood of the economy. Most of our successful creative businesses 
are SMEs and we know that Intellectual Property represents a big part of their assets 
DQGJURZWKSRWHQWLDO%XWWRRRIWHQWKURXJKULVNDYHUVLRQRUEDQNV¶FRQVHUYDWLYH
lending practices linked to property as security, IP is not catered for by traditional 
bank lending. Intellectual property is too important an asset to be undervalued by 
banks who are the main source of finance. That is why I commissioned a report to 
H[SORUHKRZZHFDQLPSURYH60(V¶DFFHVVWRFDSLWDO:HZLOOORRNFDUHIXOO\DWLWV
recommendations in order WREHWWHUVXSSRUWWKLVFRXQWU\¶V creators and IP-rich 
businesses.20 
 
                                                 
17
 &ROODWHUDOLVWKH86WHUPIRUµVHFXULW\¶ 
18Garrett J. F. Banks and Their Customers (1995) Dobbs Ferry NY: Oceana Publications, p99 
19
 Brassell, M. and King, K. Banking on IP? The role of Intellectual Property and Intangible Assets in 
Facilitating Business Finance Final Report (6 November 2013) Independent report commissioned by the 
UKIPO 
20
 µ3ODQV8QYHLOHGWRVXSSRUW,3-ULFKEXVLQHVVHVJHWIXQGLQJ¶2FWREHU'HSDUWPHQWIRU%XVLQHVV
Innovation & Skills, Intellectual Property Office and the Rt. Hon Dr Vince Cable MP 
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 7KH(8¶VFinal Report from the Expert Group on IP Valuation (2014) relates to 
future actions on IP policy, especially with respect to the changing European Commission 
and review of Europe 2020.21  These publications indicate that both the UK and the EU seek 
to achieve a better understanding of the interplay between IP and debt finance, increasing 
confidence in IP valuation with the goal of facilitating financing to innovating SMEs. These 
reports show a high level of momentum in the region to tackle this important commercial 
problem, a challenge that has the potential to transform the future of commercial lending.  On 
31 March 2014, the UK government formally responded to the Banking on IP report 
promising to promote a greater understanding of IP within businesses seeking finance and the 
financial sector; and to create systems to give lenders confidence in assessing the value of IP 
and the risks involved in lending using IP as security.22  The UKIPO stated: 
 
 «,QWKHIPO will therefore focus attention on improving the ability of IP-rich 
businesses to secure access to growth finance - by building understanding of IP in the 
business and the financial services communities, by enabling a more productive 
dialogue between businesses and lenders, and by building greater confidence in the 
value of IP assets as collateral.23 
 
 Similarly, this thesis focuses on a practical commercial problem within a legal 
context, namely how to improve access to patent-backed debt finance by innovating SMEs.24   
For our purposes, use of the term ³LQQRYDWLQJ60(V´ refers to SMEs involved in research 
                                                 
21
 Final Report from the Expert Group on Intellectual Property Valuation (2014)  
22
 Banking on IP? an active response (31 March 2014) UKIPO at 
https://www.gov.uk/government/publications/banking-on-ip-an-active-response 
23
 Ibid p20 
24
 In the UK, ss382 and 465 of the Companies Act 2006 define a SME for the purpose of accounting 
requirements. A small company is one that has a turnover of not more than £6.5 million, a balance sheet total of 
not more than £3.26 million and not more than 50 employees. A medium-sized company has a turnover of not 
more than £25.9 million, a balance sheet total of not more than £12.9 million and not more than 250 employees.  
The EU definition (Recommendation 2003/361/EC adopted on 1st January 2005) is similar to the UK definition 
H[FHSWLWLQFOXGHVDFDWHJRU\FDOOHGµPLFUR¶ 
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and development (R&D) with a view to making patent applications or holding granted 
patents.  We assume that an innovating SME with patent assets adopts a private limited 
company legal structure registered with Companies House and is classified under the s.477 of 
Companies Act 2006 (CA 2006) as a SME for financial reporting purposes.  The reason for 
concentrating on innovating SMEs is that, following the global financial crisis which began 
in 2007,25 SME access to finance was formally recognised as an issue of pressing importance 
at the G20 summit held in 2009.26  Since that period, the ability and willingness of 
commercial banks to fund SMEs in the UK has generally declined despite government 
initiatives to increase lending.  At the same time, a bank loan or commercial mortgage is the 
preferred method of finance for 36% per cent of SMEs, followed by a bank overdraft (23% 
per cent) and loans/equity from friends and family (10% per cent).27  There are also gaps in 
the level of finance and patent law knowledge in many innovating SMEs.28  Data from BIS, 
as reported by the Federation of Small Businesses (FSB), confirms that at the beginning of 
2013, SMEs accounted for an astounding 99.9% per cent of private sector business in the UK, 
59.3% per cent of private sector employment and 48.1% of private sector turnover.  SMEs 
employed 14.4 million people and had a combined turnover of £1,600 billion.  Over 62% per 
cent were sole proprietorships, 28.5 % per cent (1.4 million) were companies and 8.9% per 
cent were partnerships.29  The Federation of Small Business (FSB) reported that one in five 
firms blamed their poor ± or non-existent ± access to finance as the main barrier to achieving 
                                                 
25
 The run on the Rock Fifth Report of Session 2007-2008 House of Commons Treasury Committee (2008) 
Vol.1, House of Commons London: The Stationer Office Ltd pp 4 ± 20. Also known as a credit crunch, it is a 
decline in the general availability of loans (or credit) coupled with a tightening of the conditions required to 
obtain bank loans.  A credit FUXQFKLVDFFRPSDQLHGE\D³IOLJKWWRTXDOLW\´E\OHQGHUVDVWKH\VHDUFKIRUOHVV
risky investments, often at the expense of SMEs.  
26
 µ*/HDGHUV¶6WDWHPHQW¶6HSWHPEHU 
27Lomax, S. and Davies, E. Small and Medium Sized Enterprise (SME) Journey towards raising external finance 
(October 2013) A Report by BMG Research commissioned by BIS, p68 
28Supra [10] 
29
 Small Business Statistics (2013) 
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growth aspiration plans.30  The significance of these statistics should not be underestimated 
JLYHQWKDW60(VFROOHFWLYHO\SURGXFHPRUHWKDQKDOIRI%ULWDLQ¶VZHDOWKJURVVGRPHVWLF
product or GDP).31   FSB Chairman John Walker declared tKDW³,IVPDOOILUPVFDQQRWDFFHVV
FUHGLWLWFRQVWUDLQVWKHLULQYHVWPHQWSODQV´7KH8.¶VORQJ-term economic growth and 
prosperity depends on SMEs. 
 Although there are presently many barriers to patent-backed debt finance in the UK, 
one barrier that has not been studied sufficiently is the unintended effect RIWKH³VPDOO
FRPSDQLHV¶UHJLPH´32 aimed at reducing administrative regulatory burdens on by exempting 
directors of SMEs from providing a narrative corporate report concerning their stewardship 
of company assets.  The combined effect of traditional accounting principles (with respect to 
intangibles) and corporate disclosure laws has created a void of publicly available patent 
information in the format typically used by commercial lenders when assessing a ERUURZHU¶V
credit application.  This thesis adopts a multidisciplinary approach, in particular, by adding a 
company law and corporate disclosure layer into the analysis, in order to derive the research 
objective and research questions.  It investigates the deficiencies in traditional accounting for 
intangibles which can, it is argued, be potentially solved by increased corporate narrative 
disclosure concerning those patent assets in order to change the perception of risk currently 
held by lenders contemplating patent-backed loan transactions.  Enhanced narrative 
disclosure could help to reduce the information gap, make patent assets more visible in public 
accounts and assist lenders to seize the opportunity to develop a lending relationship with the 
innovating SME, rather than remain inactive.  Another alternative is a test case to judicially 
                                                 
30
 Federation of Small Businesses Quarterly Report (18 June 2012) Independent report produced by the Centre 
for Economic and Business Research (CEBR) for the FSB   
31
 Ibid 
32
 Small Companies and Groups $FFRXQWVDQG'LUHFWRUV¶5HSRUW Regulations 2008 as amended by the Small 
Companies (Micro (QWLWLHV¶ Accounts) Regulations 2013.  This means that SMEs can take advantage of some 
exemptions to disclose less information.  
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consider whether International AccountinJ6WDQGDUG,$6SURYLGHVD³WUXHDQGIDLU´ view 
with respect to the financial value of patent assets.  This could result in legal authority to 
depart from the IAS 38 standard.  Thus, it is argued, company law should take the lead to 
SURYLGHDWUXHDQGIDLUYLHZRI60(V¶SDWHQWDVVHWV 
 This research investigates how certain risks inherent in patent assets can be managed 
to reduce the level of uncertainty perceived by lenders.  The following statement by Scott 
%HOO+HDGRI8.,QYHVWPHQW%DQNLQJDW'HXVWFKH%DQNFODULILHVWKHOHQGHU¶VSHUVSHFWLYH
about the lack of patent information and the impact on lending decisions: 
 
 «:LWKRXWGDWDDERXWYDOXHDQGULVNRZQHUVKLSVWUDWHJ\DQGLQIRUPDWLRQDOORZLQJXV
to make market comparisons, it is hard to see how a functional and active market can 
be developed; and while data is not the only ingredient, transparency, visibility and 
understanding of the patent world has to be the starting point.33 
 
 Given the broad nature and characteristics of the patent ecosystem,34 it was not 
possible to deal with all the potential risks that might create uncertainty concerning patents as 
a form of loan security.  Accordingly, this study focuses on the earliest steps in the credit 
appraisal stage of the secured loan transaction and the need for increased corporate disclosure 
of patent assets and strategy at this point in time in order to create transparency, visibility and 
XQGHUVWDQGLQJRIWKHERUURZHUV¶SDWHQWVDVYDOXDEOHFRPPHUFLDODVVHWV7KLVZRXOGDVVLVW
lenders to forecast the growth potential and future cash flow of the 60(¶VEXVLQHVVZLWK
greater precision and accuracy and put a probability on the forecast.  As noted by Phillips:  
                                                 
33
 Phillips, J. (Ed.) The Trillion Dollar Tipping Point AISTEMOS Report (September 2014) AISTEMOS, 
London, p8 
34
 $µSDWHQWHFRV\VWHP¶LVDWHUPFRLQHGXVLQJ-DPHV)0RRUH¶VVWUDWHJLFSODQQLQJFRQFHSWRIDEXVLQHVV
ecosystem developed in the early 1990s and now widely adopted by the high technology community in the US.  
7KHEDVLFGHILQLWLRQZDVQRWHGLQ0RRUH¶VERRN, The Death of Competition:  Leadership and Strategy in the Age 
(1997) HarperCollins Publishers, p22 
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 «7KHUHVHHPVWREHDGLVMXQFWLRQEHWZHHQWKHKLJKYDOXHRILQWDQJLEOHVVXFKDV
patents in court and in transactions, on the one hand, and their relative lack of appeal 
as security for loans on the other.  Faced with a request for finance backed by such 
intangibles, banks sometimes appear to behave as though the choice before them lies 
between taking a bad risk and making no loan at all.  This is not the result of malice or 
willful blindness, but stems from the paucity of information on which banks can 
assess the nature of the risk they take in lending on intangible securities.35 
  
 The advantage in applying for and being granted a patent is that in addition to creating 
a new asset which can be used as a source of security for loans, patent assets have the 
potential to create a royalty revenue stream, bolster financial statements and provide a shield 
against aggressive competitors.  However, this requires a largely upfront financial investment 
by the owner.  Imperfect access to debt finance funding has a comparatively greater negative 
impact on SMEs at the beginning of the business life cycle than on larger firms who have 
more finance options.36   
 Another barrier to patent-backed lending is the uncertainty inherent in the boundaries 
DQGHQIRUFHDELOLW\RIWKH60(¶VOHJDOO\FRQVWUXFWHGSDWHQWULJKWV$QDO\VLQJWKHXQGHUO\LQJ
financial value of the SMEs patent assets and associated risks is still difficult for lenders.  
Intangible patents are constructed by legal rules and the rules that define patent monopolies 
are the subject of constant change via case law and the doctrine of judicial precedent which in 
the short term reduces certainty, although in the long term the stare decisis37 legal method 
                                                 
35
 Supra Phillips [32]  
36
 Supra [9] p18 
37
 The phrase µVWDUHdecisis¶ is an abbreviation of the Latin phrase stare decisis et non quieta movere  which 
WUDQVODWHVDV³WRVWDQGE\GHFLVLRQVDQGQRWWRGLVWXUEVHWWOHGPDWWHUV´  The doctrine provides that the decision of 
a higher court acts as binding authority on a lower court within that same jurisdiction 
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increases certainty.  The more complex the uncertainties, the higher the risk for the lender in 
the event of default. This, and other factors, make a patent difficult, but not impossible (if the 
lender has adequate and sufficient information) to value.  In the absence of trust and 
confidence, commercial lenders rely disproportionately on security and when they do its 
quality can easily come into question.38  Therefore in order to reduce the uncertainties 
inherent in intangible patent assets, three salient issues need to be addressed:   
 
(1) reducing uncertainty in relation to the time-limited value generating potential of patents; 
LQFUHDVLQJWKHILQDQFLHURUEDQN¶VWROHUDQFHRIWKHOHJDOrisks inherent in lending against 
patents; and  
(3) improving the liquidity RISDWHQWDVVHWVWRFXVKLRQWKHOHQGHUV¶SRVLWLRQLQWKHHYHQWRI
default.    
  
 The issues affecting credit appraisal decisions require detailed research and efforts by 
policymakers, lenders and borrowers as well as interested parties, such as the accounting, 
legal and patent attorney professions in order to overcome the patent information gap.  The 
aim of this thesis is to add to the body of knowledge related to patent-backed debt finance 
with a view to its application within the UK.    
 The rest of this introductory chapter is organised as follows.  In section 1.1 the 
DXWKRU¶VPRWLYDWLRQIRUXQGHUWDNLng the research is discussed.  Section 1.2 highlights the 
emergence of law and finance as an interdisciplinary academic discipline.  Deficits in the 
current research and literature are explained in section 1.3.  Section 1.4 sets out the research 
concept and methodology.  Section 1.5 focuses on the originality of the thesis.   
 
                                                 
38
 Innovation in access to finance for SMEs (2014) Association of Chartered and Certified Accountants,  p11 
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1.1 Motivation:  SMEs and patent finance 
 
 As in-house legal counsel for a publicly listed Australian mining technology 
FRPSDQ\%UDQGLOO/LPLWHGQRZPHUJHGZLWK³$XVGULOO´39 the author became interested in 
the clash between three cultures:  IP law, finance and corporate governance.  In the 1990s the 
business acquired a patent portfolio of certain non-explosive rock breaking technology 
inventions (based on NASA rocket technology) at a bargain price from a small private US 
firm in Chapter 11 insolvency proceedings.40  Although the US firm owned a valuable patent 
portfolio it was in financial dire straits and had exhausted its ability to finance operations and 
was wound up.  On insolvency its patent portfolio was still a valuable asset.  As such, it was 
perplexing why the company was unable to borrow additional funds to stabilise its cash flow 
and continue to trade.  At that time, as a new student of IP in the 1990s, albeit with a law and 
business background, the variety of factors inhibiting access to debt finance within the patent 
ecosystem were not clear.  As a public company, my duties included drafting Australian 
Stock Exchange announcements and annual reports including corporate disclosure of IP 
assets.   It is still the case that most lenders are unwilling to accept patent assets as security, a 
barrier to business growth.  Yet, modern capitalism is propelled forward by innovation and 
finance, despite the fact that these two powerful factors have different outcomes.  While 
innovation is typically growth-friendly, financing innovation is often described by lenders as 
high-risk speculation.  Lenders are more likely to ration credit and this undermines 
innovation rather than promotes it.  When the author began her research as a part-time 
doctoral student in 2007, little was known about the intersection between patent law, finance 
and corporate governance.  Presently, the field is gaining momentum.  
 
                                                 
39
 Brandrill Limited (BDL) was de-listed from the Australian Stock Exchange following the merger with 
Ausdrill Limited effective 12 December 2009.  
40
 Title 11 of the United States Bankruptcy Code 
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1.2 Emergence of law and finance as a new interdisciplinary discipline 
  
 Recent global attention on innovation and IP finance41 has led to a greater focus on 
the need for research that addresses complex questions that cannot be answered within a 
single discipline.  The research integrates the insight of the traditional disciplines to create 
new knowledge.  The legal profession has always learned about business and finance as a 
function of legal practice, and finance professionals learn about business law as a requirement 
of their professional accreditation.  Indeed corporate lawyers and financiers are professional 
cousins who interact closely over the course of their careers.  It is not surprising that 
important research into IP finance (specifically patent-backed finance) and corporate 
governance transcends the scope of the single discipline.  Research integrating information, 
perspectives and concepts derived from bodies of specialised knowledge is required in order 
to advance fundamental understanding and solve problems that are beyond the scope of the 
single discipline.42  In this thesis, multi-disciplinarity brings patent law, accounting and 
company law to the same table and has the goal of connecting the disciplines in pursuit of an 
increased understanding of the barriers to patent-backed debt finance.  The 
increasing awareness of the need for interdisciplinary research is echoed by Dr Leon 
Vinokur, at Queen Mary University of London, who VWDWHV³In the current 
HQYLURQPHQW«there is a growing demand for experts that can understand the interdisciplinary 
complexity of the financial system.´43  Published research on the subject of law and finance is 
beginning to emerge, mainly in the field of financial regulation (law) and economics.44  In 
                                                 
41
 A major reason for this is due to two patent transactions in 2011, namely (1) the sale of the Nortel patent 
portfolio for USD $4.5B to a consortium of smart phone manufacturers and (2) Google's stock acquisition of 
Motorola Mobility for USD $12.5B. 
42
 Adapted from the definition created by the Committee on Facilitating Interdisciplinary Research, Committee 
on Science, Engineering and Public Policy (2004).  Facilitating interdisciplinary research.  National 
Academies. Washington: National Academy Press, p2 
43
 http://www.law.qmul.ac.uk/docs/postgrad/50754.pdf. 
44
 See UK law journals such as the Law and Financial Financial Markets Review (Hart Publishing) and 
Butterworths Journal of International Banking and Financial Law 
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terms research activity in Europe, the IP Finance Institute (IPFI) based in Torino, Italy carries 
out research projects about IP as an economic asset and IP-based financing solutions.45      
 
1.2.2 WIPO initiatives 
 :,32¶VLQYROYHPHQWLQ,3)LQDQFLQJLVWRUDLVHDZDUHQHVVDPRQJLWVPHPEHUVWDWHV¶
IP offices, and the wider IP community of the current international policy development. 
WIPO held its inaugural Information Meeting on IP Financing in 2009 in Geneva, 
Switzerland.  Director-General Francis Gurry identified what he believed to be the principal 
reasons for considerable difficulty in developing IP financing: (1) the lack of a clear 
connection between the security and the underlying asset; and (2) the complexity; and         
(3) lack of transparency in the IP system that results in distrust of the intangible economy.46  
The latter statement directly supports a key aim of this thesis - to encourage further narrative 
corporate disclosure of patent asset information and strategy.  This will improve transparency 
and reduce complexity in a format that lenders and other stakeholders will trust to better 
inform their understanding of intangibles as business assets.   
 In 2008, a WIPO-$UJHQWLQD&RQIHUHQFHHQWLWOHG³,QWHOOHFWXDO5HDGLQHVV7KH5ROHRI
Intangibles as a Tool for Raising FiQDQFH´ZDVKHOGLQ%XHQRV$LUHV47 followed by a WIPO 
Information Meeting on IP Financing in 2009µ7KHPH:  Financial Institutions Perspective 
RI,3)LQDQFLQJ¶LQYROYHGMs Megan Deane, Deputy Managing Director of the national 
Export-Import Bank (E-IB)48 of Jamaica who SUHVHQWHGRQµTaking IP WRWKH%DQN¶.49  She 
stated the 2010 Vision for E-,%ZDVWRLQFUHDVHWKHEDQN¶Vtolerance for credit risk.  This idea 
is discussed further in Chapter 3.  Ms Helena Tenoria Veiga de Almeida is Head of Policy 
                                                 
45http://www.ipfinance-institute.com  
46
 Tuncak, B. The WIPO Information Meeting on IP Financing: Some Notes (1 April 2009)  
47
 6HHGHWDLOVRI:,32¶V,3)LQDQFHUHODWHGPHHWLQJVDW
http://www.wipo.int/meetings/en/details.jsp?meeting_id=16342  
48
 A bank wholly-owned by the government of Jamaica. 
49
 http://www.wipo.int/meetings/en/doc_details.jsp?doc_id=118034  
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Design Department, Intangible Assets Evaluation Program of the Brazilian Development 
Bank (BNDES).  She discussed IP asset valuation for finance purposes using internally 
developed methodology for intangibles to evaluate 56 quantitative and qualitative and patent 
information indicators to derive an intangible capital (IC) rating.  The need for both 
quantitative and qualitative patent information is further developed in Chapters 4 ± 7.   
      
1.2.3 UN Commission on International Trade (UNCITRAL) initiatives 
  Since 2004 WIPO has cooperated with UNCITRAL to ensure that the views of the IP 
community are taken into consideration in policy development on the issue,50 participating in 
deliberations to develop the Legislative Guide on Secured Transactions (LGST) to assist 
states modernise their secured transactions laws and enable effective access to finance.  
Theme 6 of the WIPO Geneva 2009 meeting focused on international policy development for 
IP financing.  Mr Spiros Bazina, Senior Legal Secretary of UNCITRAL and Working Group 
VI51 explained the relationship between IP, secured transactions law and the interaction 
between the LGST and the IP Annex.  Briefly, the LGST is not a restatement of current law, 
but rather a guide to reform of secured transactions law with the economic goal of facilitating 
the use of both movable and intangible property as security to facilitate increased access to 
credit at lower cost.   
 Both UNICITRAL and WIPO continue to play vital roles as facilitators for the 
international debate on IP finance, signaling the credibility and need for additional research.   
 
 
 
                                                 
50
 WIPO Meeting to Explore IP as a Financing Tool Geneva (5 February 2009) 
 
51
 http://www.wipo.int/meetings/en/doc_details.jsp?doc_id=118036  
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1.2.4 UK initiatives 
 The first notable UK initiative for innovation finance took place in 2006 when the 
UKIPO jointly organised a FRQIHUHQFHRQ³PatentVUHDOLVLQJDQGVHFXULQJYDOXH´ together 
with the European Patent Office (EPO) and the Organization for Economic Cooperation and 
Development (OECD).  This high-level event was aimed at raising awareness of the crucial 
role of IC in the knowledge economy.  In particular, conference literDWXUHVWDWHGWKDWµWKH
economic impact of patents still enjoys little attention from the business and finance 
FRPPXQLWLHV¶52     
 In 2008, the UKIPO partnered with the Austrian and Hungarian Patent Offices and the 
National Board of Patents and Registration of Finland to hold four international symposiums 
on ³IP 9DOXDWLRQLQ%XVLQHVV´Whe primary aim of which was to raise awareness of IP 
valuation issues and increase dialogue among stakeholders. 
 Further interest in UK IP finance issues has been led by Professor Jeremy Phillips,53 
founder of the weblog IP finance in January 2008 whose webpage banner declares:   
 «:KHUHPRQH\LVVXHVPHHW,3ULJKWV7KLVZHEORJORRNVDWILQDQFLDOLVVXHVIRU
intellectual property rights: securitization and collateral, IP valuation for acquisition 
and balance sheet purposes, tax and R&D breaks, film and product finance, 
calculating quantum of damages²anything that happens where IP meets money.54 
 
 The IP finance blog is an offshoot of Professor Phillips¶ earlier blog the IPKat55 
which began in June 2003 and covers IP issues generally, from a UK and European 
perspective.   The IPKat team organised the first UK IP finance conference in London on 15 
                                                 
52
 µPatents: realising and securing value - an international conference in London¶$XJXVW 
53
 Professor Phillips is an IP consultant for commercial law firm, Olswang and editor of the European Trade 
Mark Reports and the Journal of Intellectual Property Law and Practice and formerly Research Director of the 
8.¶V,QWHOOHFWXDO3URSHUW\,QVWLWXWH 
54
 http://ipfinance.blogspot.co.uk/ 
55
 http://www.ipkat.com/ 
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October 2009. A second conference, IP and Finance 2010: exploring and explaining the 
financial dimensions of IPRs, soon followed which shared the knowledge of speakers from a 
range of disciplines to identify the complex issues arising when IP and finance interact.   
 
1.2.5 6LQJDSRUH¶V IP financing scheme 
 However, Asia is currently setting the pace in IP-backed lending and UK lenders need 
to consider adjusting their mind-set to profit from the changing environment.  At the forefront 
of such initiatives is Singapore.  In April 2014 the IP Office of Singapore (IPOS)56 launched 
DVXEVWDQWLDO6PLOOLRQ³,3)LQDQFLQJ6FKHPH´ designed to support local SMEs to use 
their granted patents as collateral for banks loans.57  To be eligible, applicants must be 
incorporated and have granted patents to use as security.  The scheme has three steps.  First, 
with its granted patent(s), an applicant can approach a participating financial institution for a 
preliminary assessment.  The participating banks are: DBS Bank Ltd;58 Overseas-Chinese 
Banking Corp Ltd;59 and the United Overseas Bank Ltd.60  Next, a panel of IPOS-appointed 
YDOXHUVDVVHVVWKHDSSOLFDQW¶VSDWHQWSRUWIROLRXVLQJVWDQGDUGJXLGHOLQHVWRSURYLGHOHQGHUV
with a basis on which to determine the amount of funds to be advanced.  The development of 
a national valuation model is a noteworthy aspect of the scheme and could lead to an 
accepted valuation methodology for the future.  Finally, the applicant submits a formal 
application to the participating lender.61  Under the terms of the loan agreement, the interest 
rate for repaying the loan is not fixed and depends on the granted patent portfolio valuation.62  
The Singapore government will subsidise the valuation but this is capped at 50% of the IP 
                                                 
56
 IPOS is a statutory board under the Ministry of Law that advises and administers the IP regime, promotes its 
XVDJHDQGEXLOGVH[SHUWLVHWRIDFLOLWDWHWKHGHYHORSPHQWRI6LQJDSRUH¶V,3 eco-system at www.ipos.gov.sg 
57
 µSingapore Launches S$100M IP Financing Scheme & First One-6WRS,36HUYLFH&HQWUH¶$SULOIP 
Office of Singapore 
58
 www.dbs.com.sg 
59
 www.ocbc.com.sg 
60
 www.uob.com.sg 
61
 IP Financing Scheme (14 November 2014) IPOS see 
http://www.ipos.gov.sg/IPforYou/IPforBusinesses/IPFinancingScheme.aspx 
62
 µ6LQJDSRUH,3)LQDQFLQJ6FKHPH/DXQFKHG¶-XO\Managing IP 
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valuation cost, or 2% of the value of the IP, whichever is lower.63  If the borrower defaults, 
the loan will be partially underwritten by the Singapore government, thus the liquidity of the 
patent assets on default is minimised.64   
 The IPOS IP Financing Scheme is contributing to the evolution of patent-backed debt 
finance with the Singaporean government investing a substantial sum in creating an 
environment in which patent-backed debt finance has the potential to thrive.  If the scheme 
proves to be a credible model it could become the preferred template within the international 
IP community.  Singapore ranks first in Asia and second globally for IP protection according 
WRWKH:RUOG(FRQRPLF)RUXP¶V*OREDO&RPSHWLWLYHQHVV5HSRUW-2015.65  7KHFRXQWU\¶V
strong IP regime together with its well-established and diverse finance sector and support 
from major financial institutions adds to its credibility.   
 
1.2.6 The PRC IP pledge financing programme  
 Also of interest, but less influential, are the 3HRSOH¶V5HSXEOLFRI&KLQD¶V35&6WDWH
IP Office (SIPO) patent-backed debt finance initiatives.66  In terms of a functional 
comparative analysis of IP finance related issues, a foreign system should always be seen 
from the inside and in a socio-cultural context.67  7KH35&¶V,3UHJLPHLVMXVWRYHU\HDUV
old, yet its government has been extremely proactive in raising awareness to ensure that 
domestic enterprises understand the future value-creating potential of IP.68  In 2004, SIPO 
EHJDQWRGHVLJQWKHQDWLRQ¶V,3VWUDWHJ\ZKLFKHYROYHGIURPPHPEHUVKLSLQWKH:RUOG7UDGH 
Organization.  In 2006, the landmark policy, The Guidelines on National Medium and Long-
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 Ibid 
64
 µ)URPLGHDVWR$VVHWV6LQJDSRUH¶V,3)LQDQFLQJ6FKHPH¶6HSWHPEHUManaging IP 
65
 µ6LQJDSRUHUDQNVWRSVLQ$VLDIRU,33URWHFWLRQ¶6HSWHPEHUZZZLSRVJRYVJ 
66
 µ3DWHQW5LJKW3OHGJH)LQDQFLQJ$PRXQWHGWR%LOOLRQ<XDQ¶0DUFKIP China News as reported in 
English at http://www.chinaipr.gov.cn/policyarticle/policy/statistics/201403/1801673_1.html 
67
 3DOPHU9µ)URP/HURWKROLWR/DQGR6RPH([DPSOHVRI&RPSDUDWLYH/DZ0HWKRGRORJ\¶Global 
Jurist Frontiers, Vol. 4 Issue 2, Art. 1, pp2- 5 
68Shao, F. and Feng, X. Innovation and Intellectual Property in China (2014) Edward Elgar, US as stated by 
Graham Duffield in the Foreword. 
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Term Program for Science and Technology Development (2006-2020) was issued.69   A pilot 
³,3SOHGJHILQDQFLQJ´ programme followed in 2008.  According to China IP News, only 6 
years later in 2014, SIPO reported that Chinese companies had secured over £6 billion GPB 
in patent-backed loans since the programme launched.  In 2013, Chinese companies had 
apparently secured over £2.4 billion GPB (25.4 billion yuan) of credit against patent assets.70  
Unfortunately, SIPO does not appear to have published information about how the scheme 
works.  From the standpoint of Western lenders and borrowers, it is difficult to determine 
how Chinese financial institutions carry out credit appraisals leading to positive decisions to 
grant patent-backed loans.  However, the fact that the Chinese government has more direct 
control and input into commercial bank lending policy and capital adequacy requirements 
enables it to vigorously and potently implement its strategic goal of increasing patent-backed 
OHQGLQJ,Q&KLQD¶V0LQLVWU\RI)LQDQFHLVVXHGWKHQHZ³0HDVXUHVIRUWKH
$GPLQLVWUDWLRQRI6SHFLDO)XQGVIRU6XEVLGLVLQJ)RUHLJQ3DWHQW$SSOLFDWLRQV´7KH
regulation outlines policies for PRC citizens and entities that file patent applications abroad.71    
 Further, in 2014 the largest-ever IP-backed debt finance loan emerged in the PRC.  A 
trade publication, China Paper, reported72 that Quanlin Paper, a Shandong province-based 
company, secured a loan of approximately £78 million GPB (RMB 7.9 billion) against a 
small portfolio of 110 patent and 34 trade mark rights from a lending consortium led by the 
China Development Bank (CDB).73 AOWKRXJKWKHTXDOLW\RI4XDQOLQ¶VSDWHQWDQGWUDGHPDUN
portfolio is indeterminate, the scale of the loan speaks for itself and for that reason alone, is 
ZRUWK\RIDWWHQWLRQ7KHORDQZDVUHSRUWHGO\UHFRUGHGRQ)HEUXDU\RQ6,32¶V,3DVVHW
                                                 
69
 Ibid pp30 ± 31 
70
 &RKHQ0&KLQDEORJµ&KLQDWR3URYLGH)LQDQFLDO,QFHQWLYHVIRU)LOLQJ3DWHQW$SSOLFDWLRQV$EURDG¶-XQH
2012) ChinaIPR blog at http://chinaipr.com/2012/06/ 
71
 µ&KLQHVHFRPSDQ\¶VELOOLRQSDWHQWDQGWUDGHPDUNORDQHQWHUVWKH,3GHDO3DQWKHRQ¶ (4 April 2014) 
Intellectual Asset Magazine blog at http://www.iam-media.com/blog/Detail.aspx?g=481b76b6-637f-427f-b8d6-
78d06cece504 
72
 The original report was in Mandarin and was translated into English.  
73
 Supra [70] 
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register.  The CDB is a PRC government-owned financial institution created in 1994 by the 
Policy Banks Law of 1994.74  At its head is a cabinet minister level Governor, under the 
direction of the State Council.  It is one of three policy-making banks in the PRC primarily 
responsible for raising finance for large infrastructure projects.  The CDB was involved in 
financing the Three Gorges Dam and the Shanghai Pudong International Airport and is 
GHVFULEHGDVµWKHHQJLQHWKDWSRZHUVWKHQDWLRQDOJRYHUQPHQW¶VHFRQRPLFGHYHORSment 
SROLFLHV¶75  MRVWRI4XDQOLQ3DSHU¶Vsmall portfolio of IP rights are limited to China.76  The 
portfolio was valued at £600 million GPB (RMB 6 billion)77 but details as to the valuation 
process for credit purposes has not been officially reported to date.  This would assist to 
FRQILUPLIWKHVDOHRI4XDQOLQ¶VSRUWIROLRZRXOGHQDEOHWKH&'%WRUHFRXSLWVORDQLQWKH
event it defaults.  Whether the PRC credit appraisal methodology is capable of being adopted 
by Western economies, and is a compelling and credible case for change, is certainly 
debatable and an area for future research.  In a public statement, Jiang Lurong, general 
manager of the Shandong branch of Bank of Communications (part of the consortium that 
syndicated the loan) said: 
 
 ³«IP seems intangible, but it reflects the ability of value creation and sustainable 
 operation of enterprises. Banking risk is not increased, but may be  able to  get a hold 
 of high-quality customers early and improve the structure/makeup of the client 
 base.´78  
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 http://www.cdb.com.cn/web/ (no English translation)  
75
 )RUV\WKH0DQG6DQGHUVRQ+µ)LQDQFLQJ&KLQD&RVWV3RLVHGWR5LVH:LWK&'%/RVLQJ6RYHUHLJQ-Debt 
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 Debts issued by the CDB owned E\ORFDOEDQNVDUHWUHDWHGDV³ULVN-IUHHDVVHWV´.  
UQGHUWKHSURSRVHG35&¶VFDSital adequacy rules for intangible they receive the same 
treatment as government bonds and the CDB is effectively insured by the government.  In 
contrast, under Basel III,79 applicable to the UK and the EU, intangibles are rated as more 
risky types of assets requiring banks to hold more capital under the capital adequacy 
regulations which is a deterrent to patent-backed lending.80  Intangibles are treated as lower-
TXDOLW\VHFXULW\DQGLQWDQJLEOHDVVHWVDUHQRWXVXDOO\FRXQWHGWRZDUGWKHORDQ¶VVHFXULW\
because they are considered too difficult to value.  The barrier to patent-backed debt finance 
created by banking capital adequacy requirements will be discussed in section 3.8. 
 The amount of funding Quanlin secured against its IP portfolio signals the substantial 
support for patent-backed debt finance initiatives in the PRC.  Empirical research has shown 
that the increase in government subsidies, equity capital and bank loans have all helped to 
improve the capacity for self-driven innovation in Chinese enterprises.81   
 
1.2.7 Malaysia Debt Ventures Bhd (MDV) IP Financing Scheme (IPFS) 
 This RM200 million82 IPFS was introduced by the Malaysian government in 2013 to 
assist the tech sector.  The scheme has since disbursed RM40 million in loans to 11 
companies and there are reportedly 19 new applications worth RM70.8 million, 6 of which 
are in the final evaluation stage.  The applicants, most of whom emanate from the ICT83 
sector, are qualified to enjoy the 2% government rebate and 50% government guarantee 
administered by Credit Guarantee Corp Malaysia BhD.  The loan term is 5 years (including a 
grace period of up to 12 months) carrying an interest rate of between 7.5% and 9.5%.  MDV 
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 µ%DVHO,,,$JOREDOUHJXODWRU\IUDPHZRUNIRUPRUHUHVLOLHQWEDQNVDQGEDQNLQJV\VWHPV¶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allocates a margin of 80% of the value of the IP (if the IP is valued at RM10 million then the 
amount advanced can be up to RM8 million).  Although all forms of IP are accepted as 
security, trade marks and patents are preferred.  However, MDV generally requires a 
corporate guarantee and takes a debenture84 RYHUWKHFRPSDQ\¶VRWKHUDVVHWV85   
 In summary, patent-backed debt finance has arrived in Asia and lenders in the UK and 
around the world should sit up and take notice.  Although beyond the scope of this thesis due 
to the language barrier and lack of publicly available English translation of key documents, 
SinJDSRUHWKH35&DQG0DOD\VLD¶Vprogress with patent-backed debt finance should be 
carefully studied by the UKIPO and other government policymakers.  The high level of 
public funds to support IP finance stands in marked contrast to the position in the UK and 
other patent-intensive developed nations.    
 
1.2.7 The US Patent Quality Initiative (PQI) 86 
 The US is an important global player that is also steadily advancing the IP finance 
agenda.  In October 2014 the Clearing House,87 a US banking industry group representing 
more than 20 US and international financial institutions, formed the PQI, a project aimed at 
eliminating inferior patents through better prior art searching, research and filing thereby 
enhancing the quality of patents used as security.88  According to Lloyd, the initiative reflects 
the increased sophistication of financial institutions with respect to patents, as lenders begin 
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to realise the value of their own e-commerce patent portfolios and create internal IP teams to 
more effectively manage their patent strategies.89  
 
1.3  State of the field and deficits in the current research and literature 
 Academic studies from several domains, for example accounting, economics, finance 
and law have extensively documented how patents are increasingly prominent in commerce.  
Patents no longer play solely the role of legal instrument, but also act as a valuable 
commercial tool.  The increase in the number of patents filed worldwide over the last two 
decades and the growth of the markets for these assets has convincingly confirmed this 
trend.90  While there are volumes of material concerning patent law, patent litigation, 
increasingly significant publications relating to patents and economics (Italy and Germany); 
non-practising entities (NPEs) and the patent transactions market, there remains a significant 
deficit in the current research and literature related to patent-backed lending, intangibles, 
innovation financing and corporate disclosure of IP.  There is little widespread understanding 
of the patent-backed debt finance transaction from the standpoiQWRIOHQGHUV¶FRQFHUQV
regarding uncertainty, risk and liquidity.  Nor is there detailed literature available as to how 
to facilitate patent-backed debt finance transactions from a commercial perspective, given the 
multidisciplinary actors involved.  There is little grasp (especially for actors outside the inner 
circles) of the difficulties arising at the initial decision-making stage when the lender 
DSSUDLVHVWKHLQQRYDWLQJ60(¶VORDQDSSOLFDWLRQ and evaluates the patent portfolio, especially 
the paucity of relevant, reliable and accurate information about the value of patent assets and 
strategy.  This is largely due to the fact neither common principles nor best practice in 
corporate IP disclosure have emerged.  How these limiting factors should be addressed to 
LPSURYHSDWHQWRZQHUV¶DFFHVVWRGHEWILQDQFHLVGLVFXVVHGLQ Chapters 4-8.  Nevertheless, a 
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commercial lending methodology based on the estimated present and potential value of the 
patent assets, which requires analysis of non-financial qualitative patent indicators, has begun 
to develop in the UK.  A small group of lenders, the Clydesdale Bank,91 Santander92, and the 
UK branch of the Silicon Valley Bank are expanding the market for patent-backed finance.93   
 Academic and industry literature, Internet and desk research have been used as 
background; however, very few documents focus on patent-backed debt finance per se.    
There is little literature from the viewpoint of the lender (a major actor and stakeholder in the 
patent-backed finance transaction) or concerning corporate narrative reporting of IP.  This 
thesis canvasses the literature concerning patent-backed debt finance specifically (as opposed 
to intangibles and innovation financing generally which includes other IPR e.g. copyright and 
trade marks) and corporate narrative disclosure of patent assets.    
 The literature available on the subject of IP, secured transactions and debt finance 
began to appear in the 1980s, published by members of the legal profession and researchers 
from a variety of industrialised countries, notably Canada$QHDUO\ZRUNLV0F/DUHQ¶V
Secured Transactions in Personal Property relating to Canadian law.94  At McGill 
University, Allsebrook and Maestre published an article entitled Intellectual Property as a 
Security Device.95  In 1997 Norman Siebrasse published a working paper for the World Bank 
entitled, A Review of Secured Lending Theory.96  In 2002 Canadian legal practitioner, 
Howard Knopf,  published a seminal monograph entitled, Security Interests in Intellectual 
Property.97  In 2004, the Law Commission of Canada published its report Leveraging 
Knowledge Assets Reducing Uncertainty for Security Interests in Intellectual Property.98  In 
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2006, K. Hatzikiriakos narrowed the focus to copyright and software with her monograph, 
Secured Transactions in Intellectual Property: Software as Collateral which also included a 
Canadian-US comparative law approach.99  Meanwhile, in 2000 Australian Professor 
Jacqueline Lipton published Security Over Intangible Property which included a chapter with 
an overview of the issues arising when using patents as security. 100  These early works in the 
field are a valuable contribution to the subject of IP finance as they begin to provide a 
common theoretical framework.  However, they only briefly touch on patent-backed debt 
finance, nor are they studied from a UK jurisdictional perspective.   
 In the US several publications became bestsellers in the American business 
community and captured worldwide attention7KHVHLQFOXGHG5LYHWWHDQG.OLQH¶V
Rembrandts in the Attic: Unlocking the Hidden Value of Patents (2000)101 which addressed 
the corporate challenge of how to strategically use patents as business assets. In 2001 Baruch 
/HY¶VIntangibles Management, Measurement, and Reporting102 was followed by Einstein in 
the Boardroom: Moving beyond Intellectual Capital to I-stuff .103  The former advances the 
literature in three dimensions relevant to this thesis:  the economics of intangibles; the 
empirical record of intangibles; and the harms arising from the lack of information regarding 
in intangibles.   
 In Europe, Italian research into IP finance began to emerge with some profundity.  
Elisa Ughetto¶VFKDSWHUHQWLWOHG ³The Financing of Innovative Activities by Banking 
Institutions: Policy Issues and Regulatory Options´ in Powerful Finance and Innovation 
Trends in a High-Risk Economy articulates the European OHQGHU¶Vperspective.104  In 2011, 
Munari, Odasso and Toschi co-authored a chapter on patent-backed finance from an 
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economics perspective, using case studies involving multinational pharmaceutical 
companies.105  This work inspired the GlaxoSmithKline (GSK) case study in Chapter 6 with 
respect to corporate disclosure.  The Munari et al research is relevant, although written from 
and economic theory of finance perspective focusing on large powerful borrowers, as 
opposed to innovating SMEs, as in this thesis.     
 In 2014, the Final Report from the Expert Group on Intellectual Property Valuation 
(IP Valuation Report) published.106  The European Commission appointed multi-disciplinary 
panel of experts to consider how IP valuation plays a part in innovation policy and where 
bottlenecks occur.  This report investigated European best practice in IP valuation as 
performed by financial institutions that provide capital to SMEs, including examples relating 
to debt-financing.  The panel noted a significant difference in the approach to lending to 
SMEs compared with large companies with a strong trading history and further, financial 
institutions interviewed expressed the view that IP is usually too risky to be used as security 
for traditional commercial loans.107  The Final Report explored the inadequacy of IAS38 
intangibles aQGUHFRPPHQGHGWKHILOLQJRID³PDQDJHPHQWUHSRUW´ WRJHWKHUZLWKDFRPSDQ\¶V
annual report, giving detailed information about IP value in order to improve publicly 
available information on intangibles generally.108  This thesis further develops the Expert 
*URXS¶VUHVHDUFKthrough the creation of a narrative patent information and strategy 
disclosure model in Chapter 7.   
 In the UK, the academic literature is quite limited but of high quality beginning with 
%H]DQW¶Vµ7KH8VHRI,3IRU6HFXULW\LQ'HEW)LQDQFH¶ in 1997,109 followed by Davies article 
µ6HFXUHG)LQDQFLQJRI,QWHOOHFWXDO3URSHUW\$VVHWVDQGWKH5HIRUPRI(QJOLVK3HUVonal 
3URSHUW\6HFXULW\/DZ¶LQ which examines the commodification and valuation of 
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IPR.110  'U-RDQQD3HUNLQV¶111 article µ5HJLVWUDWLRQRI&KDUJHVRYHU,QWDQJLEOHV8.¶112 is 
narrowly focused on advising legislators of registration regimes applicable to financial 
intangibles on the impact of certain European measures.  In 2010, Dr Andrea Tosato,113 at the 
University of Nottingham, published an influential article entitled µ6Hcurity Interests over 
,QWHOOHFWXDO3URSHUW\¶114 which adopts a broader approach than the former, dealing with 
specific legal issues associated with security devices, registration and priority within the UK 
legal framework.  
 Turning to the scant interdisciplinary literature on the subject of IP and accounting, 
legal scholar and economist, Dr Roya Ghafele115 studied how the highly formalised language 
of accounting deals with the concept of intangibles.  In µ$FFRXQWLQJIRU,3"¶116 she notes that 
accounting processes and terminology document past performance rather than expectations of 
the future resulting in accounting statements inadequately reflect how IP relates to business 
performance.  This suggests that inadequate information negatively impacts on WKHOHQGHU¶V 
ability to accurately DVVHVVDERUURZHU¶V creditworthiness in patent-backed transactions.  Dr 
*KDIHOH¶VZRUNLVDVSULQJERDUGIRUWKHGHYHORSPHQWRIWKHWKLQNLQJLQWKLVWKHVLVZKLFK
argues that law, rather than accounting, should take the leDGWRHQVXUHD³WUXHDQGIDLU´ view 
of patent assets and to overcome the invisibility of those assets in the traditional financial 
accounting statements.  Dr Ghafele participated in the Panel of Experts that produced the 
2014 IP Valuation Report.117 
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 Finally, the UKIPO commissioned the comprehensive Banking on IP?  Report118 
published in late 2013 which catalogued the challenges facing IP-backed debt financing, 
making recommendations as to how these obstacles might be surmounted.  The report 
broadly discusses SMEs, IP awareness, IP value and accounting rules, UK debt and equity 
ILQDQFHDQGSROLF\LQLWLDWLYHV&O\GHVGDOH%DQN¶V*URZWK)XQGOLTXLGLW\DQGrecording 
security interests.  The key findings for the purpose of this thesis are (1) IP and intangibles 
must be identified during the financing process; (2)  IP value needs to be taken into account; 
and (3) lenders need additional guidance by way of legal templates and a resource toolkit.119  
The authors state: 
 
 «,I,3DQGLQWDQJLEOHVDUHWREHJLYHQDQ\consideration within credit decision-
making, tools to identify and describe the actual assets (not merely evidence of 
expenditure) need to be embedded within the lending process.  Businesses must use 
them, and lenders must understand and take note of them.  This step will have the 
wider benefit of boosting IP awareness amongst the business community as a whole 
and will establish base data for thHSRVVLEOHIXWXUHXVHRI,3DV³IXOO´ security.  The 
first steps are to provide a means for companies to identify the assets they own and to 
build information on IP and intangibles into the templates companies use when 
present information to prospective funders.120   
  
 Following publication of Banking on IP?, the UKIPO convened a series of roundtable 
discussions with a multi-disciplinary group comprising representatives from the financial 
services sector, including banks, equity investors and insurers, from the business advisory 
community, including the IP profession, lawyers, accountants and general commercial 
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advisers, and from a number of SMEs.  In March 2014, the UKIPO published Banking on IP: 
An Active Response confirming that, µHDUO\DFWLRQPXVWIRFXVRQUDLVLQJDZDUHQHVVDQG
stimulating an appetite for change within both business and the financial services 
FRPPXQLW\¶121  The UKIPO intends to develop a series of real life case studies showing how 
a business has, through their IP management, secured finance and is working with the British 
%DQNHUV¶$VVRFLDWLon (BBA) and its Business Finance Roundtable to create an awareness 
campaign.122  The UK is pressing ahead with its IP finance agenda.  
 The leading professional publication in the field is Intellectual Asset Management 
(IAM) launched in 2003 edited by Joff Wild.  IAM and its associated blog123 address the need 
for organizations to maximize the IP value and examine the strategies they can put in place to 
do this.  IAM states that it is unique because it treats IP as a business asset and tool rather 
than simply a legal right.124  
 For the most part, until 2013-2014, the international and UK literature adopted a 
traditional legal analysis approach, critically analysing the relevant legislative instruments 
and case law.  The literature did not obviously address or assume a multidisciplinary 
approach from either the OHQGHUV¶RUFRUSRUDWHUHJXODWRUs¶ perspective.  Recent exceptions to 
this are the Banking on IP? and the IP Valuation reports.  While both adopt a 
multidisciplinary approach, only the latter directly addresses corporate narrative reporting, 
but not corporate governance or regulatory issues.  Accordingly, there is embryonic scholarly 
research and professional interest in relation to IP finance.  However, this thesis takes the 
view that as a matter of modern corporate governance, it is timely to introduce company law 
and corporate ODZUHJXODWRUVLQWKHGHEDWHH[DPLQLQJFRPSDQ\GLUHFWRUV¶VWHZDUGVKLSDQG
existing legal obligations to deal with intangible IP assets in their corporate reporting.  
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1.4 Research concept and methodology 
 This thesis focusses on maximizing the use of patents as security for lending 
concentrating on the credit appraisal stage of the secured loan transaction.  This type of 
research involves tackling an old problem from a multidisciplinary problem-solving 
perspective, which is necessary given the need to align the legal and finance environments to 
commercial reality.  The starting point is defining the real-world problems faced by lenders.  
Figure 1 illustrates the interplay of the academic disciplines in the patent-backed finance 
transaction.   
 
Figure 1  The patent asset as a tool to secure finance and the interplay of the academic disciplines 
 
 
 
 The methodology is mainly doctrinal involving traditional-style legal and business 
research into relevant primary sources for each discipline (patent law, accounting and 
company law); and partly qualitative involving examination of the relevant literature. Given 
the multidisciplinary subject matter, a variety of methodologies are used to identify and 
explore the various barriers to patent-backed debt finance.  Chapter 2 uses Dµ3ROLWLFDO
(FRQRPLF6RFLDO7HFKQRORJLFDODQG/HJDO¶(PESTL) analysis125 to provide an overview of 
and evaluate the different macro-environment factors that collectively impact on borrowers 
                                                 
125
 Aguilar, F. Scanning the Business Environment (1967) Macmillan, USA 
36 
 
and lenders contemplating a patent-backed lending transaction.  This framework is commonly 
used in a business context but is uniquely and originally applied to the patent ecosystem.  In 
Chapter 3 the methodology includes an RULJLQDOTXDQWLWDWLYHDQDO\VLVRI:,32¶VIP 
Advantage database as well as a traditional legal analysis approach to banking capital 
adequacy regulation and the registration of patents as security.  Chapter 4 adopts a traditional 
legal research methodology evaluating accounting rules, corporate legislation and case law.  
Chapter 5 involves a comparative functional analysis of narrative corporate IP asset 
disclosure using the US, Canada, Denmark and Germany as comparators, describing the 
conceptual frameworks and evaluating key principles. Chapter 6 considers company 
corporate narrative patent disclosure in practice, adopting a case study methodology which, 
according to Robson, is a strategy for doing research involving an investigation of a 
particular contemporary phenomenon in its real-life context.126  Actual corporate patent 
information narrative disclosures are hermeneutically interpreted and evaluated.  Chapters 5 
and 6 provide the basis for the development of the proposed new model for patent 
information and strategy disclosure in Chapter 7.   
 
1.4.1 Research questions  
 As the research progressed it was clear that a variety of reforms was needed to 
facilitate patent-backed debt finance and the best place to begin the study was at the early 
steps of inquiry taken by the lender during the credit appraisal stage where valuing the patent 
assets is critical.  The main research question was ³+RZVKRXOGDQLQQRYDWLQJ60(
overcome the astonishing lack of relevant, useful and reliable information regarding its patent 
assets and strategy for generating value from those assets to enhance access to patent-backed 
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GHEWILQDQFH"´Answering this question would open up an awareness of the finance potential 
of patents by lenders.  Sub-research questions include: 
 
x What environment do innovating SMEs seeking to borrow to finance their inventions 
and business presently face?  Although concentrating on the UK, the thesis is not 
geographically limited in its perspective and draws on multidisciplinary developments 
in other countries with patent-backed lending experience.   
x What PESTL factors indirectly affect patent-backed debt finance transactions?    
x Are lenders interested in financing innovation and is the current commercial lending  
system conducive for doing so?    
x How could debt finance feature at an earlier stage in innovation business life cycle?   
x Why is IAS 38 Intangibles ill-equipped to document the value of patents?   
x Is additional corporate narrative disclosure the proper way forward from a legal 
standpoint to show that the financial value attributed to internally develops patent 
DVVHWVLV³WUXHDQGIDLU´?   
x How should additional narrative corporate disclosure of patent information and 
strategies be presented to order to giYHD³WUXHDQGIDLU´ view of the future value 
creating potential of the patent assets?    
x What is the role of company law and corporate governance in this respect? 
x How does a global company with access to the best advice present its patent 
information and strategy in its company annual return? 
x Is the Intellectual Capital Statement (ICS), mandated in Denmark, an appropriate 
form of disclosure?  Or should disclosure be by way of a management report, a 
growth report or a strategic report?  
38 
 
x Should the disclosure be voluntary or mandatory under the CA 2006 with respect to 
innovating SMEs? 
x How should commercial lenders design their patent-backed debt lending policy?  
x What UK policy reforms are needed to facilitate patent-backed debt finance?   
x What international developments are taking place that may inform UK policy? 
 
 The research to answer these questions began with a deductive approach of the   
existing multidisciplinary literature including new materials published in 2015, refereed 
journal articles, practitioner articles, blogs, legal and business news.  The author focused 
primarily on a legal and commercial analysis of patent-backed debt finance comprising 
reports, articles, books, opinions and legal writing, government information and website 
content.  The multiplicity of materials used reflects the complex nature of the issues and 
considerations involved in the process of resolving multidisciplinary issues.  The materials 
were examined in a critical manner anGWKHDQDO\VLVIROORZHGERWKD³ZKDWLVWhe current 
SUDFWLFH´DSSURDFKDQG³what tKHODZDQGSUDFWLFHRXJKWWREH´ approach.  The final objective 
was to conceptualise a model for SME corporate patent information and strategy disclosure to 
simplify and provide an abstraction of a complex and diverse sphere of activity.  The model, 
along with other aspects of the research, is presented using visuals.  The use of visualisation 
in law is increasing as a means to present complex ideas simply. The analysis follows a 
logical design with issues divided into three main areas by:   
 
(1) identifying the source of the uncertainty (traditional accounting principles and lack of 
 corporate narrative reports by SMEs);  
(2)  reducing uncertainty through additional narrative corporate disclosure and 
 determining the nature and format for such additional disclosure; and 
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 (3)  making policy recommendations with respect to commercial lenders, government and 
 stakeholders to facilitate innovative SME access to patent-backed debt finance.      
 
 While the analysis begins with the UK patent-backed debt finance landscape as 
formed presently, it moves beyond the present situation to achieve a plan for greater 
coherence of patent, accounting and corporate governance issues.  The principles 
underpinning the narrative corporate disclosure solution will potentially have impact in 
jurisdictions beyond the UK and may apply to other forms of IP.   
 
1.4.2 Scope and limitations: what the research does not do / does not cover  
 The thesis does not cover patent-backed securitisation (an American term), namely, 
the conversion of assets, cash flow or royalty streams into marketable securities (shares).  
This is not borrowing as such, since the entity securitising its assets is not borrowing money, 
rather it is selling interests in its future royalty stream or cash flow (a form of equity finance). 
Nor do we study patent aggregating (except in relation to these entities/actors as 
intermediaries to promote liquidity).  Patent aggregators buy patents and are sometimes 
known as patent holding companies or patent intermediaries.  They are not usually practising 
entities involved in R&D to patent inventions, generate products or processes.  This thesis is 
not concerned with lending to patent aggregators, rather it focuses on lending to innovating 
SME R&D intensive operating companies that actively develop innovations for the market.  
However, one of the benefits of patent aggregators is that they operate as intermediaries in 
the unregulated patent market.  Small inventors who find it difficult to finance their 
invention, or who lack the funds to defend their patent, may be tempted to sell to a patent 
aggregator.  This financially benefits the inventor and some argue that such intermediate 
transactions indirectly promote innovation.  Research into the creation of regulated patent 
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markets or patent auctions, needed to promote patent asset liquidity, are also not covered 
except in passing in connection with accounting concepts in Chapter 4.  The research was 
limited by language barriers and developments in countries in few English language 
documents could not be pursued.   
1.4.3 Thesis structure: flow of the thesis 
  
 This thesis focuses on patents and is structured as follows: 
 
 
Figure 2   Focus and scope of the thesis 
 
Intangible Assets Patents Copyright Trademarks Other forms of IP 
Financing Sources Private Finance  Public Finance  
Perspectives Borrower 
x Savings 
x Family, friends 
x Private Equity 
x Loans 
Lender 
x Uncertainty 
x Risk 
x Risk tolerance 
 
Government 
x Policy 
x Support via 
awareness 
raising and 
education 
x Corporate 
governance 
regulation 
 
Company Size SMEs SMEs   
Geographical 
Focus 
UK 
 
Europe 
Denmark, Germany  
US Singapore, PRC, 
Malaysia,   
Hong Kong  
 
 
1.5 Originality 
 
 The research is original in the following respects.   Chapter 2 makes an original 
contribution to knowledge in several respects.  First, the concept of applying a PESTL 
analysis127 approach to identify and evaluate the barriers to patent-backed debt finance in 
patent ecosystem as a whole.  Second, the author introduced a behavioural finance analysis to 
the social factors affecting innovating SMEs inventors aQGOHQGHUVWRHQKDQFHOHQGHUV¶³WUXVW´ 
in patents as asset class.  Third, the author identifies how the well-established Technology 
Readiness Level (TRL) system128 could be used (see the new Model presented in Chapter 7).  
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 In Chapter 3 an original quantitative analysis oI:,32¶V,3$GYantage database is 
carried out.    
 Chapter 4 legally analyses whether the application of IAS 38 Intangibles as applied to 
internally generated SDWHQWSURYLGHVD³WUXHDQGIDLU´ view as required by s393(1) CA 2006  
from a corporate governance perspective and considers whether there is scope to depart from 
the standard if its application would result in untrue or unfair financial information.   
 This research fills a gap in the field as it examines the unintended impact of company 
law regulations on innovating SME access to patent-debt finance.  Chapters 4 and 5 identify 
that the accounting for intangibles problem is exacerbated by the fact that SMEs are exempt 
IURPWKHUHTXLUHPHQWWRSUHVHQWDGLUHFWRUV¶VWUDWHJLFUHYLHZLQWKHLUDQQXDOFRPSDQ\UHWXUQ
(in order to reduce the burden of corporate regulatory compliance for SMEs).  This 
astonishing lack of SME patent information available to lenders may itself restrict SME 
access to debt capital because lenders are unaware of, and lack understanding of the potential 
YDOXHRIWKH60(¶VSDWHQWDVVHWEDVHDQGFRPPHUFLDOLVDWLRQstrategy.  This research suggests 
that what is needed is a better understanding of the intersection between accounting for 
intangibles, corporate governance, company law corporate disclosure requirements and credit 
appraisal with respect to innovating SMEs.  Disclosure made within the legal framework of 
the CA 2006 increases legitimacy and authority of the information disclosed.   
 The key claim of this thesis, expanded in Chapters 4 ± 7, is that narrative corporate 
reporting in the Strategic Report section RID8.60(¶VDQQXDOUHWXUQRI³WUXHDQGIDLU´ 
patent information and strategy would support iQQRYDWLQJ60(VWRRYHUFRPHWKH³RIIEDODQFH
VKHHW´ valuation problem.  The policy aim of increased disclosure by innovating SMEs is to 
facilitate more positive patent debt finance decisions being made by commercial lenders.   
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 Chapters 5 - 7 also explore whether patent information and strategy disclosure by 
innovating SMEs should be mandatory or voluntary.  This corporate governance issue has 
never been fully explored with respect to qualitative patent information in any of the 
innovation or IP finance literature.  An original contribution to knowledge may be achieved 
by a comparative study of law.  The issue under consideration is how to construct a better 
framework of legal measures for narrative corporate reporting of patent assets.  Studies of the 
US, Danish and German of corporate narrative reporting of IC and IP have import for the UK 
jurisdiction.  A comparative functionality study is relevant here because functionalism is an 
orientation towards the practical application of aspects of the law.129 
 In terms of the format for disclosure, an original contribution in Chapter 7 is the 
creation of the Essential, Desirable or Optional disclosure model for qualitative non-financial 
patent information, designed to fit within the existing UK corporate reporting regime. This 
involved the novel use of organising qualitative patent indicators that, it is suggested, should 
form the basis for the content and structure of corporate narrative patent information and 
strategy disclosure.  Thus it will offer an insight into normative possibilities for narrative 
corporate disclosure, which if adopted by innovating SMEs, can be used by commercial 
lenders to make better informed decisions. 
 
1.5.1 Multi-disciplinary approach  
 This research is multidisciplinary legal scholarship in a UK context that further 
develops and advances the findings of recent academic and professional IP finance 
publications through a detailed analysis of corporate governance and corporate reporting law.  
This research makes new government policy recommendations to enhance innovating SME 
access to patent-backed debt finance, that advance various recommendations made in earlier 
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reports.  It also considers, in more depth, how lenders should progress their patent-backed 
commercial lending policy (Chapter 8).   
 
1.6 Importance of the topic and the future 
    In summary, according to Edwards, a confluence of factors has combined to set the 
stage for the need to develop access to patent-backed debt finance:   
 
x the increase in technological innovation and the ensuing growth in patents; 
x an environment of restricted capital markets especially in the venture capital and 
private equity arenas; and 
x the growing realisation that patents represent strategic advantage that when viewed as 
financial assets that can greatly impact market value.130 
 
 Moving into the future, patent-backed debt finance will become important as patent 
assets are a relatively untapped source of value and security while tangible personal and 
business assets, such as buildings and land, continue to decline within the UK SME 
community.  As such, it less likely that SME company directors will have sufficient tangible 
assets over which to give the loan guarantees required by lenders.  Lenders who recognise 
and act to benefit from the enormous security potential in patent assets ZLOOKDYH³ILUVW
PRYHU´ advantage in the market.  This thesis calls for the growth, development and 
maximisation of the use of patents as security for lending and involves analysing a variety of 
issues, regulations and approaches, ranging across several disciplines since the problems 
relating to patent-backed debt finDQFHDUHUDWKHU³PHVV\´ and not soluble within the confines 
of the discipline of law.  The main difficulty is how to adapt to the unique dynamic of legally 
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 Edwards, D. Patent-backed securitization: A Blueprint for a New Asset Class, Gerling NCM 
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created, intangible patent monopoly rights.  This thesis argues WKDWOHQGHUV¶ULVNWROHUDQFHLQ
relation to patent assets would be improved by supplementing the traditional financial 
statements with additional relevant and reliable information via the FRPSDQ\¶VStrategic 
Report and that such qualitative disclosure is increasingly a corporate governance issue.  The 
OLWHUDWXUHVXJJHVWVWKDWWKHUHLVDVWURQJSRVLWLYHDVVRFLDWLRQEHWZHHQWKHH[WHQWRIDFRXQWU\¶V
financial development and its growth rate, and that the direction of causation runs from 
finance to growth rather than the reverse.131  In other words, this thesis identifies the concept 
RI³FUHGLWHQKDQFHPHQW´ where the lender will be reassured by company law taking the lead 
to ensure a stable, effective and efficient patent ecosystem.  This thesis comprises 8 chapters.    
 
 Chapter 2 THE PATENT-BACKED FINANCE ECOSYSTEM uses a PESTL 
analysis methodology to set out the current environment in which patents operate in the UK 
and internationally.   
 Chapter 3 FINANCE AND INNOVATING SMEs confirms why debt finance remains 
a critical funding mechanism compared with other finance options with pilot study drawing 
on :,32¶VIP Advantage database.  The focus then turns to the impact of banking capital 
DGHTXDF\UHTXLUHPHQWVIRULQWDQJLEOHVWKHOHQGHUV¶WULDGRIFRQFHUQVXQFHUWDLQW\ULVNDQG
liquidity; and the system for registering security interests in patents.  
 Chapter 4 TRUE AND FAIR PATENT VALUATION: A CORPORATE 
GOVERNANCE ISSUE examines the uncertainties involved when measuring the patent 
value.  This is not a legal problem, nor is it a patent law problem ± this is an accounting 
discipline problem.  The legal status of IAS 38 intangibles is analysed to determine whether 
LWVDSSOLFDWLRQSURYLGHVD³WUXHDQGIDLU´ view of patent assets in financial statements.    
                                                 
131
 Beck, T., Demirguc-.XQW$DQG/HYLQH5µ/HJDO7KHRULHVRI)LQDQFLDO'HYHORSPHQW¶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 Chapter 5 THE NEED FOR INCREASED VOLUNTARY CORPORATE PATENT 
ASSET DISCLOSURE BY INNOVATING SMEs examines the lack of publicly available 
financial and corporate narrative information concerning an innovating UK SME patent 
assets.  The benefits accruing to entities that disclose additional qualitative information 
concerning their patents in corporate reports is discussed leading to an investigation of the 
viability making supplementary disclosure using the 6WUDWHJLF5HSRUWLQDFRPSDQ\¶VDQQXDO
return.  We investigate whether the ICS, mandated in certain jurisdictions and encouraged by 
certain banks in Hong Kong, is appropriate for innovating UK SMEs.   
 Chapter 6 THE DISCLOSURE OF PATENT INFORMATION IN UK CORPORATE 
NARRATIVE REPORTING introduces the views of the Financial Reporting Council (FRC) 
followed by exaPSOHVRITXDOLWDWLYHQDUUDWLYH³patenWGLVFORVXUHV´ made by pharma company 
GSK in its 2012 annual report.  
 Chapter 7 A MODEL FOR VOLUNTARY CORPORATE NARRATIVE PATENT 
INFORMATION AND STRATEGY DISCLOSURE draws on the literature and findings in 
Chapter 6 to present an original Essential, Desirable and Option Patent Information and 
Strategy Disclosure Model.  Potential criticism of enhanced patent disclosure is also 
discussed.   
 Chapter 8 FACILITATING PATENT-BACKED LENDING DECISIONS IN THE 
UK:  CONCLUSIONS AND RECOMMENDATIONS considers first how innovating SMEs 
could enhance their access to patent-backed debt finance, secondly how banks could develop 
their patent-backed lending policies and thirdly, the role of the government as policy co-
ordinator in this multidisciplinary field, culminating with WKHDXWKRU¶VFRQFOXVLRQVDQG
recommendations.   
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2 The patent-backed finance ecosystem 
 
 The patent system introduces some of the greatest complexities in the capitalist  
                rules of the game and leads to many anomalies.   
 
          J. Robinson, 
             The Accumulation of Capital, 1956 
 
 The patent ecosystem is the subject of this chapter and a broad overview of the 
environment in which patent-backed lending operates is presented.  This serves as a 
theoretical framework, adopting a multidisciplinary approach to examine specific factors that 
affect the extent to which commercial banks are willing to engage in patent-backed lending to 
innovating SMEs.  An effective patent granting and enforcement system is vital.  Our 
evaluation enables us to conclude that the UK patent ecosystem is sufficiently equipped and 
well-developed to facilitate this finance method.  Section 2.1 explores the strategic 
commercial reasons for patenting inventions.  Section 2.2 introduces the Political, Economic, 
Social, Technological and Legal (PESTL) analysis132 to give an overview of the external 
macro-environment factors that collectively impact on borrowers and lenders.  Section 2.3 
evaluates the political factors affect UK patent policy.  Section 2.4 studies economic factors 
that affect innovating SME access to finance.  Section 2.5 adopts a behavioural finance133 
approach to critically analyse social factors influencing inventors and lenders.  Section 2.6 
considers emerging technologies, patent backlogs, Horizon 2020: The EU International 
Strategy for Research and Innovation and Technology Readiness Levels (TRL).  In section 
2.7 conclusions gleaned from the PESTL analysis support policy design to enhance access to 
patent-backed debt finance addressing forecasted changes to the patent ecosystem.  
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2.1 Why innovating SMEs patent 
 
 Patent rights protect new, industrially applicable inventions and give the inventor or 
SURSULHWRUµWKHSDWHQWHH¶DOHJDOO\UHFRJQLVHGPRQRSRO\WRZRUNWKHLQYHQWLRQIRUDSHULRG
of up to 20 years.134  A UK patent is governed by national laws, and also by international 
treaties, when those treaties have been given effect in UK domestic law, providing exclusive 
rights only in the UK and not in any other country.  Patents are legal instruments intended to 
encourage innovation by providing a limited monopoly to the inventor (or their assignee) in 
return for the disclosure of the invention.  Publication of the invention is mandatory in order 
to be awarded a patent.135  The patent law system recognises that innovation and 
WHFKQRORJLFDOGHYHORSPHQWVERWKFUXFLDOWRROVIRUDFRXQWU\¶VILQDQFLDODQGVRFLDOZHDOWK
cannot be motivated solely by market competition.  In Chapter 1 we saw that IP and patents 
in particular, are increasingly reshaping the landscape of modern business.  A key 
commercial advantage of a patent monopoly is that it can prevent unauthorised third parties 
from using the invention for a limited period.  While under monopoly protection, the Patent 
Act 1977 provides that only the patentee is lawfully allowed to commercially exploit the 
invention.136  The scope of that right in any particular case is determined by the claims in the 
patent specification.137  Further, there is strong evidence pointing to a positive association 
between patenting and measures of firm performance.138  Patenting is correlated with superior 
performance, as LQGLFDWHGE\DILUP¶VVDOHVRIinnovative products and growth in 
employment.139  Firms with innovations that are new to the market are considerably more 
                                                 
134
 Section 25(1) PA 1997 
135
 3KLOOLSV-µ7KH(QJOLVK3DWHQWDVD5HZDUGIRU,QYHQWLRQ7KH,PSRUWDQFHRIDQ,GHD¶Journal of 
Legal History 71 
136
 Section 60 PA 1977 
137
 Section 14 PA 1977 
138
 +DOO%+HOPHUV&5RJHUV0DQG9DQLD6µ7KHLPSRUWDQFHRUQRWRISDWHQWVWR8.ILUPV¶SDW 
http://niesr.ac.uk/sites/default/files/publications/dp410.pdf 
139
 Ibid p4 
48 
 
likely to patent.140  Further, innovating SMEs usually prefer patents over the cost and 
inconvenience of maintaining their inventions secret (although un-SDWHQWDEOH³NQRZKRZ´ 
may need to be kept confidential).  Typically, firms that apply for patents have undertaken a 
commercial analysis of the pros and cons of patenting and arrived at a considered conclusion 
that the benefits of obtaining a monopoly over their invention exceed the costs and that patent 
rights will provide stronger protection than keeping the invention confidential141 or defensive 
publication.142   Strong patents (certain validity) are preferred over weak patents (at risk of 
being invalidated).  However, even weak patents can be used anti-competitively and have 
their strategic uses which should be borne in mind.  In addition, firms patent their inventions 
because they wish to: (1) prevent others from copying or free-riding; (2) block other firms 
from competing; (3) use them in cross-licensing negotiations and raise licensing revenue; and 
(4) enhance their business reputation.143  These IP management strategies are important 
information for lenders to consider.144 
 
2.2 The PESTL model 
 
 An innovating SME on its own cannot make patent-backed finance more accessible, 
many factors will play a part.  By scanning the environment, we will have a better 
understanding of the positive and negative influences that impact on the development of 
patent-backed debt finance.  The PESTL framework is commonly used in a business context 
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and represents one of the vertebrae of the backbone of strategic analysis providing a broad 
overview of the factors that are beyond the control of both innovating SMEs and financiers 
(an external perspective) yet which play an important role in value creation and the potential 
for enhancing patent-backed lending in the UK.    
 
2.3 Political factors that impact on UK patent policy 
 
 Over the past two decades, the patent system has experienced significant changes 
ZRUOGZLGH&RQVHTXHQWO\WKH8.¶VSDWHQWLQJEHKDYLRUDQGOHJLVODWLRQDUHSURPLQHQWSXEOLF
policy themes.  Analysis of the political environment will focus on patent law regime policy 
as it relates to innovating SMEs.  The UKIPO145, an Executive Agency of the Department for 
Business, Innovation and Skills (BIS) is responsible for IP rights granting, formulating and 
delivering policy on patent topics.146  It has direct administrative responsibility for examining 
and issuing or rejecting patents, and maintaining the UK patent register.  Several reports are 
published annually, including a Patent Office Annual Report and Accounts147, a Corporate 
Plan and a Facts and Figures report.  The latter provides statistical data on annual trends for 
patents.  The UKIPO actively engages with BIS, supporting the wider BIS agenda.  It has 
been a key delivery partner in the BIS Knowledge and Innovation Group, and contributed 
GLUHFWO\WRWKH*RYHUQPHQW¶V Growth Agenda by improving the accessibility of the IP system 
to UK businesses at home and abroad.  
 In 2005, the Chancellor of the Exchequer commissioned Andrew Gowers to conduct 
an LQGHSHQGHQWUHYLHZLQWRWKH8.¶VIP framework known as the Hargreaves Review of IP 
and Growth published in May 2011.148  The Government expressly acknowledged that its 
decision to carry out the Review was in recognition of the growing important of IP and the 
                                                 
145
 http://www.ipo.gov.uk 
146
 The Patents Law Amendment Act 1852 established the first patent office in the UK on 1 October 1852.   
147
 The Annual Report is presented to Parliament pursuant to section 121 of the PA 1977.    
148
 Supra Hargreaves [11] pp18-19 
50 
 
challenges brought by the changing economic environment.149  The Review concluded that 
WKH8.¶V,3V\VWHPLVIXQGDPHQWDOO\VWURQJEXWPDGHUecommendations for enhancements 
and with respect to SMEs, recommended: 
 
 Better provision of IP information to UK businesses at home and abroad.  This will 
extend from greater information provided to firms on how to use IP strategically when 
they register at Companies House, through stronger support and better information via 
the Business Link network, to expert advice provided by UK Trade and Investment 
and the Patent Office for UK firms abroad.150   
 
 The Review made five recommendations relevant to this thesis.  Recommendation 22 
sought to maintain the high quality of patents awarded by increasing the use of section 21 PA 
1977 observations, thereby streamlining procedures and raising awareness.  This is positive in 
terms of patents as financial assets because high quality patents have less risk of invalidity 
and will be assessed as more valuable.  Recommendation 24 was for the UKIPO to develop 
stronger links with universities and other research institutions to ensure that IP examiners are 
aware of recent developments in technology, thus enhancing the examination process and 
therefore the quality of patents.  Recommendation 27 sought to improve SME business IP 
support by establishing formal collaboration between the UKIPO and Business Link151 and 
by conducting DSLORWUHSOLFDWLQJWKH)UHQFK³,3*HQHVLV´scheme. The latter offers a free IP 
audit to French SMEs who are not using the French IP system, especially the patent system.   
Recommendation 31 asked the Department for Trade and Industry (DTI) to consider whether 
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guidance for firms on intangible asset reporting could be improved, including the provision of 
model IP reports.  This recommendation did not specifically contemplate corporate narrative 
disclosure by SMEs (the subject of Chapters 5, 6 and 7 of this thesis) rather it was aimed at 
forming a working group to identify and promote best practice to maximise the use of 
effective financial support schemes nationwide.  Unfortunately, a relatively low proportion of 
*RZHUV¶recommendations were taken forward.  In February 2007 the UKIPO launched its 
Innovation Support Strategy to implement Recommendation 27.     
 In June 2007 the position of Minister of IP at BIS was creating making the UK the 
only country in Europe to have a dedicated Minister with an IP portfolio, though it is a junior 
ministerial role, showing the UK is a leading nation within global patent ecosystem.  For all 
practical purposes however, the impact of the Minister of IP has not been very visible to date.  
This is likely because since 2007 there have been 6 ministers and little continuity in policy 
implementation.152  Originally, the IP Minister was to take forward the implementation of the 
*RZHUV¶UHFRPPHQGations, however, the role does not hold responsibility for small business, 
enterprise and access to finance which is another minister¶VUHVSRQVLELOLW\.  There is a need 
for the IP Minister to play a more active role in coordinating policies relating to innovating 
SMEs, IP awareness raising, advice and innovation finance.   
 In 2008 the UKIPO appointed its first IP economist (the EPO appointed its first Chief 
Economist in 2004) and in 2009 developed a complementary work programme to build 
economic evidence for the development of IP policy.  This unit is important for quantifying 
and analysing IP-related data.153  This led to tKHQH[WHYHQWRQWKHJRYHUQPHQW¶VSROLF\
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agenda, namely, WRRYHUFRPHZHDNQHVVHVLQWKH8.¶V,3V\VWHPidentified in the Hargreaves 
Review focusing on recommendation 8 Enforcement of IP rights and the need to introduce a 
small claims track for low monetary value IP claims in the Patents County Court.154  This 
measure is in place and enhances IP enforceability for smaller firms via the new IP Enterprise 
Court (IPEC).155  Hargreaves Recommendation 9 Small Firm Access to IP Advice echoes the 
Gowers Review stating that: 
 
 The IPO should draw up plans to improve accessibility of the IP system to smaller 
companies who will benefit it.  This should involve access to lower cost providers of 
integrated IP legal and commercial advice.156     
 
 Other key issues currently being dealt with by the UKIPO include: 
(1) substantive patent law harmonisation;  
(2) patent backlogs;  
(3) the proposed EU (Community) Patent;  
(4) the reform of the Patent Convention Treaty (PCT) system;  
(5) computer-implemented inventions i.e. software patents;  
(6) collaboration with the EU to create a European Patent Court (EPC).     
   
 7KH8.¶VILUVWHYHU,3$WWDFKpZDVDSSRLQWHGLQWRZRUNLQBeijing, PRC as part 
RIWKH*RYHUQPHQW¶VSODQVWRXQORFk the growth potential of business abroad as and to assist 
with advice on IP enforcement. 157  This led to the creation of a network of IP Attachés to key 
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foreign markets including Brazil, India and South East Asia managed and funded by the 
UKIPO, supported by the Foreign & Commonwealth Office and UK Trade and 
Investment.158  The IP Attaché Evaluation Report concluded that while 85% of businesses 
state their IP assets are important, only 56% of businesses felt they had a comprehensive 
understanding of IP.159 
 In 2013 the UKIPO published its plans to help all SMEs maximise the value of their 
,3DVSDUWRIWKH%,6LQQRYDWLRQVWUDWHJ\VHWWLQJRXWWKH8.,32¶VHQJDJHPHQWZLWK60(V160    
The GOV.UK website offers basic advice regarding finance and investment for start-ups 
including equity finance and loans.161 $VDWWKH8.,32¶VVXLWHRIWRROVIRUEXVLQHVVHV
and their advisors to enhance awareness of IP assets and how they can be protect and 
exploited includes: 
 
x IP Basics ± a free guide on the different types of IP and how they can be used to add 
value to a business; 
x IP Equip ± a free interactive e-learning tool to help identify assets which may be 
protected by IP; 
x IP Health Checks ± a series of free basic diagnostics to allow business to identify 
potential risks and opportunities; and 
x IP Master Class ± a more in-depth training package, offered in online or in person 
which covers IP and its use in business, including the topic of IP enforcement.162  
x IP Tutor ± an IP awareness and education online package aimed at Universities.163 
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x IP Finance Toolkit ± a 44 page document published by Coller IP (who participated in 
the project).164   
 
 The IP Finance Toolkit is a significant step to advance the core topic of this thesis, 
patent-backed lending.  It was developed in response to the recommendations made in 
Banking on IP? Report and was achieved by the UKIPO forming a working group consisting 
of representatives from banks, IP professionals, business support networks and businesses. It 
is aimed at assisting lenders and businesses and is an excellent starting point for creating the 
dialogue needed to facilitate patent-backed lending.  It is recommended future developments: 
 
x provide more specific advice and templates to capture the different types of IP e.g. 
patents, trade marks and copyright;  
x include case studies to illustrate positive lending decisions (particularly to encourage 
lenders confidence in IP-backed lending); 
x highlight the availability of the free interactive online IP Health Check Tool which 
can be used in tandem with the IP Finance Toolkit to produce a confidential IP asset 
report; 
x indicate that SMEs may make a voluntary narrative report on their IP assets and 
strategy in the Strategic Report of their annual report to Companies House using the 
new disclosure model developed in Chapter 7.   
 
 In summary, pROLWLFDOIDFWRUVSOD\DNH\UROHLQVKDSLQJWKH8.,32¶VDFWLYLWLHVDQG
priorities in the public interest and influences the government national and international 
objectives and priorities.  The need to educate businesses, lenders and financial professionals 
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to increase awareness of the value of IP assets and support a constructive dialogue is ongoing, 
yet lacks visibility in terms of policy.  In conclusion, the government needs to demonstrate 
more effectively that its structures and ministerial appointees are coordinating policies in 
relation to innovating SMEs, IP, finance and in particular corporate regulation (to be 
discussed in the following chapters).  Next, we consider patent monopoly rights from an 
economic perspective.  
 
2.4 Economic approach to patents as a driver for innovation:  influence on lenders 
 and borrowers in patent-backed lending transactions 
 
 Everyone in the UK has an important stake in the modern market economy as it has 
the potential to continue to create prosperity and maintain a high standard of living.  From a 
21st century economic point of view, a patent is an instrument of competition165 that has 
grown in value in an increasingly knowledge-based economy.  Offering individuals the short-
term right to exclude others from practising an invention provides them with the opportunity 
to earn royalties or supra-normal profits which are higher than they would earn if there were 
immediate free entry into imitation of their invention.166  This is why the patent system is 
widely believed to stimulate inventive and economic activity.  For example, innovating SMEs 
try to use any new technological advance or invention as a way of boosting their profits.  
However, there are also weaknesses in the market system.  Both economic theory and 
practical experience have established many examples of where markets, free and unfettered, 
bring inefficiency.167  This is currently the problem plaguing undeveloped and underused 
patent-backed debt finance.  Where the distant future is concerned, or where rational 
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decision-making involves making a careful assessment of risk or where borrowers and 
lenders have asymmetric information (an imbalance in the quality and quantity of 
information) about the future potential economic value of patents, the transactions between 
them are distorted and lending transaction costs increase.168  Many market-oriented patent 
owners suffer frustrations as they attempt to educate the government, the judiciary and 
lenders as to the role their innovations should play to support the economy.  Defects in 
information regarding patent rights and patents as business assets are serious considerations 
for lenders, but they are also fairly tractable as shall be argued in the chapters that follow.  To 
date, the way most banks and lenders have dealt with patent assets as potential security has 
been to restrict access to borrowing as IP value is perceived as too uncertain to be covered by 
a reasonable risk premium; or charge higher interest rates.  However, if the information 
asymmetry problem could be improved, in terms of economic theory,169 this should have a 
SRVLWLYHLPSDFWRQOHQGHUV¶DYHUVion to patent-backed lending as illustrated in the Banking on 
IP Report (2013) which concluded: 
 
 The main obstacle is that IP is generally regarded as being too complex an asset class 
to finance within the constraints of normal lending margins, mainly due to the 
difficulties in understanding what it is, how it relates to cash, and were its value can 
be realised independently of a business.  However, this is a perception that is open to 
challenge, not least because these are the primary assets modern businesses own and 
use.170  
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 This thesis adopts the view that in most western democracies such as the UK, the 
market system has been most successful when it is supported by government regulation.171    
However, within the financial market system lenders are prone to behaviour akin to herd 
behaviour.172  &XUUHQWO\WKH³OHQGHUKHUG´ continues to ration lending against patents and 
other IP assets because they are not comfortable with those assets as security.  Group think173 
is a natural consequence of human social nature because we cannot predict the future.  
Predicting the future is of overwhelming importance to present decision-making, so people 
cling to what has worked in the past when attempting to forecast the future.  Lenders have 
developed a strategy for dealing with uncertainty by adopting the conventional view that 
patents as an asset class are not suitable as security for loans.  It is critically important to shift 
this type of thinking by lenders for two reasons.  First, because of the increasing amount of 
patent asset value that resides in firms.  Secondly, because access to finance enables inventors 
and innovating firms with ideas and inventions, technical ability and opportunity, but no cash 
- to invest profitably, using the money of others who do not have the ideas, inventions or 
technical abilities.  This mechanism ultimately leads to economic growth and better standards 
of living.  Consequently, it is vital to realign business lending from the industrial age to the 
modern age of the innovation economy.   
 Lenders should consider formulating lending strategy with respect to the business 
growth cycle of innovating SMEs.  Funding is an essential building block of economic 
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development, yet innovating SMEs find it challenging to secure loans from the retail banks 
using IP.  UK lenders should consider expanding their lending portfolios secured by 
traditional assets to include patent assets enabling them to diversify risk by spreading and 
minimising it.  This will help to safeguard their position by lowering lending risks in the long 
term as some portion of their lending portfolio will perform favourably during economic 
cycles. 174   
 Fortunately, lenders such as the Clydesdale Bank, Santander and the Silicon Valley 
Bank UK branch are not following the herd175  and are actively taking steps as early entrants 
in the intangibles lending market.  The talent of these lenders is to see what others do not, or 
to see it earlier.  They regard patent assets as an alternative asset category, affording the 
opportunity for greater diversification.  This is skill, not luck.  It is a skill that is honed via 
awareness of valuable patent assets, learning about them (education) and practising the skill 
of lending against patent assets to develop expertise in the field.176   
 Turning to the borrower, the first management decision an innovating SME has to 
make is whether to invest in patenting its invention.  This is an economic decision that 
depends on the impact investing resources in the patent will potentially have on profits.  
Further, according to the CA 2006, the board of directors now also have a statutory obligation 
to have regard to promoting the success of the company, which includes the likely 
consequences of any decision in the long term: s172.  According to ministerial statements,  
 
 7KHZRUGVµKDYHUHJDUGWR¶PHDQµWKLQNDERXW¶WKH\DUHDEVROXWHO\QRWDERXWMXVW
 WLFNLQJER[HV,IµWKLQNLQJDERXW¶OHDGVWRWKHFRQFOXVLRQDVZHEHOLHYHLWZLOOLQ 
                                                 
174Tier, Mark The Winning Investment Habits of Warren Buffett & George Soros 6W0DUWLQ¶V3UHVV1<
NY, pp296±298  
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 The Silicon Valley Bank opened its first UK branch, offering a full range of services (June 2013) 
176Maubussin, Michael J. The Success Equation: Untangling Skill and Luck in Business, Sports, and Investing  
(2012) Harvard Business Review Press. For further information on Clydesdales Growth Fund see Banking on 
IP? Report (2013) pp135-136,  IP Valuation Report (2014) p29 
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 many cases, that the proper course is to act positively to achieve the objectives in the 
 FODXVHWKDWZLOOEHZKDWWKHGLUHFWRU¶VGXW\LV,QRWKHUZRUGVµKDYHUHJDUGWR¶PHDQV 
 µJLYHSURSHUFRQVLGHUDWLRQWR¶.177 
 
 The revenue generated by the invention should cover the costs of making a patent 
application and as well as the renewal costs of maintaining any patent subsequently granted, 
so that the net profit is positive.  This will depend on the success and value of the invention.  
At this point, the innovating SME has already made a preliminary assessment of the 
economic value of the patent to the business.  Yet while the patent ecosystem is effective in 
terms of encouraging innovation, it stalls at the decision-making level by external financiers.  
This is problematic when the UK is a key patent-intensive region in the EU with more than 
2,000 UK patents a year being granted in the region during the period 2010-2013.178  Indeed, 
there is patent activity across virtually every sector of the UK economy as patentees seek to 
gain proprietary market advantages.  The top ten companies with the most patents granted by 
the UK IPO in 2013 are unsurprisingly all large companies.179  However, the more patents 
issuHGWKHJUHDWHUERWKWKHSXEOLF¶s awareness of them and the pressure on innovating SMEs 
to apply for them.  Inventors increasingly realise that neglecting to patent an invention may 
result in losing it to someone more pro-active, who would demand a royalty for its continued 
use or production.  Every year in the last decade, investment by UK business in intangible 
assets including patents has outstripped investment in tangible assets by £137 billion to £104 
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billion in 2008.180  This investment in intangibles led to the UK IP Ministerial Forum on the 
Economic Value of IP held in 2009 to further understand the impact of intangibles on the 
economy.  Due to the level of patenting activity, there is a scramble for both public and 
private funds in a harsh economic climate.181  IP-intensive industries report that little money 
is available to support innovation, and where it is, it comes with onerous conditions.182    
 Turning our economic analysis to debt finance and innovation, in 2009 the National 
Endowment for Science, Technology and the Arts 1(67$VWXGLHGLQQRYDWLQJILUPV¶HDVHRI
access to loans in the UK and confirmed that they found it difficult to obtain a bank loan with 
only a good business plan and no tangible security.  The trend is that the UK has declined in 
terms of access to loans falling from 4th to 5th since 2008 and that the current economic 
environment with tightening credit conditions adversely impact new businesses set out below 
in Figure 3.   
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Figure 3  Access to loans  
This chart shows the results of a EXVLQHVVVXUYH\PHDVXUHRIUHVSRQGHQWV¶YLHZVRQKRZHDV\LVLWWRREWDLQD
bank loan in a country with only a good business plan and no security (1 impossible, 7 = easy) 
 
 
Source:  The NESTA Innovation Index 2009, p23 
  
 From the standpoint of the SME as a borrower, access to loan finance is the most 
significant barrier to economic growth. 
 
Figure 4 Companies identifying access to finance as the most pressing problem they face 
 
This chart shows that 15% of UK firms (Eurobarometer survey) report that access to loan finance as their most 
pressing business development problem.   
 
 
 
 
Source:  The NESTA Innovation Index 2009, p23 
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In its Innovation Report, NESTA concluded that: 
 
 The UK is a relatively good place to innovate, but has some important 
 short-FRPLQJV2QWKHEDVLVRIDYDLODEOHLQWHUQDWLRQDOO\FRPSDUDEOHGDWD« 
  the UK performed less well on three important indicators: access to finance, demand 
 for innovation  (in particular the use of government procurement to encourage 
 innovation), and skills for innovation.183 
 
 So while the UK has a highly sophisticated financHVHFWRU1(67$¶V2009 data and 
research confirmed that access to credit was restricted and a pressing concern.  SMEs were 
particularly vulnerable as their size prevented them from accessing alternative sources of 
finance.184  Commentators and businesses were critical of the lack of willingness on the part 
of the banking sector to lend to small business generally.  BIS has strategically prioritised and 
committed to improving the interface between innovation SMEs and lenders to assist them to 
commercialise their inventions.185  In 2013 BIS reported that over half of SMEs have used 
finance in the last 3 years.  Bank overdrafts, credit cards and a loan from an individual were 
the most common forms of debt finance used, followed by a bank loan or commercial 
mortgage or leasing/hire purchase.186  SMEs that sought finance did so to obtain working 
capital or for cash flow.187  The preferred source of finance overall, regardless of reason, was 
a bank loan or commercial mortgage followed by a bank overdraft and loan/equity from 
friends and family.188   
                                                 
1837KH,QQRYDWLRQ,QGH[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 *OREDOO\WKH8.¶VSRVLWLRQLVVWLOOHQFRXUDJLQJO\VWURQJLQWHUPVRf the ease of doing 
business.  In the 2013World Bank assessment of 183 countries, the UK ranked an 
encouraging 7th IRU³HDVHRIGRLQJEXVLQHVV´189 indicating that the UK is in a prime position 
to lead the development of patent-backed debt finance.  The author recommends that 
UKIPO¶V Chief Economist elevate economic analysis of the impact of its patent policies and 
SME business finance policies on patent-backed debt finance, under the umbrella of the 
UKIPO, BIS and Companies House (which receives innovating SMEs corporate reports).  
Strategic realignment to evaluate the effects of alternative patent policies on innovative SME 
debt finance and the relationship between IP and economic development would be beneficial.   
 
2.5 Social impact: A behavioural finance approach 
 
 
Social factors contribute to the barriers faced by innovative SME who seek to access to 
patent-backed debt finance.  This section explores the interface between innovating SMEs 
(and their inventors) and lenders.  Behavioural finance studies the effects of psychological, 
social, cognitive and emotional factors on economic decisions.190  Although psychology has 
been used to support economic analysis since the early 20th century, it was in the 1960s that 
cognitive psychology shone a light on how the brain processes information.  Psychologists 
such as Amos Tversky and Daniel Kahneman began to compare their cognitive models of 
decision-making under risk and uncertainty to economic models of rational behavior.191 
Initially we consider the inventor mind set turning to the lender mind set to cogitate their 
underlying social and cultural values at the point at which the innovating SME applies for 
debt finance and the lender contemplates a decision to lend. 
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Social factors are an important feature of the inventor mind set.  Believing the same 
thing as other people makes life easier.  Holding unconventional views can be isolating.  As 
parents will often make great sacrifices for their children, inventors will make sacrifices to 
see their ideas and inventions thrive.  This motivation is partially a form of self-
actualisation192 but is also altruistic in the sense that the invention is a public good that solves 
a problem experienced beyond the inventor him or herself.  Roger Bootle, a modern British 
economist states: 
 
 At the sharp end of the economy, for its real creators and drivers, the entrepreneurs 
and the inventors, money is seldom the driving force.  What drives them is the sheer 
pleasure of creation, the joy of envisaging, doing and developing something and then 
working to make it happen.  Money is usually no more than a way of keeping score.193 
 
In making a credit appraisal, the lender should consider the high degree of personal 
motivation that inventors within innovating SMEs bring to the table.  As for the social 
motivation of professional lenders, they typically take pride in carrying out their professional 
duties and want to provide a good service to their customers, while acting in a prudent way to 
EDODQFHPDNLQJPRQH\IURPWKHLUOHQGLQJDFWLYLWLHVDQGSURWHFWLQJWKHEDQN¶VSRVLWLRQ
/HQGHUV¶DWWLWXGHVDQGEHKDYLRXUDUHHQVKULQHGLQSURIHVVLRQDOFodes of conduct and via laws 
regulating banking and finance and they risk loss of reputation and risk fines if they fall short 
of their professional standards.  Lenders do not see themselves in an adversarial relationship 
with their customers until the customer defaults on its loan.  What needs to be fostered as 
between innovating SME borrowers and lenders who can distribute capital is D³WHDPVSLULW´
so that these stakeholders work cooperatively rather than in a dysfunctional manner.    
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As for banks, they are part of the institutional structure of society194 and are social 
constructs.195  How lenders think about patent assets matters and how they behave are social 
phenomena.196  The lending environment is part of the financial system and is inherently 
fragile because it depends on trust.  Trust is important because it is based on the ability to 
predict the future.  In the paragraphs that follow, a short introduction to the research on 
human decision making relevant to lending is presented.  Lenders need to trust the innovating 
SME and have confidence that the loan will be repaid before they will lend.197  Innovating 
60(VDOVRQHHGWRDFNQRZOHGJHWKDWJDLQLQJDOHQGHUV¶WUXVWLVWKHNH\WRDQDIILUPDWLYH
lending decision in their favour.  Trust is an elusive element in many business dealings and is 
a critical aspect of a lending decision, because trust is a feeling.  Trust is crucial in building 
long term success with a lender and vice versa (mutual functional trust).  The trust the lender 
needs to feel lies not only with the borrower but the lender must also have confidence in the 
patent asset and the patent system which currently are not appreciated in mainstream UK 
lending.198  The author submits that lenders suffer from a cognitive bias in relation to patents 
as a form of intangible personal property capable of securing a loan as explained by an 
interviewee in the Banking on IP? Report:    
 
 2XUFUHGLWWHDPZDVLQFOLQHGWRWXUQGRZQDQ\WKLQJWKH\GLGQ¶WXQGHUVWDQGDQGZKLFK
 GLGQ¶WKDYHWKHVRUWRIDVVHWVWKDWZHUHIDmiliar.  However, we did manage to turn 
 round a lot of decisions that were initially declined.199  
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In other words, they do not see patents as a functioning asset class.  This cognitive bias 
includes being risk averse with respect to patent assets.200  Trust is a form of faith in that the 
lender also has to believe in what the innovation SME is doing and their plans for the future.  
Lenders need UHOHYDQWXVHIXODQGUHOLDEOHTXDOLWDWLYHLQIRUPDWLRQDERXWWKH60(¶VSDWHQW
strategy for generating future value from those assets.  For example, lenders may trust the 
SME as a business, but not have faith in the value or quality of the patent(s) as a business 
asset.  Alternatively, the lender may believe in the value and quality of the patent asset, but 
not trust the SME borrower (based on past lending experience or credit history).    
A common misconception is the view that numeric (quantitative) accounting 
information is more trustworthy than other qualitative formats201 because it is less vulnerable 
WR³VSLQ´.  It will be argued in the chapters to follow that improving communication of the 
³SDWHQWYDOXHVWRU\´ to lenders supported by corporate narrative patent information and 
VWUDWHJ\GLVFORVXUHZLWKLQWKHFRPSDQ\¶VDQQXDO6WUDWHJLF5HSRUWILOHGZLWK&RPSDQLHV
House LVQHHGHGWRJDUQHUOHQGHUV¶WUXVWCorporate annual and quarterly narrative reports are 
WKHPRVWFUHGLEOHDQGFRPSHOOLQJPHGLXPIRUWHOOLQJDFRPSDQ\¶V³IP value story´.  They are 
also corporate reporting documents with which lenders are familiar.  Further, disclosure made 
within the company law framework substantially increases the legitimacy and authority of the 
information disclosed, which comforts lenders.   
In essence, lenders need to have a high level of trust in borrowers because they are 
contemplating lending money and want to know it is safe and will be repaid.  Trusting a 
borrower is a risk.  The lender will typically examine the possibility of the SME defaulting on 
the loan within a 1-2 year time frame, taking into consideration current information about the 
borrower.202  Defaulting on a loan is trust lost and lenders will be reluctant to trust for a 
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SHULRGRIWLPH,IDOHQGHUORVHVIDLWKLQDERUURZHUV¶DELOLW\WRUHSD\GHEWHYHQWKRXJKLW
PD\QRWEHWKHERUURZHUVIDXOWWKHOHQGHU¶VWUXVWHYDSorates and the lender does not really 
care what caused the default.  When trust is present, banks will lend because lending is a core 
business.  Relevant, useful and reliable information about the proposed patent assets to secure 
a loan is economically sound and will increase trust.   
 In a social context, a OHQGHUV¶WUXVWLQLWLDOO\LVWHQWDWLYHDQGPXVWEHHDUQHG± this is the 
case for any borrower.203  Lenders use different methods to assess the risk of default.  They 
use either quantitative methods (such a financial statement lending) and credit scoring or 
more qualitative methods such as relationship lending to assess the borrower and their 
business strategy.204  Quantitative credit appraisal methods involving numbers are potentially 
problematic to the extent that they give the illusion of providing more truth than they actually 
do.  They favour what is easiest to measure, not necessarily what is the most important.205  
They can easily be used to dress up failure as success.206  A combination of quantitative and 
qualitative methods would complement each other and assist to reduce lending risk assisting 
experienced loan officers undertake a more thorough evaluation before making a lending 
decision.207  It is fair that lenders are sceptical about patent assets because they generally do 
not have a great deal of experience with them as an asset class with collateral potential.  Both 
the amount of financial information and the type of information influence lending 
decisions.208  In traditional banking, lending decision-PDNLQJLVJXLGHGE\WKH³&VRI
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OHQGLQJ´ that apply to both transactional and relationship lending.  The 5Cs, which should be 
evaluated equally, are: 
 
(1) character (i.e. evaluation of the prospective ERUURZHU¶VSHUVRQDOFKDUDFWHULVWLFV 
(2) capital (i.e. the borURZHU¶VQHWZRUWK 
(3) collateral  LHWKHERUURZHU¶VSOHGJHRISURSHUW\WRVHFXUHWKHGHEW 
(4) FDSDFLW\LHWKHERUURZHU¶V ability to service the debt out of current income); and 
(5) conditions (i.e. present market conditions for both the borrower and the general 
economy).209 
  
 However, according to Hedelin DQG6MR¶EHUJLWDSSHDUVWKDWWKHERUURZHU¶VSHUVRQDO
characteristics are over-emphasised in lending-decision making.210  The author considers that 
conversely, it is likely that the borroweU¶VFROODWHUDOLVunder-emphasised if it comprises 
patents with which lending officers have little expertise.  It may be they neglect to take into 
account important patent information as it does not usually form part of any common 
documentation used to approve loans.   
 
 Humans dislike change and this dislike goes further than fear of material loss.  A 
solution for patent-backed lending is for the innovating SME to seek small patent-backed 
loans initially.  Lenders learn from experience and may draw conclusions from earlier 
situations and can match these with present situations.211  As the lender becomes more 
comfortable, it will consider increasing the amount of funds advanced as with credit card 
limits, which are only increased once the borrower has shown discipline by meeting the 
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monthly repayments and develops a positive credit history.  Lenders test borrowers this way 
because they want to feel safe, breeding confidence in future favourable lending decisions.     
 Another solution is for innovating SMEs to approach small banks that form closer 
relationships with their client-borrower, relying more heavily on traditional relationship 
lending, qualitative lending risk assessment and take greater risks.212  In How to Change the 
World concerning social entrepreneurs and the Ashoka Foundation, Bornstein states: 
 
 «IXQGHUVVKRXOGUHPDLQFDXWLRXVZKHQHPEUDFLQJQXPHULFDODVVHVVPHQWV7KHTXHVW
for quantifiable social returns or outcomes has become an obsession in a sector that 
envies the efficiency of business capital markets.  Given this obsession, it is important 
to remember that a number has an unfortunate tendency to supersede other kinds of 
knowing.  The human mind is a miracle of subtlety: It can assimilate thousands of 
pieces of information ± impressions, experiences, intuition ± and produce wonderfully 
nuanced decisions.213  
 
 The positive benefits of relationship lending were experienced by Sir James Dyson, 
inventor, billionaire engineer, industrial designer, founder of the Dyson company and knight 
of the realm, who experienced cash flow pressures with his fledgling business: 
 
 Dyson vacuum cleaners would not exist were it not for Mike Page, my bank manager, 
who personally lobbied an initially reluctant Lloyds Bank to loan me the £600,000 I 
needed for tooling ± the only way to start out on my own.214 
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 Mr Page possibly used an intuitive approach215 and rated '\VRQ¶Vmanagerial and 
business experience as an important factor in the credit assessment.216  Nevertheless, the 
status quo is that lenders are averse to patent-backed lending and this is a barrier to 
RYHUFRPH,QWKHDXWKRU¶VYLHZWKHEDUULHULVQRWWKHSUREOHPUDWKHULWLVDV\PSWRPRIWKH
problem and work needs to be done to lower the barriers.  Lenders currently trust in tangible 
assets, intangible equity assets (shares) and all kinds of other tricky, risky and complex 
financial products (derivatives and hedge funds etc.).  Nobel prize winning Grameen Bank 
has even pioneered and popularised a methodology for extending small collateral-free loans 
for self-HPSOR\PHQWWRVRPHRIWKHZRUOG¶VSRRUHVWSHRSOHZKLFKKDVKDGDQHQRUPRXV
impact.217  If it is possible to make cost-efficient loans to borrowers with no security at all, 
surely it should be feasible to make loans to innovating SMEs against patents that have an 
existing and potential future value? 
 :KDWOHQGHUVDQGEDQNLQJUHJXODWRUVDUHUHDOO\VD\LQJWRSDWHQWRZQHUVLV³ZHWUXVW
ERUURZHUVZKRRZQRWKHUFODVVHVRIDVVHWPRUH´%XWLVWKLVWUXVWLQRWKHUDVVHWs classes 
misplaced and are patent assets really more risky?  Banks perceive less risk in lending against 
land, shares and other financial products and even to the poor, but the global financial crisis 
2007-2012218 tells a different story.  Traditional forms of security are riskier than commercial 
lenders originally perceived.  In time, OHQGHUV¶WUXVWLQSDWHQWDVVHWVZLOOGHYHORSDQGWKH
patent asset class will mature and foster a solid reputation (a past credit history).   
 *DLQLQJWKHOHQGHUV¶WUXVWGRHVQot mean innovating SMEs will successfully 
commercialise innovations, however it does provide the funding to move forward at a 
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significantly increased rate than would otherwise be the case.  A favourable lending decision 
means that over the term of the loan, the innovating SME will deliver more detailed 
information about its business strategy, positively impacting on the lender/borrower 
relationship.  This takes place through WKHEDQN¶VORDQrisk monitoring procedures under the 
loan documentation applicable to all loans.  A dynamic risk monitoring system provides an 
intelligence framework for collecting real-time information by scanning for events relevant to 
loan quality, as opposed to a creditor scoring system which relies on historical data about the 
borrower to predict loan quality. 219  Loan monitoring systems directly EHQHILWWKHEDQN¶V
VKDUHKROGHUVE\HQKDQFLQJWKHYDOXHRIWKHEDQN¶VORDQSRUWIROLR220  More importantly for the 
development of patent-backed lending, banks havHLQFUHDVHGLQFHQWLYHVWRKROG³ULVN\´ loans 
ZKHQWKH\FDQPRQLWRUVXFK³ULVNLHU´ loans in real time.221  7KLVLVZKHUHWKH³PLVVLQJ´ 
narrative corporate disclosure regarding patent information and strategy will be felt in the 
long term, by improving the business relationship.  The challenge for the innovating SME, as 
a trusted borrower, is to provide real time information that is accurate, visible and has value 
to the lender, breeding confidence.   
 Trust is the highest level of human and social interaction and it is also the most 
complex.222  The simplicity of trust is that if lenders do not have trust in patent assets, it is 
because that trust has yet to be earned.  Lenders must be confident that the innovating SME 
trusted to repay the loan will do what is expected.  It is important to analyse the patent 
ecosystem to understand why lenders do not generally trust in patent assets and then to work 
to lower the barriers to gain that trust.223  In economic terms, trust is viewed as an economic 
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lubricant, reducing the cost of transactions between parties, enabling new forms of 
cooperation and generally furthering business activities and prosperity.224  Without trust in 
patents as an asset class, lender are paralysed into inaction.  The Banking on IP?225 report 
confirmed that the role of IP in facilitating business finance was not appreciated in 
mainstream UK lending and that IP was therefore a missed opportunity.    
 A problem facing lenders is that borrowers can be dishonest and provide less than 
accurate information.  Fraud is a risk with respect to intangibles as with any asset.  There is 
risk with regard to genuine uncertainty as to the future.  Dishonest or misleading patent 
valuations may involve collusion with accountants, solicitors, patent attorneys and other 
professional intermediaries who inflate the value of the asset.  This is why making patent 
LQIRUPDWLRQDQGVWUDWHJ\GLVFORVXUHLQWKH6WUDWHJLF5HSRUWRIDQ60(¶VDQQXDOUHWXUQLV
critically important.  It is argued that if lenders are in a position to triangulate226 quantitative, 
qualitative and strategic IP information this promotes validity, reliability and accuracy - 
increasing predictability and decreasing the volatility of quantitative IP asset values.  This 
VKRXOGHQKDQFHOHQGHUV¶WUXVWLn patent as an asset class for use as security. The information 
PXVWPHHWWKH³WUXHDQGIDLU´ standard set by corporate disclosure regulations.  Having 
UHOLDEOHLQIRUPDWLRQZLOOIDFLOLWDWHOHQGHUV¶GXHGLOLJHQFH)XUWKHUKDYLQJERWKtypes of 
information will also assist the lender to dynamically monitor the loan by triangulating the 
information with the borrowers current account activity.  Thus, to enhance patent-backed 
lending it would be beneficial for lenders to introduce effective dynamic monitoring systems 
WRDOLJQWKHEDQNV¶DQGEDQNLQJUHJXODWRU¶VLQWHUHVWV.227 
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 )LQDOO\DQRWKHUZD\IRULQQRYDWLQJ60(VWRJDLQDOHQGHUV¶WUXVWLVWRGHPRQVWUDWH
competency, superior skills and passion.  The patents themselves demonstrate a degree of 
novelty and inventive step over the state of the art, in other words, over the competition.  
Innovating SMEs need to show lenders the value by showing the problem it solves, not just 
how the patented invention works ± this is part of the ³3DWHQW9DOXH6WRU\´.  Patents granted 
in countries with a thorough system of examination carried out by highly qualified patent 
examiners, demonstrate a high degree of validity.  Winning prizes or professional accolades, 
writing publications, speaking at conferences and being perceived as an authority on the 
subject also demonstrates superior skills and builds a valuable reputation.  Thus, patent-
backed debt finance can be thought of as a mixture of applied economics and human nature.   
Lenders cannot trust in what they do not understand, therefore the UKIPO agenda to raise 
awareness and understanding of IP and IP finance methods is the right approach.  Measures 
to enhance the interface between patent owner borrower and lender will be addressed 
throughout the thesis.  Innovative SMEs will struggle to thrive and grow without access to 
debt finance if all lenders continue think and behave the same way, treating patents and other 
IP assets as having little or no value for security purposes.  
 ,QWKH8.¶V&RQVHUYDWLYH3DUW\LQYLWHG-DPHs Dyson to help them reawaken 
%ULWDLQ¶VLQQDWHLQYHQWLYHQHVVDQGFUHDWLYLW\WRJHQHUDWHDQGH[SRUWPRUHWHFKQRORJ\7KLV
UHVXOWHGLQ'\VRQ¶VIngenious Britain: making the UK the leading high tech exporter in 
Europe report228 which recommended the UK government tackle the issue of ³)LQDQFLQJKLJK
tech start-XSV´.229  '\VRQ¶VUHSRUWLGHQWLILHVWKDWDVWKHYDVWPDMRULW\RIKLJKWHFKLQQRYDWLQJ
SMEs rely on debt financing for growth it is vital to examine better routes to access same as 
this will have a high impact on the domestic economy.230  The report recommends the 
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government address the apparent unwillingness of banks to lend to small businesses: 
 
 Clearing banks231 have a unique understanding of small businesses and have the 
infrastructure to monitor small debt financing.  The process of obtaining a clearing 
bank loan is simpler and more easily understood by fledgling start-ups.  A loan 
guarantee scheme similar to the National Loan Guarantee Scheme to stimulate small 
business lending, especially to those exploring new technology, should also be 
explored.232   
 
 '\VRQ¶VUHSRUWUHLWHUDWHVWKHQHHGWRLPSURYHDFFHVVWRGHEWILQDQFHto assist the UK 
maintain and improve its status as a nation at the forefront of technologies of the future.    
 
2.6 Technology issues that affect the patent ecosystem 
 
 Emerging technologies underpin the creation of a sustainable and resilient future for 
the UK and are at the heart of the inventive patentable subject matter of the future.  This 
section considers the external technology issues that affect the patent ecosystem.   
 
2.6.1 Emerging technologies 
 The Summit on the Global Agenda is organised annually by the World Economic 
)RUXP¶V:()*lobal Agenda Council on Emerging Technologies.  It LVWKHZRUOG¶VODUJHVW
global brainstorming event, assembling thought leaders comprising eight  expert groups from 
business, academia, government and civil society to advance knowledge and jointly explore 
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critical issues shaping the world.  In 2011, the Summit determined the following technology 
trends would make the greatest impact on the world in the near future: 
 
x Informatics and adding value to information; 
x Synthetic biology and metabolic engineering; 
x The green revolution ± technologies for increasing food and biomass; 
x Nano-scale design of materials; 
x Use of carbon dioxide as a resource; 
x Wireless power; 
x Personalised medicine, nutrition and disease prevention; and 
x Enhanced education technology.233 
 
 However, without appropriate systems and capabilities to develop and commercialise  
inventions, their safe and successful development is not guaranteed.  The UKIPO will need to 
ensure its human resources plan enables it to recruit suitable and sufficient patent examiners, 
who have expertise in the emerging technology fields identified above.  
 
2.6.2 Patent application examination backlogs 
 Technological pressures are also at work in the patent system due to the high level of 
patent applications. WIPO reported that in 2011 global patent applications reached the 2 
million mark evidencing almost constant growth spanning more than two decades.234  In the 
UK and other patent rich jurisdictions, this is leading to problems of patent office backlogs 
and the emergence of so called ³SDWHQWWKLFNHWV´, which obstruct entry to some markets and 
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so impede innovation.  $³SDWHQWWKLFNHW´ is a strategy whereby a patent owner develops  a 
thick, dense collection of overlapping patent rights which means that innovators need to 
license multiple patents to use the technology.  From a strategic point of view, patent thickets 
are also used to defend against third party competition who might otherwise design around a 
single patent.235  This is normal according to Sir Robin Jacob236 stating: 
 
  «HYHU\SDWHQWHHRIDPDMRULQYHQWLRQLVOLNHO\WRFome up with improvements and 
DOOHJHGLPSURYHPHQWVWRKLVLQYHQWLRQ«LWLVLQWKHQDWXUHRIWKHSDWHQWV\VWHPLWVHOI
that [patent thickets] should happen and has always happened.237    
 
 The Hargreaves Review took the view that patent thickets could reduce technological 
development and innovation.  It is important the UK continues to engage in international 
cooperation to address the backlogs and thickets.238  The UKIPO published Patent Thickets ± 
an overview239 and A Study of Patent Thickets240 to gain a better understanding of: 
 
 (1)  whether thickets deter new competitors, especially innovating SMES, from entering a 
 field of technology; and  
(2)  the effect of pending patents have as a barrier to enter a technology area and their 
 relationship with patent thickets.    
 
 The latter concluded that the growth of patent thickets in the European patent system 
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negatively impacts on innovating SME entry into certain fields of technology, coupled with a 
³lack of resources and misaligned incentives in patent offices faced with a flood of patent 
DSSOLFDWLRQV´241   How to reduce patent pendency and uncertainty in the patent ecosystem is 
an administrative issue of key concern.  Over the past two decades, the number of UK patent 
applications filed annually has mostly grown in an upward trajectory.  However, the volume 
of patent applications outpaces the UK,32¶VFDSDFLW\WRH[DPLQHWKHP$VDUHVXOWD
substantial backlog of unprocessed patent applications has accumulated resulting in longer 
periods of patent pendency.  This problem is affecting patent offices worldwide.   
 Patent applications are less valuable security than granted patents.  Backlogs in 
processing and examining patent applications cause delays in patents being granted, together 
with the rights afforded by granted patents (which in turn increases their economic value).  
Delays in processing patent applications also impedes new products and processes from being 
commercialised, as the incentive to create and innovate is reduced.   
 Lenders are reluctant to lend against new technologies that are not protected by a 
granted patent (the Singaporean patent finance initiative discussed in Chapter 1 echoes this) 
and neither can patent owners take legal action for infringement until their patent is granted.   
7KHH[SUHVVLRQ³SDWHQWSHQGLQJ´RU³SDWHQWDSSOLHGIRU´ are notices that inventors are entitled 
to use to indicate that they have filed a patent application, but the application has not yet been 
granted.  This puts potential infringers on notice that they may be liable for damages 
(including damages back-dated to the priority date of the patent) as well as other remedies 
available under the PA 1977.  Lengthy periods of patent pendency also lead to greater 
uncertainty about the potential validity of the inventions and whether they will in fact ever be 
patent-protected.   
 One legal issue arising is that the claims which define the patent monopoly are not 
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available to the public, nor can they be searched until published.  This is the period from the 
priority date until publication date of the SDWHQWSDUWRIWKHSHULRGRI³SHQGHQF\´.  The 
content of the patent claims therefore remains confidential as between the patent applicant 
and the UKIPO and is not aEOHWREHVHDUFKHGFUHDWLQJD³EODFNER[´ of claims.  Thus, later 
patent applicants may not be aware of the earlier confidential claims and their own patent 
application may fail for lack of novelty or worse, they risk infringing the pending patents.  
The greater the patent backlog, the greater the risk for patent applicants.  This creates 
uncertainty regarding the patent asset, lowering its value as an asset to secure lending.  
Simply put, longer pendency periods reduce the value of the patent.  Although pending 
patents cannot be enforced, they still have value, although not as much as either a granted 
patent or a granted patent that has been successfully challenged and held to be valid.  Figure 5 
below depicts the patent value continuum. 
 
 
 
Figure 5   The Patent Value Continuum 
 
  
 The increasing complexity of technology and volume of prior art that needs to be 
examined is making the role of patent examiners more difficult.  However, if the average 
period of patent pendency remains constant, the UKIPO backlog will continue to grow as 
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patent applications grow.  Further, if the patent pendency periods increase, then the system 
becomes even more backlogged.  The EPO estimates that it will take over 4 years to clear its 
patent backlog.  A recent economic study entitled, Patent Backlogs and a System of Mutual 
Recognition242 made two important conclusions relevant to this thesis.  First, backlogs reduce 
the effectiveness of the patent system by creating costs for the applicant.  Costs arise because 
any uncertainty about validity complicates planning and formulating business strategy, 
investment decisions and access to funding.  Secondly, backlogs impact on patent quality.  
Uncertainty over the scope of patent quality deters lenders as a patent pending asset has less 
value than a granted patent.  IIWKHEDFNORJVWUHWFKHVWKH8.,32¶VUHVRXUFHVDQGSDWHQW
quality decreases, morHDSSOLFDQWVDUHHQFRXUDJHGWR³WU\WKHLUOXFN´ by making low quality 
patent applications.  This predictably means patent litigation will increase.243   
 The UKIPO recognises this operational challenge stating WKDW³LWLVSOD\LQJDQDFWLYH
role in encouraging international cooperation between IP offices through work-sharing to 
UHGXFHEDFNORJV´244  This is sensible as it is estimated that approximately one third of patent 
applications worldwide are duplicate applications.  A mutual recognition system will allow 
the UKIPO to reduce the time it spends examining duplicate applications also being reviewed 
by foreign patent examiners, with a knock-on effect on the backlog.  However, even with 
work-sharing programs, without sufficient resources and suitably qualified and experienced 
patent examiners, this will remain a challenge for the foreseeable future.    
 For the reasons set out above, it is important to ensure that the UKIPO is adequately 
IXQGHGWRWUDLQDQGHPSOR\SDWHQWH[DPLQHUVWRRYHUFRPHWKH8.¶VSDWHQWEDFNORJDQG
reduce pendency times in the interest of further developing innovative SME access to patent-
backed lending.   
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2.6.3 Horizon 2020: The EU International Strategy for Research and Innovation 
 
 The latest financial development to impact on the patent landscape is the Horizon 
2020, the EU Framework Programme for Research and Innovation.245  Horizon 2020 is the 
public funding financial instrument that implementVWKH³,QQRYDWLRQ8QLRQ´, an initiative 
aimed at positioning Europe as top global competitor in terms of research and innovation as 
well as to creating new economic growth and jobs within the EU.  The Horizon 2020 
programme will proceed from 2014 to 2020 with DPDVVLYH¼ELOOLRQEXGJHW7KHPDMRU
advantage for innovating SMEs is that Horizon 2020 simplifies the availability of public 
funding through the use of a single set of rules.  According to the European Commission, the 
proposed support for research and innovation under Horizon 2020 will:  
 
x sWUHQJWKHQWKH(8¶VSRVLWLRQLQVFLHQFHZLWKDGHGLFDWHGEXGJHWRI¼ 598 million, 
thereby providing a boost to top-level research in Europe, including an increase in 
funding of 77% for the very successful European Research Council; 
x strengthen industrial leadership LQLQQRYDWLRQ¼938 million via major investment 
in key technologies, greater access to capital and support for SMEs; 
x pURYLGH¼ 31 748 million to help address major concerns shared by all Europeans such 
as climate change, developing sustainable transport and mobility, making renewable 
energy more affordable, ensuring food safety and security, or coping with the 
challenge of an ageing population.246 
 
 It is envisaged that a significant percentage of the budget will be allocating to SMEs.  
Horizon 2020 will be complemented through additional measures to advance the European 
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Research Area by breaking down barriers to develop a unified EU market for knowledge, 
research and innovation.  This market-driven strategic approach to enhance greater access to 
public capital is a positive development providing UK-based innovating SMEs with a 
tremendous opportunity to access funds to support innovation.  The Horizon2020 SME 
Instrument is an entirely new line of EU funding to support innovating SMEs with high 
potential and high risk R&D projects by providing direct financial support and indirect 
support to increase their innovation capacity.  Phase 1 requires an initial business proposal 
and if chosenZLOOUHFHLYH¼funding and business coaching.  However, all projects 
must be at Technology Readiness Level 6 (TRL 6) or more.247  TRL 6 requires a 
system/subsystem model or prototype demonstration in a relevant environment.  
 
2.6.4 The TRL System 
The TRL system is a well-established method of estimating the maturity of critical 
technology elements on a scale of 1 to 9 with 9 being the most mature technology.  It was 
originally developed by the US National Aeronautics and Space Agency (NASA) in the 
1980s.   See figure 6 below. 
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Figure 6  1$6$¶V7HFKnology Readiness Levels 
 
    Source: NASA public domain 
 
 The use of TRLs enables consistent uniform discussions of technical maturity across 
different types of technology.  Although common in the R&D and public finance field, it is 
less well known in private finance and banking and is also used in the European Commission, 
the European Space Agency (ESA), NASA and the Canadian Innovation and 
Commercialization Program. The latter provides financial assistance by awarding contracts to 
entrepreneurs with pre-commercial innovations, provided the innovation is between TRL 7 
and 9.  The TRL system could be used by innovating SMEs (see the model in Chapter 7) and 
by lenders to assess patent-backed loan applications.    
 In summary, changes in the technological environment have a direct impact on 
LQQRYDWLQJ60(VDQGWKH8.¶VSDWHQWV\VWHP  In addition to reducing patent examination 
backlogs, patent pendency and dealing with patent thickets, it is crucial for UKIPO and BIS 
to work with innovating SMEs in the interim to educate them as to all available methods of 
public R&D funding for potentially patentable inventions, until such time as commercial 
lending evolves to the point where banks have patent-backed lending policies in place and are 
ready and willing to make patent-backed loans.  There is also the opportunity for lenders to 
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learn about the TRL system, an existing tool to assess funding risks.  
 
2.7  The legal factor: enforcing patent rights 
 
 It is commonly said that patent rights are only as valuable as the ability to enforce 
them.   However, patent infringements are often difficult to identify, involve considerable 
expense to gather evidence of infringement and arduous to litigate.   Patent disputes present 
an enormous business risk for both the innovating SME and the lender.  At stake is the ability 
to sell, market share, damages and costs orders, possible future licensing royalties and the 
validity and thus the commercial value of the patent itself.  Prudent management of patent 
assets is essential for the sustainability of the innovating SME, but knowing how to 
proactively enforce patent rights is far from intuitive.  The ability to enforce patent rights is a 
key legal factor that impacts on the development of patent-backed lending.    
 The Patents Act 1977 (as amended), the Patents Act 2004, the Patent Rules 2007 and 
the Intellectual Property Act 2014 represent the modern governing UK national legislation 
that create the patent law framework.  These derive from a hybrid of national, European and 
international agreements.248  As a minimum, the UK is required to ensure its patent rights 
enforcement system complies with the Agreement on Trade-Related Aspects of IP (TRIPS)249 
which provides: 
 
 Article 41 
Members shall ensure that enforcement procedures as specified in this Part1 are 
available under their law so as to permit effective action against any act of 
infringement of IP rights covered by this Agreement, including expeditious remedies 
to prevent infringements and remedies which constitute a deterrent to further 
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infringements. These procedures shall be applied in such a manner as to avoid the 
creation of barriers to legitimate trade and to provide for safeguards against their 
abuse. 
 Procedures concerning the enforcement of IP rights shall be fair and equitable. They 
shall not be unnecessarily complicated or costly, or entail unreasonable time-limits or 
unwarranted delays.  
  
 Enforcing patent rights is a major concern for innovating SMEs and lenders.  In 2000, 
the EU study entitled, Enforcing Small Firms Patent Rights250 found that every single 
valuable EU invention that an innovating SME held had been copied at least once (in every 
case at least once) yet not one EU innovating SME had been able to successfully enforce their 
patent.  Fortunately, recent legal reforms level the playing field for innovating SMEs who 
wish to take enforcement action in the specialist IP Enterprise Court (IPEC), the High Court 
and the new Unified Patent Court (UPC).   
 
2.7.1 IP Enterprise Court (IPEC) and the High Court, Chancery Division 
 
 As of 1 October 2013, the Patents County Court (PCC) was reformulated as a 
specialist list of the High Court as the IP Enterprise Court (IPEC).251 Thus, currently in the 
legal system of the Courts of England and Wales, IPEC (previously the Patents County 
Court) in London is an alternative venue to the High Court for bringing legal actions 
involving IP matters including patent rights.252  The IPEC provides access to justice for 
litigants who are unable to afford the costs of litigation in the High Court.   
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 Revitalised rules of procedure require more detailed particulars of claim,253 no 
disclosure, no examination-in-chief of expert witness and tight control by the Judge of the 
issues that go to trial.  Financial ceilings were introduced to both the damages (at £500,000) 
and the legal costs (at £50,000, with an additional cap per stage) recoverable. Trials should 
last no more than two days.  IPEC judges have specialist IP and patent knowledge and can 
order the full range of IP remedies including financial compensation/damages, an account of 
profits, final injunction to prevent future infringements, search and seizure and freezing 
assets.  Although the IPEC is now part of the High Court, patent and trade mark attorneys 
retain their rights of audience and litigation.254   
 Within IPEC there are two systems: the multi-track described above and the small 
claims track for claims of less than £10,000 with restrictions on costs orders, however, the 
latter is not appropriate for patent claims.  
 The creation of IPEC is a positive development supporting innovating SME access 
justice in respect of their patent rights.  IPEC deals with smaller, less complex, lower value 
actions with procedures specifically designed for these type of cases, aimed at ensuring IP 
owners are not deterred from enforcing their patents due to potential litigation costs.  Longer, 
more complex, higher value actions, as is often the case with patent litigation, are heard in the 
High Court.  IPEC aims to strike a balance between swift, low cost, streamlined litigation and 
while ensuring a proper investigation of the claim in an informal courtroom environment. 
 Lenders should take comfort in the high quality of the specialist IP courts and judges 
available in the UK to enforce patent rights and resolve disputes.  Further, tKH8.¶VEU 
membership has had a huge impact, in particular the PA 1977 which harmonised UK patent 
law with the European Patent Convention (EPC).255  Consequently, there is now a fusion of 
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UK and European patent law and practice which has been largely positive in practical terms, 
resulting in a solid degree of legal certainty in the patent legal framework.  
 
2.7.2 The European Unified Patent Court (UPC) 
 Although the European Patent Office (EPO) provides single patent grant procedures, 
the ability to enforce European patents is in the process of change with the advent of the 
UPC.  Consequently, the 8.¶VIntellectual Property Act 2014 streamlined parts of existing 
laws, including improvements to the patent law regime.  The Act provided the foundation for 
the UK to sign the UPC Agreement and lays out the groundwork for introducing the UPC.  
 ³3DWHQWSURVHFXWLRQ´refers to the interaction between patent applicants, their 
representatives and the relevant patent granting office and is divided into:  (1) pre-grant 
prosecution which involves negotiating with the patent office for the patent to be granted; and 
(2) post-grant prosecution which relates to post-grant amendments to the patent or responding 
to opposition to the patent by third pDUWLHV7KLVLVGLVWLQFWIURP³SDWHQWOLWLJDWLRQ´ which is 
legal action taken to enforce the patent monopoly against an infringing third party.  The 
Agreement on the UPC signed by 24 EU Member States on 19 February 2013 creates a 
specialised patent court with exclusive jurisdiction for litigation relating to European patents 
and European patents with unitary effect.  According to the EPO, the UPC was needed to 
address the problem of the high legal costs that ensue when patent litigation has to be 
undertaken in two or more national courts, with the risk of diverging decisions and lack of 
legal certainty.  Forum shopping also occurred as the parties sought to take advantage of 
GLIIHUHQFHVEHWZHHQQDWLRQDOFRXUWV¶LQWHUSUHtation of harmonised European patent law and 
procedure.256  The new court system paves the way for the implementation of a unitary patent 
system in Europe.  EPO President Benoît Batistelli stated,  
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 The signing of the UPC agreement is a decisive step towards the long-awaited 
introduction of a truly supranational patent system in Europe.  Following the 
endorsement of the unitary patent package by the European Parliament and Council in 
December 2012, the creation of a European court specialised in patent matters will be 
a tremendous boost for the completion of the European patent system.257  
 
 This is the most dramatic change in the patent landscape across most of Europe in the 
last 30 years.  A unified patent system should reduce the cost of acquiring patents in Europe.  
It will be similar to the existing system in that one can apply centrally to the EPO in Munich, 
but rather than choosing to acquire a bundle of single national patent monopolies, the 
applicant will acquire a single monopoly covering the relevant EU member states.  Existing 
UK national patent rights will not change.     
  For the patent owner, the new system means that in the near future, when filing a UK 
patent application, the applicant will obtain a single European patent that will stand or fall 
across the whole of Europe.  There will be a transition period for the first 7 years during  
which the applicant can choose to opt-in its existing portfolio, or not opt-in for strategic 
easons e.g. uncertainty as to implementation of new system with the patent owner preferring 
to remain in the existing more predictable national-based UK system.     
 The UPC will be one court but will sit in a number of different locations and will hear 
disputes pertaining to the Unitary Patent.  It will be composed of a central division with its 
main seat in Paris, with further seats in London and Germany.  The London court will hear 
patent disputes relating to chemistry and pharmaceutical patents, with the German court 
hearing mechanical engineering cases.  The UPC system aims to reduce complexity and 
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increase legal certainty for patent owner, however, this remains to be seen as it has yet to be 
fully implemented although the Preparatory Committee published the 83&¶Vth draft of the 
Rules of Procedure in November 2014 (which are to be agreed by May 2015). Judges may 
only be formally appointed once the UPC is established.258  
 For innovating SMEs who choose to file a Unitary Patent, it appears they will obtain 
an advantage through simpler administration processes for patent prosecution.   
   Since the EU patent system was formulated in the 1970s, there has been a desire to 
have a single EU patent and single European court for resolving disputes.  It has taken four 
decades to create such a system, largely due to the key stumbling block, language.  Overall, 
the development is a positive step for the EU in the long term, although there will be a period 
of uncertainty for business (and therefore lenders) in the short term.  A key decision to be 
made by innovating SMEs in the short term will whether to opt-in or opt-out.  At the moment 
it is still not possible to apply for a unitary patent although this option is not far off once the 
UPC goes live.  After the UPC Agreement comes into force, there will be a transitional 
period of 7 years that may be extended to 14 years.259   In terms of patent-backed lending, on 
balance, a pan-European approach should create greater certainty (single system, single 
patent, single court, single renewal fee) and thus value in the medium to long term.   This 
should be viewed as a positive development by lenders.  However, a unitary patent will be 
vulnerable across Europe to a single unfavourable UPC decision which is a new risk that both 
innovating SMEs and lenders will need to take into account.   
 The Taylor Wessing Global IP Index 2014 provides a comprehensive assessment of 
how 36 important IP regimes compare with each other.  The UK IP legal regime ranks first 
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overall, and second for its patent regime after Germany.260   This is a strong endorsement of 
WKHRYHUDOOTXDOLW\RIWKH8.¶V,3OHJDOUHJLPH 
 Finally, the procedure for registering security interest in patents (an aspect of UK 
secured transaction law and reform) is also a relevant legal factor.  There is potential for this 
procedure to be streamlined.  As its impact on patents (a form of personal property) is 
primarily of relevance to lenders, it is covered in Chapter 3, section 3.9. 
 
2.8 Conclusion  
 The PESTL analysis is a widely-used tool that provides a fuller picture of the 
political, economic, socio-cultural, technological and legal environment for innovating UK 
SMEs and lenders.  It identified areas of concern and weakness which helps to design policy 
to deal with forecasted changes to the patent ecosystem.  Minimising the weaknesses and 
limitations will increase certainty in patents as asset class and should in theory improve 
access to patent-backed debt finance.  7KH8.¶Vpatent ecosystem is comparatively well-
developed to facilitate patent-backed lending.   
 At a political level, the government needs to demonstrate more effectively that its 
structures and ministerial appointees are coordinating policies in relation to innovating SMEs, 
IP, finance and corporate regulation and that UKIPO, BIS and Companies House efforts are 
synergised.  Companies House does not appear to feature in the IP finance discussions.   
 From the economic standpoint, the government should ensure that public funding 
remains available until patent-backed debt finance is more accessible.     
 In terms of the impact of social factors, it was identified that lenders¶need a higher 
level of  trust in patents as an asset class. It was argued that in theory, triangulating 
quantitative, qualitative and strategic IP information should improve validity, reliability and 
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accuracy (thus increasing predictability and decreasing volatility) of quantitative asset values.   
 Addressing the increasingly complex high-tech nature of patent applications in terms 
of volume, reducing patent backlogs and patent pendency periods are important aspects of 
improving legal certainty with respect to granted patents (which are more valuable than 
patent applications).  Cross-pollinating the TRL system to estimate the maturity of critical 
technology elements may assist lenders with technology risk assessment.   
 The evolving pan-European patent law framework should create greater legal 
certainty (single system, single patent, single court, single renewal fee) and thus ³value´ in 
the medium to long term and should be viewed as a positive development. 
 Applying a PESTL analysis approach to the patent ecosystem and introducing 
behavioural finance analysis to a patent-backed debt finance transaction is an original 
contribution to knowledge.  Where a patent portfolio contains international patents, a PESTL 
analysis could be performed on a country-by-country basis.  Chapter 3 explains why debt 
finance, given the range of finance options available, remains critical to innovating SME 
success.   
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3 Financing Innovating SMEs  
 
³7KHGLIILFXOW\OLHVQRWVRPXFKLQGHYHORSLQJQew ideas as in escaping from old RQHV´ 
 
               John Maynard Keynes (1883-1946) 
                (Influential economist of the 20th century) 
 
 
Introduction  
 
 %DQNVOHQGIXQGVEDVHGPDLQO\RQDERUURZHUV¶EDODQFHVKHHWILQDQFLDOKLVWRU\FDVK
flow and available security.  Patent-backed debt finance is a viable finance method, 
challenging us to question the status quo and facilitate its use by innovating SME borrowers.  
One argument why it is rarely used is because the traditional financial statements, analysed 
by lenders WRGHWHUPLQHDERUURZHUV¶FUHGLWZRUWKLQHVV- the treasure map - do not map well 
RQWR³LQWDQJLEOHV´ (the accounting term which includes IP).   
 Although there are many public and private avenues for financing a business, debt 
finance is the critical method of financing innovating SMEs for four reasons.  First, the pool 
public finance is limited.  Secondly, the power of debt-funded working capital to generate 
financial returns is formidable.  Thirdly, debt finance is less expensive than equity finance.  
Fourthly, debt finance is a more strategic financing method as it does not involve diluting 
equity in the business, selling or losing control of the SDWHQWV7KH8.¶V³LQQRYDWLRQVHFWRU´ 
requires a debt finance banking service specific to its needs which are presently unmet.261  
This is thought to be because banks are traditionally conservative and process-driven in terms 
of risk assessment; they deem IP value is uncertain, volatile and thus unable to be covered by 
a reasonable risk premium.  This view will be examined in more detail and in doing so we 
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 There is an opportunity for the new UK Government-backed British Business Bank, which supports 
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finance in the future.   
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cannot avoid touching on the fallout from the global financial crisis that began in August 
2007 which affected access to finance generally.262  While innovating SMEs may have some 
working capital, large pools of readily available funds to self-fund a business are rare.  As 
such, the role of credit providers in the early stage of the business life cycle is crucial.   
 Section 3.2 explains the power of debt finance to generate returns.  Sections 3.3-3.4 
analyses the stakeholders in the development of patent-backed lending and the innovation 
business life cycle.  Section 3.5 discusses the current funding landscape as well as newer 
funding options.  Section 3.6 analyses data from the WIPO IP Advantage Database to 
provide evidence that patent-backed debt finance is underused.  Section 3.7 enlightens our 
understanding of the negative impact of banking capital adequacy requirements and Basel III 
on patent-backed debt finance.  Section 3.8 H[DPLQHVWKHOHQGHU¶VWULDGRIFRQFHUQV
introduces the issue of legal risk, uncertainty in patent valuation and the process for 
registering security interests in patents.   
 
3.1 The power of debt finance to generate returns for innovation firms 
 Debt finance is critical given the power of debt to generate returns.  Compare and 
contrast an investment with a loan.  If an innovating SME invests £100 capital in its business 
and the return is 10%, then the profit is £10 gross.  If it invests £100 but also borrows £900 at 
5% per annum interest, then the return will be £55 (calculated as £100 gross minus £45 
interest).  Leverage transforms a return of 10% into one of 55%.  Financial institutions are in 
the business of lending, receiving deposits and lending the funds, lending much more capital 
than they are legally required to hold (capital adequacy requirements).  Private equity firms 
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act in an analogous way.  However, when an asset declines in value, leverage wipes out 
capital at a faster rate than the rate of fall in asset value.263  This is the dark side of borrowing.   
 
 
Figure 7  Balance sheet diagrams for funding a patent and selling it a year later. 
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 Debt finance is cheaper and is usually the preferred option for innovating SMEs 
because of the increase in the value/equity upside as demonstrated above.  Borrowers benefit 
from the full upside of risks being taken, while the downside is shared by the creditors (both 
trade and finance) if there is a possibility of default.  We also know that it is difficult for 
innovating SMEs to access debt financing in the current economic climate.  Consequently, 
the upside in equity necessary to fund the growth stage of the business is lacking.   
 
3.2 Patent-backed lending transactions stakeholder analysis 
 The turbulence and fallout from the global financial crisis264 resulted in further 
uncertainty for innovating SMEs who wish to borrow and also adversely affected 
stakeholders who have an interest in and an ability to influence innovating SMEs.  The 
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stakeholder approach assumes that an effective finance strategy for the innovating SME 
requires consensus from a plurality of key stakeholders about what it should be doing and 
how these things should be done.265  The greatest challenge involves LQQRYDWLQJ60(V¶
efforts to influence and shape the finance market in their favour.266  
 IWLVLPSRUWDQWWRDVVHVVHDFKVWDNHKROGHUV¶SRWHQWLDOWRLQIOXHQFHWKHLQQRYDWLQJ60(
successfully obtaining debt finance.  The author has identified the key stakeholders and 
classified the stakeholder relations in Figure 8 below.  According to the framework,267 
primary stakeholders have a direct economic and/or legal interest in the issues.  Secondary 
stakeholders have an indirect interest. Tertiary stakeholders have no direct economic or legal 
interest in the debt-finance transaction, rather they are influenced further downstream.  
Stakeholder relations are divided into four types: (1) supportive; (2) mixed blessing; (3) non 
supportive; and (4) marginal.268  Stakeholder interests need to be balance to achieve the best 
possible outcome.   
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Figure 8  Stakeholder analysis 
 
Category Stakeholder Status Stakeholder Relation 
SMEs Innovating Sector Owners/Shareholders Primary Supportive 
Finance Section Banks/ Lenders Primary Mixed blessing 
Government Banking Regulator Primary Non-supportive (Regulators 
have high power and 
legitimacy and real direct 
impact as they are standards 
makers) 
Government Legislature/UKIPO/ BIS Primary Supportive infra-structure 
provider 
 Companies House Secondary Non-supportive infra-structure 
provider 
 DTI Secondary Supportive facilitator 
 Legal Profession Secondary Supportive facilitator 
 Accounting Profession Secondary Supportive facilitator 
 Patent Attorney 
Profession 
Secondary Supportive facilitator 
 Insolvency Profession Tertiary Non-supportive facilitator 
(acts in the interests of 
creditors) 
Business Sector Competitors Tertiary Non-supportive 
 Suppliers Tertiary Marginal 
The Public Customers Tertiary Marginal 
   
  
   
 Only one ³mixed bleVVLQJ´ or ambivalent stakeholder has been identified, namely the 
banks/lenders.  This is because they have a high potential to benefit as well as a high potential 
to be harmed by the LQQRYDWLQJILUPV¶SDWHQW-backed lending transaction.  The other 
stakeholders are not negatively affected in the same way as is, potentially, the lender.   In 
high risk situations, lenders ZLOOW\SLFDOO\VKLIWLQWRWKH³QRQ-VXSSRUWLYH´ category.  If 
however, trust is established between the innovating SME and the lender, it will become 
supportive unless and until the borrower is unable to repay the loan.   Accordingly, the 
³mixed blessing´ category is very narrow, see Figure 9 below. 
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Figure 9  6WDNHKROGHUV¶UHODWLRQVZLWKWKHSDWHQW-backed finance transaction 
 
  
 Even though all organizations have a role to play in the patent-backed lending 
ecosystem, the diagram depicts where to focus efforts in terms of strategy ± squarely on the 
banks in their role as lenders.  It is more efficient to focus on the stakeholder from which the 
patent-backed lending transaction has the most to gain.  There is a need to understand how to 
positively influence banks to support patent-backed lending transactions.  Strategies should 
emphasize:  
 
(1) how banks will profit from the new role they play by providing debt finance;  
(2)  the medium-term benefit to be achieved by nurturing the business relationship as it 
 grows and requires additional financial services generating additional banking fees;  
(3)  that lenders such as Santander, Clydesdale Bank and Silicon Valley Bank, who are 
 more receptive, risk tolerant, flexible and creative in relation to patent-backed lending 
 ZLOOJDLQ³HDUO\PRYHU´ advantage269 by gaining a share in the innovation finance 
 market. The optimum strategy is financial to show how patent-backed loans give 
 value (profits) to lenders.   
Next, we consider the business life cycle and the existing innovation finance paradigm.  
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 Four our purposes, early entrants into the patent-backed debt finance market will enjoy preferential access to 
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3.3 Financing innovation and the business life cycle 
 
 To commercialise an invention working capital (money) is typically needed for a 
variety of business activities including:  market research; patent and prior art searches; 
prototype development; patent filing and legal fees; professional advisers (e,g, patent 
attorneys, accountants and lawyers); and patent renewal fees.  Many of these costs are unique 
to innovation.  The principles of business finance are broadly the same for innovating SMEs 
as for any larger organisation.  Innovating SMEs have a predictable life cycle and we will use 
the term to mean the firm has a potentially patentable invention.  In short, they start with an 
idea leading to a potentially patentable invention, search for a business model, then build an 
appropriate infrastructure via the legal forms of business organisation (e.g. partnership or 
company) and then grow as they commercialise their invention and bring it to market 
generating profits.  Figure 10 depicts the classic business life cycle. 
 
Figure 10  The business life cycle ± the journey between concept and commercialisation 
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 In this thesis, our focus is early in the classic business life cycle, between the initial 
start-up and the critical early growth stages of the innovating SME.  It is at this stage that 
increased access to debt-finance is needed.  The seed stage is when the invention is simply a 
thought or an idea which can lead to the very conception of a new business.  There is no 
proven market or customers for the invention, so the start-up will rely on seed capital (cash) 
usually self-funded by the owner/ inventor, friends and family.   Debt-finance is not a viable 
option.  Using internal finance to reduce transaction costs is the cheapest option.  Famous 
examples of firms that relied solely on self-funding270 during the seed stage include Apple, 
Inc., Google and Starbucks.271  While inventor entrepreneurs may have some savings, large 
pools of readily available savings set aside to self-fund a business are rare which is why the 
role of credit providers is critical.   
 
3.4 Financing innovation ± the existing paradigm 
 A business comes into existence when it has a legal structure and a business plan ± it 
is usually small and privately owned.  During the first year of existence, R&D and the 
creation of prototypes in connection with the invention is progressing.  Patents applications 
are also being made.  At this point the financial burden on innovating SMEs who wish to 
commercialise an invention is particularly high, given the costs of applying for patents, patent 
attorney fees and prototype development, all necessary steps before a product can be 
launched.  The start-up innovating SME is only just beginning to establish a market presence 
and develop a customer base.  Meanwhile, although the patent applications are valuable 
business assets, they are LQYLVLEOHRQWKHILUPV¶EDODQFHVKeet as they are classified as 
³LQWDQJLEOHV´ for accounting purposes making successfully applying for a loan and receiving 
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a favourable lending decision difficult.  The subject of accounting for intangibles is explored 
in Chapter 4.     
 During the growth stage, the biggest challenge facing the innovating SME is dealing 
with the range of issues that demand more money.  Growth life cycle businesses focus on 
running the business in a more formal manner, improving accounting systems and hiring 
more staff to deal with the influx of business activities.  Additional sources of funding may 
become available from retained profits, suppliers, customers, government grants and 
partnerships (public funding e.g. the Creative England Business Loan Fund, Start Up Loans 
etc.),272 banks, private investors, venture capitalists (VCs) and investment funds.273  
However, each  type of funding has advantages and disadvantages coupled with availability 
and accessibility issues.  The funding needs of innovating SMEs are typically high, but their 
ability to raise external debt finance funding is limited because they have insufficient 
traditional tangible assets to offer as security to lenders.   
 Directors of innovating SMEs who own their homes and have equity by paying off a 
mortgage may be in a position to re-finance past mortgages or obtain a home equity line for 
the business.  This is a low cost finance method.   However, for those with family obligations 
using the family home as security is a least favoured innovation finance method.  Sir James 
Dyson had no other option to finance his business.274  ,QDQDUWLFOHHQWLWOHG³%LJ$FKLHYHUV
6KDUHWKH*UHDWHVW5LVNV7KH\(YHU7RRN´275 Kirdahy interviewed Dyson who stated: 
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 Every year I was getting further and further into debt.  In the end, I owed something 
like $4 million USD.  I took out two or three mortgages on my house.276  If I failed, 
HYHU\WKLQJ,RZQHGZRXOG¶YHJRQHWRWKHEDQN(YHU\ERG\ thought I was completely 
mad.  [As it turned out] I repaid the bank loan within about four or five months of 
selling the product.  The bank kept using me in their advertising as an example of how 
they loan money.  
 
 Dyson was only able to obtain the business loan using his home (traditional tangible 
security) rather his FRPSDQ\¶Vburgeoning patent portfolio.   
 Some may be tempted to use credit cards (especially those introductory 0% interest 
free periods), however this is a finance method of last resort as the interest rate ultimately 
charged is typically in excess of 16% and as high as 30%.  The high monthly interest 
payments would become a significant drain on cash flow.   
 The obstacles to accessing debt finance regularly cause innovating SMEs to seek 
alternative funding.  At this juncture they face a funding strategy choice ± should they pursue 
debt, equity or a combination of both? 
 
3.4.1. Debt finance ± the simple business loan contract 
 Debt finance involves a bank advancing money that will be repaid with interest over 
an agreed term or through a rolling arrangement such as an overdraft.  The bank makes a 
profit on the loan transaction by charging interest.  Debt finance can be more complex than a 
simple loan but for our purposes we will limit our discussion to simple loans.  In legal terms, 
it is a contractual arrangement between a business and the lender whereby the borrower pays 
a predetermined amount of interest that is not a function of its operating performance, but 
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which is treated in accounting standards as an expense for tax purposes and is therefore tax-
deductible.  The debt has a fixed life and has a priority claim on cash flows in both operating 
periods and insolvency.  This is because interest is paid before the claims to equity holders 
(e.g. shareholders), and, if the business defaults on interest payments and the loan is secured,  
the lender will sell the secured asset and the amount owed will be repaid before any payments 
are made to equity holders (see s 3.9). 
 Before making the loan, lenders will want to know what the firm will do with the 
money advanced and how it intends to allocate funds to develop the business.  A borrower 
needs to show: (1) what the money will be used for; (2) how long the money will last; and (3) 
how much revenue will be generated by the business to cover repayments.  In a conventional 
business loan, lenders perform careful analyses to make sure the borrower can repay the loan 
based on the business generating a positive cash flow.  In most cases, banks want security for 
the loan which it can take possession of and sell in the event of default in repayment.  As we 
know, this is particularly difficult for an innovating SME whose key assets are intangible 
inventions with patent protection potential.  Further, most lenders do not fund start-ups with 
seed capital, preferring to see a positive track record of revenue and a solid repayment track 
record (a credit history).  In almost all cases, lenders will require a personal financial 
guarantee as additional security (e.g. over real property, shares, mutual funds etc.) for the 
loan.  Lenders will routinely require a statement of personal assets and liabilities.  Ideally, 
WKH\SUHIHUWRWDNHDIL[HGFKDUJHRQSHUVRQDODVVHWVVXFKDVWKHFRPSDQ\GLUHFWRU¶VKRXVH277  
As more people in the UK struggle to become home owners, traditional tangible forms of 
personal security for business loans will decline.  In Banking on IP? the authors stated that, 
³WUDGLWLRQDOIL[HGDVVHWVVLPSO\QRORQJHUH[LVW´278   Inevitably, this will lead to lenders 
contemplating lending against modern intangible forms of personal property including IP.  
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The cost of a standard debt finance business loan includes interest, administrative 
³WUDQVDFWLRQ´ costs, legal fees and the impact of the proposed loan on the firm¶VWD[SRVLWLRQ 
 
3.4.2 Debt finance ± the overdraft facility 
 The most common type of debt or loan financing is an unsecured overdraft facility 
DWWDFKHGWRWKHILUP¶VEDQNDFFRXQW279  Some SMEs will switch banks in order to obtain a 
larger unsecured overdraft facility.  It is D³IDFLOLW\´ because it is an arrangement available at 
WKHERUURZHUV¶GLVFUHWLRQWRXVHLWRU³GUDZGRZQ´ on the pre-authorised funds.  It is a 
³revolving facility´ because the borrower can repay sums borrowed and draw-down further 
sums at will over the life of the facility.  :KHQWKHFRPSDQ\¶VDFFRXQWEHFRPHVRYHUGUDZQ
the bank becomes a financial creditor of the company and the company becomes a debtor.  
As a minimum, the terms of the overdraft facility will state the maximum the company may 
owe the bank at any point in time (the limit), the interest rate payable and the circumstances 
in which the bank can require the company to repay the sum borrowed/overdrawn.       
 While lenders provide general business advice, they do not become directly involved 
in managing the business.  As the global financial crisis worsened in 2008-2009, the 
availability of debt finance fell and the cost of borrowing increased.280  The situation in 2014 
had not improved significantly.  Alisdair Steele, Head of the Financial Sector Group, Nabarro 
LLPO confirms: 
 It is widely acknowledged that banks are no longer meeting the funding needs of 
 businesses, particularly of SMEs. The scale of the funding gap is huge, with estimates 
 of £29bn to £59bn cited for SME financing alone. While the debate over exactly why 
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 this has happened (and what can be done to reverse it) continues, small businesses 
 need to find the funding that will allow them to deliver growth and jobs.281 
 The next section analyses several types of finance: equity, hybrid, mezzanine, online 
crowd and pension-led funding, explaining their advantages and disadvantages relative to 
patent-backed debt finance.   
3.4.3 Private equity finance and venture capital  
 When conventional bank lending is not available for innovation projects that a lender 
PLJKWFODVVLI\DV³specXODWLYH´, many innovating SMEs seek alternative sources of funding 
from private equity investors who make their return from the high growth of the business.  
An innovating SME needs to show they have a viable business plan for an invention with 
high commercial potential.  One method of equity financing involves bringing in 
shareholders for partial ownership in exchange for money and expertise.  Another form 
involves selling part of the business by issuing shares in the private limited company 
(possibly a subsidiary Special Purpose Vehicle) in exchange for money.  While the investors 
may receive a dividend on the shareholding, in the early stages of a business most profits are 
usually retained by the company to grow the business.  The important return for equity 
investors is when the success of the innovating SME allows their shares to be sold at a 
substantial profit.  In return for their cash, private investors will insist on a large equity stake.  
The cost of capital is typically in the range of 20% and as high as 40%.  As with commercial 
lenders,  they are often more interested in larger companies with a business track record, 
rather than start up or early growth stage firms.  Equity investors often, but not always, add 
value in addition to the funding they provide by facilitating contacts from their business 
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network; offering the benefit of their commercial experience; or potentially by serving as 
non-H[HFXWLYHGLUHFWRUVRQWKHLQQRYDWLQJ60(¶VERDUd.    
3.4.4 Venture capital 
 Venture capital (VC), a form of private equity investment, was a critical component 
of financing innovation in the 1980s.  However the amounts funded and the number of 
companies supported by such funding continues to decline.282  As at 2014, VC financing is 
the exception rather than the norm.283  In the 1980s, the VC model comprised mostly wealthy 
individuals investing funds in a business.  As such, investors were able to maintain a patient 
outlook for a significant return on their investment within a timeframe of 10 years or more.   
However, as institutions become more prevalent as VCs, they were able to amass a greater 
quantum of money by syndicating changing the focus from nurturing growth to increasing 
fees based on larger investment syndicates.  To keep shareholders content, VC funds aim for 
maximum liquidity, creating early pay-RIIYLDSUHPDWXUH³H[LWV´UDWKHUWKDQORQJWHUP
investment. 284  Further, VCs favour investment in information technology as this type of 
technology has a lower capital investment requirements.  This preference is problematic for 
the UK, because in contrast to the US, generally only information technology hardware is 
patentable in the UK.  Patents are not granted for business methods285, nor computer 
programs or software unless they provide a technical effect: s.1 (2)(c) Patents Act 1977.  
Such technical effect or character lies not in the simple operation of computers but in effects 
which go further than normal computer operations and involve computer implemented 
inventions.  A consequence of the VC model is that to attract capital, innovating SMEs seek 
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to file patents as early as possible, to accommodate the VC¶s early exit preference.  7KH8.¶V
laws on patentable subject matter are clearly a disadvantage in terms of access to VC 
investment when compared to the US.  It is predicted that in the future, VCs both in the UK 
and abroad, will continue to play a significant, but smaller, role in channelling capital to start-
up firms286 and new hybrid methods of funding will become more common.  The type of 
funding an innovating SME ultimately pursues largely depends on the answers to the 
questions set out in Figure 10 below. 
 
Figure 11   Debt or equity finance? 
Debt finance option Private equity option 
Do I have sufficient assets that can be used as 
security to guarantee the loan? 
Am I will to give up a percentage of control in 
exchange for the funding? 
Am I willing to lose my collateral such as a house in 
the event the business fails? 
Am I willing to take advice from equity investors? 
Am I able to make the required payments to pay off 
the loan? 
Am I will to share the profits of the 
business/invention? 
Do I have a solid financial track record personally 
and in relation to past business ventures? 
Am I skilled enough to make a series of presentation 
to investors about the invention to persuade them of 
its potential for growth and high returns? 
  Source:  Valuation and exploitation of intellectual property and intangible assets (2003) 
 
 
 
3.4.5 Mezzanine finance  
 
 Mezzanine finance combines elements of debt financing and equity investment 
(hybrid finance) and can provide a relatively inexpensive financing alternative for early 
growth stage SMEs where there is an element of risk.287   It is not a source of start-up funding 
and is now available from OHQGHUVZKRDFNQRZOHGJHWKH³IXQGLQJJDS´ and the need to adapt 
the traditional lending model to the unusual dynamics of innovation.  One is Santander plc,288 
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a UK bank wholly owned by the Spanish Santander Group.  Mezzanine finance providers 
W\SLFDOO\DOWKRXJKQRWXQLYHUVDOO\VHHNWRVKDUHLQWKHILUP¶VJURZWKE\EXLOGLQJDQHOHPHQW
of equity investment as part of the finance transaction.  Figure 11 illustrates the tiers of 
finance available at different stages of the business lifecycle - the figure to the right indicates 
the approximate cost of the finance as a percentage of the amount borrowed.   
 
Figure 12   Tiers of finance 
 
 This equity component means that mezzanine providers are much more comfortable 
with risk.  The cost of equity is lower, in the range of 15% ± 25%, less than in a conventional 
VC investment, but higher than a commercial bank loan.  Mezzanine finance sits between 
conventional debt finance and private equity and may be more ³FDVKIORZIULHQGO\´.  In 
contrast with a term loan that requires regular repayments (monthly or quarterly) which 
reduces cash available to the firm, mezzanine loans are usually repaid at annual intervals.  
The mezzanine loan is structured so that a high proportion of the money is repayable towards 
the end of the life of the loan agreement.  This funding strategy enables the innovating SME 
to implement its growth strategy with lower loan repayments and consequently less impact on 
cash flow at the front end of the term of the loan.  +RZHYHU6DQWDQGHUDGYLVHV³WKLVFDQEHD
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double-edged sword, as a company that fails to deliver on its growth protections will 
nevertheless be looking at large rHSD\PHQWVWRZDUGVWKHHQGRIWKHWHUP´289  The problem for 
innovating SMEs is that most mezzanine finance providers operate at the larger end of the 
market and few offer loans less than £10 million.  Accordingly, mezzanine finance, despite 
its advantages, is currently not a feasible option for the majority of innovating SMEs in the 
early stage of their business life cycle.   
 
3.4.6 Debt finance by way of a syndicated loan  
 A sophisticated method of debt finance is the syndicated loan.  We saw earlier in 
Chapter 1 WKDWWKLVPHWKRGZDVXVHGE\WKH35&¶V&KLQD'HYHORSPHQW%DQNZKLFKOHGD
consortium of lenders to fund Quanlin Paper.  A loan is entered into between a company and 
more than one lenGHUZKRDUHWKHQNQRZQDVWKH³V\QGLFDWH´RIOHQGHUVRU³EDQNV\QGLFDWH´.  
The loan is usually substantial and the contractual arrangements between the various lenders 
and the borrowing company can be complex and require professional legal advice.  There is 
XVXDOO\DOHDGOHQGHURU³XQGHUZULWHU´ of the loan which is often the bank providing the 
largest proportion of the funds.  The main reason for syndicated loans is reduce the risk to the 
lenders by sharing the risk of the company not being able to replay the large sum of money 
borrowed between them.  The loan transaction costs will be higher given the various parties 
that need to be involved which makes such loans only viable if a large sum is to be borrowed.  
London continues to be one of the most active centres for the arrangements of syndicated 
loans.290  Syndicated loans would appear to have solid potential for patent-backed lending 
given the reduced level of risk to each lender, however the transaction costs involved may be 
high for the innovating SME at the early growth stage.   
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3.4.7 Convertible Debt 
 A convertible debt is another form of hybrid finance whereby the loan can convert to 
equity (shares in the business) instead of repaying the loan.  A better interest rate is usually 
available.  However, if the loan is not repaid, equity in the business will be lost.  American 
financier Peter Thiel entered into a convertible debt finance arrangement with entrepreneur 
Mark Zuckerberg at an early stage in )DFHERRN,QF¶Vbusiness lifecycle.291 
 
3.4.8 Financing options beyond the growth stage  
 Expanding companies are those that have succeeded in attracting clients and 
establishing a market presence.  They are likely to be financed by private equity and/or VC in 
DGGLWLRQWRRZQHUV¶HTXLW\DQGEDQNGHEW± in other words, a mix of funding sources.  High 
growth companies with rapidly growing revenues may seek to publicly trade shares for 
example on the London Stock Exchange (LSX) Alternative Investment Market (AIM).  Firms 
issue equity in the form of shares and other financial instruments, known as an initial public 
offering (IPO).  However, substantial fees and charges are involved in floating a new 
company as well as additional expenses in connection with a variety of professional advisors.      
Debt issuers must pay an admission fee to list debt on the LSX ± for standalone issues from 
UK domestic issuers, the fee is based on the face value of the share where it is admitted to 
trading292 plus VAT of 20%; and the UK Listing Authority also charges vetting fees on all 
listing applications.  In reality, few SMEs have the opportunity to float via AIM or achieve a 
full listing on the LSX main market.  A public listing is a more realistic funding option for 
firms in the expansion phase of the business lifecycle, whereas the focus of the thesis 
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between start up and growth.  Mature companies typically finance their activities by 
combination of internal financing, debt and equity.   
 
3.4.9 New financing models ±CrowdFunding293 and Peer-to-Peer Lending 
   
 If traditional lenders fail to move with the times, they may find that their out-dated 
lending model will be swept away E\DOWHUQDWLYHVVXFKDVRQOLQH³CrowdFXQGLQJ´DQG³3HHU-
to-3HHU/HQGLQJ´294  These are e-platforms via websites whereby patent owners can pitch 
their ideas, outlining to members of the public exactly how much funding they require to 
develop and commercialise their inventions inviting them to lend (debt CrowdFunding) or 
invest small amounts of money in shares (equity CrowdFunding).  The funds raised are then 
used as seed or start-up capital.     
 The CrowdFunding model is is rapidly evolving now that more online platforms are 
EHLQJIRUPDOO\UHJXODWHGE\WKH8.¶V)LQDQFLDO6Hrvices Authority (FSA) to protect 
investors.  In July 2011, Abundance Generation was the first debt finance online 
CrowdLending platform regulated by the FSA.  This online private equity platform does not 
facilitate direct investment in small businesses as such, rather it holds shares in a company as 
DQRPLQHHDQGPDQDJHVWKHPRQLQYHVWRUV¶EHKDOI The public are able to invest small 
amounts (as little as £10) in unlisted businesses (usually with no upper limit) without the 
need to use a traditional stock exchange such as the LSX.  Such websites create a public 
market minus some of the traditional market control mechanisms that are required when 
listing on a stock exchange and are a low cost option for attracting investment.  Costs are 
further reduced as the companies hoping to attract investment do not necessarily even have to 
sell HTXLW\LQVWHDGWKH\FDQJLYH³GLVFRXQWV´DQG³UHZDUGV´ in the form of free goods in 
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exchange for funding.  According to the FSA, most CrowdFunding platforms require a 
specified target to be reached during the fundraising period before the money is passed to the 
business ± the ³DOORUQRWKLQJ´ model - with contributions returned to investors if the target is 
not met.295   In February 2013, the FSA authorised CrowdCube with more e-platforms to 
follow.  The main advantage is gaining direct access to an enormous pool of investors at a 
much lower cost than private equity investors or lenders are willing to offer.     
 
3.4.9.1 Crowdfunding and IP issues 
 While it is positive that the UK financial services industry and the FSA are reacting 
dynamically to this new funding model,296 the advantages for innovating SMEs are not so 
clear-cut.  This is due to the unique features of the patent law system and the requirement of 
³DEVROXWHQRYHOW\´ as a criterion for obtaining patent monopoly protection.  A basic 
requirement under section 2 PA 1977 is that the invention be novel (new) and if a patent 
application does not satisfy this condition, it will not be granted by the UK IPO.  This legal 
requirement cannot be fully understood without first being aware of another fundamental 
concept in patent law.  The priority date of the patent application is the date on which it is 
WHVWHGDJDLQVWWKH³VWDWHRIWKHDUW´, 297 normally the fLOLQJGDWHRIWKHDSSOLFDWLRQ7KH³VWDWH
RIWKHDUW´FRPSULVHV all matter made available to the public before the priority date of the 
invention.298  This includes all knowledge anywhere in the world on the subject matter of the 
invention.  Novelty-destroying prior art could include information that is part of common 
general knowledge, information disclosed by an earlier user of the invention, information 
disclosed in a single copy of a published document or by oral communication.  A business 
must keep a potentially patentable invention absolutely confidential until a patent application 
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is filed.  Only then will then will they be able to freely disclose the invention to the public via 
the online funding platform.  Therefore a key challenge is that the patentable details of the 
invention could be exposed to the public, fall into the public domain, become part of common 
general knowledge thereby destroying novelty and the potential to acquire both a patent 
monopoly and create a valuable business asset.  The practical answer to the loss of novelty 
problem is to file any patent application(s) before accessing a CrowdFunding platform.   
 A further IP law issue arises if the innovating SMEs (pitch creator) accidentally 
and/or unknowingly incorporates IP from a third party IP rights holder for which a user 
licence is needed, giving risk to an infringement claim. The risk of potential IP infringement 
could result in loss of business, revenue, reputation and competitive advantage.  However, if 
the required licences are obtained, higher funding levels may be achieved.299  At present 
however many innovating SMEs have a low level of knowledge or understanding of patent 
law principles and patentability requirements.300  Those with conscious knowledge of patent 
law principles will be best positioned to secure funding without compromising their existing 
or future patent rights.  Further, if the funds are actually needed to pay patent application 
costs and patent attorney fees, innovating SMEs using CrowdFunding platforms may risk 
being unablHWRSDWHQWWKHLULQYHQWLRQLI³QRYHOW\´ is destroyed by disclosing how it works 
online.  Nevertheless, CrowdFunding is a new option with considerable potential.  As yet, no 
data available in the UK about innovating SMEs financed via regulated platforms.  In the US, 
one success story is that of Dan Provost and his partner Thomas Gerhardt who raised 
$137,000 USD (although they initially only asked for $10,000 USD) in 2010 via the 
Kickstarter301 for their simple yet well-designed The GLIF iPhone 4 Tripod Mount and Stand 
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invention.  They received financial support to commercialise their prototype from over 5000 
investors who could buy shares and pre-order based on the prototype.302   
 
Figure 13   The GLIF iPhone 4 Tripod Stand and Mount 
 
Photo credit: https://www.kickstarter.com/projects/danprovost/glif-iphone-4-tripod-mount-and-stand 
  
 No doubt more successful examples of how CrowdFunding has assisted inventors and 
innovating SMEs will continue to materialise.  Supporters of this funding method assert that 
it enables: (1) ideas, which conventional financiers spurn, an avenue through which to attract 
IXQGLQJYLDWKH³ZLVGRPRIWKHFURZG´; and (2) a receptive market to be identified.303  
However, innovating SMEs will need patent law advice to protect their position and 
invention before pitching to raise money on CrowdFunding platforms.  
3.4.9.2 Pension-led funding 
 
 Given the draught of bank lending, many businesses are considering non-bank lending  
finance options.  Pension-led funding uses WKHRZQHU¶Vaccrued pension funds to invest in 
their own innovating SME or larger company.  It enables the owner (typically a 
director/shareholder) with a good size pension pot to obtain funding, essentially a commercial 
loan from the pension fund, without having to provide a personal guarantee to a lender (e.g. 
over the home or other personal assets) by using IP assets to secure the loan.  Once the value 
of the patent assets has been established, the pHQVLRQ¶s trustees agree to lend money to the 
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firm secured against the patent assets or buy some or all of the patents.  As the innovating 
SME generates an income stream from its business activities, it repays the pension scheme.  
It applies to directors and/or senior executives accumulated pensions and does not affect 
employee pensions.  In the event of non-payment, only those pensions are at risk. Thus, 
pension-led funding shifts business risk to the individual(s) directors/senior executives.   
 If the innovating SME defaults, the pension scheme is protected from external 
creditors.  However, as a creditor itself to the business, the pension scheme will suffer a loss 
or be written off entirely.  One view is that pension-led funding is less risky for the 
innovating SME than a traditional bank loan which is only viable as long as the lender is 
willing to supply funds.  With pension led funding the directors may be appointed as trustees 
and have more control.  In addition, there will be no bank charges although there will be legal 
costs in drafting the pension loan documentation.  If a pension scheme member retires, the 
value of the IP may be adversely affected depending on his or her role within the business.  
This type of non-bank lending only has potential for pension-rich innovating SMEs.  
 
 
3.4.10 UK innovating SMEs and access debt finance 
 
 Financing a business is not static.  Rather the financing models change over time in 
response to the business life cycle; the relative costs of different types of financing; and their 
impact on control or ownership of the business.  The amount of funding depends on business 
needs, whereas the type of financing arrangement used to obtain the required funding will 
largely by determined by the relative costs of different types of financing.  Assuming a key 
corporate objective is to maximise profits, then a business will prefer least expensive finance 
and no loss of control or ownership of the business.  At present, debt finance is available for 
well-run, profitable companies of any size provided they generate regular cash flows with 
traditional assets to act as security e.g. property, machinery, other capital assets, cash, stock, 
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receivables, etc.  The problem for innovating SMEs is when they are only able to provide 
intangibles as security.  Commercialising an invention is a lengthy process and establishing 
regular cash flows, either via purchasing orders or a licensing revenue streams is challenging.  
In light of the global financial crisis,304 lenders are more cautious about the scale of their 
commercial lending and quality of the assets offered as security.305  In April 2013 the 
International Monetary Fund (IMF) pointed out that a continuing problem for UK fiscal 
policy is that growth in the private sector is still being hampered by a lack of debt finance: 
 
 In the euro area, real GDP is projected to contract by about ¼ percent this year 
 before growing again in 2014. Credit channels are broken: better financial conditions 
 are not yet passing through to companies and households because banks are still 
 hobbled by poor profitability and low capital.306 
 
 7KH%LJ,QQRYDWLRQ&HQWUH¶s Entrepreneurial Finance Hub307 is presently developing 
an investment and trading finance platform (physical and digital) to finance high-growth 
firms through critical phases of growth.  The project has promise, but is at an early stage.  A 
group of high profile banks, business incubators, universities, global corporates, alternative 
finance providers, VCs and business angels, government agencies are participants.   
 The next section investigates the types of funding innovation firms surveyed by 
WIPO actually used to develop their inventions and get them to market. 
 
  
                                                 
304
 Supra [24] 
305
 Fraser, S. The Impact of the Financial Crisis of Bank Lending to SMEs: Economic Analysis from the EU 
Survey of SME Finances (July 2012) University of Warwick, Report prepared for the Breedon Review of 
Business Finance for the Department of Business Innovation and Skills at pp4-6 
306
 http://www.imf.org/external/pubs/ft/survey/so/2013/RES041613A.htm  
307
 www.biginnovationcentre.com/entrepreneurial-finance-hub 
115 
 
3.5 WIPO IP Advantage database analysis 
 In 2010, WIPO launched IP Advantage308 a database of over 100 case studies 
covering 48 different countries which profiles the experiences of inventors, creators, 
entrepreneurs and researchers - the only database of its kind that has an innovation finance 
component, as far as the author is able to ascertain.  It provides an intuitive interface that 
enables one to search according to type of IP and the focus (e.g. R&D, financing).  IP 
Advantage is a valuable and unique resource as the case studies provide a rare opportunity to 
analyse how innovating SMEs obtain finance to commercialise their inventions. A database  
search was made VHOHFWLQJ³SDWHQWV´ DQG³ILQDQFLQJ´as the focus returning 19 case studies 
for evaluation, including 4 from the UK.  The dataset captures the financing experience of a 
collection of innovating SMEs in the recent past.  The basic proposition is that patent-backed 
debt financing will feature rarely, if at all, as funding PHWKRGJLYHQOHQGHUV¶DSSDUHQW
aversion to using patents as security.  Figure 13 below contains a table summarising the IP 
Advantage results.  The country, company name and industry sector is set out for each entry, 
followed by a brief description of the finance method used, classified and colour coded 
according to type:  self-finance, public, private or debt. 
 
  
                                                 
308
 The IP Advantage is based on a proposal and funding from the Japanese government and is one of the first 
concrete deliveries of the WIPO Development Agenda project were agreed by member states at the end of 2009.  
French and Spanish versions are under development. At 
http://www.wipo.int/pressroom/en/articles/2010/article_0037.html  
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Figure 14   (YDOXDWLRQRI:,32¶VIP Advantage Case Studies focussing on Patents and Financing 
Country Name/Industry Financing Type 
Argentina Descorjet SA - Durable Household Products Private funding 
Australia ITL Limited  - Health Care Equipment and Services Self-financing 
Public funding 
Brazil  FK Biotecnologia S.A - Pharmaceuticals and Biotechnology Private funding (VC) 
Chile/USA Florencio Lazo Barra ±Farming, Fishing & Engineering Public funding 
Colombia Ecoflora S.A.S Corporation Colombia  N/A 
Denmark Borean Pharma A/S Pharmaceuticals and Biotechnology Public funding 
Private funding (VC 
syndicate) 
India/ USA Dr Ashok Gadgil  - Durable household Products Public funding 
Indonesia Indonesian Planters Association for R&D (IPARD), Dept. 
of Agriculture - Pharmaceuticals and Biotechnology 
Public funding 
Italy GEOX S.P.A. - Clothing, Footwear Debt finance 
Japan Tefco Aomori Co Ltd Chemicals, Clothing and Accessories Private funding 
Japan Yamanashi Hitachi Construction Machinery Co. Ltd.  Private funding 
Nigeria EAT-SET Industries - Health Care Equipment and Services Self-financing 
Public funding 
Private funding 
Nigeria/USA Bioresources Development and Conservation Programme 
Pharmaceuticals and Biotechnology 
Public funding 
Private funding 
Singapore iTwin Ptd. Ltd / The Institute for Infocomm Research 
(I2R)Technology Hardware and Equipment 
Public funding 
Private funding (VC) 
UK Surface Processing Limited Chemicals Public funding 
UK Faveo Ltd - Clothing and Accessories Public funding 
Debt finance refused. 
UK Junkk.com Ltd - Packaging Public funding 
UK MakMarine - Industrial Engineering Self-financing 
Public funding 
Zimbabwe Algorhythm Private Limited Industrial Engineeing Self-financing 
Private funding including 
(VC) 
 
Source of data:    WIPO IP Advantage Database  
Colour-coding Key: Self-financing, Private Finance, Public finance, Debt finance 
    
 The pilot study provides quantitative data on the type of financing successfully 
sourced by international innovating SMEs in their home countries which are all WIPO 
members and adhere to TRIPS.309   
Figure 15 Statistical  analysis of the types of finance used 
 
Type of finance Number of firms Percentage 
Public finance 12 63% 
Private Finance 9 47% 
Self-financing 4 22% 
Debt finance 1 5% 
 
                                                 
309
 The TRIPS Agreement is Annex 1C of the Marrakesh Agreement Establishing the WTO, signed in 
Marrakesh, Morocco on 15 April 1994 to which the UK is a signatory.  
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 In 12 out of the 19 case studies (63%) the evidence shows the importance of public 
funding in the form of grants and financial assistance to support R&D and other business 
expenditure.  This was closely followed by equity finance which featured in 9 cases (47%); 
then to a lesser extent, self-financing in 4 cases (22%); and lastly, debt finance obtained in 
only 1 case (5%).  This pattern follows the traditionally held view that early growth stage 
business primarily rely on public funding.  Debt finance features rarely (as predicted).   
However, in most cases the firms accessed a funding mix.  Figure 15 below sets out the 
statistics depicting the funding mix sourced by the firms.   
 
Figure 16 Mix of financing types used in the cases studied 
 
Mix of funding Number of firms Percentage 
Self-financing only Nil 0% 
Public funding only 5 26% 
Debt finance only 1 5% 
Private Finance only 4 21% 
Self-financing & Public funding 2 11% 
Public funding  & Private funding 3 16% 
Self-financing & Private funding 1 5% 
Self-financing, Public funding  & Private funding 1 5% 
 
 The data reveals only 2 out of the 19 firms even applied for banks loans.  Of those 2, 
only 1 case (5%), the Italian firm GEOX, successfully accessed debt finance.  This figure 
PDNHVWKHDXWKRU¶VDUJXPHQWthat debt finance is underused powerful and persuasive.  Even 
more importantly, none of the UK cases studied obtained debt finance, although Faveo Ltd 
documented that it unsuccessfully applied.  It is recommended that UKIPO/BIS collect 
similar innovating SME case studies to shed more light on debt-finance situation in the UK.  
,QWKHDXWKRU¶VYLHZLWLVOLNHO\WKH WKDWILUPVSDUWLFLSDWLQJLQ:,32¶V IP Advantage database 
would have described both negative and positive attempts to obtain bank loans as they were 
GLUHFWO\DVNHGWRUHSRUWRQµtheir experience in financiQJWKHLULQQRYDWLRQV¶A further 
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outcome of the dataset analysis demonstrates that debt finance did not even feature as part of 
a funding mix nor was there a single documented instance of patent-backed debt finance.  
These are the most significant aspects of the IP Advantage multi-case study in relation to 
innovating SMEs and patent-backed debt finance.  The results of the IP Advantage database 
analysis are compelling, providing a portrait of the bleak environment facing innovating 
SMEs.  This is preliminary evidence that change is required and that a shift in the innovating 
SME-lender relationship is desperately needed.  Funding is critical to the survival of 
innovating SMEs as they face unique overheads (discussed in section 3.3) that simply do not 
exist in other creative businesses.  Further, several prototypes are needed to bring the 
invention to market, a process which can take several years.  Commercialisation will take 
eveQORQJHULIWKHQHZWHFKQRORJ\³GLVUXSWV´ existing markets.  Yet, it is precisely disruptive 
technology that has the most positive impact on society in the long term and the biggest 
returns.  These overheads are unique to patent innovation and not required for other types of 
creative businesses, resulting in a less favourable finance environment for innovating SMEs.  
 
 
3.6 Implications and recommendations for future research  
 
 Over the past decade there has been a growing interest in the SME ³IXQGLQJJDS´ and 
how to facilitate access to patent-backed debt finance necessary for innovation firms to grow. 
The evidence from the IP Advantage database analysis confirms that banks are not important 
sources of credit for innovating SMEs. Large financial institutions are costly to run and are 
geared to serving the needs of customers for whom the volume of activity justifies the costs 
of acquiring information about the LQQRYDWLQJ60(¶Vprospects, intangible patent assets and 
ability to repay. Even if one assumes that the cost of ascertaining creditworthiness was not a 
GHFUHDVLQJIXQFWLRQRIWKHERUURZHU¶VVL]HDQGQXPEHURI\HDUVLQRSHUDWLRQWKHFRVWWRWKH
bank per pound (£) loaned is greater for SMEs than for large-scale enterprises.  The 
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difficulties are likely to be greater for innovating SMEs outside the main financial centres.  
The author feels strongly that debt finance holds significant untapped potential for both 
innovating SMEs and lenders.  The pilot study has clear implications for policy makers, 
lenders and borrowers despite the small sample size.  Innovating SMEs require additional 
public finance support to enable them access private debt finance. Commercial banks do 
engage in patent-backed lending to larger firms with significant patent portfolios and other 
assets, but that lending experience needs to flow downstream to innovating SMEs. 
 Next we identify how banking capital adequacy requirements impact on patent-
backed lending.   
 
3.7 Basel III banking capital adequacy requirements: impact on patent-backed 
 debt finance 
 Research has identified that the global financial crisis310 actually had little to do with 
traditional banking, commercial lending or, indeed, bankruptcies.  In 2008-2009, banks that 
were vulnerable because they had too much debt simply cut back sharply on their lending.  
The severe credit crunch was caused by a combination of excessive bank borrowing, thus 
carrying too much debt, couSOHGZLWKWKHULVHDQGIDOORI³VHFXULWL]HG´ lending, which enabled 
banks to originate loans but then repackage and sell them on coupled with a lack of 
transparency.311  In response, bank regulators imposed tighter restrictions.  Josef Ackermann, 
then CEO of Deustche bank, asserted in an interview that tighter restrictions on bank 
ERUURZLQJ³ZRXOGUHVWULFW>EDQN¶V@DELOLW\WRSURYLGHORDQVWRWKHUHVWRIWKHHFRQRP\7KLV
reduces growth DQGKDVQHJDWLYHHIIHFWVIRUDOO´312  However, Admati and Hellwig argue that 
$FNHUPDQQ¶VVXJJHVWLRQWKDWDFKRLFHPXVWEHPDGHEHWZHHQHFRQRPLFJURZWKDQGILQDQFLDO
                                                 
310
 Supra [24] 
311
 Final Report of the National Commission on the Causes of the Financial and Economic Crisis of in the 
United States (January 2011) The Financial Crisis Inquiry Commission Pursuant to Public Law 111-21 
Washington, DC at p xvii; Ferguson, N. (2012); Admati, A. and Hellwig, M. (2013) p4 
312
 JRVHI$FNHUPDQQLP*HVSUDFKµ2KQH*HZLQQLVWDOOHVQLFKWV´ interview Suddeutsche Zeitungµ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stability, rather than have both, is unnecessary.  Instead they ask³ZK\ZRXOGUHVWULFWLRQV on 
EDQNERUURZLQJKDYHDQ\HIIHFWRQEDQNOHQGLQJDWDOO"´313  ,QWKH%ULWLVK%DQNHUV¶
$VVRFLDWLRQ%%$FODLPHGWKDWWLJKWHUQHZUHJXODWLRQVZRXOGUHTXLUH8.EDQNVWR³KROGDQ
extra £600 billion of capital that might otherwise have been deployed as loans to businesses 
RUKRXVHKROGV´314  Admati and Hellwig comment that although this statement sounds 
reasonable, it is misleadLQJGXHWRWKHXVHRIWKHZRUG³FDSLWDO´.  They explain further: 
 
 In the language of banking regulation, this word refers to the money the bank has 
received from its shareholders or owners.  This is to be distinguished from the money 
it has borrowed.  Banks use both borrowed and un-borrowed money to make their 
loans and other investments.  Un-borrowed money is the money that a bank has 
obtained from its owners if it is a private bank or from its shareholders if it is a 
corporation, along with any profits it has retained.  Elsewhere in the economy, this 
type of funding is referred to as equity.  It banking, it is called capital.    
 
 
 &DSLWDOUHJXODWLRQUHTXLUHVWKDWDVXIILFLHQWIUDFWLRQRIDEDQN¶VLQYHVWPHQWVRUDVVHWV
be funded with un-borrowed money.  This is similar to the requirement that a home 
buyer make a minimum down payment when buying a house.  Having a minimal ratio 
of un-borrowed funds relative to total assets is a way to limit the share of assets that is 
funded by borrowing.  Because un-borrowed funds are obtained without any promise 
to make specific payments at particular times, having more equity enhances the 
                                                 
313
 Admati, A. and Hellwig, M. 7KH%DQNHUV¶1HZFORWKHV:KDW¶VZURQJZLWK%DQNLQJDQG:KDWWR'RDERXW,W 
(2013) Princeton University Press, p5 
314
 µ7LJKWHU%DQNLQJ5XOHV:LOO'UDLQWUIURP)LQDQFLDO6\VWHP6WXG\6KRZV¶-XO\7KLVZDVUDLsed 
before the G20 in June 2010, referring to a preliminary report prepared by PricewaterhouseCoopers, at the 
EDQNLQJLQGXVWU\¶VUHTXHVW 
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EDQNV¶DELOLW\WRDEVRUEORVVHVRQLWVDVVHWV315   
 
 7KH%%$¶VVWDWHPHQWLPSOLHVWKDWFDSLWDOUHTXLUHPHQWVDUHDERXWKRZPXFKDEDQN 
ERUURZVDQGWKDWFDSLWDOLVD³FDVKUHVHUYH´ that banks hold and must not use to make loans.   
In reality, capital regulations set out only what percentage of the fund they use must be un-
ERUURZHG7KHUHIRUHDVGHPRQVWUDWHGE\$GPDWLDQG+HOOZLJWKH%%$¶VVWDWHPHQWWKDW
tighter capital adequacy regulations would require UK EDQNVWR³hold an extra £600 billion of 
capital´ does not make sense.  The implication that loans to businesses or households are 
automatically reduced by that £600 billion is incorrect.  Rather, capital requirements do not 
prevent banks from lending and have no automatic effect on bank lending.  If capital 
requirements are increased or are higher for loans against intangible assets, there is nothing in 
the regulation that prevents corporate banks from issuing additional shares and raising new 
funds to make loans they might find profitable.  Capital regulation does not force banks to 
reduce their capacity to make loans.  Viable banks can increase their reliance on un-borrowed 
funds without any reduction in lending.    
 This is an extremely important argument that innovating SMEs and government 
policy makers need to vigorously make to the BBA who would assert that tighter regulation 
prevents them from lending.  The nature of the capital adequacy requirements mandated by 
Basel III (the Third Basel Accord) with which banks need to comply when lending against 
intangible assets is discussed further below. 
 Basel III is the third in a series of comprehensive reform measures developed by 27 
member countries of the Basel Committee on Banking Supervision, to strengthen the 
regulation, supervision and risk management of the global banking sector.  It includes a 
global, voluntary regulatory standard on capital adequacy.  It originated in response to 
                                                 
315
 Supra Admati [312] pp5-6  
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deficiencies in banking regulation that emerged during the global financial crisis.316 The aim 
is to make banks better placed to absorb financial shocks in the long term, by increasing the 
size of capital reserves a bank must hold against losses.317  Under the new reforms, banks 
must progressively reach a minimum solvency ratio of 7% per cent by 2019.  The solvency 
ratio is calculated by dividing Regulatory Capital by Risked Weighted Assets.  Before Basel 
III the solvency ratio was 2%.  The new 7% minimum is being phased in and implementation 
is now extended to 31 March 2018.318  Under Basel III, intangibles are rated as riskier types 
of assets and are treated as lower quality security.  The definition of capital means that 
intangibles (e.g. patents) must be deducted from the regulatory capital.  As such, intangible 
DVVHWVDUHQRWXVXDOO\FRXQWHGWRZDUGWKHORDQ¶VVHFXULW\ because these intangible IP assets 
are considered too difficult to value.319  Set out below is the regulatory adjustment to be 
applied to Common Equity Tier 1 regulatory capital according to the Basel Committee for 
Banking Supervision: 
 
 
 
 Goodwill and other intangibles (except mortgage servicing rights) 
 67. Goodwill and all other intangibles must be deducted in the calculation of Common 
Equity Tier 1 capital, including any goodwill included in the valuation of significant 
investments in the capital of banking, financial and insurance entities that are outside 
the scope of regulatory consolidation.  With the exception of mortgage servicing 
rights, the full amount is to be deducted net of any associated deferred tax liability 
                                                 
316
 Supra [24], [310] 
317
 µ,QWHUQDWLRQDO5HJXODWRU\)UDPHZRUNIRU%DQNV%DVHO,,,&DSLWDO¶ (June 2011) Basel Committee for 
Banking Supervision, Bank for International Settlements 
318
 µ%DVHO,,,$JOREDOUHJXODWRU\IUDPHZRUNIRUPRUHUHVLOLHQWEDQNVDQGEDQNLQJV\VWHPV¶'HFHPEHU
Revised June 2011) Basel Committee for Banking Supervision, Bank for International Settlements pp6-23 
319
 µ8VLQJ3DWHQWVDV&ROODWHUDO&DQ)UHH8S)XQGVIRU*URZLQJ%XVLQHVVHV¶DWhttp://www.ipnav.com/blog 
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which would be extinguished if the intangible assets become impaired or 
derecognized under the relevant accounting standards.320   
  
 Basel III includes a voluntary bank loan rating standard which indicates the degree of 
risk regarding timely payment of the bank facility being rated.  The guidelines also require 
banks to provide capital on the credit exposure as per the credit rating assigned by approved 
credit assessment institutions.  The implication of Basel III on patent-backed debt finance is 
the hLJKHUOHYHORI³ULVN-ZHLJKWLQJ´ that applies to intangible assets in contrast with other 
forms of assets such as cash or currency that are zero risk.  If loans are secured against 
intangibles such as patents, the bank is legally obliged to make appropriate capital adequacy 
provision.  This is unhelpful with respect to nurturing the development of patent-backed 
lending.  In simple terms, BaVHO,,,UHJDUGVLQWDQJLEOHVDV³WR[LF´ assets that should be treated 
carefully.321     
 Basel III capital regulation is perceived by banks to be a major a barrier to the 
development of patent-backed lending in the UK.  Yet, Richard McCarthy, UK head of 
EDQNLQJDW.30*VDLG³:HKDYHWRUHPHPEHUWKDWEDQNLQJUHTXLUHVULVN-taking, yet in the 
rush to clean up the past, both banks and regulators have lost sight of thLV´322   
 Capital adequacy requirements should not be a barrier to lending per se as 
demonstrated by Admati and Hellwig.323  In their analysis, capital regulation does not force 
banks to reduce their capacity to lend, rather lenders need to increase their reliance on un-
borrowed funds.  Greater understanding of the implications of capital adequacy requirements, 
intangible asset risk weightings and improved dialogue between the stakeholders is 
                                                 
320
 Supra [316] p21-22 
321
 Definition of Basel III, Financial Times Lexicon at http://lexicon.ft.com/term?term=basel-iii 
322
 (FFOHV/µ+RZEDQNOHQGLQJIHOOE\%LOOLRQLQILYH\HDUV¶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 Supra Admati [312] 
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necessary.  The impact of Basel III on intangibles and commercial lending should be 
addressed by future research carried out by a multi-disciplinary panel of experts, beyond the 
scope of this thesis.    
 
3.8 7KHOHQGHUV¶WULDGRIFRQFHUQVXQFHUWDLQW\ULVNDQGOLTXLGLW\ 
 
 When an innovating SME approaches a lender to apply for a loan (debt finance to 
grow), the typical response is WKDW³,3GRHVQ¶WFRXQW´IRUWKHUHDVRQVH[SODLQHGDERYH.  In 
addition, the lender has a well-established triad of concerns when carrying out a credit 
appraisal:  (1) uncertainty of valuation; (2) legal risks; and (3) liquidity as illustrated below.   
 
Figure 17 /HQGHUV¶7ULDGRI&RQFHUQV 
 
                           Patent Value Uncertainty 
 
 
 
   Legal risks            Liquidity 
 
 This thesis focuses on the initial stDJHRIFUHGLWDSSUDLVDOZKHQWKHLQQRYDWLQJ60(¶V 
patent assets are identified and then quantitatively and qualitatively valued, although it is 
acknowledged that legal risks and liquidity issues form part of a comprehensive credit 
appraisal.  The mechanics of a simple patent-backed debt finance transaction are set out in 
Figure 18 below. 
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Figure 18  Example of a secured transaction involving a patent portfolio 
  
 At WKHRXWVHWRIWKHFUHGLWDSSUDLVDODNH\DUHDRIXQFHUWDLQW\IURPWKHOHQGHU¶VSRLQW
of view is that nothing exists to quickly tell the lender how to value the patent or small patent 
portfolio.  This results in uncertainty and impacts on the level of legal risk assigned to the 
particular patent asset.  A determining factor in the decision to lend is the availability of 
security, especially in the case of innovating SMEs with no established track record.324  
Further, small firms are most likely to fail and produce the least asset recovery value.325  This 
demonstrates the importance of available security - the lender needs more relevant accurate 
information about the LQQRYDWLQJ60(¶VSDWHQWVDQGWKH potential to generate an income 
stream to lend prudently and appropriately.  If the valuation is favourable and the lender 
proceeds with the patent-backed loan, then creating an effective security interest in the 
patent(s) is a primary concern.  Exploring the nature and historical basis for the patent 
financial valuation problem is the subject of Chapter 4.  In the next section, the legal risk 
arising from the UK procedure for lenders to register notice of their security interests in 
patents is examined.     
 
  
                                                 
324
 µ)LQDQFHIRU6PDOO)LUPV¶%DQNRI(QJODQG6L[WK5HSRUWS 
325
 µ&RUSRUDWHLQVROYHQF\LQWKH8.$'HFDGHRI&KDQJH¶Association of Business Recovery 
Professionals Tenth Report, p9 
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3.9 Registering security interests in patents 
 Banks are unwilling to lend significant sums of money to small companies on an 
unsecured basis.  The distinction between secured and unsecured lending is important 
because of the enhanced legal rights afforded the secured creditor relative to an unsecured 
creditor.  This section examines the existing UK legal framework and outlines the specific 
legal issues and risks arising when using patents and/or patent applications as security. 
 The starting point is the PA 1977 which qualifies a patent as personal property,326  a 
registrable right that can be used to secure obligations.  The PA 1977 and the Patents Rules 
2007 (SI2007/3291) also govern the security interest voluntary registration regime for UK 
patents which are registrable in the specialist UK Register of Patents (the Patents Register).  
The Patents Register is maintained by the Comptroller-General of Patents, Designs and Trade 
Marks at the UKIPO.   
 In general, the key concepts in the field of secured transactions: (1) creation of the 
security interest; (2) registration, and (3) priority.  ³&UHDWLRQ´ is the process by which the 
lender REWDLQVVHFXULW\LQWHUHVWVLQWKHGHEWRU¶VDVVHWVYLDDVHFXULW\DJUHHPHQWGRFXPHQWing 
the teUPVDQGFRQGLWLRQV³5HJLVWUDWLRQ´ is the process by which the lender ensures that, by 
giving notice, its security interest will be effective against third parties ± especially against 
the insolvency administrator or other creditors of the debtoU³3ULRULW\´ means the relative 
ULJKWVRIRQHFUHGLWRUZLWKDVHFXULW\LQWHUHVWLQWKHGHEWRUV¶DVVHWYLV-à-vis other creditors 
with claims to the same asset.327   
 
3.9.1 Secured vs unsecured transactions 
 A lender contemplating a loan transaction with the innovating SME will carry out 
certain actions to protect its position as a creditor.  Secured creditors are those who, in 
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 Section 30(1) PA1977 
327
 Flack, J.H. µ6HFXUHG7UDQVDFWLRQV3UDFWLFDO7KLQJV(YHU\%XVLQHVV/DZ6KRXOG.QRZ$ERXW8&&$UWLFOH
¶0DUFKAmerican Bar Association Newsletter  
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addition to having a contractual right to sue the innovating SME for the return of any money 
owed, have taken a property interest in RQHRUPRUHLWHPVRIWKHFRPSDQ\¶VSURSHUW\DV
security for the credit they have made available to the borrower.328 The customary security 
devices include: the possessory lien, pledges, the mortgage and equitable charges.329  In 
practice, in relation to IPRs and patents, according to Tosato: 
 
 The creation of an equitable charge requires neither transfer of ownership of the 
>SDWHQWV@WDNHQDVVHFXULW\QRUGHOLYHU\RISRVVHVVLRQ«5DWKHULWLVDµVKDGRZ¶FDVW
over the collateral until the obligation is discharged or the security is realized.   This 
legal device has a linear structure and offers great flexibility with regard to the type of 
property which can be used and the rights and remedies it can offer to the lender. In 
practice the security agreement creating the may be drafted as a deed, providing the 
secured lender with both a right of sale and a right to appoint a receiver in the event of 
default.  For these reasons, the charge is compatible with IPRs and appears to be the 
most efficient security device available in English law.330   
 
 The creation of an equitable charge is the most efficient security device to protect the 
lender in a patent-backed secured transaction involving patents and innovating SMEs.331    
There two types of charges: fixed charges and floating charges.  A charge places an 
encumbrance on the secured asset to the value of the outstanding debt.  In English law no 
simple legal definition of a fixed charge exists.332  A fixed charge, (sometimes called a 
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 Supra McLaughlin [277] p442 
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 µ5HJLVWUDWLRQRI6HFXULW\,QWHUHVWV&RPSDQ\&KDUJHVDQG3URSHUW\RWKHUWKDQ/DQG¶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Consultation Paper No 164 at paras 2.6-2.19 
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 Supra Tosato [113] p95 
331
 The situation may differ for international patents as the relevant jurisdiction may not permit equitable 
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 Supra McLaughlin [277] p443.  In Illingworth v Houldsworth [1994] AC 355, an insolvency case concerning 
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specific charge) is a property interest in specific property (e.g. patent applications or granted 
patents) preventing the owner of the property (the innovating SME) from selling it or 
otherwise dealing with it without first either paying back the sum secured against it; or 
securing the consent of the chargeholder (the lender).  A floating charge is security taken over 
one or more specified assets, present and future, which allows the innovating SME to carry 
on its business in the ordinary way in relation to those assets, including removing any assets 
from the security, until such time as the security is enforced.333  
 
3.9.2 Secured versus unsecured creditors on insolvency 
 The existence of a property interest usually permits the chargor (the lender) to take 
possession of the asset (patents) in certain circumstances thereby removing it from the 
FRPSDQ\¶VDVVHWVDYDLODEOHWRDOLTuidator to distribute rateably amongst those creditors who 
have only contractual rights against the innovating SME (unsecured creditors).  This is how 
reducing WKHOHQGHU¶VULVNfacilitates the lending of money.334   
 For example, if the innovating SME cannot pay its debts as and when they fall due, it 
is insolvent and unless the company has a realistic opportunity to obtain additional funding 
enabling it to repay its debts and trade out of insolvency, it will likely enter into insolvent 
liquidation.335  The innovating SME will be wound up (liquidated) and its assets distributed 
amongst its creditors.  At this point, creditors (the lender) cannot bring legal actions to 
enforce debts owed to them but must rely on the liquidator to distribute their fair share of the 
LQQRYDWLQJ60(¶VDVVHWVDVGHWHUPLQHGE\WKHOHJDOO\GLFWDWHGRUGHURIGLVWULEXWLRQ336  An 
unsecured lender will rank alongside all other unsecured and non-preferential creditors (trade 
                                                                                                                                                        
to the charge.  Further, Lord Macnaghten held DWS³>$FKDUJHWKDW@ZLWKRXWPRUHIDVWHQVRQDVFHUWDLQHGDQG
GHILQHGSURSHUW\FDSDEOHRIEHLQJDVFHUWDLQHGDQGGHILQHG´ 
333
 Supra McLaughlin [277] p174 
334
 Re Brightlife Ltd [1987] Ch 200 at s16.3.3 
335
 This is an insolvency procedure, administration is also an option.  
336
 See Chapter VIII Insolvency Act 1986 and the pari passu principle. 
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and judgment creditors, HM Revenue & Customs) when the liquidator distributes the 
LQQRYDWLQJ60(¶VDVVHWV+RZHYHULIWKHORDQLVVHFXUHGWKHOHQGHU¶VULJKWVLQUHODWLRQWR
the innovating SME are both contractual and proprietary.  Not all those with a property 
interest have the right to take possession of the charged property.  Floating chargeholders, for 
example, generally do not have the right to take possession of the charged property (although 
their rights are greater than those of unsecured creditors).337   
 In summary, the principal reason why the lender should take a security interest in the 
innovating SMEs asset(s) is so that it will have priority over competing creditors if the 
innovating SME becomes insolvent.  Further, a security interest in the patent(s) may also 
afford the lender the valuable right to sell or license the patent(s) and apply the proceeds to 
repay the debt, although this right is likely to be subject to an automatic stay, on the 
LQQRYDWLQJ60(¶V insolvency, from which the lender would be required to seek relief.  
However, this will depend on the insolvency procedure in question.  If liquidation, the 
secured creditor is entitled to enforce his right over his own property.338  If administration, 
the secured creditor cannot take steps to enforce the security unless the administrator 
consents or the court gives leave.339  The point is that if the lender has registered a security 
interest in the innovating SMEs patent asset(s), it will be in a much stronger position to 
recover monies to repay the loan than it would as an unsecured creditor.  However, simply 
ensuring priority for creditors is not the only important issue at stake: 
 
 The control rights provided by security will be important to a financier and this is 
 especially the case with technologically-driven SMEs as the line between equity and 
 debt finance may become blurred. When [an] SME is in financial difficulty, creditors 
                                                 
337Supra McLaughlin [277] p442. Note however that the loan contract may give the lender a right to take 
possession of the collateral or to appoint a receiver particularly where there is a fixed charge.  
338
 Re David Lloyd & Company (1977) 6 CH D 339; Re Aro Company Ltd [1980] CH 1986. 
339
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 care about issues of management capability or the threat of the business over-
 extending itself. A security interest gives creditors a voice in these decisions.340 
 
 Consequently there are a myriad of advantages for both the innovating SME in 
offering its patent assets as security and to the lender in taking security over same.     
 
3.9.3 Fixed and floating charges: advantage and disadvantages  
 Fixed and floating charges each have advantages and disadvantages in a patent-
backed lending transaction.  Legal protection via a fixed charge is exceptionally attractive to 
a lender.  Indeed, banks go out of their way to characterise charges as fixed charges, seeking 
to establish the stronger rights of a fixed chargeholder in the event of the innovating SME 
winding up.341  Identifying the patents at the outset of the credit appraisal will assist lenders 
to take appropriate controls over registered patent applications and granted patents.  Such 
FRQWUROVZRXOGLPSURYHWKHOHQGHU¶VSRVLWLRQLQDGLVWUHVVVLWXDWion.  The essence of a fixed 
charge is that control over dealing with the charged property (the patents) rests with the 
lender (bank / creditor / charge / chargeholder).342  However, without knowledge of the 
existence or details of specific patents, lenders may simply do nothing and not recognise the 
security potential of patents at all.   
 Alternatively, with general information disclosed by the innovating SME that it owns 
patent rights, lenders may take a floating charge over one or more specified classes of assets, 
SUHVHQWDQGIXWXUHHJSDWHQWVEXVLQHVV¶LQYHQtory or accounts receivable).  The floating 
charge was invented by Victorian lawyers to enable manufacturing and trading companies to 
raise loan capital on debentures.343  The innovating SME is free to carry on business in the 
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ordinary way in relation to those assets, including removing any assets from the security.  A 
non-payment by the ERUURZHUFDXVHVWKHFKDUJHWR³FU\VWDOOLVH´ at which point it is converted 
into a fixed charge.344  The lender can then takes steps to enforce (sell) the secured assets to 
recoup the funds advanced to the borrower.  The risk to the lender is that by this time the 
specific patent assets may have already been sold or left to lapse or been further charged, 
OLPLWLQJWKHOHQGHU¶VSRWHQWLDOWRUHFRYHUILQDQFLDOYDOXHIURPWKRVHDVVHWV345 A lender is 
always free to take a risk when lending, but the law will not protect the lender if the risk 
materialises.  The preferred option for the innovating SME is a floating charge over its 
personal property (patent applications and granted patents) so that it can continue to deal with 
the patent portfolio in the ordinary course of business without the lender¶VFRQVHQW.    
 However, a problem with the floating charge in contrast to a fixed charge, from the 
lender's point of view, is that on insolvency any realisations from the sale of the collateral are 
available to pay: a) preferential debts;346 b) the prescribed part;347 and the expenses of the 
procedure,348 before the security holder.  In other words, the value of the security is less than 
a fixed charge because others stakeholders have to be paid first.  The fixed charge, on the 
other hand, is invulnerable to these, and other ³ZHDNQHVVHV´ of the floating charge.  The main 
question for a lender is which type of equitable security is preferable when dealing in patents.  
The fixed charge appears to be the better option, considering some of the vulnerabilities of 
the floating charge on insolvency, particularly when dealing with SMEs which have a greater 
risk of insolvency than more established companies.349 The fixed charge gives the lender 
stronger security (better priority) as it is paid ahead of preferential creditors and not subject to 
a deduction under the Enterprise Act 2002 contra the floating charge.  Having said that, 
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reliance on a fixed charge only, leaves the lender without the option to appoint an 
DGPLQLVWUDWRULQWKHHYHQWRIWKHERUURZHU¶VLQVROYHQF\DOWKRXJKIL[HGFKDUge receivership 
might be available).   
 When deciding whether to establish fixed or floating charge(s) the lender should 
FRQVLGHUWKHH[WHQWRIWKHLQQRYDWLQJ60(¶VSDWHQWSRUWIROLRQHHGHGWRVHFXUHWKHORDQ
Although fixed charges have clear advantages LQWKHHYHQWRIWKHLQQRYDWLQJ60(¶V
insolvency, they only cover the existing patent applications and granted patents on the Patent 
Register as documented in the loan security agreement (e.g. GB123456, GB9876554).  The 
lender cannot take a fixed charge over future property e.g. a patent application that does not 
yet exist.  A floating charge has WKHDGYDQWDJHWKDWLWZRUNVWR³FDWFK´ all of the innovating 
60(¶VDVVHWFODVVHVDOOSDWHQWVSUHVHQWDQGIXWXUHLQFOXGLQJIRUH[DPSOHDQHZSDWHQW
application created after the date of the security.  7KXVDOHQGHUZKRVHHNVWR³FDWFK´ future 
patent applications and granted patents may prefer to create a floating charge.  At the early 
stage of its business lifecycle, an innovating SME may well be contemplating registering new 
patent applications.  
 In practice, a lender can combine both types of charges, seeking to combine the 
priority advantages of the fixed charges with the flexibility of the floating charge in a 
carefully documented loan security agreement.  Once the type(s) of security is agreed and 
validly created by the security agreement, it is binding as between the innovating SME and  
the lender, and no transfer of title to the relevant patents or patent applications is required.   
The lender should then proceed to register the security.    
 
3.9.5 Registering security interests: where patent, company and insolvency law meet  
 The gist of the problem for patents as an asset class (and other registered IP assets 
such as trade marks and designs) is that presently there are two security registers for 
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recording property interests in patent assets used as security DQGWKLVFDQJLYHULVHWR³SULRULW\
GLOHPPDV´.  First, notice of the security interest should be registered on the Patent Register 
under s33 PA 1977.  Secondly, as an innovating SME is company the security interest should 
also be registered at Companies House as required by ss859 A ± Q, CA 2006.350  This is 
problematic as the specialist Patent Register alone (an external legal factor) cannot be 
considered a one-stop source of information.  This gives rise to a degree of legal uncertainty 
for the lender when searching the Patent Register for competing interests and registering its 
own security interests.   
  In practical terms, checking the security register(s) for competing interests is an 
DVSHFWRIWKHOHQGHUV¶GXHGLOLJHQFH351 which involves fees, human resources and time, all of 
which contribute to the transaction costs for the patent-backed loan which are passed on to 
the borrower in one form or another.  Consequently, simplifying and streamlining the 
procedure for recording security interests in patent assets is needed to improve access to 
patent-backed debt finance.  However, reforming the system is not straight forward.  It 
involves a complex analysis of UK secured personal property law, IPR and patent law, 
company and insolvency law which converge to regulate security interests in patents.  The 
Secured Transaction Law Reform Project (currently being led by Professor Louise Gullifer of 
Oxford University) is considering how to improve the system and will be discussed in section 
                                                 
350
 A charge is defined in s 859A(7) CA 2006 and registration requires a statement of particulars (s859D).  
Registration is voluntary ± there are no criminal sanctions for non-registration (c.f. the old regime) ± and can be 
effected by either chargor or chargee, but if it is not effected the charge is void against the administrator, 
liquidator or creditor of the company.  
351
 In the patent-backed loan context, due diligence also refers to the care a reasonable person should take before 
entering into a security agreement or a transaction with another party.  In particular, financial due diligence 
involves the lender investigating or carrying out an audit of the potential patents and/or patent applications being 
proposed as collateral for the loan to confirm all materials facts in connection with the viability of the assets, 
including whether they are already encumbered.  An encumbered asset is owned by one party but subject to the 
legal claims of another party, whereas a lender will prefer to deal with an unencumbered asset.   
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3.9.11.352   Legal formalities in respect of the two relevant security registers in the UK are 
discussed below.  
 
3.9.6 The specialist Patents Register 
 The general rule of priority is that the first creditor to register obtains priority as to the 
security (collateral).  However in the UK, security interests in respect of patents or patent 
applications take priority according to the date on which they were registered in the Patents 
Register, regardless of whether or not the security was also perfected by registration at 
Companies House.353  This is important for lenders to understand ± they need to engage with 
two registration systems, namely, the Patents Register and Companies House.   
 
3.9.7 When a competing interest exists 
 For a lender to protect its position, as a matter of due diligence during the credit 
appraisal process it should verify whether any competing interests encumber the patent assets 
offered as collateral by the innovating SME.  If a search of either register reveals an earlier 
competing interest, would the lender SURFHHGZLWKWKHWUDQVDFWLRQ"$FFRUGLQJWRWKHDXWKRU¶V
discussions with Dr Sandra Frisby354 the answer depends on the estimated value of the 
patent(s) and whether an agreement could be reached between lender 1 and lender 2 to 
subrogate lender 1's security to that of lender 2.  In the right circumstances if the patents are 
RIVXIILFLHQWYDOXHWRFRYHUERWKOHQGHUV¶ORDQVDQGFRVWVWhis is a possibility.  Nevertheless, 
the existence of a prior ranking security interest would be problematic for lender 2 and 
increase its risk.  However, the possibility of lending against patents on fixed charge security, 
if lender 1 has only a floating charge over the patents, should also be considered.  In any 
                                                 
352
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event, it is crucial for the lender to acquire an indisputable position in terms of priority.  The 
Patent Register plays a decisive role in this regard.355    
 
3.9.8 Registering a charge over a patent application or granted patent 
 A lender is advised to register the charge at the UK Intellectual Property office first.  
This is because the granting of security over a UK patent or patent application is a registrable 
³tUDQVDFWLRQLQVWUXPHQWRUHYHQW´ under s.33 PA 1977.  A failure to register the fixed charge 
at the UKIPO would mean that a subsequent assignee, licensee or chargee of the patent would 
take free of charge if they were not aware of the fixed charge.  A security interest in respect 
of a patent or an application for a patent is registrable in the Patent Register under ss 32(2) 
and 33(3) PA 1977 using Form 21.  Completing Form 21 is straightforward and should 
contain the following information:  
x the patent number or patent application number;  
x the security provider(s) and the secured party (ie names, addresses and Patents ADP 
numbers if known);  
x the nature of the security;  
x the date of the securit\GRFXPHQWDQGWKHQDPHRIWKHDSSOLFDQWV¶DJHQWDQGWKHLU
address for service.356   
 
 An application to register a security interest in respect of a patent can simply be 
posted to the UK IPO and should contain: 
x a copy of the security document (an original is not required) if the Form 21 is not 
signed by the security provide or its representative; 
x a fee sheet ie Form FS2; and 
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x the appropriate fee.  
 
 Registration is voluntary and there is no time limit for registration, but as a matter of 
best practice the security should be registered as soon as possible.357  The most important 
outcome of registering a security interest is on priority between competing security interests.  
Thus, a security interest registered on the Patent Register will bind any party which acquires a 
security interest in the same patent at a later date.  If a security interest is not registered, it 
will not bind another secured creditor which later acquires a conflicting security interest 
without knowledge of the existing unregistered security interest.358  There also certain 
practical administrative benefits of registration on the Patent Register that flow to the chargee 
where it becomes owner of the patent by virtue of the security (e.g. by an assignment by way 
of security).  The chargee will receive patent renewal notices (to ensure that patent does not 
lapse)359 and notices of proceedings concerning the patent.360  Further, the chargee (as 
registered owner of the patent) will be entitled to be awarded costs in any proceedings.361   
Whereas, if the chargee has not registered its security on the Patent Register, it will only be 
entitled to be awarded costs in any proceedings for infringement of the patent if:  
 
x it was not practicable to register its security within the six-month period beginning on 
the date of the security document; or 
x if the court or Patent Comptroller is satisfied that it was not practicable to register the 
security before the end of the 6 month period but the security was registered as soon 
as practicable thereafter. 
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3.9.9 A floating charge over present and future granted patents and applications 
 ,IWKHOHQGHUWDNHVDIORDWLQJFKDUJHRYHUQRWRQO\WKHSDWHQWVEXWWKHFRPSDQ\¶VRWKHU
business assets, it will have the power to appoint an administrator with authority to run the 
business if the company defaults on the loan.362  The lender will typically also have the power 
to appoint a receiver to the patents subject to the charge enabling the lender to sell the patents 
or collect the income generated by the patents via licences in order to repay the loan.363  The 
lender will typically request the innovating SME to guarantee that it has the right to grant the 
security and that the patents are free from other charges, encumbrances or other rights 
exercisable by third parties.364  Further, the lender will seek to ensure that the value of the 
charged patents are maintained and may seek to place obligations on the firm in respect of the 
security agreement e.g. a general obligation to maintain the patents and patent application 
(pay any applicable renewal fees) without any right to allow unimportant patents to lapse, or 
to abandon patent applications and the ensuing cost implications.  The innovating SME may 
wish to reserve the right to allow to lapse or abandon the patents or patent applications it 
reasonably considers are no longer of value.  The GHILQLWLRQRIWKHLQQRYDWLQJ60(¶V
obligations under the security agreement should be carefully worded to determine whether or 
it has an obligation to assert granted patent rights against an infringer, as this often provokes 
a challenge to the validity of the patent rights.365   
 
3.9.10 The Companies Register 
 The registration regime for security created by a UK company is governed by CA 
2006, Pt 25 is optional but the consequences of non-registration are severe on insolvency.  
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The register is maintained by the Registrar of Companies at Companies House.366  Section 
859D CA 2006 makes it clear that a charge over any intangible or incorporeal property, such 
as an IP right, can be registered: s859D(e)(ii) CA 2006.  This includes any patent or any 
licence under or in respect of any such right.  Where a UK company creates security of a 
patent right, the security is perfected by registration within 21 days of its creation at 
Companies House.  The registration process simply involves submitting the prescribed form 
together with a certified copy of the security agreement (charging document) which can be 
done online through the Companies House portal.367  Failure to register security over a patent 
right at Companies House in the correct way and on time will mean that the security is void 
against a liquidator, an administrator or a creditor of the security provider.368  
 The relationship between the two registers in respect of patent-backed security 
operates to achieve different aims with respect to each register.  Where security over a patent 
is created, registration on the Patent Register safeguards the priority of the security, whereas 
the security is perfected by registration at Companies House.  This ensures that the security 
will be valid in the event of the innovating 60(¶VLQVROYHQF\DQGDJDLQVWRWKHUFUHGLWRUVRI
the SME.369  Failure to register on the Patent Register does not make the security interest void 
LQWKHHYHQWRIWKHLQQRYDWLQJ60(¶VLQVROYHQF\5DWKHULWSXWVWhe security at a 
disadvantage to competing security taken by other secured creditors without notice of the 
existing security.370  In contrast, failure to register security at Companies House seriously 
undermines the value of that security for many practical purposes because it will be void 
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against the liquidator, an administrator or a creditor of the innovating SME.371    
 Using patent rights can be trouble-free, provided the lender is cautious when creating 
the security interests.  Registering the charge over the patents on both registers is a 
straightforward exercise in practice.  However, potential problems may arise if the lender has 
to confirm whether competing interests encumber the patents as the Patent Register alone 
cannot be considered a one-stop source of information and there is a degree of legal 
uncertainty.372  This means that lenders need to carry out preliminary due diligence and 
subsequently, over the course of the negotiations, monitor both registers.  Once the security 
agreement with the innovating SME has been finalised, the lender must register it on the 
Patent Register and on the Company Register.  The costs associated with carrying out 
searches of the two registers and registering notice of security quickly mount up.  An extra 
layer of cost applies to patent assets that do not arise in respect of other assets, especially if 
the lender needs to deal with numerous patents and applications.  Further, as the procedures 
are not routine, the lender and may require specialist legal advice.   
 
3.9.11 The Secured Transaction Law Reform Project 
 Lenders and their legal advisors are simply not at ease when registering security 
interests over patent assets.  The recent Intellectual Property Act 2014 did not take the 
opportunity to address the issue of harmonising the specialists IPR security registers373 or 
modernising the legal framework governing security interests over IPRs.  Presently, no 
government agency such as the UKIPO, Companies House, BIS or the BBA publish a 
practical yet comprehensive user guide for registering notice of security interests in patents or 
other IPR.  No doubt stakeholders in the finance community would find such a guide 
beneficial.  ,Q7RVDWR¶VYLHZWKHODZUHODWLQJWRWKHXVHRI,35VDVsecurity should be: 
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 «DQDO\VHGWKRURXJKO\LQWKHFRQWH[WRIDUHIRUPSURSRVDOIRUsecured transactions. 
These rights require specific and detailed provisions, clearly defining the impact that 
the security interest encumbering them will have on their exploitation and 
enforcement; for instance, the law should define the circumstances under which a 
secured creditor has a right to pursue infringers of an encumbered IPR in order to 
protect its value.374 
 
 Tosato LGHQWLILHVWKHFUHGLWRU¶VULJKWWRSXUVXHLQIULQJHUVRIDQHQFXPEHUHGSDWHQW as 
an important issue that remains to be addressed.  The purpose of the project, which is 
clarified below, is broader than security in IPR, which is only one of many issues being 
evaluated: 
 
 The current law of secured transactions has clear strengths but, in comparison to that 
in many leading economies around the world, it is out-of-date and cumbersome.   It is 
difficult to access, complex and, in many respects, unclear.  It is true that practitioners 
and financiers have developed ways of working around the most egregious problems, 
and of limiting uncertainty by the use of contractual devices.  However, this has the 
effect of increasing the cost and availability of credit and means that we do not have 
the most efficient system we could have.  The project therefore exists to examine how 
the current position could be improved.375  
 
 Essentially, the thrust of the project is WRFRQVLGHUWKHDGRSWLRQRID³QRWLFHILOLQJ´ 
system approach to the registration of security interests, with priority determined by the date 
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of filing.  Would this approach facilitate IP-backed lending?  The benefits of such a system 
(similar to that adopted by the US, Canada, Australia, New Zealand, Jersey, Malawi, Ghana, 
Liberia, Sierra Leone and Qatar) were set out in the Law Commission Consultative report 
No.176: the PPSA regime, which is now complete.376  It refers to IP and patents, but gives no 
extensive account.  The Law CommissLRQ¶V&RQVXOWDWLYH5HSRUWLs a starting point for 
discussion.377  7KHNH\IHDWXUHRID³QRWLFHILOLQJ´ regime is that there would be a single type 
of security interest, to which the same rules of registration, priority and enforcement 
applied.  Perfection, whereby the interest is made valid against other creditors and in the 
GHEWRU¶VLQVROYHQF\ZRXOGEHHLWKHUE\UHJLVWUation, possession or control.  Registration 
could be in advance of creation and priority would be by date of perfection.  While the 
floating charge would no longer be a distinct type of security interest, a security agreement 
could provide that the debtor could dispose of assets, and the scheme would provide that 
purchasers of cash and goods which the debtor usually sold would automatically take free of 
any security interest.  The position on insolvency, were the floating charge to cease to be a 
distinct type of security interest, is being considered by one of the working groups.378  A 
³6HFXULW\LQ,35´ZRUNLQJSDUW\KDVEHHQHVWDEOLVKHGWRPDNHUHFRPPHQGDWLRQV 
 By way of comparative system example, the Commonwealth of Australia introduced 
the Personal Property Securities Act 2009 (PPSA 2009) to provide more certain and less 
costly arrangements for personal property security through:  
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(1)  its application to any interest in personal property, whether tangible or intangible, that 
 secures payment of a debt or the performance of an obligation, regardless of the form 
 of the transaction; and  
(2)  the introduction of a single online register dealing with registration of all security 
 interests over personal property in Australia, with the implication that parties need 
 only review one register in order to understand what registered security interests 
 exists over the collateral. 379    
 
 The Australian PPSA 2009 established a centralised electronic public register to 
reduce the uncertainties in creating, registering and searching for security interests held over 
personal property (including patents and patent licences) in that jurisdiction.  The new 
register superseded a number of overlapping legal frameworks and specialist registers.   In 
addition to creating a national register of personal property securities, the PPSA 2009 sets out 
rules regarding the creation, enforcement and priority of securities, which are significantly 
different from the rules under previous legal frameworks.380  As a result of the new legal 
UHJLPHUHFRUGDOVRQ,3$XVWUDOLD¶V381 specialist patent register no longer have legal priority.    
The breadth of the PPSA 2009 holds significant interest for the UK from comparative system 
point of view.  Its impact on finance and security is broad, applies to all types of personal 
SURSHUW\DQGXVHVD³substance over IRUP´ approach.382     
 According to WKHDXWKRU¶VGLVFXVVLRQVZLWKGraham Ferris,383 UK priority rules are not 
³RQHVL]HILWVDOO´ hence the complexity vis-à -vis notice filing systems.  The UK system can 
be haphazard as to which interests obtain the best legal protection - in essence the UK system 
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rewards those who use private law to protect themselves (e.g. freedom of contract).  Those 
who can afford to pay for specialist legal advice are at an advantage.  On the other hand, the 
UK system has certain flexibilities and can take advantage of market innovations that would 
involve amending legislation in a notice filing system to adapt the statutory system.  In 
)HUULV¶YLHZWKLVLQKHUHQWIOHxibility led to the UK declining to introduce a notice filing 
system in the early 21st century for several reasons.  First, banks and their professional legal 
advisors wanted to retain a system with which they were familiar.  Secondly, D³QRWLFHILOLQJ´
system is anathema to German law.  As the UK is part of the EU and has a stake in the 
company law harmonisation agenda, interaction with other key secured transaction law 
systems is now more prominent.  Finally, a  notice filing system disorders English property 
law (either requiring a complex set of exceptions, or forcing the general law to fall into line 
with the commercial system to create a new congruence relating to concepts of notice filing 
law).  Consequently, the reform of personal property security law in the UK has foundered 
several times and there is a FRQFHSWXDOFKDVPEHWZHHQWKH8.3DWHQW5HJLVWHUDQGD³QRWLFH
ILOLQJ´VW\OHV\VWHP  
 In conclusion, without the ability to offer valuable security the innovating SME will 
find it difficult to borrow funds at all.  Offering patents as security should ensure that the 
terms of the loan will be better than an unsecured loan.384  However, the interaction between 
UK IP law, personal property security law, company law and insolvency will need to be 
improved if patent-backed debt finance is to flourish in an economically efficient manner.  
The author holds the view that to enhance access to patent-backed lending, a PPSA notice-
ILOLQJ´ system is superior in theory, although not a magic bullet, as the priority advantage is 
granted because of its functional quality.  The importance of reforming secured transactions 
law to permit filing  notice of a security interest in a patent via a single personal property 
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security register FDQQRWEHXQGHUHVWLPDWHG7KH³3ULQFLSOHRI/HDVW(IIRUW´ says that it is 
human nature to want the greatest outcome for the least amount of work (efficiency).  In 
theory, lenders will choose their behaviour based on the minimization of effort.  This can be 
viewed as interactions between jobs needing to be done (registering security), and tools 
developed to accomplish them.385  Preferably, the single register would be maintained by 
Companies House.  This would simplify, streamline and ultimately make the system more 
efficient, accessible and less costly for all stakeholders in the patent-backed secured 
transaction.  Innovating SMEs, their accountants, lenders and legal advisers are used to 
dealings with Companies House, as opposed to dealing with the UKIPO and its specialist 
registers and legislation.  Streamlining the security registration process would not preclude 
the introduction of new or specialist rules to cover patents, trade marks or designs.  The 
author agrees with Bezant386 and Davies,387 who advocate a VLQJOHUHJLVWHU³QRWLFHILOLQJ
V\VWHP´that embraces IPR for ease of use, reducing risk and enhancing certainty and argues 
further that these advantages reduce loan transaction costs (which are passed on to the 
borrower), outweighing the disadvantage of any loss of flexibility, whilst acknowledging that 
PPSA systems are not without difficulties.   
 
3.10 Conclusion 
 This chapter has illustrated why debt finance remains critically important to 
innovating SMEs despite the availability of other finance options.  The analysis of 19 case 
studies reported in the WIPO IP Advantage database confirmed that patent-backed debt 
finance did not feature at all for innovating firms.  We identified that lenders need to develop 
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more awareness and trust in patent assets as a class, leading to a higher level of risk tolerance 
at the credit appraisal stage. We then examined two important barriers to the take up of 
patent-backed debt finance by lenders: (1) the problem of banking capital adequacy 
requirement for intangibles; and (2) the legal risks involved in searching for competing 
interests in patents and registering security interests in them.  These are serious problems, but 
they are rooted in banking regulation and secured transaction law which can be improved and 
are not an inherent function of the usefulness, monopoly advantage or economic value of the 
inventions protected by the patents.  No stakeholder appears to be seriously examining reform 
to the banking capital adequacy requirements and the negative impact on intangibles and IPR 
assets such as patents in the lending environment.  This is an area ripe for further research.  
As for registering security interests over IPR, a reform agenda is underway that will likely 
improve the situation for lenders.  However, the author reiterates the need for the government 
WRFUHDWHD³6HFXULW\RYHU,35*XLGH´ for lenders which currently does not exist to facilitate 
patent-backed lending.  
 In Chapter 4, the focus shifts to the problem of the uncertainty in valuing patents, the 
most problematic of thHOHQGHUV¶WULDGRIFRQFHUQVThe fact that patents are difficult to value 
does not mean they have no value.  This is an accounting problem and, increasingly, a 
corporate governance problem.     
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4  True and fair patent valuation: a corporate governance issue? 
 
  The debate about the purpose and significance of WKHµWUXHDQGIDLUYLHZ¶ 
  corporate reporting concept is associated with two well-known dichotomies in 
   accounting:  principles versus rules and substance over form.388    
        
 
Introduction   
 Accountancy dominates patent valuation.  As such, the accounting discipline is a 
macroeconomic instrument of formidable proportions in the realm of patent-backed finance.   
Section 4.1 begins our multi-disciplinary analysis that focuses on accounting principles and 
standards as they relate to the financial recording and valuation of patent assets aiming to 
explain why patent assets are unseen, underused and undervalued.    
 Banks, as the main providers of corporate financing, use accounting and financial 
statements as a kind of internal control that impacts on lending decisions.  However, while 
the evolution of the credit and debit system that forms the basis of traditional accounting has 
been indispensable to the efficiency and material prosperity of the modern economy, 
financial innovation is urgently needed in relation to accounting for intangibles, especially 
patent assets.  We analyse why traditional accounting methodology is inadequate for dealing 
with patent assets.  Why is patent value seemingly unmeasurable and therefore largely 
invisible in the financial statements?     
 Section 4.2 critically analyses why the key methods for valuing intangibles are 
inadequate and unhelpful in the case of patent assets.  It has never been more necessary to be 
able to measure the objective value and subjective quality of patent assets.  Only when 
innovating SMEs have access to credit, granted by lending institutions who understand the 
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full value and quality of patents as a form of currency, unit of account or as a store of value, 
will patent owners be able to access the funds they need to commercialise their inventions 
and share them with the world.  Adequately valuing patents and commercialising inventions 
is a fundamental corporate governance issue for patent innovating firms.   
 Accounting standards coupled with the rise and harmonization international 
accounting standards that affect the recording and valuation of patents are a key factor 
inhibiting access to money for businesses to grow.  Section 4.3 explores the intersecting 
relationship between the requirements of International Accounting Standard for Intangibles 
(IAS 38), the characteristics of legal patent monopolies and the changing concept of 
FRUSRUDWHJRYHUQDQFHXQGHUWKHUXEULFRI³VKDUHKROGHUYDOXH´,QSDUWLFXODUa traditionial 
legal analysis of whether there is scope to depart from IAS 38, LQOLJKWRIWKH8.¶V
longstanding legal UHTXLUHPHQWWKDWDFRPSDQ\¶VILQDQFLDODFFRXQWVPXVWSURYLGHD³WUXHDQG
IDLU´view, is carried out.    
 In section 4.4, our multi-disciplinary analysis discusses the emergence of a new form 
of corporate reporting and enhanced disclosure, the Intellectual Capital Statement (ICS).  The 
ICS treats patents and other intangibles as capital rather than expenditure and are increasingly 
being used in other jurisdictions (e.g. Denmark and Sweden) to enhance intangibles 
reporting.  The ICS, or a similar type of narrative report, would assist the development of 
patent-backed finance by providing lenders with additional timely, relevant and accurate 
LQIRUPDWLRQFRQFHUQLQJDERUURZHUV¶SDWHQWDVVHWV to improve credit appraisal.   
 A thorough exploration of these fundamental issues enables us to critically analyse 
possible measures to reduce the level of uncertainty inherent in recording, valuing and the 
corporate reporting of patent assets (applications and granted patents) to improve the quality 
of information available to lenders.   
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4.1  The invisibility of patents on the balance sheet 
 
 Accounting statements provide information that shape a particular understanding of a 
business.  However, accounting principles rely on two inherent assumptions, firstly that 
tangibles rather than intangibles contribute to business performance and secondly, that 
business dHSHQGVODUJHO\RQDQDUP¶V length transaction between a willing buyer and a seller.   
Neither of these assumptions accommodates the nature of patents.389  IP is not separately 
identified and valued for the purpose of incorporation into financial accounts within the 
UK.390 This section explains how patent assets are presented in financial statements and 
highlight the problems involved when accounting for intangibles.   
 Despite the fact that the underlying value of patent assets has soared in the past 
decade, this increase in value remains largely invisible to the financial world if the patented 
LQYHQWLRQKDVEHHQGHYHORSHG³LQKRXVH´ as opposed to having been acquired (purchased) 
from a third party.  By way of introduction, in the UK and many other countries, intangible 
assets such as patents, brands, customer relationships, information technology and knowhow 
are accounted for in one way if they are created in-house (internally generated) and another if 
acquired (purchased).391  Intangible assets have been variously defined, but the common 
thread of the definitions is that these assets provide future benefits but do not have physical 
embodiment.  7KH³LQYLVLELOLW\´ of internally developed patented inventions and other 
intangible assets makes them difficult to measure and helps to explain why their value is 
UHFRUGHGµRIIEDODQFH¶VKHHWDQGGRHVQRWIRUPSDUWRIWKHILQDQFLDOVWDWHPHQWV7KLVPHDQV
that if the patented invention is developed in house by the innovating SME, it is not recorded 
LQWKHFRPSDQ\¶VEDODQFHVKHHWDQGLVQRWHYLGHQFHGLQWKHFRPSDQ\¶VILQDQFLDOVWDWHPHQWV
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Rather it is immediately expensed, thus appearing as a loss, rather than as revenue.  Further, 
these costs are reported only at a single point in time.  Therefore internally generated patent 
assets are valued at little more than the patent attorney and patent filing fees, because the 
research is deducted as an expense, and not capitalised.  In contrast, patent assets that are 
purchased are recorded at fair value using the purchase price and the assets are amortised 
accordingly.  
 With intangible patent assets dominating so much of our modern economy and 
the renewed drive to support and invest in new technology, surely it is appropriate to 
question why patent assets developed internally within a company are still largely off 
balance sheet items in UK businesses, both small and large?  As a matter of corporate 
governance, this issue warrants detailed examination.  Figure 19 below illustrates the 
increasing financial value attributable to IP.  
 
Figure 19   Distribution of value for the Apple iPhone in 2013 
The iPhone demonstrates how the value of ideas and patented inventions is steadily increasing. Although 
the iPhone (a tangible item) is wholly assembled in China, this activity results in only 28% of the profits.   
Indeed, only 28% of the value of the iPhone is earned by materials and labour input.  Seventy-two per cent 
(72%) of the value is earned by the technology and brand owners (intangible IP).  
   Share of profits on iPhone sales 
Technology and brand: Apple  58%  
Technology inputs: US, European Union, Taiwan, Japan, South Korea, 
others  
14% 
Materials  22%  
Labour, non-China  4%  
Labour, China  2%  
Source: Kramer, Linden and Dedrick (2008, 2011, 2011). Australian Intellectual Property Report 2013 
 
 It no longer makes sense that the intangibles a company develops itself are 
YDOXHG³DWFRVW´ because the research is deducted as an expense, whilst assets that are 
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purchased at arm¶V length DUHUHFRUGHGDW³IDLUYDOXH´.  This accounting treatment 
results in inconsistency and makes it very difficult to compare the corporate finance of 
patent developers versus patent acquirers.  For example, the different accounting 
treatment means that a patent developed by Company X and then sold to Company Y 
can change from a very low valuation to a high valuation, possibly worth hundreds of 
thousand or even millions of pounds, overnight.  According to Professor Abraham 
Briloff,392 this accounting difference could result in distorted market behaviour, 
tempting companies to buy patents rather than developing the inventions 
themselves.393  Indeed, is this accounting practice what paves the way for the non-
practising entities (the patent trolls)? The author holds the view that if internally 
developed intangibles are not visible on the balance sheet they should be documented 
in a new form of financial report, at an amount that more fully captures the costs of the 
R&D and the value of the patent portfolio to the business.  The object of financial 
reporting, which the detailed accounting standards are designed and assumed to 
achieve, is to SUHVHQWD³WUXHDQGIDLU´ view of financial position of the entity at a 
particular point in time.  Ultimately, the law eYDOXDWHVZKDWLV³true and fair´.  
However, neither of these approaches has yet to be accepted by the accounting 
standards bodies although there is increasing interest in intangibles accounting reform 
and several countries are permitting voluntary ICS reporting.  Accounting creates 
currency.  This in turn will enable patents to be more effectively and commonly used 
loan security.    
 Firms that conduct R&D and file patents have significant intangible assets, yet 
these are substantially recorded as off-balance sheet assets and liabilities.394  The 
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reason for this lies in the formal acFRXQWLQJGLVWLQFWLRQEHWZHHQ³RQ´DQG³RII´ balance 
VKHHWLWHPV,QJHQHUDOWHUPVDQLWHPVKRXOGDSSHDURQWKHFRPSDQ\¶VEDODQFHVKHHWLI
it is an asset or liability that the company owns or is legally responsible for.  Patent 
ownership is a fairly straightforward matter to prove by confirming the records held by 
the Patent Office.  However, as the value of internally developed patent assets is 
UHJDUGHGDV³XQFHUWDLQ´, traditional accounting principles provide that in order to be 
recorded on the balance sheet, the patent assets must also meet the tests of being:  
 
(1) probable; 
(2) measureable; and  
(3) meaningful.  
 
 This is the crux of the difficulty in accounting for patent assets.  To date, 
internally generated patents have been regarded as complex to value and as such their 
value is inadequately financially recorded for modern purposes, resulting in a lack of 
financial transparency.  From thHOHQGHUV¶SRLQWRIYLHZWKLV³LQYLVLELOLW\´ creates a 
key problem in that nothing exists on the financial statements (documents that they are 
familiar with) to quickly tell the lender how WRYDOXHWKHILUP¶VLQWHUQDOO\GHYHORSHG
patent applications or patent portfolio.  As a result, the undesirable level of uncertainty 
from WKHOHQGHUV¶SHUVSHFWLYHis a formidable barrier which prevents favourable 
lending decisions being made.  In order to lend appropriately, a lender needs relevant 
accurate information to value the patent asset as a form of security.  In the UK, banks 
adhere to the Lending Code which is monitored by the independent Lending Standards 
Board (LSB).  Certain standards are expected in connection with the assessment of 
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OHQGLQJDSSOLFDWLRQVE\³PLFUR-HQWHUSULVHV´395 i.e. very small innovating SMEs.  The 
lender will assess whether the micro-enterprise can afford to repay the money 
borrowed and, according to the Code, this may include reviewing: 
 
x why the applicant wants to borrow the money; 
x the business plan and accounts; 
x tKHEXVLQHVV¶FDVKIORZSURILWDELOLW\DQGexisting financial commitments; 
x any personal financial commitments which may affect the business; 
x how the applicant has handled its finances in the past; 
x information held by credit reference agencies, and possibly landlords. 
 
 The lender will also carry out credit assessment techniques such as credit 
scoring and consider any security provided.  Unfortunately, for the lender to assess 
patents as security, relevant useful financial information is lacking (or largely 
LQYLVLEOHRQDILUP¶VEDODQFHVKHHWFurther detailVRIWKHILUP¶VSDWHQWVWUDWHJ\
surrounding IP and know how DUHQRWDUHTXLUHGIHDWXUHRIWKHERUURZHUV¶FRPSDQ\
annual return and business review.396   
 At this point in time in the accounting field, the future value of a potential 20-
year patent monopoly largely lies in the murky realm of uncertainty, as opposed to 
calculable risk.  Uncertainty undermines value.  However, it is the accounting 
profession that has the power to define the currency of patents and other intangible 
assets in the accounting standards that apply to financial statements.  The next section 
examines how accountants value patents and why this creates uncertainty for lenders.   
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4.2 Uncertainty and patent valuation 
 Any uncertainty as to the borrower¶V ability to repay a loan is highly 
undesirable.  For a lender, uncertainty is quite a different concept from that of risk 
because without some degree of certainty, one cannot begin to mathematically 
calculate risk.  In 1921, Frank Knight argued that: 
 
 Uncertainty must be taken in a sense radically distinct from the familiar 
 QRWLRQRI5LVNIURPZKLFKLWKDVQHYHUEHHQSURSHUO\VHSDUDWHG«$
 PHDVXUDEOHXQFHUWDLQW\RUµULVN¶SURSHU«LVVRIDUGLIIHUHQWIURPDQXQ-
 measurable one that it is not in effect an uncertainty at all.397  
 
 In 1937, John Maynard Keynes398 made a VLPLODUSRLQWWR)HUJXVRQ%\³XQFHUWDLQ
NQRZOHGJH´Keynes wrote³The sense in which I am using the term is that in which the 
prospect of a European war is uncertaiQRU«WKHUDWHRILQWHUHVW twenty years KHQFH«$ERXW
these matters there is no scientific basis on which to form any calculable probability 
ZKDWVRHYHU:HVLPSO\GRQRWNQRZ´399  Continuing our discourse on the concept of 
uncertainty, Peter Bernstein400 explained: 
 
 We pour in data frRPWKHSDVW«EXWSDVWGDWD«FRQVWLWXWHVDVHTXHQFHRIHYHQWVUDWKHU
 than a set of independent observations, which is what the laws of probability demand.  
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 +LVWRU\SURYLGHVXVRQO\ZLWKRQHVDPSOHRIWKH«FDSLWDOPDUNHWVQRWZLWKWKRXVDQGV
 of separate and randomly distributed numbers.401 
 
 Is the present and future value of patents doomed to be unmeasurable and therefore 
uncertain?  TKH³XQFHUWDLQW\´IDFWRUWKDWVWLOOVXUURXQGVWKHWHFKQLTXHVDQGSUDFWLFHVRI
quantitative and qualitative patent valuation is the principal barrier to the development of 
patent-backed lending.  The core function of the lender is gathering information to reduce 
uncertainty about the borrower¶V ability to repay the loan.  What financiers need is a reliable 
method of ³PHDVXULQJ´ and recording the value of the patent.  Patent valuation is a complex 
task as there are many variables to consider thus the traditional view is that each patent is so 
entirely unique that there are no other, or an insufficient number, to make it possible to chart 
enough similar patents to form a basis for any inference of value about any real probability.   
 
4.2.1 Inadequacy of current accounting for intangibles and the need for reform of 
 accounting practices 
 
 In 2005 the WIPO recognised that current accounting standards are ill-equipped to 
address the IP dimension of business and issued the following statement:   
 Clearly, the various challenges associated with determining the value of internally 
held intellectual property, paired with the inherent volatility associated with the value 
of some forms of IP, can be cited as major reasons why accounting has been reluctant 
to report on internally generated IP, which is seen as too subjective and risky. 
Furthermore, accounting has always been reluctant to anticipate future gains, 
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overstate the value of assets or include assets on the balance sheet whose value is 
more volatile.402 
 
 Dr Roya Ghafele, a law and economics scholar, studied the language and terminology 
of accounting as it applies to IP and specifically intangibles.  She concluded: 
 
 Accounting constitutes a very specific form of language, which is highly 
standardized, mathematical in nature and seeks to uniformly and systematically 
GHVFULEHHYHQWV« On the balance sheet, IP experiences a specific form of 
authorisation.  ,WLVUHSUHVHQWHGLQWKHGLVFRXUVHRIDFFRXQWLQJE\µLQWDQJLEOHV¶DQ
LPSUHFLVHWHUPDVVRFLDWHGZLWKWKHLQFUHDVLQJO\REVHUYHGµJDSEHWZHHQWKHPDUNHW
DQGERRNYDOXH¶ZKLOHFXUUHQWDFFRXQWLQJV\VWHPVDUHGHWHUPLQHGE\DWDQJLEOH
DVVHWV¶EDsed perspective and offer little scope to document how IP relates to business 
performance. Accounting may thus be seen as a gate keeper of the status quo that 
poses significant challenges for IP-rich companies, confronted with the challenge to 
either communicate around the lingua franca of accounting or accept that under 
current accounting statements they cannot adequately document how IP relates to 
their business performance.403 
 A brief discussion of the history of double-entry bookkeeping will illustrate why the 
traditional accounting criteria is ill-adapted to recognising and valuing intangibles.  This 
research provides a deeper understanding of the practical reasons that lead to uncertainty with 
when accounting for intangible patent assets and IAS 38.  
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4.2.1.1 History of double-entry bookkeeping  
 Ideas that revolutionised the way Europeans counted and accounted for their assets 
were introduced by Italian Renaissance mathematician, Leonardo of Fibonacci in his ground-
breaking book Liber Abaci³7KH%RRNRI&DOFXODWLRQ´ published in 1202, in which he 
introduced Europe to the decimal system and showed how it could be applied to commercial 
bookkeeping.  His ideas eventually led to the birth of banking in the late 13th century.404  
Fibonacci also introduced the concept of present value (the discounted value today of a future 
revenue stream).405  Historically, the double-entry book keeping system, which forms the 
basis for modern accounting principles and is globally accepted, was simply a tool to track 
and document the exchange of tangible items and prevent embezzlement.  The method of 
preparing and presenting financial business information used by accountants, the double entry 
book keeping system, is set out in Figure 20 below and illustrates the debit and credit system 
of modern double-entry bookkeeping.  
 
Figure 20 The double-entry bookkeeping system 
Debits and credits are numbers recorded as follows: 
Account Type Debits Credits 
Assets Increase Decrease 
Liabilities Decrease Increase 
Income (revenue) Decrease Increase 
Expenses Increase Decrease 
Capital Decrease Increase 
Source: Adapted from Atrill, P. and McLaney, E. Accounting & Finance for Non Specialists (2012) (8th ed.) Pearson 
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 In double-entry bookkeeping all transactions in the accounts are entered twice:  once 
as a debit and once as a credit.  Debits increase balances in asset accounts and expense 
accounts, and decrease balances in liability accounts, revenue accounts, and capital accounts.   
Credits increase balances in liability accounts, revenue accounts, and capital accounts, and 
decrease balances in asset accounts and expense accounts.   The golden rule of accounting is 
founded on the accounting equation:   
 
   2ZQHU¶V(TXLW\ $VVHWV± Liabilities  
 
  If at any point the sum of debits for all accounts does not equal the corresponding 
sum of credits for all accounts, an error has occurred.  It follows that the sum of debits and 
the sum of the credits must be equal in value.  In essence, the accounting equation serves as 
an ³error detection tool´ by making it a record of historical transactions.   In case of error, 
each debit and credit can be traced back to a journal and transaction source document, thus 
preserving an audit trail.  The double-entry bookkeeping system was originally designed to 
prevent fraud and misappropriation by employees of the Renaissance merchants of Venice.406      
Broadly speaking, the root of the problem is that modern accounting has difficulty dealing 
with intangibles because such assets do not fit the socio-historic evolution of accounting.  
This is because when a patent is applied for and becomes a form of property (an asset of the 
innovating SME and thus a form of currency) and there are few, if any, historical market 
transactions to record in the accounts.  However, the expenditure involved in getting to the 
patent filing stage is recorded.  Thus part of the equation is missing in the balance sheet.  
 The next significant development in the history of accounting was the ³accrual´ 
method based on recording transactions.  Income items are recorded when they are earned 
                                                 
406Supra Ferguson [396] 
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and deductions  recorded when expenses are incurred. Therefore, modern accrual accounting 
still requires financial transactions to be recorded as they occur, creating an accurate record 
of all historic transactions.  This historic information is then also largely used to confirm sales 
and cash flow trends.  The nature of innovation leading to patents being filed and granted a 
IHZ\HDUV¶ODWHUdoes not map well onto the accrual method of recording of transactions.  
Nevertheless, although patents are valuable business assets, this value is not gleaned from the 
FRPSDQ\¶VILQDQFLDOVWDWHPHQWV 
 In essence, the accrual accounting system relies on a set of fundamental assumptions 
and principOHVZKLFKKDYHEHFRPHNQRZQDV³generally DFFHSWHGDFFRXQWLQJSULQFLSOHV´ 
(GAAP).  Fundamental accounting principles therefore shape a very particular perception of 
intangibles, which in turn shackles the fullest use of patent assets as security for loans.  It is 
important for those working with patents in a commercial context to have an understanding of 
these accounting principles because financial terminology and practice permeates the 
exploitation and commercialisation of patented inventions.  A basic knowledge of GAAP 
provides both context and illumination for any transaction in which patents feature. The main 
principles relevant to this discussion that underpin modern accounting rules, standards and 
practice and have been adopted by the Financial Accounting Standards Board (FASB) 
forming the basis for how intangible assets are treated in financial statements, are briefly 
summarised below.407 
 First, the revenue principle or realisation principle provides that revenue (income) is 
earned when the sale is made, typically when goods or services are provided.  A key element 
of the revenue principle in relation to the sale of tangible assets is that revenue is earned 
when legal ownership of the asset passes from seller to buyer.  
                                                 
407Nelson, S.L Understanding the Basic Principles of Accounting (2011) Quickbooks 
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  Second, the expense principle provides that an expense occurs when the business 
uses goods or receives services.  The business incurs and expense when goods or services are 
received.  
 Third, the matching principle correlates to the revenue and the expense principles.  It 
provides that when revenue is recognised, one should match related expenses associated with 
the revenue.  Accrual-based accounting is the application of the three principles.  Basically, it 
means that one records revenue when a sale is made and records expenses when goods are 
used or services are received.  
 Fourth, the cost principle provides that figures recorded in the accounts should be 
quantified (measured) using historical cost.  For example, if a firm owns a vehicle, the cost of 
the vehicle is the purchase price and not the current fair market value for the vehicle.  The 
value of the vehicle as recorded in the accounts is not adjusted for changes in fair market 
value.  
 Fifth, the objectivity principle provides that accounting measurements and accounting 
reports should use objective, factual and verifiable data.  This means that accountants, 
accounting systems and accounting reports should rely on objective data rather than 
subjective data.  This is why an accountant always uses objective data (even if it poorly 
reflects the full commercial value of a patent) rather than subjective qualitative data relating 
to the future potential of the patent.408    
 These five concepts provide a basic, but important understanding of aspects of the 
foundation on which accountants prepare financial statements that deal with assets, both 
tangible and intangible.  The diverse range of stakeholders that have an interest in the 
financial position of an entity leads to a logical division in the discipline of accounting.  
³)inancial accounting´ is designed to enhance external reporting to third parties (such as 
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lenders).  In contrast, ³managerial accounting´ is concerned with collating information for 
internal management.  Financial accounting more broadly targets a range of third parties, 
including lenders, who do not control the actual preparation of financial statements and 
reports, nor do they have access to the underlying detail.  The ability to understand and have 
confidence in the reports is directly dependent on the standardisation of accounting principles 
and practices that are used to prepare them.  Without such standardisation, the financial 
statements of different companies would be difficult to understand and even more difficult to 
compare.    
 
4.2.1.2 7KHFUHGLWDSSUDLVHU¶VDSSURDFKWRWKHERUURZHU¶VILQDQFLDOVWDWHPHQWs 
 The credit appraiser uses the traditional financial statements differently to the 
accountants.  7KH\ZDQWWKHHQWLW\¶VILQDQFLDOVtatements to help them assess the ability of the 
business to repay the principal sum borrowed with interest.  7KHFUHGLWDSSUDLVHU¶VDSSURDFK
WRWKHSRWHQWLDOERUURZHU¶VWUDGLWLRQDOILQDQFLDOVWDWHPHQWVWKHEDODQFHVKHHWDQGWKHSURILW
and loss account is explained below:  
 
 The Balance Sheet is a stock concept, while the Profit and Loss Account is a flow 
concept.  The former indicates the state of a business as on a particular date, while the 
latter tells us how the present state has come into being.  The two together finally tell 
us how the funds flowed through the business during a given period.  The accounting 
system first evolved the balance sheet, followed by the Profit and Loss Account at a 
much later date.  In fact, the Balance Sheet of a business is never static, in spite of its 
being labelled as such.  The Balance Sheet is a total concept, while the Profit and Loss 
$FFRXQWLVDSDUWLDOFRQFHSW«WKHUHDVRQZK\WKH%DODQFH6KHHWKDVUHFHLYHGVR
much attention of lenders [is] not only to see whether the loan stands secured, but also 
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to examine whether the value of the business is rising or not.  The Profit and Loss 
Account tells us more about the operating management of the business, while the 
Balance Sheet indicates the efficiency of financial management.  The ratios calculated 
between a stock variable (Balance Sheet) and a flow variable (Profit and Loss 
Account) enable us to estimate the overall efficiency of a business. 409 
 
 Thus credit appraiser¶VHYDOXDWLRQRIthe potential borrower¶V financial statements 
goes beyond checking to see if the loan stands secured; he also examines whether the 
value of the business is rising or not.  Supplementary qualitative information about 
patent assets will assist to answer WKHOHQGHU¶VVHFRQGTXHVWLRQ This is where 
corporate narrative reporting law has an important role to play.  Further, there is a risk 
that funds loaned to a business will be used for purposes that have not been agreed.  
Accounting information is also used to check that the funds have been property 
applied in the appropriate manner and that the terms of the loan agreement are being 
adhered to.410  Information contained in financial statements should reduce 
uncertainty over the financial position and performance of the business.  Having said 
that, accounting is a developing subject and we still have much to learn about user 
needs, specifically those of lenders.  Under company law provisions, a qualifying 
60(QHHGRQO\VXEPLW³DEEUHYLDWHGDFFRXQWV´QDPHO\DEDODQFHVKHHWDQGQRSURILW
DQGORVVDFFRXQWZKLFKLPPHGLDWHO\FUHDWHVDQ³LQIRUPDWLRQJDS´IRUOHQGHUV411  An 
analysis of the legal requirements and accounting standards that apply to financial 
statements in the context of UK corporate reporting ensues.   
 
                                                 
409
 Bhattacharya, H.  Banking Strategy, Credit Appraisal and Lending Decisions:  A Risk-Return Framework 
(2010), Oxford University Press p256 
410
 Atrill, P. and McLaney, E. Accounting & Finance for Non Specialists (2002) (3rd ed.) Pearson, p3 
411
 s 447(1) CA 2006 
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4.3 The intersection of accounting and company law  
 
 In the 1970s the EU initiated two directives on the harmonisation of rules of 
accounting, the Fourth and Seventh Directives 412 which made it clear that accounting is at 
the centre of company law and thus a field of highest importance for corporate lawyers.  
However, a further impetus harmonising accounting rules was the introduction of 
International Accounting Standards (IAS) including IAS 38 Intangibles which determines the 
accounting treatment of patents.  In sections 4.3.1 - 4.3.4 we introduce how the IAS operates 
within the UK corporate law system.  In section 4.3.5 we examine the detailed provisions of 
IAS 38 and consider the impact on patents.  Section 4.3.6 introduces UK company law 
financial UHSRUWLQJUHTXLUHPHQWVDQGWKH³WUXHDQGIDLU´ view concept.  Section 4.3.7 asks 
whether financial statements prepared according WR,$6SURYLGHD³WUXHDQGIDLU´ view as 
required by law and, if not, whether there is scope to depart from IAS 38.   
 
4.3.1 European and UK rules of accounting 
 
 In the UK, Generally Accepted Accounting Practice (GAAP) is the body of umbrella 
regulation that establishes how company accounts must be prepared by UK companies.    
This includes accounting standards and UK company law.  ,QGHHG³generally accepted 
DFFRXQWLQJSUDFWLFH´ is a defined statutory term LQWKH8.¶VWD[OHJLVODWLRQ7he main piece 
of legislation that governs financial reporting in the UK is the Companies Act 2006 (CA 
2006) which incorporates the requirements of European law and sets out the minimum 
corporate reporting requirements for UK registered companies.  For example, the Act 
requires limited companies to file their accounts with the Registrar of Companies, who then 
makes them available to the public (accessible to lenders).  This means that every UK 
                                                 
412
 See Medhurst, D. (1994) 145-147 detailing the harmonisation directives.    
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company (except very small companies which are exempt)413 need to prepare the accounts for 
submission to Companies House.  Section 386 CA 2006 requires every company to keep 
DGHTXDWHDFFRXQWLQJUHFRUGVWRVKRZDQGH[SODLQWKHFRPSDQLHV¶WUDQVDFWLRQVDQGWKH
directors must prepare accounts for the company for each of its financial years.414  Individual 
company accounts comprise a balance sheet (as at the last day of the financial year) and a 
profit and loss account.  TKHDQQXDODFFRXQWVPXVWJLYHD³WUXHDQGIDLUYLHZ´ of the state of 
affairs as at the end of the financial year and of the profit and loss for the financial year of the 
company according to ss396 and 494 CA 2006.  In complying with the CA 2006, the 
accountants who prepare the accounts adhere to UK GAAP or practices which necessitate the 
basic accounting concepts briefly outlined in section 4.2.   Accounting standards derive from 
a number of sources. In the UK, the chief standard-setter is the Accounting Standards Board 
(ASB), which issues standards called Financial Reporting Standards (FRS).  The ASB is part 
of the Financial Reporting Council (FRC), an independent regulator.     
 
 
4.3.2 IAS and the new UK GAAP ± legal effect in the UK  
 
 
 Cross border commercial transactions make international accounting standards a 
necessity.415  IAS are referred to as International Financial Reporting Standards (IFRS), 
although the term IAS is used in practice.  Since 2005 it has been a legal requirement that all 
listed416 European companies report under the IFRSs.417  In the UK, unlisted companies still 
have the option to report either under the IFRS or under UK GAAP.  Section 50 of the 
Finance Act 2004 UHGHILQHV³JHQHUDOO\DFFHSWHGSUDFWLFH´WRLQFOXGHERWK(&- adopted IAS 
and UK GAAP for periods beginning on or after 1 January 2005 (the date in the EC 
                                                 
413
 s 447(1) CA 2006 
414
 s 394 CA 2006 
415
 Where Internet Meets Geography, at 268 (2000) (contemplating the effect that Internet globalisation will 
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Regulation).  The vehicle of such introduction on a community wide basis is Regulation 
WKH³,$65HJXODWLRQ´ZKLFKSURYLGHVIRUWKHSURFHGXUHZKHUHE\,$6DUHWREH
adopted and sets out the financial statements to which they must be applied.418  Broadly, the 
use of IAS is mandatory for the consolidated accounts of listed companies whose securities 
are admitted to trading on a regulated market.  Although our focus is innovating SMEs, the 
IAS still make an impact as they are the basis for UK national standards.  In recent years the 
differences between the two sets of standards (UK GAAP and IAS) have been streamlined.    
 In March 2013 the FRC (the body responsible for issuing UK accounting standards) 
issued FRS 102, the Financial Reporting Standard applicable in the UK.  This followed the 
issue of FRS 100 Application of Financial Reporting Requirements and FRS 101 the 
Reduced Disclosure Framework in November 2012.  Together these standards comprise the 
³New UK GAAP´, which take mandatory effect for accounting periods commencing on or 
after 1 January 2015.419 
 
4.3.2.1 The IFRS for SMEs and micro-sized entities 
 At its September 2003 meeting, the IASB decided that it should develop accounting 
standards appropriate for SMEs and that development of IASB SME standards should start 
by extracting the fundamental concepts from the IASB Framework and the principles and 
related mandatory guidance from IFRSs and related Interpretations.  To that end, on 9 July 
2009 the IASB issued IFRS for Small and Medium-sized Entities.  On 26 July 2012, IASB 
announced that IASB staff, together with the SME Implementation Group, would develop 
guidance suitable for micro-sized entities that are applying the IFRS for SMEs.  On 27 June 
2013 IASB issued this guidance, which accompanies, but is not part of, the IFRS for SMEs.  
Essentially, the guide extracts from the IFRS for SMEs only those requirements that are 
                                                 
418
 Moore QC, M. Opinion HQWLWOHG³7UXHDQG)DLU5HTXLUHPHQW5HYLViWHG´for the FRC 
419
 Crowe Clarke Whitehall LLP Corporate Business Newsletter FRS 102: the new accounting standard for the 
UK.  
165 
 
likely to be necessary for a typical micro-sized entity, without changing any of the principles 
for recognising and measuring assets, liabilities, income and expenses.  The IASB advises 
that compliance with this Guide will result in compliance with the IFRS for SMEs.  The 
Guide will no doubt be very useful for micro-sized entities in preparing their accounts in an 
IFRS-compliant manner.  But the issue of the different treatment of internally generated 
intangible assets remains, thereby continuing to inhibit innovating SME access to patent-
backed finance.  Figure 21 notes IAS 38 for intangible assets and the equivalent UK Financial 
Reporting Standard (FRS) 102 which must be applied when preparing and presenting 
corporate financial statements.   
 
Figure 21 Comparison between IAS 38 and UK FRS 
IFRS UK FRS Subject 
IAS 38 FRS 102 Goodwill and Intangible Assets 
 
 Section 397 of the UK CA 2006 requires a limited company that submits individual 
accounts to Companies House420 (this includes SMEs) to specifically state in the notes to the 
accounts that they have been prepared in accordance with IAS.  Further, the audit report (if 
RQHLVUHTXLUHGXQGHU&$PXVWDOVRVWDWHFOHDUO\ZKHWKHULQWKHDXGLWRU¶VRSLQLRQ, the 
annual accounts have been properly prepared in accordance with the Act and whether the 
accounts give a true and fair view of the compDQ\¶VILQDQFLDOSRVLWLRQ7KH³WUXHDQGIDLU´ 
requirements of the CA 2006 will be discussed in section 4.4.   In the next section we discuss 
the legal status of accounting standards.  
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 All limited companies in England, Wales, Northern Ireland and Scotland are registered at Companies House, 
an Executive Agency of BIS.  There are more than 3 million limited companies registered in the UK and more 
than 400,000 new companies are incorporated each year.  
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4.3.3 The legal status of accounting standards 
Are accounting standards law?  No, not of themselves.  IAS and GAAP are not enacted 
by parliaments, but by private organisations (usually with government support).421 For 
example, the International Accounting Standards Committee (IASC) is an independent, 
private sector body, formed in 1973 and restructured in May 2000 with the objective of 
harmonising the accounting principles used by businesses around the world.   IASC members 
currently number 143 professional accounting bodies in 104 countries representing over 2m 
accountants worldwide.  Accounting standards and principles can be equated with codes of 
FRQGXFW IRU FRUSRUDWLRQV  +RZHYHU WKHLU VWDWXV DV ³ODZ´ LV IUDJLOH EHFDXVH WKH\ DUH QRW
formally enacted, are in a state of flux, and are simultaneously elusive and osmotic.422  The 
reporting of intangible assets and the relationship between accounting principles, practice and 
standards has been the subject of intense discussion by accountants for many years.   
 
4.3.4 IAS 38 Intangible Assets 
 IAS 38 Intangible Assets is at the heart of the issues faced by borrowers who wish to 
ensure that their patent assets are financially recorded in a way that is both visible and useful 
to lenders.  The first time accounting for intangibles were addressed in a thorough way was in 
IAS 38, promulgated in 1995 after a long and contentious gestation period that included the 
issue of two Exposure Drafts.  IAS 38 is a comprehensive standard that superseded an earlier 
standard which dealt solely with R&D expenditures.   In summar, IAS 38 outlines the 
accounting requirements for intangible assets, which are non-monetary assets without 
physical substance and identifiable (either being separable or arising from contractual or 
other legal rights).  Intangible assets meeting the relevant recognition criteria are initially 
measured at cost, subsequently measured at cost or using the revaluation model, and 
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amortised on a systematic basis over their useful lives (unless the asset has an indefinite 
useful life, in which case it is not amortised).423  IAS 38 follows a conservative path in its 
treatment of intangibles along the lines of the US GAAP.   
 
4.3.5 How does IAS 38 allow patent owners to communicate the financial value of 
 intangibles and patents?  
 
 
   IAS 38 establishes recognition criteria, measurement bases, and disclosure 
requirements for intangible assets.  Each of these elements is analysed in further detail below.  
Additionally, IAS 38 sets out impairment testing424 for intangible assets, to be undertaken on 
a regular basis.  This is to ensure that only assets having recoverable values are capitalised 
and carried forward to future periods. 
 According to the IASC, the development of IAS 38 was controversial and gave rise to 
the debate on two significant issues.  First, should internally generated intangible assets be 
recognised in financial statements?  The current IAS 38 confirms that they should be, but 
only when very strict criteria are met.  Second, should there be an arbitrary upper limit on the 
useful life of intangible assets?  In this regard, there is a presumption that the useful life of 
intangible assets will not exceed 20 years.  In relation to patents, this is a non-issue and is 
more of a concern in relation to other forms of intangibles such as trade marks, designs and 
copyright.  Accordingly, in this thesis, we focus squarely on the first issue.     
 Next, we refer to the technical summary of the text of accounting standard IAS 38 
Intangible Assets issued on 1 January 2012 by the IASB425 as the basis for discussion of the 
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relevant accounting requirements and critically analyse the provisions from a patent asset 
perspective:    
 IAS 38 Intangible Assets - Recognition and Measurement 
 The recognition of an item as an intangible asset requires an entity to demonstrate that 
the item meets the: (a) definition of an intangible asset; and (b) recognition criteria.  This 
requirement applies to costs incurred initially to acquire or internally generate an intangible 
(patent) asset and those incurred subsequently to add to, replace part of, or service the asset. 
Intangible assets are categorised by accountants as either identifiable or unidentifiable (e.g. 
JRRGZLOODVVHWV7KH³identifiability´ test is set out below: 
 
 An intangible asset is identifiable if it either: 
 (a) is separable, i.e. is capable of being separated or divided from the entity and sold, 
 transferred, licensed, rented or exchanged, either individually or together with a 
 related contract, identifiable  asset or liability, regardless of whether the entity 
 intends to do so; or 
 (b) arises from contractual or other legal rights, regardless of whether those rights  are 
 transferable or separable from the entity or from other rights and obligations. 
 
 A patent is therefore recognised as an identifiable intangible asset. A patent may have 
VRPHSK\VLFDOIRUPDVWKHUHPD\EHWDQJLEOHHYLGHQFHRILWV¶H[LVWHQFHVXFKDVDFHUWLILFDWH
indicating that a patent has been granted or patent application documents, but this does not 
constitute the asset itself.  Goodwill, on the other hand, cannot be meaningfully transferred to 
a new owner without also selling the other assets and/or the operations of the business.426  
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Other identifiable assets can result from R&D activities e.g. a prototype or model, but this is 
secondary to the idea, knowledge or invention that is the primary result of the R&D activities.  
It is a fairly straightforward exercise to identify and classify inventions (patent assets), 
distinguishing them from goodwill.  Next, the patent asset must EH³UHFRJQLVHG´: 
 
 Recognition test 
 An intangible asset shall be recognised if, and only if: 
 (a) it is probable that the expected future economic benefits that are attributable to 
 the asset will flow to the entity; and 
 (b) the cost of the asset can be measured reliably. 
 
 These two limbs of IAS 38 comprise the challenging aspect of the standard in 
connection with internally generated inventions.  When patent assets are purchased or 
acquired, there is no such difficulty as IAS 38 clearly states that: 
 
 The probability recognition criterion is always considered to be satisfied for 
 intangible assets that are acquired separately or in a business combination. 
 
 An intangible asset shall be measured initially at cost. 
 
 The cost of a separately acquired intangible asset comprises: 
 (a) its purchase price, including import duties and non-refundable purchase taxes, 
 after deducting trade discounts and rebates; and 
 (b) any directly attributable cost of preparing the asset for its intended use. 
                                                                                                                                                        
liabilities in the consolidated financial statements.  Although purchased goodwill is not in itself an asset, its 
LQFOXVLRQDPRQJVWWKHDVVHWVRIWKHUHSRUWLQJHQWLW\UDWKHUWKDQDVDGHGXFWLRQIURPVKDUHKROGHUV¶HTXLW\
recognises that goodwill part of a larger asset, the investment, for which management, remains accountable. See 
https://frc.org.uk/Our-Work/Codes-Standards/Accounting-and-Reporting-Policy/Standards-in-Issue/FRS-10-
Goodwill-and-Intangible-Assets.aspx 
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 In accordance with IFRS 3 Business Combinations, if an intangible asset is acquired 
 in a business combination, the cost of that intangible asset is its fair value at the 
 acquisition date. If an asset acquired in a business combination is separable or arises 
 from contractual or other legal rights, sufficient information exists to measure 
 reliably the fair value of the asset. 
 
 In accordance with this Standard and IFRS 3 (as revised in 2008), an acquirer 
 recognises at the acquisition date, separately from goodwill, an intangible asset of the 
 acquiree, irrespective of whether the asset had been recognised by the acquiree 
 before the business combination. This means that the acquirer recognises as an asset 
 separately from goodwill an in-process research and development  project of the 
 acquiree if the project meets the definition of an intangible asset. 
  
 Thus, acquired patent assets may be capitalised rather than expensed on the balance 
sheet, putting ³SDWHQW acquirers´ in a positive financial position UHODWLYHWR³internal patent 
GHYHORSHUV´.  Reverting to internally generated patent assets, IAS 38 continues as follows: 
 
 Internally generated intangible assets 
 Internally generated goodwill shall not be recognised as an asset. 
  
 No intangible asset arising from research (or from the research phase of an internal 
 project) shall be recognised. Expenditure on research (or on the research phase of an 
 internal project) shall be recognised as an expense when it is incurred. 
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 An intangible asset arising from development (or from the development phase of an 
 internal project) shall be recognised if, and only if, an entity can demonstrate all of 
 the following: 
 (a) the technical feasibility of completing the intangible asset so that it will be 
 available for use or sale. 
 (b) its intention to complete the intangible asset and use or sell it. 
 (c) its ability to use or sell the intangible asset. 
 (d) how the intangible asset will generate probable future economic benefits. Among 
 other things, the entity can demonstrate the existence of a market for the output of the 
 intangible asset or the intangible asset itself or, if it is to be used internally, the 
 usefulness of the intangible asset. 
 (e) the availability of adequate technical, financial and other resources to complete 
 the development and to use or sell the intangible asset. 
 (f) its ability to measure reliably the expenditure attributable to the intangible asset 
 during its development. 
 
 The cost of an internally generated intangible asset for the purpose of paragraph 24 
 is the sum of expenditure incurred from the date when the intangible asset first meets 
 the recognition criteria in paragraphs 21, 22 and 57. Paragraph 71 prohibits 
 reinstatement of expenditure previously recognised as an expense. 
 
 In other words, expenditure on an intangible item shall be recognised as an expense 
when it is incurred, unless it forms part of the cost of an intangible asset that meets the 
recognition criteria; or the item is acquired in a business combination and cannot be 
recognised as an intangible asset.  If this is the case, it forms part of the amount recognised as 
goodwill at the acquisition date (see IFRS 3).  Within the category of internally generated 
intangibles other than goodwill (such as patents), the patent(s) must demonstrate each and 
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every one of the requirements set out in (a) to (f) above.  There is no discretion to be 
exercised even if one element is lacking.  A key issue is the future economic benefit 
requirement in (d) mandated by IAS 38.  Under IAS 38 an intangible asset is only recognised 
if it is probable that future economic benefits specifically associated therewith will flow to 
the reporting entity, and the cost of the asset can be measured reliably.  The recognition 
criteria for intangible assets are derived from the IASC Framework and are similar to the 
recognition criteria for tangible assets (property, plant and equipment etc). 7KH³IXWXUH
economic benefit´ envisaged by the standard may take the form of revenue from the sale of 
products and services, costs savings, or other benefits resulting from the use of the intangible 
asset by the firm.  If these types of future economic benefit are not available, then the 
LQDELOLW\WRUHFRJQLVHVXFKSDWHQWDVVHWVFDXVHVWKHILUP¶VEDODQFHVKHHWWRunder-report its 
economic resources ± having a negative effect on any lending decision.   
 Another key element of the test for recognition of intangibles in (f) is also problematic 
in that the availability of  ³ILQDQFLDORURWKHUUHVRXUFHV´ to complete the development and to 
use or sell the intangible asset must be objectively shown.  Very few innovating SMEs will 
be in a financial position to do this, which is why they seek debt finance.  This can only lead 
WRD³Which comes ILUVW"7KHFKLFNHQRUWKHHJJ"´ debate ± in other words, the futility of 
identifying the first case (e.g. financial resources) of a circular cause and consequence.  
Meeting the requirements in (f) is a hurdle for innovating SMEs.  
 In a nutshell, IAS 38.51.67 initially requires the application of a cost approach 
relation to the valuation of intangible internally generated patent assets.  When an internally 
generated patent asset meets the recognition criteria, the cost is determined using the same 
principles as for an acquired tangible asset.  Thus, cost comprises all costs directly 
attributable to creating, producing and preparing the asset for its intended use.  IAS 38 
closely follows IAS 16 Property, Plant and Equipment with regard to elements of cost that 
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may be considered as part of the asset.  This means that the book value at initial recognition 
is the sum of expenditure incurred from the date when the development phase in relation to 
the patented invention began.  Thus internally developed patents will be recognised at the 
cost of creation, exclusive of costs which would be analogous to research.  Under IAS 38, 
which must be applied by UK companies, a patent valuation must adopt the cost approach for 
this valuation purpose.  The next part of IAS 38 discusses the concept of financial 
measurement of the intangible asset, following the recognition process discussed above.  
 
 Measurement after recognition 
 An entity shall choose either the cost model or the revaluation model as its accounting 
 policy. If an intangible asset is accounted for using the revaluation model, all the 
 other assets in its class shall also be accounted for using the same model, unless there 
 is no active market for those assets. 
 
 Cost model: After initial recognition, an intangible asset shall be carried at its cost 
 less any accumulated amortisation and any accumulated impairment losses. 
 
 Revaluation model: After initial recognition, an intangible asset shall be carried at a 
 revalued amount, being its fair value at the date of the revaluation less any 
 subsequent accumulated amortisation and any subsequent accumulated impairment 
 losses. For the purpose of revaluations under this Standard, fair value shall be 
 measured by reference to an active market. Revaluations shall be made with such 
 regularity that at the end of the reporting period the carrying amount of the asset 
 does not differ materially from its fair value. 
 An active market is a market in which all the following conditions exist: 
 (a) the items traded in the market are homogeneous; 
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 (b) willing buyers and sellers can normally be found at any time; and 
 (c) prices are available to the public. 
 
 ,IDQLQWDQJLEOHDVVHW¶VFarrying amount is increased as a result of a revaluation, the 
 increase shall be recognised in other comprehensive income and accumulated in 
 equity under the heading of revaluation surplus.  However, the increase shall be 
 recognised in profit or loss to the extent that it reverses a revaluation decrease of the 
 VDPHDVVHWSUHYLRXVO\UHFRJQLVHGLQSURILWRUORVV,IDQLQWDQJLEOHDVVHW¶VFDUU\LQJ
 amount is decreased as a result of a revaluation, the decrease shall be recognised in 
 profit or loss. However, the decrease shall be recognised in other comprehensive 
 income to the extent of any credit balance in the revaluation surplus in respect of that 
 asset. 
 
 After initial recognition of the intangible patent asset, it should be carried at its cost 
less any accumulated amortisation and any accumulated impairment losses.  An allowed 
DOWHUQDWLYHWUHDWPHQWLV³UHYDOXDWLRQ´.  As with tangible plant, property and equipment assets 
under IAS 16, the standard for intangibles permits revaluation subsequent to original 
acquisition, with the asset being written up to fair value.  TKHUHTXLUHPHQWRIDQ³DFWLYH
PDUNHW´ as defined in IAS 38 is highly problematic in the field of patents as there is no active 
regulated market (such as the London Stock Exchange for company shares). Such a market 
does not yet exist.  The traditional accounting position is that a reporting entity will be unable 
WRGHWHUPLQH³UHOLDEO\´ (in the sense of objectively as opposed to subjectively) the fair value 
of a patent asset when comparable market transactions are non-existent, infrequent and when 
alternative estimates of fair value cannot be calculated.   
 A further problem for innovating SMEs is that under IAS38, if the intangible patents 
assets were not initially recognised (i.e. they were expensed rather than capitalised) it will not 
be possible to later recognise them at fair value.  Accordingly, the revaluation option is 
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unlikely to apply, especially to small businesses.  While the IAS 38 comprises further 
requirements, a discussion of these aspects is unnecessary for the purpose of this thesis.   
 On the one hand, Gilbert Gélard, Chairman of the IASC Steering Committee on 
Intangible Assets, KDVVWDWHGWKDW³,$6LVDVWHSIRUZDUGWRZDUGVWKHVHSDUDWHUHFRJQLWLRQ
of intangible assets for the better understanding by users of financial statements of 
investmentVLQLQWDQJLEOHDVVHWV´2QWKHRWKHUKDQGWKH,$6&¶VIRUPHU6HFUHWDU\-General, 
Sir Bryan Carsberg,427 has clarified that:   
 
 Knowledge about intangible assets, particularly how to value them, is still in its early 
days.  IAS 38 reflects the current limits of this knowledge, focusing on reporting the 
cost of intangible assets.  There is growing demand for further information on the 
value of intangible assets using financial and non-financial indicators, maybe not as 
part of the financial statements.  Debates on the subject are very much alive.  IASC 
will watch the developments in this area and may do more work in the future when 
preparers and users have gained more experience on the value of intangible assets.428 
 
 &ULWLFVRI,$6KROGWKDW6LU&DUVEHUJ¶VWDWHPHQWGHOLPLWVUDWKHUWKDQH[WHQGVWKH
possibilities to capitalise intangibles and that the issue of intangibles is still being addressed 
in an overly conservative manner.  According to accounting Professors Ulf Johanson of the 
University of Lund and Jan-Erik Grojer (deceased) of the Swedish University of Uppsala: 
 
 It is important to note that IASC has never approached the issue of how to separate or 
and label expenses on intangibles; nor has it dealt with the issue of qualitative 
LQIRUPDWLRQDERXWLQWDQJLEOHV«7KHFRQVHUYDWLYHDSSURDFKRIWKH,$6&DQGRWKHU
                                                 
427
 From 1995 to 2001, Sir Bryan Carsberg, former Professor of Accounting and Business Finance at the 
Victoria University of Manchester, served the IASC as Secretary-General. 
428
 http://www.ll-a.fr/intangibles/international accoutningh.htm  
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national standard setting authorities is not very surprising.  The standard setting 
bodies are not expected to take the lead in the issue of accounting for intangibles; in 
complex matters they are supposed to take the position of codifying best practice.429 
 
 Dr Ghafele, critiquing IAS 38 and the language of accounting, states that the term 
³LQWDQJLEOHDVVHW´WULJJHUVWKHSKUDVHRIWKH³gap between the market DQGWKHERRNYDOXH´, 
another expression that inadequately communicates about IP.430 
 Despite these views, it appears that the existing philosophy for the accounting 
treatment of intangible assets will essentially be continued and the problem of accounting for 
internally generated patent assets remains. Yet the IAS 38 standard is inappropriate from both 
a legal and a technological point of view.  The author argues that there is no legal or technical 
difference in substance between a patent that has been internally generated as against that 
exact same patent which is purchased by a third party and they should not be treated 
differently in the accounts.  In the case of an innovating SME, the value of its patents to the 
business model is greater than simply what someone else, at this point in early in the business 
life cycle, will pay for it.  In other words, IAS 38 has a greater negative impact on innovating 
SMEs in the early stage of their business, than on larger more established enterprises that 
have a strong trading history.  The vulnerable position of innovating SMEs is confirmed in 
the 2014 IP Valuation Report which states: 
 
 The Expert Group reports that there are limitations on when and how it is possible to 
 place the value of IP assets on the balance sheet of the company.  The complexity of 
                                                 
429
 In their report of DZRUNVKRSHQWLWOHG³7R0anage and Account for IntanJLEOHV´KHOGLQ)HEUXDU\ 
Brussels as quoted at http://www.ll-a.fr/intangibles/international accounting.htm  
430
 Supra Ghafaele [115] pp521-530 
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 IP from an accounting perspective leads to problems in its reporting, which may 
 result in the vulnerability of firms which base most of their performance on IP.431 
 They found a significant difference in the approach to lending to SMEs and start-ups 
compared with larger corporates that have strong trading history.432  Figure 22 below shows 
the difference in the reported value of an internally generated patent as compared to an 
acquired (purchased) patent.   
 
Figure 22 Internally generated GB patent 123456 vs Acquired GB Patent 123456 
GB Patent 123456  
Internally generated by Company X  
 
 
Inventor:  Steve Jones 
 
Claims: A, B & C 
 
Granted 5 September 2013 
 
GB Patent  123456 
Acquired by Company Y from Company X for 
£100,000 on 6 September 2013 
 
Inventor:  Steve Jones 
 
Claims: A, B & C 
 
Granted 5 September 2013 
Development costs £25,000 Purchase price £100,000 
Patent value for financial reporting: £25,000 Patent value for financial reporting: £100,000 
 
 Patent GB123456 that is internally developed is the same as Patent 123456 that is 
acquired the next day.  It is the exact same patent legally and technically.  The inventor is the 
same.  The patent claims that create the legal monopoly are the same.  The duration of the 
patent is the same.  The quality of the patent is the same.  Yet for accounting purposes, Patent 
123456 is inconsistently valued.  This is a simplistic illustration but it does show how this 
approach is irrational from both a legal and a technical point of view.  There needs to be a 
way that the patent value for Company X is closer to the figure recorded for Company Y for 
the system to be fair to patent developers and patent acquirers.  
                                                 
431
 Supra IP Value [20] p6 
432
 Ibid p6 
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 As early as 1999, it has been argued that there should be no difference between the 
requirements for: (a) intangible assets that are acquired externally; and (b) internally 
generated assets, whether they arise from development activities or other types of 
activities.433  For patent-backed lending purposes, there are two main areas of inconsistency 
between the accounting for acquired versus internally generated patents.  These are initial 
recognition at cost, and measuring fair value.  Leo argues as follows: 
 
 It may be strictly correct to state that acquired and internally generated   
 intangibles are both treated the same in that both are being recognised at cost.  
 However, even though the assets are in substance the same, initial recognition at fair 
 value is allowed for acquired intangibles but not for internally generated intangibles.  
 Acquirers are being given an advantage not available to those who generate their 
 assets internally. 434  
 
 IAS 38 recommends showing IC in the notes to the balance sheet.   However, such 
notes are very brief and are only designed to clarify and explain specific individual line items 
in the financial statements and would not normally be comprehensive (see section 6.X for an 
illustration).  While IAS has a high standing globally through policies designed to foster 
long-term agreement between domestic standards (as in the UK and other countries with 
well-developed accounting professions) and international standards, the flip side is that IAS 
38 is now well-entrenched internationally.  IAS 38, as it currently stands, continues to 
reinforce a lack of consistency between internally generated and purchased intangible assets 
as it appears to give precedence to historical cost.  Further, it restricts the development of 
useful and relevant information for lenders.  Despite its shortcomings, this is the price of 
                                                 
433
 /HR.µ,QWDQJLEOHDVVHWV6HHNLQJFRQVLVWHQF\¶1RYHPEHUAustralian CPA p31 
434
 Supra Leo [432] 
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harmonising accounting standards.435  Consequently, stakeholders involved in patent-backed 
security transactions are likely to be in the progressive/reformist camp.  This group holds the 
view that useful and relevant information is more important than information which is high in 
the traditional value of objectivity and reliability, but low in terms of relevance and 
usefulness.  Can this problem be overcome?  Higson argues that the difference between 
³progressLYHV´DQG³WUDGLWLRQDOV´ are the outcome of a lack of a clear basis within the 
conceptual accounting framework about what the financial statements are intended to 
achieve.  If different groups are trying to achieve different things through the same medium, 
then conflict will be inevitable. 436  The Banking and IP? Report largely adheres to the 
³WUDGLWLRQDOV´ view7KHDXWKRUVVWDWH³«WKLVUHSRUWGRHVQRWDGYRFDWHFKDQJHVWR« 
accounting standards.  The steps required to unlock the business value of IP are pragmatic 
PHDVXUHVWKDWEXLOGRQSULQFLSOHVDQGSUDFWLFHVZKLFKH[LVWWRGD\´437  The authors accept the 
status quo, they did not consider recommending amendments to IAS 38 by way of 
introducing alternative (subject and qualitative) valuation methodologies to measure patent 
value.  Nor does the 2014 IP Valuation Report directly consider the accounting standards or 
advocate any changes to them.   
 In June 2001, the US FASB unanimously approved Statement 141 Business 
Combinations and Statement 142 Goodwill and Other Intangible Assets which provides that 
HYHU\HQWLW\GRLQJEXVLQHVVLQWKH86PXVWGHWHUPLQHWKH³IDLUPDUNHWYDOXH´RIWKHLU
LQWDQJLEOHVUDWKHUWKDQUHO\RQ³KLVWRULF´YDOXHV438  This important accounting policy 
development requires US companies to adopt a more rigorous and controlled method for 
                                                 
435
 0DWKHZV05DQG+LJVRQ$:µPotentially dysfunctional impacts of harmonising accounting standards: 
WKHFDVHRILQWDQJLEOHDVVHWV¶(2000) Massey University 
436
 Higson, A.W., Corporate Communication: An Alternative Basis for the Construction of a Conceptual 
Framework Incorporating Financial Reporting: Discussion Paper Series 192. Massey University:  Department 
of Accountancy and Business Law.  
437
 Supra Banking on IP? [118] p16  
438
 See http://www.fasb.org/summary/stsum142.shtml 
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tracking and valuing IP assets leading to increased corporate reporting of IP asset439 is a 
potential solution for the UK and to be discussed further in Chapter 5.  
 From a legal perspective, company law goes a long way in prescribing the form and 
content of the accounting statements that companies must publish.  UK financial statements 
are required to comply with ss 393-397 and 495 CA 2006.  The ability to depart from 
accounting standards (whether domestic or international) is only available in cases where the 
result would be so misleading as to conflict with the objective of the relevant financial 
statements.  In section 4.3.6 we critically examine the requirement under s 393(1) CA 2006 
WKDWDFRPSDQ\¶VILQDQFLDOVWDWHPHQWVPXVWSURYLGHD³true and fair´ view.  The requirement 
IRUDFFRXQWVWRVKRZD³WUXHDQGIDLU´YLHZWHQGVWRRYHUULGHDQ\RWKHUUHTXLUHPHQWV440  We 
then attempt to answer the question whether the traditional accounting treatment of intangible 
patent assets (which includes IAS 38) meets this overarching legal requirement.    
 
4.3.6 How UK and international accounting standard setters intersect with UK 
 company law requirements 
 
In the UK Parts 15 and 16 of the CA 2006 drive the legal requirements for corporate 
accounts, financial reporting and the audit.  As always, human actors have roles to play.  It is 
of the highest importance to focus on the professional group that shapes the new company 
law.  Who is WKH³VWDQGDUGVHWWHU´ZKRLVWKHde facto ³FRPSDQ\ ODZPDNHU´"  In Germany, 
aFFRXQWDQWV KDYH WKH XSSHU KDQG WKURXJK WKH ³*HUPDQ ,QWHUQDWLRQDO $FFRXQWLQJ 6WDQGDUGV
&RPPLWWHH´XQGHURIthe German Commercial Code) which rules out the recognition 
of intangibles unless acquired.441  In the US, we have seen that the Federal Accounting 
Standards Committee is the accounting standard setter. Powerful national groups such as 
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 Neuhausen, B., Schlank, R. and Pippin, R. Accounting for Business Combinations, Goodwill, and Other 
Intangible Assets (2007) CCH Incorporated, p246 
440
 Supra Atrill [409] p127 
441 German Commercial Code as translated by A.F. Schuster, Barrister of the Inner Temple 
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these have much control over the rise and fall of accounting concepts and they participate 
heavily in the ongoing debate on the IAS.  The Australian government¶V initiative to carry out 
further research on this intangible assets issue was not accepted by other members of the 
IFRS, primarily because certain associations were concerned with tax implications for its 
members associated with addressing this inconsistency.442 The global process of accounting 
standard setting and the UK standard setting process are intertwined. Nonetheless, the 
political struggle towards further recognition of intangible IP through accounting continues to 
evolve and is gaining momentum.  
 
4.3.6.1 Assisting patent owners ± a legal basis for departing from IAS 38? 
 There are ways to assist patent owners who need to apply IAS 38.  One answer lies in 
solving the traditional accouQWLQJREMHFWLYHTXDQWLWDWLYH³meaVXUHPHQW´ problem to 
overcome the obstacle created by the lack of an active patent market.  A regulated market for 
patents would provide the information input necessary to meet the traditional (objective and 
quantitative) valuation methodology so that patent assets could be traded and then recognised 
under IAS 38.  A patent market may come into existence in the future, and the EU is involved 
in developing an initiative to set up such a market,443 however it is unlikely to assist 
innovating SMEs.  As with regulated stock markets, only a small percentage of companies 
achieve a listing.  This approach involves playing the accountants at their own game on their 
home field.  Alternatively, one could establish legal authority to depart from IAS 38 
altogether in order to reconfirm that the overarching legal policy with respect to financial 
statements is the substance of the information they contain, rather than the form.    
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 µ&RQVLGHULQJWKHHIIHFWVRIDFFRXQWLQJVWDQGDUGV$Q$XVWUDOLDQ5HVSRQVHWRWKH(XURSHDQ)LQDQFLDO
5HSRUWLQJ$GYLVRU\*URXS¶Institute of Public Accountants, pp15-16 
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 Creating a financial market for IPR Final report for EU Tender No3/PP/ENT/CIP/10/A/N02S003, 5 
December 2011.  In the conclusions of its meeting on 4 February 2011, the European Council invited the 
Commission to explore the options for setting up and IPR valorisation instrument at the European level, in 
particular to ease SME access to the knowledge market and to report back to the Council by the end of 2011. 
182 
 
As far as this author can see, no banking or lending association, nor any Law Society, 
corporate law association or patent attorney association is actively involved in the debate on 
IAS 38 and the accounting treatment of intangibles. Accountants continue to control the 
redirection and growth of the financial recognition of patent assets in the corporate and 
financial world. Patents as financial assets ³DUH´ ZKDW DFFRXQWDQWV preparing the financial 
statements by following accounting standards WHOO XV WKH\ ³DUH´ If patent assets are not 
reflected in the balance sheet and are fully expensed as they are undertaken, both the earning 
DQGERRNYDOXHRI D FRPSDQ\¶V HTXLW\ ZLOO EHXQGHUVtated by the accounting model. Thus, 
OHQGHUVZLOOEHSURYLGHGZLWKELDVHGFRQVHUYDWLYHHVWLPDWHVRIWKHILUP¶VSDWHQWYDOXHVDQG
of its capability for the creation of future wealth as a result of those patents.  Accordingly, a 
key aim of this thesis is to inform the lawyers, patent attorneys and lenders as to the critical 
issues that arise directly as a result of IAS 38. These stakeholders need to more fully 
appreciate why IAS 38 is generally unhelpful in representing internally generated patent 
assets in UK company accounts, which results in them often being under-valued leading to 
unfair or inaccurate credit risk evaluations. This causes the even more significant problem of 
limiting the growth of the domestic economy through lack of support of innovating firms 
which are in a worse position than NPEs that purchase patents.  Given the outcome, the 
importance of asking the following legal question should not be underestimated.  
 
 
4.3.7 Do financial statements prepared DFFRUGLQJWR,$6SURYLGHD³true and  
  IDLUYLHZ´ as required by s 393(1) CA 2006?   
 
 $FRPSDQ\¶V annual return includes its financial statements which are publicly available 
documents. If those financial statements provide the public with biased (conservative) 
HVWLPDWHVRIWKHILUP¶VYDOXHHTXLW\DQGLWVFDSDELOLW\WRFUHDWHZHDOWKLQWKHIXWXUHFXUUHQW
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earnings), this implies that current accounting statements fail to provide an unbiased (true and 
fair) view of the FRPSDQ\¶V ILQDQFLDO SRVLWLRQ This is an important corporate governance 
LVVXHEHFDXVHLWLVWKHERDUGRIGLUHFWRUVWKDWKDVSULPDU\UHVSRQVLELOLW\IRUWKHFRUSRUDWLRQ¶V
external financial reporting functions.  Section 393 CA 2006 states that the directors must not 
approve the accounts unless they are satisfied that they give a ³true and fair´ view of the 
assets, liabilities, financial position and profit or loss of the company.444 Section 393 CA 
2006 provides: 
 
(1) The directors of a company must not approve accounts for the purposes of this 
Chapter unless they are satisfied that they give a true and fair view of the assets, 
liabilities, financial position and profit or loss:- 
(a) in the case of the FRPSDQ\¶VLQGLYLGXDODFFRXQWRIWKHFRPSDQ\ 
(b) LQWKHFDVHRIWKHFRPSDQ\¶VJURXSDFFRXQWVRIWKHXQGHUWDNLQJVLQFOXGHGLQWKH
consolidation as a whole, so far as concerns members of the company. 
(2) The auditor of a company in carrying out his functions under this Act in relation to 
WKHFRPSDQ\¶VDQQXDODFFRXQWPXVWKDYHUHJDUGWRWKHGLUHFWRUV¶GXW\XQGHUVHFWLRQ
(1).  
  
 Section 495(3) CA 2006 sets out the obligation of the auditors to prepare a report and 
FOHDUO\VWDWHZKHWKHULQWKHDXGLWRU¶s opinion, the annual accounts: 
(a) Give a true and fair view:- 
                                                 
444
 The term true and fair was first used in the UK, where it originates, in legislation of 1948. However, prior 
legislation had used similar phrases. Companies legislation dated 1844 required UK companies to present a full 
and fair balance sheet, though the meaning of this phrase was never defined. A company was required to keep 
full and true accounts. By 1900 the auditor was required to state whether the balance sheet was properly drawn 
up so as to exhibit a true and correct view. This phrase was retained until 1948. 
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(i) in the case of an individual balance sheet, of the state of affairs of the 
company as at the end of the financial year, 
(ii) in the case of an individual profit and loss account, of the profit and loss of 
the company for the financial year, 
(iii) in the case of group accounts, of the state of affairs as at the end of the 
financial year and of the profit or loss for the financial year of the 
undertakings included in the consolidation as a whole, so far as concerns 
members of the company 
(b) have been properly prepared in accordance with the relevant financial reporting 
framework; and 
(c) have been prepared in accordance with the requirements of this Act (and, where 
applicable, Article 4 of the IAS Regulation).  
  
 As the requirement to prepare accounts which show a ³true and fair´ view is a legal one, 
what is true is a question of fact and what is fair is a question of law for the Courts to 
determine.  7KH³WUXHDQGIDLU´ concept has been part of English company law for decades 
and is central to accounting and auditing practice despite this no statutory definition of the 
phrase exists in the CA 2006 or in other UK legislation.  1RULVWKHH[SUHVVLRQ³WUXHDQGIDLU
YLHZ´, defined in the accounting literature. However, the phrase has been the subject of FRC 
research and case law which will be discussed. 
 The practical effect of s 393 is that all UK company directors have a duty to ensure that 
the financial statements are free from material misstatements and faithfully represent the 
financial performance and position of the company. In larger companies, the Managing 
Director and the Chief Financial Officer are crucial participants and boards usually have a 
high degree of reliance on these officers to ensure the integrity and supply of accounting 
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information. These corporate officers oversee the internal accounting systems but they are 
dependent on accountants and auditors for the actual supply of the information.  In the UK, 
auditors must also consider and expressly state in their audit report whether or not company 
directors have fulfilled their responsLELOLW\ IRU WKH SUHSDUDWLRQ RI ³WUXH DQG IDLU´ financial 
statements when providing an audit opinion and expressly state in this in their audit report.    
Qualified UK accountants and auditors are members of accounting bodies which adopt 
codes of professional conduct and standards of ethical and technical conduct and competence.   
Accounting associations typically require their members to adhere to the accounting 
standards set by the IAS and the IFRS.  This means that to avoid professional negligence, 
accountants must conform with IAS 38.  Conversely, if they apply IAS 38 in carrying out 
their accounting duties, they will not be negligent even if the financial statements do not 
SURYLGHD³WUXHDQGIDLU´ view of the patent assets.   
 In terms of corporate governance and company law, the supply of accounting 
information forms a crucial link in enabling the providers of finance to monitor directors.  
Imperfections in the financial reporting process will cause imperfections in the effectiveness 
of corporate governance. The company law disclosure requirements have largely evolved to 
protect shareholders and creditors. The long-held public policy motive is that increased 
transparency will prevent fraud largely due to over-valuing corporate assets.  Chapter 2 of 
Part 10 the CA 2006 sets RXWGLUHFWRUV¶GXWLHVLQVs. 171-177  with the aim of amending and 
codifying the common law to bring it into line with the expectations of the modern business 
world. They also attempt to set out in whose interest a company should be run. Broadly 
speaking, the common law duties of directors were designed to prevent directors from being 
negligent and WRPDNHVXUHWKDWWKH\SXWWKHFRPSDQ\¶VLQWHUHVWVDKHDGRf their own interests.  
The codified statutory duties have the same objectives. Section 172 includes the duty to 
promote the success of the company.  It states that: 
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(1) A director of a company must act in the way he considers, in good faith would be 
most likely to promote the success of the company for the benefit of the members of 
the who, and in doing so have regard (amongst other matters) to:- 
(a) the likely consequences of any decision in the long term; 
(b) WKHLQWHUHVWVRIWKHFRPSDQ\¶VHPSOR\HHV 
(c) WKHQHHGWRIRVWHUWKHFRPSDQ\¶VEXVLQHVVUHODWLRQVKLSVZLWKVXSSOLHUVFXVWRPHUV
and others; 
(d) WKHLPSDFWRIWKHFRPSDQ\¶VRSHUDWLRQVRQWKHFRPPXQLW\DQGWKHHQYLURQPHQW 
(e) the desirability of the company maintaining a reputation for high standards of 
business conduct; and 
(f) the need to act fairly as between members of the company. 
 
 This section codifies the common law and is intended to promote the concept of 
³enlightened shareholder YDOXH´(69.  The Rt Hon Margaret Hodge MP, Secretary of State 
for Trade and Industry, as she then was, made it clear in her Ministerial Statement on the 
UHIRUPVWRGLUHFWRUV¶GXWLHVLQWURGXFHGE\WKH&$WKDW 
 
 There are two ways of looking at the VWDWXWRU\VWDWHPHQWRIGLUHFWRUV¶GXWLHVRQWKH
one hand it simply codifies the existing common law obligations of company 
directors, on the other ± especially in section 172: the duty to act in the interests of the 
company ± it marks a radical departure in articulating the connection between what is 
good for a company and what is good for society at large.445 
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 She was referring to the introduction into company law of the ESV concept whereby 
companies should pursue shareholder wealth in the long term, ensuring sustainable growth 
and profits based on a wider range of stakeholder interests.   According to McLaughlin,446 
although the articulation of the connection between what is good for a company and what is 
good for society at large may be a radical step, ESV is not.  She holds that it preserves the 
central role of the interests of shareholders in the structure of corporate governance. As 
directors are fiduciaries447 they are expected to act in good faith to promote the success of the 
company.   
This challenging new duty has given company directors the most cause for concern because it 
has no obvious precursor, although it has clear links to the duty to act bona fide in the best 
interests of the company, which was the predominant and core fiduciary duty.448  At this 
stage, the nature and extent of the duty is difficult to interpret as it not closely aligned to any 
previous duty when compared with other duties in Chapter 2 of Part 10 of the Act, parts of 
this paper, while informed by existing case law and academic opinion, involve some 
speculation.449 
 However, turning to the list of matters to which the directors must have regard in 
promoting the success of the company, the most relevant provisions are: s 172(1)(a) the likely 
consequences of any decision in the long term; and (b) WKHLQWHUHVWVRIWKHFRPSDQ\¶V
employees.  Directors need to ensure that the company is appropriately financed to carry out 
LWVRSHUDWLRQV,IDFRUHDFWLYLW\RIWKHFRPSDQ\¶VRSHUDWLRQVLQYROYes internally generating 
                                                 
446
 Ibid 
447
 A fiduciary is a person who holds a legal or ethical relationship of trust between himself or herself and one or 
more other parties (person or group of persons). Typically, a fiduciary prudently takes care of money for another 
person. A director is in a fiduciary relationship with shareholders who have invested funds in the company.  
448
 .HD\$µ7KH'XW\WR3URPRWHWKH6XFFHVVRIWKH&RPSDQ\,VLW)LWIRU3XUSRVH"¶
http://www.law.leeds.ac.uk/assets/files/research/events/directors-duties/keay-the-duty-to-promote-the-
success.pdf ,  pp3-4.  This implies that to be successful, directors must manage risk. Directors are accountable 
for how they conduct the affairs of the company.  The overarching concept of good faith includes not simply the 
duty of care and loyalty, in the narrow sense, but promoting the welfare of the company must guide the fiduciary 
(director).   
449
 Ibid, p4 
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patents, then a central matter for the directors should be to endeavour to ensure their value is 
reflected in a true and fair ZD\LQWKHFRPSDQ\¶VDFFRXQWVto facilitate access to finance 
needed for commercialization, generating a profit for shareholders.  Inadequate finance will 
have a detrimental effect both on the long-term success of the company, profits and the job 
security of its employees (if any).  The list of matters to which the directors must have regard, 
as set out in s172 (1), is not exhaustive.    
Consider this: what if the problem is that internally generated patents have been 
XQGHUYDOXHGDQGDVD UHVXOWDFRPSDQ\¶s potential to succeed is hindered by an inability to 
finance its activities?  Have the directors fulfilled their duty to the company?  Have the 
directors acted in a way they consider in good faith would be most likely to promote the 
success of the company for the benefit of the members?  For the director of a micro company 
with no other assets save a single internally generated patent, coupled with a duty to promote 
the success of the company, the question of the accounting treatment required by IAS 38 
should play on his or her mind, especially in terms of accountability to shareholders and had 
employees.  What if the directors of a company that internally generates patent assets, in 
carrying out their duty under s172, genuinely believed that the company was being 
disadvantaged by adhering to IAS 38?  In other words, that applying IAS 38 mandated 
accounting treatment to their patent assets does not result in a ³true and fair´ view?  What if 
they refused to sign off the accounts under s393 because they are unconvinced that the 
accounts JLYHDWUXHDQGIDLUYLHZRIWKHFRPSDQ\¶Vintangible assets?  The answer requires a 
critical analysis as to whether there is a viable legal argument for directors of innovating 
SMEs to depart from IAS 38 and adopt a different accounting treatment for their internally 
generated patent assets (e.g. GSK¶V,QWHUQDO5DWHRI5Hturn is discussed in Chapter 6). This 
leads to an evaluation of the legal research undertaken in connection with judicial 
conVLGHUDWLRQRIWKHFRQFHSWRI³WUXHDQGIDLU´ financial statements.    
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 Prima facie WKHZRUG³WUXH´ in this context is taken to mean that the financial statements 
are factually correct and have been prepared according to applicable reporting frameworks 
such as the IFRS and do not contain any material misstatements that may mislead users. 
³)DLU´ value is primarily a legal concept and is intended to estimate a fair or reasonable or 
equitable (to use legal terminology) amount. It is not necessarily intended to reflect a likely 
cost, market or income approach to valuation.  The essence of fair value, from a legal point of 
view, lies in the desire to be equitable to all parties.  Fair valuation in respect of a patent is the 
amount that will fairly compensate an owner who is deprived of the economic enjoyment of 
the patent where there is neither a willing buyer nor a willing seller.  However in 2012, the 
8.¶V)LQDQFLDO5HSRUWLQJ&RXQFLO)5&SXEOLVKHGLWVSROLF\VWDQFHDnd clarification of the 
SKUDVH³WUXHDQGIDLU´ view.  
 
4.3.8 FRC research as tRWKHPHDQLQJRI³7UXHDQG)DLU9LHZ´  
 
 On its website the FRC announced that the most authoritative statement as to the 
PHDQLQJRI ³WUXH DQG IDLU´ have been legal opinions written by Lord Hoffmann and Dame 
0DU\ $UGHQ LQ  DQG  DQG DOVR E\ 'DPH 0DU\ $UGHQ LQ  µWKH 2SLQLRQV¶
Since  then significant changes in accounting standards and company law have taken place 
leading some to query whether the views expressed in those Opinions still apply.  The FRC 
commissioned a further legal opinion from Martin Moore (QC) to ascertain whether the 
DSSURDFKWR³WUXHDQGIDLU´ taken in the Opinions needed revision.  The FRC reported:   
  
    In his Opinion, Mr Moore has endorsed the analysis in the Opinions of Lord 
   Hoffmann and Dame Mary Arden and confirmed the centrality of the true and 
   fair requirement to the preparation of financial statements in the UK, whether 
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   they are prepared in accordance with international or UK accounting  
   standards.   
 
    Directors must consider whether, taken in the round, the financial statements 
   that they approve are appropriate.  Similarly, auditors are required to  
   exercise professional judgment before expressing an audit opinion.  As a  
   result, the Opinion confirms that IT WILL NOT BE SUFFICIENT FOR  
   EITHER DIRECTORS OR AUDITORS TO REACH SUCH   
   CONCLUSIONS SOLELY BECAUSE THE FINANCIAL STATEMENTS 
   WERE PREPARED  IN ACCORDANCE WITH APPLICABLE   
   ACCOUNTING  STANDARDS [emphasis added]. 
 
    The FRC believes that this Opinion is an important confirmation of a key  
   contributor to the integrity of financial reporting in the UK.450   
 
 The relevance of the ³true and fair´ concept has been squarely confirmed by the FRC 
in its short 6 page report, True and Fair published in July 2011.451  Further, according to FRC 
Press Notice 338 the Accounting Standards Board and Auditing Practices Boards reaffirmed 
the importance of the ³true and fair´ view in both UK GAAP and IRFS.  The first page of 
True and Fair states: 
 
 In this note we discuss the continuing primacy of the true and fair requirement and its 
 relevance to preparers, those charged with governance and auditors. 
 
                                                 
450
 The FRC at http://www.frc.org.uk/Our-Work/Codes-Standards/Accounting-and-Reporting-Policy/True-and-
Fair.aspx  
451
 See http://www.frc.org.uk/FRC-Documents/FRC/Paper-True-and-Fair.aspx 
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 Preparation of accounts 
 In his Opinion Martin Moore notes, in relation to the gradual shift over time to more 
 GHWDLOHGDFFRXQWLQJVWDQGDUGVWKDW³,WGRHVQRWIROORZWKDWWKHSUHSDUDWLRQRI
 financial statements can now be reduced to a mechanistic process of following the 
 relevant standards without the application of objective professional judgement 
 applied to ensure that those statements give a true and fair view, or achieve a fair 
 SUHVHQWDWLRQ´ 
 This professional judgement is all important. 
 The same page specifically mentions that this applies to ³making judgements about 
valuation, aimed at giving a true and fair view´ as well as ³standing back at the end of the 
accounts process and making sure the accounts overall do give a true and fair view´.    
 The FRC then issues the followLQJFDXWLRQDU\VWDWHPHQWDERXW³WUXHDQGIDLU´ and 
accounting standards, warning that a departure from the standards should only be taken in 
extremely rare circumstances: 
 
 True and fair is not something that is merely a separate add-on to accounting 
 standards. Rather the whole essence of standards is to provide for recognition, 
 measurement, presentation and disclosure for specific aspects of financial reporting 
 in a way that reflects economic reality and hence that provides a true and fair view. 
 Accounting standards are arrived at after extensive consultation and after full due 
 process. As a result, in the vast majority of cases compliance with accounting 
 standards will result in a true and fair view, and disagreement with a particular 
 standard does not, on its own, provide grounds for departing from it. Indeed under 
 UK GAAP almost all true and fair overrides in the past were of law rather than of a 
 standard. 
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 Where the accounting standards clearly address an issue, but the answer does not 
 VHHPWRDFFRUGZLWK³FRPPRQVHQVH´LQDSDUWLFXODUFDVHWKHVROXWLRQLVQRUPDOO\
 proper disclosure. 
  
 +RZHYHULQWKRVH³H[WUHPHO\UDUH´ circumstances where directors and auditors do not 
 believe that following a particular accounting policy will give a true and fair view 
 they are legally required to adopt a more appropriate policy, even if this requires a 
 departure from the standard. As IAS 1 states, an entity cannot rectify inappropriate 
 accounting policies by disclosure.  These circumstances are more likely to arise where 
 the precise circumstances are not covered by a relevant standard. 
 
 Where a company departs from a standard in order to give a true and fair view and a 
 proper explanation is given of the reason for the departure and its effects, the 
 Financial Reporting Review Panel will be reluctant to substitute its own judgement 
 IRUWKDWRIWKHFRPSDQ\¶VERDUGXQOHVVLWLVQRWVDWLVILHGWKDWWKHERDUGKDVDFWHG
 reasonably. There are a number of examples where the override has been used under 
 IFRS, both inside and outside the UK.452 
  
 The six-page True and Fair Report relates to general principles and does not discuss 
any particular accounting standards nor does it mention intangibles assets or internally 
generated patent assets.  Nor does Moore (QC)¶VRSLQLRQ453 from which the report is derived.  
At the conclusion of the Report, the following advice is made to preparers, directors and 
auditors to ensure that accounts in the UK continue to provide high quality information:  
 
                                                 
452
 True and Fair, FRC, July 2011, p3 
453
 Moore QC, M. Opinion entitled, The True and Fair Requirement Revisited for the FRC 
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x Always to stand back and ensure that the accounts as a whole do give a true and fair 
view; 
x Be prepared, albeit in extremely rare circumstances, to consider using the true and fair 
override; and 
x Ensure that the consideration they give to these matters is evident in their 
 deliberations and documentation.454 
 
 In this legal analysis, the author submits the existence of internally generated patents 
assets is not an ³extremely rare occurrence´, it is commonplace.  Second, IAS 38 clearly 
addresses the accounting treatment of intangible assets, but LQWKHDXWKRU¶VRSLQLRQWKH
outcome of the application of IAS 38 (for the reasons detailed earlier in this chapter) does not 
VHHPWRDFFRUGZLWK³FRPPRQVHQVH´.  In such a case, according to the FRC, the solution is 
proper disclosure.  This implies additional narrative disclosure.  Companies that internally 
generate patents could voluntarily prepare the new ICS advocated by a significant proportion 
of the accounting profession, and which is already mandated in Denmark.  Alternatively, 
anoWKHUIRUPRIFRUSRUDWHQDUUDWLYHUHSRUWFRXOGEHXVHGWRVXSSOHPHQWWKHFRPSDQ\¶V
traditional financial statements.  The ICS format will be discussed in Chapter 5.   
 However, in his Opinion to the FRC Moore (QC) FOHDUO\VHWVRXWWKDWWKH³WUXHDQG
IDLU´UHTXLUHPHQWLVDQRYHU-arching concept, and is not the same as compliance with 
accounting standards.  Thus, even where a company complies with an accounting standard, if 
the accounts fail WRSURYLGHD³WUXHDQGIDLU´view, then they are inadequate.  Is this a question 
for the accountants or for the courts?   Moore (QC) states that the scope for arguing that non-
compliant financial statements nevertheless give a ³true and fair´ view, or a fair presentation, 
is very limited (paras 38-40).   ,QGHWHUPLQLQJZKHWKHUDFRPSDQ\¶VDFFRXQWVVKRZD³WUXH
                                                 
454
 https://www.frc.org.uk/FRC-Documents/FRC/Paper-True-and-Fair.aspx at p4 
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DQGIDLU´view, the Courts will rely heavily on the ordinary practices of professional 
accountants (para 8(c)).  At this point, it would appear that the accountants are in thHGULYHUV¶
seat on IAS 38.  According to Moore (QC):  
 
 8. &«7KDWLVEHFDXVHWKRVHSUDFWLFHVUHIOHFWWKHDFFXPXODWLRQRIH[SHULHQFHDQGJRod 
professional practice and mould the expectations of users of accounts as to the 
sufficiency and utility of the information in terms of quantity and quality.455 
And further:- 
  (D) Compliance with generally accepted accounting principles as set out in relevant 
statements of standard accounting practice will be prima facie evidence of satisfaction of 
the true and fair standard and vice versa.   
 
 (E) The application of the concept involves judgment on questions of degree.  
Reasonable business men and accountants may differ over the degree of accuracy or 
comprehensiveness, there may be differences over the method used to adopt a true and 
fair view and there may be more than one view of a financial position, any of which 
could be described as true and fair.   
 
 However, an important argument in favour of companies that internally generate patents, 
is what Moore (QC) goes on to say: 
 
 (F) The concept is dynamic, evolving and subject to continuous rebirth.  Accordingly, 
 the detailed provisions of the Schedules to the Companies Act may have to yield to 
 the overriding requirement to produce accounts which give a true and fair view. 
                                                 
455
 Supra Moore [452] p38 
195 
 
 
 There is little case law specifically on the question of whether accounts show a ³true 
and fair´ view and none that addresses the issues of inconsistent treatment of internally 
generated patent assets versus acquired patent assets (of which the author is aware).456      
Over a decade ago, in 2000, the Basel Committee on Banking Supervision concluded that in 
the absence of active markets it would be difficult to obtain or calculate a reliable fair value 
for certain non-marketable financial instruments held at cost.  The Committee concluded that 
³it did not believe the time was right to proscribe full fair value accounting . . . for all 
financial assets and liabilities´.457  +RZHYHULQWKHDXWKRU¶VRSLQLRQWKHWLPHLVQRZULJKW$
test case would be welcome given the increasing interest and support from within the 
accounting community and others that IAS 38 should be amended to include and deal with 
qualitative information about intangibles.  This would require the input of the legal profession 
and patent attorneys who possess the relevant legal and technical knowledge.  The Courts 
could evaluate the primacy of the overarching concept of financial statements providing true 
and fair information, rather than the current position ± financial statements providing 
objective but inconsistent and incomplete information regarding intangible patent assets.    
 The IASB Framework for the Preparation and Presentation of Financial Statements 
WKH³)UDPHZRUN´sets out the concepts on which accounting practice is founded.  It is 
similar in scope to the Statement of Principles of Financial Reporting made by the ASB in 
1999.   This Statement is explicit in reference to the ³true and fair´ requirement and provides: 
 
                                                 
456
 See the House of Lords in HMRC v William Grant & Sons Distillers Limited [2007] UKHL 15, a revenue 
case in which considered whether a profit or loss has been FDOFXODWHGLQDFFRUGDQFHZLWK³WKHFRUUHFWSULQFLSOHV
RIFRPPHUFLDODFFRXQWDQF\´EHLQJXVHGZKHQSUHSDULQJDFFRXQWV that show a true and fair view; Balloon 
Promotions Limited v Wilson (Inspector of Taxes) 3 March 2006 SPC00524; Odeon Associated Theatres v 
Jones (Inspector of Taxes) [1971] 1 WLR 442; Gallagher v Jones (Inspector of Taxes) [1994] Ch 107.   
457
 Basel Committee on Banking Supervision (2000). Report to G7 Finance Ministers and Central Bank 
Governors on International Accounting Standards.  
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12. It is inherent in the nature of the true and fair concept that financial statements 
will not give a true and fair view unless the information they contain is sufficient in 
quantity and quality to satisfy the reasonably expectations of the readers to whom 
they are addressed.  Such expectations change over time and the Board seeks, through 
it accounting standards and other authoritative pronouncements, both to respond to 
those expectations and to influence them.  The Statement of principles may therefore 
be expected to contribute to the development of the concept.   
 
13. The Statement of Principle does not, however, define the meaning of true and 
fair ± it is detailed legal requirements, accounting standards and, in their absence, 
other evidence of generally accepted accounting practice itself, that normally 
determine the content of financial statements.  Nevertheless, as the Statement is a set 
of high level accounting principles designed to help in setting standards, it has the true 
and fair view concept at its foundation.  Its insistence on relevant and reliability as 
prime indicators of the quality of financial information is just one example of this. 
 
 As we know, the new UK GAAP which adopts IAS 38 will determine the method of 
recognising intangibles and measuring them for the financial reporting elements of the 
FRPSDQ\¶V DQQXDO UHWXUQ commencing after 1 January 2015, resulting LQ WKH ³PHFKDQLFDO
appliFDWLRQ´RI,$6WRLQWDQJLEOHV.   
 
 
 
 
 
197 
 
4.4 Conclusion 
 
The time is ripe for a test case to obtain a judicial opinion focusing squarely on whether 
the application of IAS 38 provides a ³true and fair´ YLHZRIDFRPSDQ\¶VLQWHrnally generated 
intangibles.  IAS 1 permits departure from IFRS if a particular IFRS (e.g. IAS 38) would be 
so misleading that it would conflict with the objective of the financial statements set out in 
the Framework.  IAS 1 was adopted by EC 1725/2003 and thus the ability to depart from an 
IFRS is incorporated by reference.458  A UK court may have regard to accounting standards 
VXFKDV,$6EXWLVQRWOHJDOO\ERXQGE\WKHPLQZKHWKHUDFRPSDQ\¶VILQDQFLDOVWDWHPHQWV
give a ³true and fair´ view.  The Court may take into account other evidence and expert 
evidence presented by accountants, lawyers, patent attorneys and lenders in arriving at their 
decision.  Is there a special case to be made for a new bespoke financial standard for patents 
assets or intangibles generally, especially with respect to innovating SMEs?   
In reply, accounting experts will likely argue that IAS 38 remains appropriate because in 
in their opinion there is no way to reliably measure the probability that the expected future 
economic benefits attributable to the asset will flow to the entity using accepted accounting 
methodology.  Further, they will point out that tangible assets and intangible assets should be 
treated the same.  However, lawyers know that fair is not always equal and what is equal is 
not always fair.  It can be fair to treat situations (or for our purpose, asset classes) differently, 
yet equitably. By way of analogy, imagine a teacher puts a chocolate bar on the top of a tall 
bookshelf and asks the tallest and the shortest students in the class to try to get it.  That would 
be equal but unfair.  If the shorter student got a boost up, that would be unequal, but fair.   
If, hypothetically, the courts were to decide that the application of IAS 38 did not provide 
a ³true and fair´ YLHZ RI WKH FRPSDQ\¶V ILQDQFLDO SRVLWLRQ DQG DFFRUGLQJO\ SHUPLWWHG D
                                                 
458
 Supra Moore [452] p38 
198 
 
departure from IAS 38 in the treatment of internally generated intangibles (patent assets) 
what are the alternatives?  How should the strict criteria set out in IAS 38 be relaxed?  What 
new conceptual framework should the International Accounting bodies adopt?  The answers 
to these questions are important, but beyond the scope of this thesis. 
 Earlier in section 4.3.7 above, we noted that if the outcome of applying IAS 38 to patent 
DVVHWVGLGQRWDFFRUGZLWK³FRPPRQVHQVH´WKHQ LQVXFKDFDVHDFFRUGLQJWRWKH)5&WKH
proper solution is additional corporate and financial disclosure.  In Chapter 6 we investigate 
the viability of additional voluntary corporate reporting of patent assets using the new 
Strategic Report (which replaced the Business Review in 2FWREHU  RI D FRPSDQ\¶V
annual return or alternatively, using the emerging ICS format. 
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5 The need for increased voluntary corporate patent asset disclosure by SMEs  
 
 The more visible it [IP]  becomes in public accounts, the easier its value becomes to 
 realise.  This will lead to greater opportunities for lenders ± and higher risks of 
 inaction. 
       Martin Brassell and Kelvin King 
       Banking on IP? (2013)459 
 
Introduction   
 In Chapter 4 we confirmed that current UK corporate reporting and disclosure laws, 
which hinge on IAS 38 in respect of intangible assets, arguably do not go far enough to give a 
³WUXHDQGIDLU´view with respect to the internally generated patent assets on an innovating 
SMEs balance sheet.  Therefore, given the accounting methods currently used and likely to 
remain in place in the foreseeable future, enhanced voluntary disclosure of patent information 
and the business strategy to generate future value from the patents is recommended as a 
means to supplement and complement the traditional financial statements.  Shareholders and 
other outsiders, including lenders, need accurate, relevant and timely information to enable 
them to assess whether the company directors, who have the legal responsibility for 
managing the patent assets, are ensuring a reasonable return on those assets; and secondly, to 
control directors acting in their own self-interest as opposed to acting in the interests of the 
company.460  Lenders are key users of financial statements and it is vitally important to 
facilitate a positive yet prudent credit decisions being made.  Bhattacharya, formerly 
Professor of Finance at the Indian Institute of Management, confirms that in relation to credit 
appraisal:  
 
                                                 
459
 Supra Banking on IP? [18] p15 
460
 York Building Co v MacKenzie 3DWZKLFKKHOGWKDW³+HWKDWLVHQWUXVWHGZLWKWKHLQWHUHVWRI
others cannot be allowed to make the business an object of interest to himself; because from the frailty of nature, 
one who has the power will be too readily seized with the inclination to use the opportunity for serving his own 
interest at the expense of those for whom he is entrusted.   
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 Additional information may be relevant to users in understanding the financial 
 position and liquidity of an enterprise.  Disclosure of this information, together with 
 a commentary by the management is encouraged.461 
 
 This chapter aims to contribute to a better understanding how UK innovating SMEs 
could approach patent information and strategy reporting.  IQVHFWLRQOHQGHUV¶H[SHULHQFH
regarding the lack of useful IP asset information available to them is highlighted.  Section 5.2 
examines the UK and European law on the level of corporate reporting required by SMEs to 
answer the questions, ³'o corporate disclosure laws reach far enough to include intangible 
assets in the context of accounting methods currently used?´462  DQG³What legal 
responsibility do company directors have for managing and ensuring a proper return on 
patent and other IP assets?´  As long as there is no place for patents, IP and other intangibles 
on balance sheets, corporate law needs to ensure that such increasingly valuable assets, for 
which directors are responsible, are not ignored nor hidden from shareholders and the public.  
If traditional accounting for IP is an ineffectual gatekeeper of the status quo because 
accounting statements cannot adequately document how patents and IP relate to business 
performance, then the law must step up and confront this challenge of communicating this 
crucial information.   Next, a comparative functional analysis of narrative corporate IP asset 
disclosure in Canada, the US, Denmark and Germany is carried out, describing the 
conceptual frameworks and evaluating relevant principles.  Section 5.3 considers the benefits 
of enhanced patent information disclosure for innovating SME, despite the increased 
                                                 
461
 Supra Bhattacharya [408] p464 
462
 µThe Perfect Storm: Corporate Disclosure, Shareholders, and the Importance of Intellectual Property¶at 
www.ipprospective.com  
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regulatory burden and costs involved.  Section 5.4 analyses the format for making patent 
information disclosure.  In section 5.5 we study the mandatory corporate reporting of 
intellectual capital (IC) and intangibles regime in Denmark and the US followed by the 
voluntary ICS reporting regime in Germany in section 5.6. 
 
5.1 $FFHVVLQJERUURZHUV¶SDWHQWLQIRUPDWLRQWKHlHQGHU¶VH[SHULHQFH  
 
 Credit appraisal involves evaluating a variety of information sources in order to arrive 
at a decision to lend.  This includes Companies House records, credit history, automated tools 
and scoring systems.  Richard Holden, Head of Manufacturing at Lloyds Banking Group, 
states that the current position within the SME debt finance market is that: 
 
  $WSUHVHQWWKHVHVHOGRPLIHYHULQFOXGHLQWDQJLEOHVRU,3WKH\GRQ¶WJHWRIIHUHGRU
 asked for ± they are just not on the agenda.  As a result, it is unlikely in most cases, 
 that the credit decision process considers IP to any degree. Paying much attention to 
 IP at the moment would be a big leap in any event, but at least when it comes to 
 XQGHUVWDQGLQJDFRPSDQ\¶VRYerall position, it may provide comfort between doing 
 VRPHWKLQJRUQRW,WGRHVQ¶WQHFHVVDULO\IROORZHYHQDWWKDWpoint that lending will 
 increased or be directly assigned to IP, but it might make the difference between 
 lending and not lending.463   
 
 There is a material disconnect bHWZHHQWKHHQWLUHW\RIWKHFRPSDQ\¶Vintangibles and 
the legal requirements of corporate reporting.  Improving the quality of IP information 
available to lenders would probably involve a non-standard form or process with bespoke 
documentation, at least initially.  This would have a cost attached to it which the bank would 
                                                 
463
 Supra Banking on IP? [118] p61 
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pass on in some way, unless standardised approaches were available.464  It is essential to 
make patent information as easy as possible for lenGHUVWRXQGHUVWDQGVRWKDWWKH³LQYLVLEOH´
patent value cDQEH³VHHQ´ to inform lending decisions.   The purpose of corporate narrative 
reports, to supplement and complement the financial statements, would assist in this regard.  
 
5.2 Corporate reporting under the CA 2006 
 Since 1844 when the registration and incorporation of companies first took place, 
public disclosure has been an important aspect of company law.  The debate on how 
intangibles should be accounted for and reported in the financial statements has been present 
in the literature for over a century.465  Today, private micro and SME companies, as well as 
the majority of non-listed UK companies, operate under a set annual financial disclosure 
requirement which may be accessed by the public.  Section 854 CA 2006 requires every 
company to submit an annual return to Companies House.  The annual return sets out basic 
information about the company on a particular date (its return date) every year.  Such 
periodic annual reporting rarely takes the long-term nature of patents into account. 
Companies must develop a method of reporting on their intangible patent assets that is 
reflective of the value they provide to the business in the medium to long-term given that the 
sustainability of the organisation and the long-term view is now enshrined in the CA 2006 via 
the ESV concept and reform of the diUHFWRUV¶GXWLHVXQGHUV includes the duty to promote 
the success of the company.  Patents, as corporate assets, have the potential to contribute to a 
FRPSDQ\¶VSURfitability, long-term growth over the potential monopoly period, and ultimate 
success.  Arguably, patents are an easier form of intangible to report on for two reasons: they 
require registration; and, as there is a cost involved, company directors will be aware of their 
existence.  This level of awareness may even be higher when compared with other forms of 
                                                 
464
 Supra Banking on IP? [18] p62 
465
 Cañibano, L et al µ7KH9DOXH5HOHYDQFHDQG0DQDJHULDO,PSOLFDWLRQVRI,QWDQJLEOHV$OLWHUDWXUHUHYLHZ¶
(1998) OECD, Directorate for Science, Technology and Industry, p19  
203 
 
intangibles such as knowhow, confidential information and copyright, all of which are 
unregistered rights and thus incur no registration fees that must be accounted for.    
 Every company is required to keep accounting records which must show with 
reasonable accuracy the financial position of the company at any particular moment in 
time.466  $FRPSDQ\¶VDQQXDODFFRXQWVFRQVLVWRIDEDODQFHVKHHWDSURILWDQGORVV account, 
the Directors Report467 and, if the company LVQRWH[HPSWIURPDXGLWWKH$XGLWRUV¶5eport.468  
Currently, companies which are classified as small469 are permitted to submit abbreviated 
accounts to the Registrar of Companies, although full accounts will still have to be delivered 
to shareholders.  This means that SMEs can submit shorter accounts to Companies House 
created from the statutory accounts - therefore even less information about the company will 
be publicly available.470  The Financial Reports Standard for Smaller Entities (effective 1 
January 2015) provides detailed guidance to the legal requirements.471  As discussed in 
Chapter 4, the directors must not approve the accounts unless they are satisfied that they give 
a ³true and fair´ view of the assets, liabilities, financial position and profit or loss of the 
company: s393 CA 2006.  Under the legal requirements, companies that classify as small can 
FKRRVHQRWWRVXEPLWD'LUHFWRUV¶5HSRUWZLWKWKHLUDFFRXQWVAt the expense of transparency, 
small companies can lawfully reduce the regulatory corporate reporting burden disclosing  
less in their financial statements and choosing not to submit a DirecWRUV¶5HSRUW.   
                                                 
466
 Section 386 CA 2006. Failure to keep accounting records may be punished by a fine and/or 2 \HDUV¶LQMDLO
s389 CA 2006.  
467
 Section 415 CA 2006 
468
 SMEs are typically exempt from the need to have their accounts formally audited.  
469
 6HFWLRQ&$GHILQHVDFRPSDQ\DVµVPDOO¶LILWPHHWVWZRRXWRIWKHIROORZLQJWKUHHUHTXLUHPHQWV
LWKHFRPSDQ\¶VDQQXDOWXUQRYHULVPLOOLRQRUOHVVLLWKHWRWDODVVHWVRIWKHFRPSDQ\DUHPRUOHVV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(iii) the company has 50 or fewer employees.   
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 Accounts and Tax Returns for Smaller Companies at https://www.gov.uk/prepare-file-annual-accounts-for-
limited-company/prepare-annual-accounts.  Further, the new Small Business, Enterprise and Entities Act 2015 
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company has delivered all the information it was required to provide in the period to which the confirmation 
statement relates (new section 853A(1), CA 2006).  This will result in even less disclosure by SMEs.  
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 (July 2013) FRC at https://www.frc.org.uk/Our-Work/Publications/Accounting-and-Reporting-
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5.2.1 7KH'LUHFWRUV¶ Report and the former Business Review  
 In January 2006 thH8.JRYHUQPHQWLQWURGXFHGWKH³%XVLQHVV5HYLHZ´ 472 in the 
'LUHFWRUV¶5eport based on best practice and not on mandatory OFR Reporting Standard 
(RS1)473  to inform shareholders.474  The Business Review was aimed at presenting a fair 
UHYLHZRIWKHFRPSDQ\¶VEXVLQHVVDQGDGHVFULSWLRQRIWKHSULQFLSDOULVNVDQGXQFHUWDLQWLHVit 
faces, among other items.  
  ,IWKHFRPSDQ\¶VVKDUHVDUHSXEOLFO\OLVWHGRQDVWRFNH[FKDQJHZLWKLQWKH(XURSHDQ
Union or on the New York Stock Exchange or the American Nasdaq Stock Market, public 
disclosure under the Financial Services and Markets Act 2000 (FSMA)475 requires the 
Business Review to report on additional matters including the main trends and factors likely 
WRDIIHFWWKHIXWXUHGHYHORSPHQWSHUIRUPDQFHDQGSRVLWLRQRIWKHFRPSDQ\¶s business.  Thus 
if patent rights are likely to have an impact on the business, relevant information concerning 
those rights must be disclosed.  The FSMA also requires half-yearly financial reports as well 
as interim management statements.476  For example, in a life science or technology company 
the value of a patent portfolio is likely to be central to appraising the value of the company.   
Obvious examples of key patent-related risks that must be disclosed are: (1) material 
litigation involving the patent portfolio; or (2) a revocation proceeding concerning a patent 
that is central to business operations.  Another less obvious risk that should be disclosed is 
the expiry of a patent right owned by the company.  Such disclosures are legally required if 
they have a potential financial impact and would assist the public to evaluate the future 
development, performance and position of the publicly listed FRPSDQ\¶s business. 
 
                                                 
472Section 417 CA 2006 
473
 <HRK3µ1DUUDWLYHUHSRUWLQJWKH8.H[SHULHQFH¶International Journal of Law and Management 
Vol. 52, No.3, p211 
474
 Section 172 CA 2006 
475
 Via the Disclosure and Transparency Rules promulgated by FSA pursuant to the FSMA 2000.   
476
 DTR Rule 4.  
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5.2.2 UK company law reform ± the ³6WUDWHJLF5HSRUW´   
 The reform of narrative reporting (i.e. the information that was formerly required in 
the business review) was one aspect of a wider reform agenda477 aimed at modernising 
company law by making corporate UHSRUWLQJ³VLPSOHUFOHDUHUDQGPRUHIRFXVHG´478 and to 
³LPSURYHFRUSRUDWHDFFRXQWDELOLW\DQGWUDQVSDUHQF\´479  In October 2012, a revised structure 
for narrative reporting in the form of the CA 6WUDWHJLF5HSRUWDQG'LUHFWRUV¶5HSRUW
Regulations 2013 WKH³655HJXODWLRQV´ZDVHQDFWHG.  The regulations introduced a 
³6WUDWHJLF5HSRUW´ that applies to all companies and since October 2013 has replaced the 
previous Business Review described above pursuant to new ss 414A-D CA 2006.  The 
requirements for the Strategic Report are similar to the Business Review (except for quoted 
companies which have to include qualitative information to provide an understanding of the 
development, performance and position in relation to their business model and strategy, 
gender diversity, human rights and greenhouse emissions).  The reforms demonstrate the 
importance of narrative disclosures on diverse subject matter that the government believes is 
in the public interest IRUFRPSDQLHVQRWFODVVHGDV³VPDOO´.  The Strategic Report enables a 
company to tell its story, starting with the strategy, business model and the principle risks and 
challenges the company has faced.480  Reporting on IC, intangibles or IP is not specifically 
mandated.  This format could provide an opportunity for innovating SMEs to voluntarily 
express their patent strategy and business model.   These reforms suggest that voluntary 
disclosure of patent information and strategy would be viewed positively as a powerful 
means for an innovating SME to communicate to its stakeholders.   
                                                 
477
 µEncouraging Employers to Use Human Capital Reporting: A Literature Review of Implementation Options, 
Briefing Paper¶)HEUXDU\S8  
478
 Ibid p17 
479
 µThe Coalition: our programme for government¶ (May 2010).  However, the Small Business, Enterprise and 
(PSOR\PHQW$FWDLPVWRVLPSOLI\VPDOOFRPSDQ\¶VVWDWXWRU\ILOLQJUHTXLUHPHQWVHYHQIXUWKHUby replacing 
annual returns with a requirement to 'check, notify changes if necessary and confirm' the statutory information at 
least once in a 12 month period, however this has yet to be implemented.  
480
 µ%HWWHUDQG6LPSOHU&RPSDQ\5HSRUWLQJ¶-XQH 
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5.2.3 European corporate reporting reform 
 In April 2013 the EC published a draft directive to require large and listed companies 
to include additional disclosures of non-financial information in their annual reports.  The 
directive will not become law until 2016 or even later, but has the potential to increase 
reporting of non-financial information, such as patent information.481  This EU-wide reform  
highlights the growing importance of disclosure of non-financial information which will 
benefit patent owning entities.  
 With respect to SMEs, the European Parliament has adopted Directive 78/660/EEC on 
the annual accounts of certain types of companies as regards micro-entities that consolidates 
EU accounting requirements into one directive, in particular relaxing the accounting rules for 
smaller companies.482  The Directive took effect in 2013 and Member States, including the 
UK, will have two years to implement the Directive which XSGDWHVWKH(8¶VDFFRXQWLQJ
framework, and in particular, for our purposes:    
 
x permits micro-entities to prepare a very simple balance sheet and profit and loss 
account with virtually no notes (Directive 2012/6). Micro entities are companies with 
OHVVWKDQHPSOR\HHVDWXUQRYHURI¼0 and/or a balance sheet total of not 
PRUHWKDQ¼0.000;483 
x reduces the information to be provided by small companies in the notes to the 
accounts; and 
x removes the EU requirement for small companies to be audited (though Member 
States can take a more proportionate approach).  
                                                 
481
 µNew UK Annual Report and Requirements to disclosure human rights, diversity and greenhouse gas 
HPLVVLRQV¶-XQH 
482
 Directive 2012/6/EU of the European Parliament and of the Council of 14 March 2012 amending Council 
Directive 78/660/EEC on the annual accounts of certain types of companies as regards micro-entities, (2012) 
Official Journal of the EU pL81/3  
483
 Ibid 
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The recitals to the Directive expressly state the following: 
 
 (10) The aim of this Directive is to enable Member States to create a simple financial 
reporting environment for micro-entities. The use of fair values can result in the need 
for detailed disclosures to explain the basis on which the fair value of certain items 
has been determined.  Given that the micro-entity regime provides for very limited 
disclosure by way of notes on the accounts, the users of the accounts of micro-entities 
would not know whether the amounts presented in the balance sheet and the profit and 
loss account incorporate fair values. Accordingly, to provide certainty for such users 
in this regard, Member States should not permit or require micro-entities using any of 
the exemptions available to them under this Directive to use the fair valuation basis in 
drawing up their accounts. Micro-entities that wish or need to use fair value will still 
be able to do so by using other regimes under this Directive where a Member State 
permits or requires such use.484 
  
 This development echoes the current regulations and legislation applicable to small 
UK companies which have significantly reduced legal corporate reporting requirements.  As 
such, it is uncommon for innovating SMEs in the UK and EU to report on patent information 
at all, not even in notes to the accounts.     
 
5.2.4 7KH'LUHFWRUV¶5HSRUW 
 TKHODZGHHPVWKHGLUHFWRUV¶duty to prepare WKH'LUHFWRUV¶5HSRUWso important that 
the failure to do so is a criminal offence.485  Corporate disclosure is a tool used to drive 
behaviours by company directors that are considered desirable.  The board of directors, or 
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individual directors, needs WRPDNHVXUHWKDWWKHFRUSRUDWHPDQDJHPHQWRIWKHFRPSDQ\¶V
patent portfolio complies with CA 2006.  Directors cannot ignore their duty to oversee these 
activities, even if the balance sheet obscures patent assets and other intangibles.  Thus 
narrative reporting (e.g in the Strategic Report) complements account reporting, setting out 
WKHGLUHFWRUV¶YLHZRIWKHIXWXUHSURVSects and risks they must minimisH:KLOHWKH³EXViness 
MXGJPHQWUXOH´486 is a relevant consideration, such business judgment must result from the 
directors being properly informed.  As long as they do this they will not become liable merely 
because a decision turns out to have been a bad one.  However, this section needs to be read 
in conjunction with s.174 CA 2006 which imposes a duty to exercise reasonable care, skill 
and diligence.487  The paramount consideration is that the board ensures that it is 
appropriately informed and this requires it to be provided with accurate, relevant and timely 
information.488  ,QUHODWLRQWRWKHFRPSDQ\¶VSDWHQWVDSSropriate information should be 
GLVFORVHGLQWKH'LUHFWRUV¶5HSRUWDQG6WUDWHJLF5HYLHZDVOHJDOO\UHTXLUHGShareholders are 
in a vulnerable position and justifiably vest confidence, good faith, reliance, and trust in the 
directors whose aid, advice or protection is sought to safeguard their investment.489  As we 
saw in Chapter 4 earlier, each individual director on the Board owes statutory duties to the 
FRPSDQ\DQGPXVWDFWLQJRRGIDLWKWRRYHUVHHWKHFRPSDQ\¶VDVVHWVLQFOXGLQJDQ\SDWent 
portfolio:.490  7KHVHSURYLVLRQVJXLGHGLUHFWRUV¶PDQDJHPHQWDFWLYLWLHVDQGGHWHUPLQHV
                                                 
486
 The courts are reluctant to second-guess business decisions as they are not business people and hold that 
business decisions are best left to the board of directors. As Lord Eldon stated in Carlen v Drury (1812) 1 Ves & 
%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whether they have acted properly.491  The ESV concept (discussed in section 4.3.7) requires 
directors to be more inclusive in their decision-making, taking into account the relationships 
which the company has with stakeholders, such as financiers and lenders, in seeking to 
benefit the shareholders.492 The independent auditors of the company have a duty to ensure 
WKDWWKHQDUUDWLYHSUHVHQWHGLQWKH'LUHFWRUV¶5HSRUWDOLJQVZLWKWKHILQDQFLDODFFRXQWV Next, 
we consider why voluntarily reporting on patent information would be a positive step for 
innovating SMEs, even though they are not legally obliged to do so.  
 
5.3 The benefits of increased disclosure of patent information 
 Voluntary corporate disclosure by innovating SMEs is recommended to rectify the 
LQYLVLELOLW\RILQWDQJLEOHDVVHWVRQDFRPSDQ\¶Vbalance sheet and to overcome the 
deficiencies that result from applying IAS 38 to internally generated patent assets.    
 In 2002 a Canadian study analysed the content of the annual reports of 10,000 
Canadian companies searching for a list of IC-related terms and reported that only a very 
small number of IC disclosures actually took place.493  As a common law country, the 
Canadian corporate reporting regime is generally similar to that required in the UK.  In both 
Canada and the UK, the legal corporate reporting requirements drive the level of information 
that is available to the public (including lenders).  Little information related to patents or 
other IC is publicly available via corporate reporting in either jurisdiction in the SME field.       
 In relation to debt finance, there is also evidence that increased disclosure is positively 
correlated with lower effective interest costs.494  Companies with additional informative 
disclosure policies have more accurate earnings forecasts, reduced estimated risks and 
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 Bontis, N. (2003) pp9-20 
494
 /DQJ0DQG/XQGKROP5µ&RUSRUDWH'LVFORVXUH3ROLF\DQG$QDO\VW%HKDYLRXUµ2FWREHUThe 
Accounting Review Vol. 71, No.4, 467-492 
210 
 
reduced information asymmetry.  The reduced risk that results from the greater disclosure of 
information leads to lower borrowing costs.  Equally, lower borrowing costs provide 
organisations with an incentive to disclose greater amounts of information.495  This outcome 
is directly relevant to patent-backed finance.  In truth, lenders can never know precisely how 
much value will be realised at a future point in time for any given asset, however they need to 
develop the skills to become better at predicWLQJWKHIXWXUHYDOXHRIDERUURZHU¶VSDWHQWV
Certainly, there is a cost involved in compiling the patent information.  However, once the 
required patent information and reporting format is standardised, the cost of collecting and 
reporting is likely to be outweighed by the increased access to debt finance.   
 Annual reports are a key communication tool to legitimise corporate activity.496    
Accuracy is positively associated with market value (because it reduces uncertainty) and 
improved forecasts of future value.497  Borrower-provided disclosure via the legally mandated 
company annual return (which must be signed off by the directors as givLQJD³WUXHDQGIDLU
YLHZ´) is information that is already required by the lender at no cost to it.  Lenders would 
incur costs if they had to actively acquire the information independently from other sources.  
Such due diligence costs will be passed on to the borrower in any event by way of 
arrangement fees, disbursement and/or the interest rate applied to the loan.  Voluntary 
disclosure would also help directors document how they have carried out their duty to 
promote the success of the company, a legal requirement for which there is minimal guidance 
from the case law.  The ICS, an alternative corporate disclosure format, is discussed below.   
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496
 *XWKULH-DQG3HWW\5µ,QWHOOHFWXDO&DSLWDO/LWHUDWXUH5HYLHZ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5.4 The Intellectual Capital Statement (ICS) 
 The philosophy underpinning IC asset reporting is that while accountants report 
numbers in the common language of monetary value, there is no logical reason why decision-
makers, directors or other stakeholders such as lenders should restrict themselves to such an 
information set.  A modern format for the increased disclosure of intangible assets (including 
patents) originated in the 1990s led by a handful of Scandinavian companies including 
Skandia, Carl-Bro and Celemi.  Sveiby argued that these companies sharply illustrate the 
differences in managerial attitude between the industrial and post-industrial ages with respect 
to corporate reporting.498  The ICS has now existed for over two decades, led by Denmark 
and an analysis of the literature is set out below. 
 
5.4.1 The literature relating to the ICS 
 Professor Leif Edvinsson,499 regarded a pioneering contributor to the theory of IC, 
instigated the creation of the world's first public corporate IC Annual Report in 1994.  In 
March 1997, he and co-author Michael S. Malone published Intellectual Capital: Realizing 
\RXU&RPSDQ\¶V7UXH9DOXHE\)LQGLQJ,WV+LGGHQ%UDLQSRZHU500  This work defined the 
meaning of IC, how it is classified and how it could be measured.  In Chapter 3 they offer 
guidance on how to build an IC report.  Edvinsson subsequently published other monographs 
including Accounting for Minds (1997)501; Intellectual Capital: Navigating in the New 
Business Landscape (1998)502; and Corporate Longitude: Discover Your True Position in the 
Knowledge Economy (2002) and several academic articles, the most relevant of which is, 
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µ'HYHORSLQJDPRGHOIRUPDQDJLQJLQWHOOHFWXDOFDSLWDO¶ZLWKFR-author Patrick 
Sullican.503   Edvinsson was the first director of IC at Skandia, a Swedish financial services 
company and is a Professor (adjunct) of IC at Lund University, Sweden.  The aim of his work 
is to integrate the role of knowledge and intangible assets into accounting procedures and 
financial practices.  His research began with the following question: 
 
 Read a useful prospectus lately? How about an informative annual report?  
  
 How come few of these traditional reports offer a clue about which emerging young 
 company is about to take over the world, about which established blue-chip 
 company is about to fall into a competitive black hole? 
 
 And even when these reports do manage to capture a glimmer of reality, how come 
 those clues lie between the lines of the accompanying, barely legible text504 and not in 
 bold type in the balance VKHHW"«7KHDQVZHUWRWKDWLVLQWKHWUDditional model of 
 ³DFFRXQWLQJ´ZKLFKVREHDXWLIXOO\GHVFULEHGWKHRSHUDWLRQVRIFRPSDQLHVIRUKDOID
 millennium, is now failing to keep up with the revolution taking place in business.505  
 
 EdvinVVRQFRQFOXGHGWKDW³,WKDVEHFRPHREYLRXVWKDWWKHUHDOYalue of companies 
cannot be determined only E\WUDGLWLRQDODFFRXQWLQJPHDVXUHV´506 Gary Hamel, Professor at 
the London School of Business, argues IXUWKHUWKDW³an asset is really only a perception of an 
opportunity about which a PDMRULW\RISHRSOHKDYHDJUHHG´.507  Keith Bradley of the Open 
%XVLQHVV6FKRRO8.DVNHG³'RZHKDYHWKHWRROVWRPDQDJHWKHVHKLGGHQDVVHWV"7KH
sLPSOHDQVZHULV³no, we dRQ¶W´508   The ICS provides a methodology for enhancing 
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corporate disclosure of intangibles, supplementing the information available in the traditional 
financial accounts. 
 Other important works on the subject of IC UHSRUWLQJLQFOXGH$QQLH%URRNLQJ¶V
Intellectual Capital: Core Asset for the Third Millennium Enterprise (1996)509 and Value-
Driven Intellectual Capital: How to Convert Intangible Corporate Assets into Market Value 
(2000) by Patrick H. Sullivan510 which further the discourse on the subject.   
 In 2001, the first IC World Congress took place at McMaster University, Canada.  
Since then Austria511 and Denmark have introduced regulatory reporting of IC.  The Danish 
Financial Statements Act (DFSA)512 requires reporting on IC resources and environmental 
aspects in the management report if it is material to providing a true and fair view of the 
FRPSDQ\¶s financial position.513  In particular, the DFSA 2001 states in Chapter 11, s 99(2)  
WKDWWKHPDQDJHPHQW¶VUHYLHZ³VKDOOGHVFULEHWKHHQWHUSULVH¶VNQRZOHGJHDQGNQRZ-how 
resources if they are of special importance to the its future performDQFH´Other countries, 
including Germany, Norway, Hong Kong, Japan514 and Australia515 also have voluntary 
reporting guidelines.   
 In 2007, the Research Committee of the Institute of Chartered Accountants of 
Scotland commissioned a 134-page rigorously refereed report, Intellectual Capital Reporting: 
Lessons from Hong Kong and Australia which confirmed the limitations of traditional 
accounting and examined IC reporting in various nations.516  The study investigated the 
voluntary IC disclosure of Australian and Hong Kong companies observing:  
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 The fact that traditional financial practice does not include non-financial 
 performance adversely impacts knowledge-based organisations.  Those that are 
 looking to raise capital in the debt and/or equity markets are particularly affected.517 
  
 The research, although it did not address patent assets specifically, concluded that IC 
is expressed in narrative rather than numerical terms; the current IC policy vacuum results in 
a lack of standardisation of corporate reporting and there is a need for a level of international 
standardisation;  the level of IC disclosure is relatively low and linked to company size; and 
finally, the voluntary reporting of IC information indicate that the data has a value.518 
 Accordingly, it is confirmed that there is a need to report IC information, and for our 
purposes, for innovating SMEs to voluntarily report on their patent assets.  In the next 
section, the mandatory enhanced corporate disclosure regime adopted by Denmark in 2000 is 
examined.  This regime requires Danish companies to increase the level of corporate 
reporting of all company assets, both tangible and intangible.    
 
5.5 International policy initiatives regarding mandatory IC reporting   
 
5.5.1 Denmark 
 
 Denmark is a key system of interest given its mandatory narrative IC reporting regime 
which has led to the use of the ICS becoming accepted practice.  It is also noteworthy that 
there is a strong voluntary component in the reporting procedure and culture.519 According to 
the Danish Ministry of Science, Technology and Innovation (DMSTI), ³DQIC statement is an 
integrated part RIFRPSDQ\NQRZOHGJHPDQDJHPHQW´.520  Constructing an ICS is based on 4 
types of knowledge resources (as commonly applied in the IC field): employees, customers, 
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processes and technologies. These are evidenced by a statement representing the 
RUJDQLVDWLRQ¶VNQRZOHGJHPDQDgement work through a:  
 
(1) knowledge narrative;  
(2) set of managerial challenges;  
(3) number of initiatives; and  
(4) relevant indicators.521   
 
 In 2000, the DMSTI published the first ICS guidelines in the world, based on the 
experience of 17 companies who participated in a Danish Agency for Trade and Industry ICS 
Project. This ICS project laid the foundation for the Danish ICS guidelines.522  The guidelines 
demonstrate that the corporate reporting approach is built on the same principles as financial 
statements which ask questions relating to the same issues.  The difference lies in how the 
questions are asked and that the answers are provided in narrative form, rather than numerical 
form.  Figure 23 below presents a comparison of the questions that underpin financial 
statement and ICS questions.  
 
Figure  23 Comparing financial statements and IC statements 
Financial Statement Intellectual Capital Statement 
:KDWDUHWKHRUJDQLVDWLRQ¶VDVVHWVDQGOLDELOLWLHV" +RZLVWKHRUJDQLVDWLRQ¶VNQRZOHGJHUHVRXUFH
comprised?  
What has the organisation invested? What has the organisation done to strengthen its 
knowledge resource? 
:KDWLVWKHRUJDQLVDWLRQ¶VUHWXUQRQLQYHVWPHQW" What are the effects oIWKHRUJDQLVDWLRQ¶VNQRZOHGJH
work? 
Source: Danish Ministry of Science, Technology and Innovation (2003a) 
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 The ICS is not a balance sheet in the classical financial sense. It gives a detailed 
account of DILUP¶V,&ZKLFKmay include patents and patent applications) and balances this 
with achieving targets.  The DMSTI report (2003) gives guidance on how to prepare ICSs.523  
However, this guidance is limited for the purpose of this thesis as it does not give specific 
information on how to disclose patent information and strategy.  
 A study published in the British Accounting Review in 2008 found no evidence of use 
of the ICS in the UK, in the form of a separate statement produced by a company that focuses 
exclusively on the reporting of aspects of their IC, management and resources.524   
Another study found that while no UK publicly listed company in its sample had published a 
stand-alone ICS, 10.6% of the annual report was devoted to disclosing IP information.525   
Nevertheless, the adoption of ICS format is potentially one way to assist innovating SMEs to 
overcome the distortion of the IAS38-related financial calculations concerning the fiscal 
value of their patent portfolios, improving the quality of non-financial patent information 
available to external stakeholders.  However, producing an ICS is likely to be an expensive 
exercise for the innovating SME.  Further, dedicated patent information disclosure guidance 
is needed as the evidence shows that UK companies generally have very little experience 
with this category of IC subject matter.  
 
5.5.2 The US experience:  corporate reporting and IP  
 The US approach to corporate reporting for listed companies mirrors that of the UK 
and is of comparative system interest in connection with corporate reporting of IP and 
compliance costs.  Increased corporate reporting of all company assets (tangible and 
                                                 
523ICS± The New Guideline (2003b) 
524
 Striukova, L. et al µ&RUSRUDWH5HSRUWLQJRI IC: Evidence from UK companies (2008) Vol. 40 pp297-313 The 
British Accounting Review at pp298-301 
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 Ibid, pp308-309 
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intangible) is mandated by Sarbanes Oxley Act 2002 (SOX 2002).526  The Act requires 
publicly listed companies (not SMEs) to increase their reporting on internal control structures 
and procedures for financial reporting.527   Title III comprises 8 sections that mandate senior 
executives take individual responsibility for the accuracy and completeness of corporate 
financial reports.  SOX 2002 was enacted in reaction to a number of major corporate and 
accounting scandals in that country.528  Thus, US public companies (as with UK listed 
companies) have a legal obligation to effectively measure, closely monitor and disclose the 
relationship between the IP rights and their financial performance.  They translate changes in 
the scope and strength of those rights into reportable indicators of financial performance.529  
SOX 2002 and the US securities laws generally require that processes be in place to ensure 
that financial statements and reporting are reliable under GAAP standards.  IP rights that 
have a material effect on financial performance must be disclosed, including off-balance 
sheet instruments.530  Essentially, greater emphasis on the accurate valuation of all assets, 
including IP assets is prescribed by the SOX 2002 even though, as in the UK CA 2006, there 
is no statutory language that refers specifically to IP.  IP is also largely invisible or hidden, 
not only in the financial accounts but also more generally in corporate law.  SOX 2002 
requires GRFXPHQWDWLRQRIWKH³IDLUYDOXH´DQGQRWWKH³YDOXHLQXVH´ of corporate assets.  It 
adheres to the generally accepted definitions of intangibles.531  Item 101(c)(1)(iv) of 
                                                 
526
 (Pub, L. 107-204, Stt.745 Pub .L. enacted July 30, 2002), also known as the "Public Company Accounting 
Reform and Investor Protection Act" (in the Senate) and "Corporate and Auditing Accountability and 
Responsibility Act" (in the House), is a US federal law that set new or enhanced standards for all US public  
boards,  management and public accounting firms. 
527
 Sections 302 (Disclosure controls), 401 (off balance sheet items), 404(Assessment of Internal Control)  SOX 
2002 
528
 Enron and  Worldcom. The bankruptcy of Enron highlighted how off balance instruments that were 
fraudulently used.   
529
 0DQLFNDYDVDJDP9µ,3%HVW3UDFWLFHVLQWKH3RVW6DUEDQHV-2[OH\$FW(UD¶)HEUXDU\ 
530
 Kote, L. et al (2005); Report and Recommendations Pursuant to Section 401(c) SOX 2002. On Arrangements 
with Off-Balance Sheet Implications, Special Purpose Entities, and Transparency of Filings by Issuers (PDF) 
531
 *DOODJKHU	&DZVH\&Rµ:DGLQJ7KURXJKWKH,QWHOOHFWXDO3URSHUW\5HTXLUHPHQWVRIWKH6DUEDQHV-Oxley 
Act of 2002¶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Regulation S-K clarifies that the Act requires a public company to disclose in its Annual 
Report: 
 «WKHLPSRUWDQFHWRWKHLQGXVWU\VHJPHQWRI the company, and the duration and effect 
 of all patents, trademarks, licenses, franchises and concessions held by the company 
 to the extent the IRUHJRLQJLV³PDWHULDO´ 
 
 This US regulation expressly refers to disclosure of IP rights.  In relation to patents, it 
is taken to mean that any material information regarding patents and the licensing of such 
patents is required to be disclosed in a publicly listed US FRPSDQ\¶Vannual report.  
Commentators have pointed out that some of the important IP issues raised by this Item are 
QRWRQO\ZKDWLV³PDWHULDO´but what is meant by the phrase ³LPSRUWDQFHWRWKHVHJPHQW´RI
the company being reported on, and the ³HIIHFWRI´WKH IP?532  Ultimately, disclosure of a 
patent asset is required if it assists the public (e.g. potential investors or lenders) in evaluating 
the company or has a potential financial impact.  Company directors face a significant 
challenge in balancing the disclosure obligations against the fiduciary duty to preserve asset 
value, magnified when that asset value may be destroyed by premature disclosure or 
diminished by excessive disclosure.  However, even where disclosure of a patent licence or 
other sensitive disclosure might otherwise be required, the SEC has a confidential treatment 
procedure which may be followed for certain information otherwise subject to disclosure.533   
The author is unaware of a similar procedure under CA 2006.  In the UK, s 414C(14) CA 
2006 makes clear that the disclosure of information about impending developments or 
matters in the course of negotiation is not necessary if the disclosure would, in the opinion of 
                                                 
532
 Ibid, p7 
533
 The SEC has set forth substantive and procedural guidelines for Rule 24b-2 confidential treatment requests in 
WKH'LYLVLRQRI&RUSRUDWLRQ)LQDQFH6WDII/HJDO%XOOHWLQ1RZLWK$GGHQGXP³&RQILGHQWLDO7UHDWPHQW
5HTXHVWV´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the directors, be seriously prejudicial to the interests of the company. This is the case even if 
that information is considered material. 
 In the US, SOX 2002 has reaffirmed the need to meticulously value and monitor IP 
assets from a corporate disclosure compliance perspective.  These requirements ensure that 
information about all IP is communicated and translated into financial reports.  However, 
critics argue the onerous corporate reporting requirements have negatively impacted the 
system.  A significant body of academic research exists regarding the costs and benefits of 
SOX 2002, which arrive at different conclusions.534 This is due in part to the difficulty of 
isolating the impact of SOX from other variables affecting the stock market and corporate 
earnings.  It has been mooted that average cost for a publicly listed US company to comply 
with the SOX 2002 legal disclosure requirements is circa $4m USD per annum.535  A Foley 
and Lardner Survey in 2007 analysed the change in the total costs of being a U.S. public 
company (e.g. external auditor fees, directors and officers insurance, board compensation, 
lost productivity, and legal costs). They found they were significantly affected by SOX 2002 
legal requirements. Nearly 70% of survey respondents indicated public companies with 
revenues under $USD 251 million should be exempt from SOX Section 404.536  While the 
rationale for the stricter level of corporate reporting for publicly listed companies is sound, 
the practical cost of doing is clearly very high.  Nevertheless, as the Chief Executive Officer 
and the Chief Financial Officer are required to unequivocally take ownership for their 
financial statements under Section 302, SOX 2002 requirements have enhanced corporate 
                                                 
534
 6KDNHVSHDUH&µ62;002 Five <HDUV2Q:KDW+DYH:H/HDUQHG"¶Journal of Business & 
Technology Law: 333; µ)LYH\HDUVRI6DUEDQHV-2[OH\¶-XO\The Economist 
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 Halling, D. B. (2009) Mr Halling is a US patent attorney.  His Chapter 6 discusses the effect of SOX on the 
US technology start up ecosystem.   
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transparency (based on the accuracy of analyst forecasts) significantly improving investor 
confidence and more accurate, reliable financial statements.537    
 
5.5.3 Cost issues associated with corporate disclosure of patent information 
 Cost is the one important reason why, in WKHDXWKRU¶VRSLQLRQcorporate narrative 
reporting on off balance sheet items such as patent assets should remain voluntary and not a 
formal legal requirement for UK innovating SMEs.  Another important reason relates to 
GLUHFWRUV¶OLDELOLW\IRUPLVOHDGLQJ information, to be discussed further in Chapter 7.     
 In some cases the costs involved in formally disclosing patent assets will be warranted 
given the potential benefit that information will bring to assist to secure a line of credit.  
However, innovating SMEs who choose to voluntarily report to enhance the prospect of 
successful loan applications should have more guidance on how they should do so.  A lender 
does not need to know the exact value of the patent rights.  Rather, lenders simply need to 
know that the value of the patent rights is sufficient to cover monthly repayments and any 
unpaid amounts if the debtor defaults on the loan.538    
 We have seen that the corporate disclosure requirements for SMEs are minimal under 
the CA 2006 given availDELOLW\RIXVLQJWKH³aEEUHYLDWHG´ reporting format (Chapter 4).  The 
ICS is not a legal requirement under UK company law.  Presently, only a few countries 
provide IC reporting guidelines.  However the OECD, the EC and the World Bank are also 
supporters. 539  Next we IRFXVRQYROXQWDU\,&UHSRUWLQJDQG*HUPDQ\¶V ICS guidelines.   
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5.6 Voluntary ICS reporting in Germany 
 This section explores and compares the German ICS reporting system to identify the 
effectiveness, limitations and solutions as regards narrative corporate reporting of patent 
assets.  A 51-page document entitled Intellectual Capital Statement ± Made in Germany 
Guideline 1.0 on the preparation of an ICSµGuide¶Sublished in 2004 by the Federal 
Ministry Economics and Labour is evaluated.540   ICS reporting in Germany (known as 
Wissenbilanz) is voluntary and the Guide is highly relevant as it targets SMEs ± indeed the 
opening paragraphs specifically comment on debt finance provided by banks, stating: 
 
 ICSs can be used for external communication in order for instance to acquire funding 
for future investments. Since classical balance sheets have to date only included past 
events and largely tangible assets such as real estate or technical plant, entrepreneurs, 
banks and other investors are in fact faced by a dilemma. The information which they 
need for an investment decision is not available, and purely tangible assets as reported 
in customary balance sheet accounts are not sufficiently authoritative in forecasting 
the potential earnings and innovation of an enterprise. For instance, the (subjective) 
opinion of financial analysts as to this criterion which is vital when it comes to buying 
shares or granting a loan and to the management of SMEs remains at present based 
solely on intuitive lobbying for their idea. The consequence is that either no loan is 
granted, or that the cost of funding it is (too) high. This problem is made worse by the 
new guidelines on granting loans contained in Basel II541 which is to officially enter 
into force at the end of 2006.  Previously, large groups and corporations were able to 
objectivise their credit worthiness and future ability via ratings. The ICS is an aid here 
to SMEs. It offers a structure for the presentation and evaluation of competences that 
                                                 
540
 http://www.akwissensbilanz.org/Infoservice/Infomaterial/Leitfaden_english.pdf 
541
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222 
 
are critical to success and the innovative potential of the enterprise. The ICS portrays 
the intangible assets, and hence supplements the traditional balance sheet with the 
criteria missing today. If an enterprise is able to make its IC transparent on the 
financial market in such a form, it becomes easier to take up loans, and funding costs 
for innovative and risk-prone investments will be reduced. For instance, it will also 
become possible for SMEs to report their entire corporate value ± including the 
intangible assets. At the same time, the ICS offers banks and investors a better basis 
for their decision-making on investments in these enterprises.542 
 
 This statement comprehensively acknowledges the reasons for the  
government¶Vsupport of the use of ICS by SMEs, namely to:  close the information gap; 
improve transparency; facilitate access to debt finance; and standardise the capture and 
processing of IC information.  The Guide is the result of a project supported by the Federal 
Ministry of Economics and Labour whereby prototype ICSs were drafted by 14 
representative SMEs.  Encouragingly, all the SMEs involved unanimously agreed that 
drafting their ICS was beneficial.  The German model builds on and further develops the 
Danish ICS method and the drafting mechanics are discussed below.   
 
5.6.1 The German model for ICS drafting  
  The German ICS PRGHOEHJLQVZLWKDFRUSRUDWH³Fitness Check´ as set out in Figure 
24 below.  A company answers 11 questions in the left-hand column of the table with yes (1) 
or no (0).  The ratio between the positive and negative answers shows the degree to which the 
requirements are met.  The more questions that are answered positively, the easier it will be 
to draft the ICS.  Conversely, if the majority of the answers are negative, this highlights the 
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need to give particular attention to these areas when drafting the ICS.  The 14 SMEs in the 
pilot study completed the Fitness Check. 
 
Figure 24 The ICS Fitness Check 
 
Fitness Check on preparation of an Intellectual Capital Statement Yes/No  Comparative 
Value 
Q1 Are many of your employees engaged in intellectually challenging 
 tasks? 
 6 out of 14 
Q2  Have we already dealt with controlling and management systems (such 
 as quality management process optimisation, BSC, etc)? 
 10 out of 4 
Q3  Does our management want and support intellectual capital 
 statements? 
 12 out of 14 
Q4  Is our organisation willing to devote time and resources to intellectual 
 capital statements? 
 12 out of 14 
Q5  Do the employees regard intellectual capital statements as an important 
 project?  
 6 out of 14 
Q6  Can we involve employees from various areas of our enterprise in 
 intellectual capital statements?  
 13 out of 14 
Q7  Are we willing to discuss our strengths and weaknesses openly and 
 constructively? 
 12 out of 14 
Q8  Is management open to proposals and change?  10 out of 14 
Q9  'RZHUHFRJQLVH³VRIWIDFWRUV´DVLPSRUWDQWVXFFHVVIDFWRUV"  14  out of 14 
Q10  Are future topics already touched upon and broadly discussed?   12 out of 14 
Q11  Do we have a documented, communicated business strategy?  10 out of 14 
       RESULT   
Source:  ICSs - Made In Germany Guide 1.0 p14 
 
 The Guide then sets out 6 steps for drafting an ICS with four milestones.543  This is 
simple, non-technical approach that would be straightforward for an SME to carry out, as 
summarised in Figure 25 below.  
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Figure 25  Six Steps to Drafting an Intellectual Capital Statement 
 
 
Source:  Intellectual Capital Statements - Made In Germany Guide 1.0 p16. 
 
 
 Further detail of the type of information to be taken into account is determined by 
following the structure for drafting the ICS narrative, set out in Figure 26. 
 
Figure 26 Structure for the ICS Narrative  
 
1. Why do we need an ICS in our organisation? 
2. Company description 
3. Business success and challenges 
4. Business and knowledge strategy 
5. Our intellectual capital 
6. Future perspectives and measures 
7. Collection of indicators 
Source:  ICSs - Made In Germany Guide 1.0 p31 
 
 The Guide does not provide a sample report as completed by one of the SMEs in the 
pilot study which would have enhanced its usefulness.  Nor does the Guide address IP or 
patents specifically or give any example of the narrative style of IP asset reporting which is a 
weakness.  The Guide adopts a more general approach and this limits its utility from a patent-
backed debt finance perspective.  However, the author assumes that an innovating SME with 
a patent portfolio would address each of the seven items with a patent focus.  Scott Bell, 
Head of UK Investment Banking at Deutsche Bank, gives an indication of the type of patent 
information that would be useful to a lender:  
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 Without data about value and risk, including fundamentals such as ownership, 
 strategy and information to support comparisons, it is hard to see how a functional 
 and active market can be developed; and while data is not the only ingredient, the 
 demand for data and analytics to facilitate a better understanding must be met and is 
 an essential starting point.544 
 
 SME patent portfolio owners still need additional bespoke guidance, for disclosing IP 
and patent information in a standardised format or model that is better tailored to their needs.   
 
5.7 Conclusion 
 
 In 2002 Edvinsson warned, ³There have always been occasional and temporary gaps 
between market perception and accounting reality. But now that gap is turning into a chasm.  
And that suggests that we are not looking at aberration but a systemic flaw in the way we 
measure value.´545 This chapter illustrated the conceptual differences between accounting 
presentation and corporate disclosure law.  It suggests that patent-backed lending decisions 
could be significantly improved by recognising that patents can be simultaneously quantified 
(using the market approach where historical transactions exist), quality assessed, compared 
and evaluated with additional disclosure of relevant, timely and accurate qualitative narrative 
information.  In Chapter 6 we examine what patent information innovating SMEs should 
report and how to report it.  Using a case study approach, the author examines disclosures 
made by global pharmaceutical company GlaxoSmithKline (UK) plc, an enterprise whose 
business model depends on its large and well-established patent portfolio.   
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6 Disclosure of patent information in UK corporate narrative reporting  
 
 A true and fair view implies that all statutory and other information is not only 
 available but is presented in a form in which it can be properly and readily 
 appreciated.  
       Sir Russell Kettle (1887-1968) 
       Chartered Accountant and Author546 
        
Introduction 
 ,QWKLVFKDSWHUZHDGGUHVVWKHTXHVWLRQ³How should innovating SMEs at the early 
stage of their business cycle voluntarily report their patent assets"´,WLVYLWDOIRUWKHPWR
provide a coherent shape for identifying, reporting and presentinJWKH³SDWHQWDVVHWYDOXH
VWRU\´ to potential lenders and other stakeholders interested in the future growth prospects of 
WKHILUP,QRWKHUZRUGVWKH³SDWHQWYDOXHVWRU\´ZLOOVKRZ³KRZWKHPRQH\LVPDGH´ in a 
consistent, clear and uncluttered manner.547  In addition, the innovating SME should 
demonstrate the role the patent assets play within the business, whilst adopting a balanced 
perspective, with a view to increasing transparency and reducing asymmetric information 
regarding the financial accounting metric currently used to value its patent portfolio.  One 
desired outcome is to enhance favourable lending decisions.  The aim of this chapter is to 
consider the content and structure for voluntary disclosure of patent information.  Currently, 
this could be voluntarily included as part of the Strategic Report (a form of corporate 
narrative reporting) FRQWDLQHGLQWKHILUP¶VDQQXDOUHSRUW discussed in Chapter 5 for the 
reasons as outlined above and in Chapter 4.   
 In section 6.1 we introduce the views of the Financial Reporting Council (FRC) on 
the subject of IC reporting and the relevant literature.   
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 Section 6.2 presents a case study that qualitatively analyses the specific narrative 
³patent disclosures´ made in a publicly listeGFRUSRUDWLRQ¶VDQQXDOUHSRUWThe purpose of the 
case study is to critically examine one example of best practice when informing external 
stakeholders (such as lenders) as to the existence and strategies for generating value from the 
FRPSDQ\¶VNH\SDWHQWDVVHWV.  GlaxoSmithKline plc (GSK) was selected because it is a global 
pharmaceutical firm headquartered in the UK and must fully comply with UK legal corporate 
disclosure requirements as set out in the CA 2006 and the UK Corporate Governance 
Code.548  Further, pharmaceutical firms rely heavily on patents to support their business 
model and to safeguard their market share through the product lifecycle549 and the sector 
makes the highest level of IP disclosure in listed companies.550  The narrative style and the 
level of patent disclosure adopted LQ*6.¶V annual report is extensive and enables us to 
identify, critically analyse and hermeneutically interpret and evaluate a wide variety of key 
patent information indicators.  Thus the GSK 2012 Annual Report provides a rich source of 
material.  The aim of the case study analysis is to derive the basis of a guide for voluntary 
patent information disclosure using a much more streamlined format appropriate for 
innovating SMEs.  
 Section 6.3 discusses the recommendation made in the March 2014 the Final Report 
from the Expert Group on IP Valuation551 that companies with IP assets should file a 
³PDQDJHPHQWUHSRUW´ together with their annual report which gives external users detailed 
information about IP value.  The Report concluded that such additional corporate disclosure 
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ZRXOGEHD³useful vehicle to improve public availDEOHLQIRUPDWLRQRQLQWDQJLEOHV´ and 
IXUWKHUWKDW³introducing an additional reporting section for intangible assets and IP would 
increase the transparency of IP value within company accounts, providing important 
information to lendHUVLQYHVWRUVDQGVWDNHKROGHUV´.  This recommendation directly supports 
the approach in this thesis, namely that innovative SMEs could disclose in a narrative form 
additional relevant information concerning the vaOXHRIWKHSDWHQWVWRWKHILUP¶V bottom line 
and business strategy in order to enhance access to debt finance  even though there is no legal 
requirement for them to do so.  The relevant findings and recommendations of the Banking 
on IP Report552 commissioned by the UKIPO are discussed.  This material supplements the 
GSK case study with current thinking by EC and UK multidisciplinary subject matter experts 
in order to derive a basis on which to build a guide for UK innovating SME voluntary patent 
information and strategy disclosure.  Finally, section 6.4 sets out the conclusions drawn from 
the case study and the relevant literature. 
 
6.1 FRC guidance on the Strategic Report  
 In August 2013 the UK Parliament approved The CA 2006 (Strategic Report and 
Directors¶5HSRUW5egulations 2013.  The purpose of the strategic report is to inform 
shareholders and help them to assess how the directors have performed their duty to promote 
the success of the company.553  ,WLVVHSDUDWHWRWKH'LUHFWRUV¶5HSRUWDQG must be separately 
approved by the board of directors.  The FRC LVWKH8.¶VLQGHSHQGHQWUHJXODWRUUHVSRQVLEOH
for promoting confidence in corporate reporting and governance mandated by the CA 2006 to 
foster investment.554  It VHHNVWRHQVXUHWKDW³Corporate reports contain information which is 
relevant, reliable, understandable and comparable, and are useful for decision-making, 
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LQFOXGLQJVWHZDUGVKLSGHFLVLRQV´.555  It encourages entities to prepare a high quality strategic 
UHSRUWZKLFKSURYLGHVD³holistic DQGPHDQLQJIXOSLFWXUHRIDQHQWLW\¶VEXVLQHVVPRGHO
strategy, development, performance, position and future prospects´.556  According to the 
FRC:  
 
 In practice, an annual report comprises three distinct components ± narrative 
 reports; corporate governance statements; and financial statements. The information 
 contained in these components has different objectives which should guide preparers 
 to where disclosures could be located. The aim is to promote cohesiveness and enable 
 related information to be linked together.557 
 
And further,  
 
The overriding objective of narrative [company] reporting is to provide information 
 on an entity, insight into its main objectives and strategies, the principal risks it faces; 
 and to complement, supplement and provide context for the related financial 
 statements.558   
 
 This statement perfectly expresses why an innovating SME with little else than off- 
balance intDQJLEOHSDWHQWDVVHWVQHHGVWR³supplement and provide context for the related 
ILQDQFLDOVWDWHPHQWV´ which do not identify or reflect their value via the submission of a 
Strategic Report.  The Strategic Report should contain a fair and balanced review, consistent 
with the size and complexity of the business of: 
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556
 Exposure Draft: Guidance on the Strategic Report (2013) at p7 
557
 Ibid p10 
558
 Supra FRC [545] p10 
230 
 
 
(a)  the development and performance of thHFRPSDQ\¶VEXVLQHVVGXULQJWKHILQDQFLDO 
 year; 
(b)  the position of the company at the end of the year; and 
(c)  a description of the principal risks and uncertainties facing the company. 
 
 Large companies must include financial and non-financial key performance indicators 
(KPIs) although medium-size companies are exempt from disclosing non-financial KPIs.    
Patent information is a non-financial KPI that innovating SMEs should consider voluntarily 
disclosing in their annual return.  An annual report, tailored to meet an innovating 60(¶V
business objectives, should provide the information necessary for lenders to assess the 
60(¶V 
 
(a) development, performance and position; 
(b) future prospects; 
(c) strategy for achieving its objectives; 
(d) business model; and 
(e) governance.559 
 
 As early as 2008, the FRC recommended that listed companies needed to improve the 
inclusion non-financial KPIs (such as IC/ IP) to explain how the key drivers of the business 
DUHPRQLWRUHGDQGWKDW³quality supplemental LQIRUPDWLRQLVQHYHUFOXWWHU´.560  Crucially, the 
FRC expUHVVO\VWDWHVWKDWLWZHOFRPHV³HQKDQFHPHQW´ to narrative reporting: 
 
                                                 
559
 Supra FRC [545] p15 and s417 CA 2006 
560
 Supra FRC [545] p20 
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 Preparing a good quality annual report that communicates effectively all the 
 important information is a major intellectual and logistical challenge.  Many 
 companies continue to devote significant time and effort to improving their narrative 
 reporting, but there are always opportunities for further enhancement as experience 
 and best practice develop.561 
 
However, with respect to IC specifically the FRC has stated the following: 
 
 Off-balance sheet resources 
 0RVWFRPSDQLHVGLVFXVVWKHLUHPSOR\HHVJLYHQWKLVLVDQRZDUHTXLUHPHQWµWRWKH
 H[WHQWQHFHVVDU\¶WKLVLVQRWVXUSULVLQJ+RZHYHURQO\JREH\RQGWKLVWRGLVFXVV
 other intangible assets such as brands, intellectual capital and natural resources. The 
 off-EDODQFHVKHHWDVVHWVDUHRIWHQVRPHRIWKHPRVWLPSRUWDQWWRDFRPSDQ\¶VIXWXUH
 success; DFRPSUHKHQVLYHGLVFXVVLRQRI³SHUIRUPDQFHDQGSRVLWLRQ´ should include 
 this aspect as well as the resources on the balance sheet. 562 
 
 In other words, the FRC recommends that all company narrative reports contain more 
information and focus on the area of IC.  IC, by definition, includes IP and thus, patent 
information.   In terms of level of information, the FRC non-mandatory guidance is:  
 
 3.19 The Strategic report should be considered as the top layer of information 
shareholders.  Some users may requires a greater level of detail.  In this case the 
strategic report can be used to signpost to other complementary information. 
 
                                                 
561
 Supra FRC [545] p3 
562
 Section 417(4)(a)&(b) CA 2006 
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 3.20 SignpRVWLQJHQDEOHVVKDUHKROGHUVWR³GULOOGRZQ´ to detailed complementary 
 information that is related to a matter addressed in a particular component but that is 
 not necessary to effectively communicate the information that is required by law or 
 regulation in respect of that component. This more detailed complementary 
 information should be placed elsewhere in the annual report, or published 
 separately.563 
 
 Information is material if its omission or misrepresentation could influence the 
economic decisions shareholders take on the basis of the annual report as a whole. Only 
information that is material in the context of the strategic report should be included within 
it.564 This will very much depend on the entity in question.  Materiality is an entity-specific 
aspect of relevance based on the nature or magnitude (or both) of the actual or potential effect 
RIWKHPDWWHUWRZKLFKWKHLQIRUPDWLRQUHODWHVLQWKHFRQWH[WRIDQHQWLW\¶VDQQXDOUHSRUt. It 
requires directors to apply judgement based on their assessment of the relative importance of 
WKHPDWWHUWRWKHHQWLW\¶VGHYHORSPHQWSHUIRUPDQFHSRVLWLRQRUIXWXUHSURVSHFWV565  Finally, 
qualitative factors (such as patent information and strategy) may have a greater influence on 
the determination of materiality in the context of the strategic report than in respect of items 
in the financial statements. Both  financial and non-financial information could be material.566   
 
  
                                                 
563
 Guidance on the Strategic Report (June 2014) FRC, p12 
564
 Ibid, para5.1, p15 
565
 Supra [361], para5.3, p15 
566
 Ibid, para 5.4, p15. $OWKRXJKWKH&$GRHVQRWXVHWKHWHUP³PDWHULDO´WKHFRQFHSWLVLPSOLHGE\PDQ\
of its requirements.  
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6.1.1 Reducing uncertainty through voluntary patent asset corporate reporting 
  
 Almost two decades ago Ernst567 found that patent active firms with a narrow 
technological focus outperform other companies according to various profitability and 
productivity measurements.  In later studies, he also found that 2-3 years after a firm files 
patent applications its sales increase, showing a causal relationship.568  Ramb and Reitzig 
FRQFOXGHGWKDW(XURSHDQSDWHQWDSSOLFDWLRQVWHQGWRKDYHDVWURQJHUFRUUHODWLRQZLWKDILUP¶V
market value than its investment R&D as set out in their balance sheet.569  This study 
supports the need for enhanced patent information disclosure.  In 2013, Dr Carl Frey of 
Oxford University says: 
 
 That patent information explains the market value of firm better than information 
 EHLQJSXEOLVKHGLQILUPV¶DQQXDOILQDQFLDOVWDWHPHQWVLVDOVRHYLGHQWIURPVWXGLHV
 conducted by Hirschey and Richardson (2004) in relation to US firms, but it also 
 found to be true for Japanese firms (Hirschey and Richardson, 2001) and as well as 
 a German one (Trautwein 2007).  Accordingly, it has been suggested that patents can 
 be used to signal future economic benefits to capital markets (see for example, Blind 
 et al, 2006) a view that has received empirical support.570  
 
 'U)UH\¶VUHVHDUFKH[Slores reducing patent and trade mark information asymmetry 
by enhanced corporate disclosure by listed companies concentrating on disclosure in capital 
markets as opposed to voluntary patent information disclosure by private SMEs.  Dr Frey 
                                                 
567
 Ernst, H. 'Patenting Strategies in the German Mechanical Engineering Industry and their Relationship to 
&RPSDQ\3HUIRUPDQFH¶(1995) Technovation, Vol. 15 No.4, pp225-240 
568
 (UQVW+µ3DWHQW,QIRUPDWLRQIRU6WUDWHJLF7HFKQRORJ\0DQDJHPHQW¶World Patent Information, Vol. 
25, Issue 3 pp233-242. 
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 5DPE)DQG5HLW]LJµ$FRPSDUDWLYHDQDO\VLVRIWKHH[SODQDWRU\SRZHURIEDODQFHVKHHWDQGSDWHQW
information for market valueVRI*HUPDQILUPV¶:RUNLQJSDSHUCopenhagen Business School 
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 Frey, C.B. Intellectual Property Rights and the Financing of Technology Innovation (2013) Edward Elgar 
Publishing Limited, p19 
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concludes that reporting IP information assists companies to overcome stock market 
uncertainties due to asymmetric information, reducing the costs of capital.  We can infer that 
an innovating SME seeking debt finance will have an interest in ensuring that its patent 
information is captured, presented and made available to lenders.  The legally mandated UK 
annual corporate reporting requirements provide an opportunity to do this, however, patent 
information reporting is still at its infancy.571  ,QWKHDXWKRU¶s view capturing the ³patent asset 
value´ story DWDQHDUO\VWDJHRIWKHILUP¶V business life-cycle will have the added benefit of 
ensuring that the firm systematically reports the progress and growth of its patent portfolio 
throughout the business lifecycle.  This historical patent information will also eventually be 
highly useful (and much less costly to collate at a later date) if the firm decides to raise equity 
finance in the future.  Therefore, in order to further develop patent information corporate 
reporting and further the research carried out above, the next section critically examines the 
patent information disclosures made by GSK in its 2012 Annual Report in order to 
demonstrate how best to inform stakeholders, such as lenders, as to the value of the patent as 
assets potentially available as security.  
 
 
6.2 GSK case study  
 
 The patent-related information disclosed by the global pharmaceutical company GSK 
in its 2012 Annual Report572 was selected as an example of ³EHVWSUDFWLFH´ in respect of 
patent information disclosure.  A case study methodology was chosen because the detailed 
examination of an individual substantial corporate disclosure should provide realistic insight 
into a coherent model for presenting a variety of patent information.  It is an exploratory form 
                                                 
571
 Lev, B.  Intangibles Management, Measurement, and Reporting (2001);  Blair, M.M. and Wallman, S.M.H.  
Unseen Wealth: Report of the Brookings Task force on Intangibles (2001) Brookings Institution Press, 
Washington D.C. 
572See GSK Annual Report 2012 at  http://www.gsk.com/media/279963/annual-report-2012.pdf 
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of empirical inquiry which investigates a contemporary phenomenon within its real-life 
context.573  For our purposes, the case study is useful for demonstrating theoretical legal 
concepts in an applied setting and bridging the gap between black letter law and practice: 
descriptive (how) and explanatory (why).  The GSK 2012 annual report was carefully 
combed for specific narrative patent information disclosures and the commentary weaves in a 
critical analysis as to the significance of the disclosures.  A key assumption underlying the 
analysis is that the amount of space in the report devoted a subject indicates the relative 
importance of the subject matter from the perspective of those who have written it.574  
Although GSK has more onerous narrative corporate reporting obligations as a quoted 
company than an SME, the aim is to critically analyse: 
 
x the type of patent information GSK selected to disclose;   
x how that information is drafted and presented;  
x what type of information GSK has not disclosed; and  
x whether the selection of patent information disclosure can be used as the foundation 
for a guide to voluntary patent information disclosure by SMEs (adopting a more 
streamlined format).  
 
6.2.1 GSK corporate history 
 GSK plc was incorporated as an English public limited company on 6 December 
1999, formed by a merger of two listed companies: Glaxo Welcome plc and SmithKline 
Beecham plc.  It is the parent company of the GSK group, a major global healthcare group 
involved in the creation, discovery, development, manufacture and marketing of 
pharmaceutical products and health-related consumer products.  GSK¶VVKDUHVDUHlisted on 
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 Yin, R. K. Case Study Research: Design and Methods (1984) Sage Publications, Newbury Park, p23 
574
 Supra Striukova [516] p304 
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both the London and the New York Stock Exchanges.575  The company¶VFRPPHUFLDOVXFFHVV
depends on the creation of patent-protected innovative new medicines, vaccines and 
healthcare products.  As we have seen, UK company law requires directors to prepare 
financial statements for each financial year and GSK¶V directors are required to prepare group 
financial statements in accordance with IFRS as adopted by the EU.  In preparing the GSK 
financial group statements the directors have also elected to comply with IFRS, as issued by 
the IASB.  GSK¶VGLUHFWRUV are well aware of their legal obligations and the fact that the 
Annual Report will be heavily scrutinised by numerous experts, including accountants, 
lawyers and many others.  They take great care in preparing it to ensure its accuracy before it 
is released.  GSK make a substantial investment in their patent portfolio which is of critical 
importance to its shareholders.  Therefore, as a listed company, information pertaining to the 
FRPSDQ\¶Vvaluable patent portfolio is required by law to be disclosed in alignment with the 
UK Corporate Governance Code (September 2014).576  The patent information selected for 
disclosure and the way that GSK discloses it should therefore be of a high.  All references to 
³SDWHQWV´LQ*6.¶VDQQXDOUeport are highlighted in red.   
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 GSK 2012 p251  
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 Supra [547] 
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6.2.2 6WUXFWXUHRI*6.¶V$QQXDO5HSRUW 
 *6.¶V$QQXDO5HSRUW577 (the Report) is 252 pages long and is divided into 5 
parts as set out in Figure 27 below.  
 
Figure 27 Structure of the GSK Annual Report 2012 
 
Part 1 Strategic review 
 &KDLUPDQ¶VVWDWHPHQW 
 &(2¶VUHYLHZ 
 Strategic review 
 How we performed 
 What we do, Where we do it 
 Our market 
 How we deliver 
 Responsible business 
 
Part 4 Financial statements 
 'LUHFWRUV¶VWDWHPHQWRIUHVSRQVLELOLWLHV 
 ,QGHSHQGHQW$XGLWRU¶VUHSRUW 
 Financial statements 
 Notes to the financial statements 
 Financial statements of GlaxoSmithKline plc prepared 
 under UK GAAP. 
Part 2 Financial review & risk 
 Financial review 
 Financial position and resources 
 Financial review 2011 
 
Part 5 Investor information 
 Product development pipeline 
 Products, competition and intellectual property 
 Quarterly trends 
 Five year record 
 Share capital and share price 
 Dividends 
 Annual General Meeting 2013 
 US law and regulation 
 Tax information for shareholders 
 Analysis of shareholdings 
 Shareholder services and contacts 
 Glossary of terms and index 
Part 3 Governance & remuneration 
 Our Board 
 Our Corporate Executive Team 
 &KDLUPDQ¶VOHWWHU 
 Board report to shareholders 
 Committee reports 
 Remunerations Committee    
 &KDLUPDQ¶VOHWWHU 
 Total remuneration for 2012 
 Pay performance for 2012 
 Remuneration Policy for 2013 
 'LUHFWRUV¶HPROXPHQWVDQGWRWDO remuneration 
 Directors and Senior Management 
 
 
 
 It is evident that the Report does not contain a stand-alone section reporting on the 
FRPSDQ\¶V,3RU patent portfolio.  However, it contains D³Products, competition and IP´
section LQ³3DUW,QYHVWRULQIRUPDWLRQ´ on pp229-231 towards the very end of the Report.  
 This structure in itself underscores the patent information visibility problem.  The 
UHDGHU¶V attention is not specifically drawn to the patent information in the Report at any 
                                                 
577
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point.  Rather, one has to analyse the whole Report very carefully to find the relevant patent 
information disclosed (other than in Part 5, much of which forms notes to the accounts).  
*6.¶V5HSRUWwas drafted to comply with legal UHTXLUHPHQWVIRUOLVWHGFRPSDQ\¶V
disclosures using the former Business Review format as set out in Figure 28 below.   
 
 
Figure 28 CA 2006 requirements for listed company disclosures 
1. Fair review: business description and strategy (CA417(3)(a)) 
2. Principal risks and uncertainties (CA 417(3)(b)) 
3. Financial review: performance and position (CA 417(4)(a)&(b)) 
4. Trends and factors (CA 417(5)(a)) 
5. CSR: environment, employees, social & community (CA 417(5)(b)) 
6. Relationships: contractual and other arrangements (CA 417(5)(c)) 
7. Financial Key Performance Indicators (KPIs) (CA 417(6)(a)) 
8. Non-financial Key Performance Indicators (KPIs) (CA 417(6)(b))578 
 
 ,QVXPPDU\*6.¶VSDWHQWLQIRUPDWLRQGLVFORVXUHVDUHHPEHGGHGWKURXJKRXWWKH
Report as the company proceeds to address the disclosure requirements mandated by the CA 
2006.  This is not problematic for our purposes as we are interested in analysing the nature 
and content of the patent information disclosures which can be adapted to provide guidance 
for SMEs to report their patent information using the new Strategic Report format (discussed 
in section 6.1 above).   
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 A Review of Narrative Reporting (2009) pp5-17 
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6.2.3 *6.¶V)LQDQFLDO6WDWHPHQWV 
 ,QRUGHUWRFRQWH[WXDOLVHRXUGLVFXVVLRQRI*6.¶VQDUUDWLYHSDWHQWGLVFORVXUHVZH
firstly consider the consolidated financial statements in Part 4, namely, the traditional 
financial reports. The Report discloses thaWDVDW'HFHPEHU*6.¶VLQWDQJLEOHDVVHWV
were worth £10,161 million (reproduced in Figure 29 below).  Note 19 elaborates on these 
intangible assets.579  *6.¶VEDODQFHVKHHWZDVSUHSDUHGXVLQJWKHKLVWRULFDOFRVWFRQYHQWLRQ
and complies with application UK GAAP accounting standards.  The figures and the 
accounting treatment were independently audited by PricewaterhouseCoopers LLP 580 who 
FRQILUPHGWKDWLQWKHLURSLQLRQ³WKH*URXSILQDQFLDOVWDWHPHQWVJLYHDWUXHDQGIDLUYLHZRI
WKHVWDWHRIWKH*URXS¶VDIIDLUV´ 
 
 
Figure 29  GSK Consolidated balance sheet as at 31 December 2012 
 
Non-current assets Notes 2012£m 2011£m 
Property, plant and equipment 17 8,776 8,748 
Goodwill 18 
 
 
Other intangible assets 19 10,161 7,802 
Investments in associates and joint ventures 20 579 560 
Other investments 21 787 590 
Deferred tax assets 14 2,385 2,849 
Derivative financial instruments 41 54 85 
Other non-current assets 22 682 525 
Total non-current assets  27,783 24,913 
 
 
 Note that (a) intangible assets are of by far the greatest value in this balance sheet and 
(b) they appear to have increased in value by the greatest proportion between the 2 years. The 
accounting treatment in respect of µ2WKHULQWDQJLEOHDVVHWV¶, (including patent assets) is set 
out in Note 19 at p146 of the Report and is reproduced below: 
 Other Intangible Assets 
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 Intangible assets are stated at cost less provisions for amortisation and impairments. 
 Licences, patents, know-how and marketing rights separately acquired or acquired as 
part of a business combination are amortised over their estimated useful lives, 
generally not exceeding 20 years, using the straight-line basis, from the time they are 
available for use. The estimated useful lives for determining the amortisation charge 
take into account patent lives, where applicable, as well as the value obtained from 
periods of non-exclusivity. Asset lives are reviewed, and where appropriate adjusted, 
annually. Contingent milestone payments are recognised at the point that the 
contingent event becomes certain. Any development costs incurred by the Group and 
associated with acquired licences, patents, know-how or marketing rights are written 
off to the income statement when incurred, unless the criteria for recognition of an 
internally generated intangible asset are met, usually when a regulatory filing has 
been made in a major market and approval is considered highly probable.  
 
 Note 19 adopts the language of accountants and focuses on amortisation issues for 
intangibles which are affected by patent expiry dates.  This is entirely appropriate, but an 
external stakeholder such as a lender would need to look further into the Report to find out 
more relevant information to identify the nature patent portfolio and *6.¶VIP management 
strategy ³WKHSDWHQWYDOXHVWRU\´for deriving value and cash flow from those assets.   
 
6.2.4 *6.¶VCEO Review and Business Review581  
 The CEO Review and Business Review are the critical sections of interest in terms of 
the content and level of patent information disclosure.  Sir Andy Witty¶V &(2¶V5HYLHZRQ
p3 does not specifically mention either IP or patents although it discusses R&D.  The 
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Business Review is a lengthy section of the Report contained in pp1- 86.  On p10 under the 
KHDGLQJ³,QQRYDWLRQ´*6.UHSRUWV that: 
 
 At the core of our business model is the use of knowledge and the development of 
 IP.  We create value by researching, manufacturing and making available products 
 WKDWLPSURYHSHRSOH¶VKHDOWKDQGZHOO-being.   
 This statement is highly significant as it accentuates the value the Board ascribes to 
*6.¶VIP which implies legal monopoly protection using patent rights.  This theme is echoed 
under the headinJ³6XVWDLQDELOLW\´ also on p10 where GSK reports: 
 
 Sustainability in our business performance is critically important if we are to deliver 
continued innovation and access to our products. We must produce profitable 
performance to ensure we remain competitive and have the funds to invest in our 
people and assets. A key element of this is an environment that appropriately rewards 
innovation across both patent-protected and branded products.  
 
 Patents are specifically mentioned for the first on p10.  In a diagram on p11, GSK 
confirms that its assets include LWV³IPSHRSOHDQGLQIUDVWUXFWXUH´, a phrase that implies 
patents.  IQIRUPDWLRQRQ*6.¶VDSSURDFKWRIP is set out on p15 under the specific heading 
µ,3 DQGWUDGHPDUNV¶DQGLVWKHVHFRQGWLPH*6.directly refers to patents and the following 
issues are disclosed: 
 
x patent protection 
x challenges to the validity of granted patents and legal proceedings; 
x patent life (duration and expiration of the legal monopoly); 
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x generic medicine pressures; and   
x competitors.    
 *6.¶Vsubstantial patent portfolio protects is investment in the development of 
pharmaceuticals by giving it the exclusive right to sell the medicine while its patent is in 
force.  A generic medicine contains chemically identical active ingredients (or within an 
acceptable bioequivalent range) as the original (usually patent-protected) GSK formula.  
However, a generic medicine is one that is manufactured and distributed in a jurisdiction in 
which GSK has no patent protection.  Sometimes the formulation of the generic medicine 
may be patent-protected, but not the active ingredient.  When a generic medicine is put on the 
market, market competition typically leads to substantially lower prices for both the original 
brand and the generic forms.  Lower market price would negatively impact *6.¶VSURILWV
from sales.  Given the substance of the patent information disclosure, it is reproduced below: 
 
 The process of discovering and developing a new medicine or vaccine takes many 
years and can cost up to £1 billion. IP and the effective legal protection of our IP ± via 
patents, trademarks, registered designs, copyrights and domain name registrations ± is 
critical in ensuring a reasonable reward for innovation and to fund R&D. (See pp33 to 
38 for the pharmaceutical and vaccines development process.) Patent protection for 
new active ingredients is available in major markets, and patents can often be 
obtained for new drug formulations, manufacturing processes, medical uses and 
devices for administering products. Emerging markets are not all aligned on their 
approach to recognising patent-protected medicines.582 
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 Although we may obtain patents for our products, this does not prevent them from 
being challenged before they expire. Further, the grant of a patent does not mean that 
it will be held valid and enforceable by a court. If a court determines that a patent we 
hold is invalid, non-infringed or unenforceable, it will not protect our innovation in 
that legal jurisdiction. Significant litigation concerning such patent challenges is 
summarised in Note 44 to the Financial SWDWHPHQWVµ/HJDOSURFHHGLQJV¶7KHOLIHRID
patent in most countries is 20 years from the filing date. However, the long 
development time for new medicines can mean that a substantial amount of this patent 
life has been eroded before launch. In some markets it is possible to have some of this 
lost time restored and this leads to variations in the amount of patent life available for 
each product we market. 
 
 In addition all of our commercial products are protected by registered trademarks in 
major markets, and our trademarks are important for maintaining the brand identity of 
our products. There may be local variations. For example, in the USA the trademark 
Advair covers the same product sold in the EU as Seretide. Trademark protection may 
generally be extended as long as the trademark is used by renewing it when necessary. 
We enforce our trademark rights to prevent infringements. 
 Generic Pressures 
 When patents expire on medicines, these medicines can be subject to competition 
from generic products.583  The effect of this is particularly acute in Western markets, 
where generic products can rapidly capture a large share of the market. As generic 
                                                 
583
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manufacturers typically do not incur significant costs for R&D, education or market 
development, they are able to offer their products at considerably lower prices than 
branded competitors. The same pressures do not apply as significantly to vaccines, or 
to products where patents exist on both active ingredients and the delivery device, 
such as inhaled respiratory medicines. 
 
 Competition 
 Within the pharmaceutical industry, competition can come from other companies 
 making patent-protected medicines with indications to treat similar diseases to our 
 medicines, or from manufacturers making generic copies of our medicines following 
 patent expiration. Our principal pharmaceutical and vaccines competitors include: 
 Abbott Laboratories, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Johnson 
 & Johnson, Merck, Novartis, Pfizer, Roche Holdings, Sanofi and Takeda. The 
 Consumer Healthcare market has become more challenging. Consumers are 
 demanding better quality and better value. Retailers have consolidated and 
 globalised, which has strengthened their negotiation power. Our principle 
 competitors in these markets include: Colgate-Palmolive, Johnson & Johnson, 
 Procter & Gamble, Unilever, Pfizer and Novartis. In addition, many other smaller 
 companies compete with GSK in certain markets. 
 
 Highly important information regarding the use of patents and how they affect GSK¶V 
business model is ³VLJQSRVWHG´in narrative form in the Business Review.  However, to one 
with IP knowledge, the information is general in nature and by and large would apply to other 
pharmaceutical firms.  Despite its generality, the disclosure is important because it 
FRQWH[WXDOLVHVKRZSDWHQWDVVHWVLPSDFW*6.¶VEXVLQHVVVWUDWHJ\ and crucially, highlights the 
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critical value of patent monopolies to the pharmaceutical business as a whole.  This 
information acts as an introduction to those less familiar with patent rights and is relevant and 
appropriate for innovating SMEs.  General patent information drafted in a few paragraphs in 
a way that contextualisHVWKH60(¶V³patent value story´ would not be particularly onerous.  
This ³VLJQSRVWLQJ´aspect of patent information and strategy disclosure will be further 
developed in Chapter 7. 
 
6.2.5 *6.¶V,QYHVWPHQWLQ5	' 
 Information relating to R&D is regularly disclosed by innovative quoted firms and 
GSK is no exception. This is the heading under which one would most likely look for 
information about patents, given that patents flow from inventions created during the R&D 
stage of the product development cycle.  At p32 of the Annual Report, GSK describes its 
³Investment in R&D´. 
 
 In 2010, GSK became the first major pharmaceutical company to publish an internal 
rate of return (IRR) on our R&D investment, to indicate the positive value being 
realised from our choices within the R&D organisation. IRR provides a measurement 
offering an insight into how we manage our R&D business. This is based on a 
complex methodology that weighs the R&D costs incurred to discover and develop 
our late stage pipeline projects against the profits of new medicines and vaccines as 
they achieve regulatory approval and are made available to patients. It incorporates 
actual and predicted sales figures on probabilities of success for medicines in the 
pipeline. We also take into account an estimate of attributable R&D costs, estimated 
profit margins, capital investment and working capital requirements. 
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 GSK uses the Internal Rate of Return (IRR) valuation methodology in order to fill the 
gap that traditional accounting for intangibles creates (as discussed in Chapter 4).  The IRR 
figures used only for internal management purposes enables GSK to demonstrate to external 
information users the ³positive (financial) value being realised from our choices within the 
5	'RUJDQLVDWLRQ´ which would not otherwise visible in the tradition style of accounts that 
are published.  Publication of the IRR assists GSK to overcome the information asymmetry 
that arises from only publishing traditional financial accounts.  Note however, that there is no 
mention of investment in patents specifically.  *6.¶V,55YDOXDWLRQPHWKRGRORJ\LV helpful, 
and of course if an innovating SME is in the position to devote sufficient financial and human 
resources to calculate its IRR, this would be a positive disclosure from a debt finance point of 
view.  However, the IRR valuation methodology is complex (therefore expensive).  It is 
unlikely that an innovating SME would have the resources to calculate this financial 
information.  Further research is warranted to provide guidance as to standardised IRR-type 
methodologies.   
 
6.2.6 *6.¶V6WUDWHJLF5HYLHZOutlook, Risk Management Strategy and Global 
 Patents Group (GPG) 
 
 This section of the Report provides a directional map for where GSK is headed and 
how it intends to get there.  This involves the process of thinking about GSK and its related 
environment and internal business strategies as an integrated whole.  Although not expressly 
stated, patent-protected products will be a key component in how GSK will achieve the aims 
VWDWHGLQLWV³2XWORRN´.  The following paragraphs analyse the patent information disclosures 
made by GSK.  
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 The FRQFHSWRI³ULVNPDQDJHPHQW´ is introduced on p47 of the Business Review.  
Risk factors alert shareholders, potential investors and financiers to those issues that could 
PDWHULDOO\DOWHUDFRPSDQ\¶VSHUIRrmance and financial outlook.  GSK GLVFORVHV³protecting 
IP ULJKWV´ as a key risk of the group.584  2QH¶VDWWHQWLRQLVQRWLPPHGLDWHO\GUDZQWRSDWHQW
information subject matter.  However, the ³ULVNIDFWRUV´ disclosure that follows on pp78-86 is 
substantial, detailed and informative and provides specific information DERXW*6.¶VSDWHQW
strategy.  Certain aspects of how GSK manages its patent assets are described supplementing 
the general information provided earlier on p15.  GSK introduces the principal risk factors 
and uncertainties it faces on p78, namely: 
 
(1) securing and protecting IP rights in products; 
(2) loss of patent monopoly rights either due to expiry or as a result of successful legal 
challenge; 
(3) patent enforcement;  
(4) the potential impact of the differing strength of legal protection for patent monopolies 
of developed countries versus lesser developed countries; 
(5) competition (e.g. from generic pharmaceutical manufacturers, such as those markets 
in which GSK does not have patent protection for its products); and 
(6) protecting confidential information.  
 
 These types of IP-related disclosures are directly relevant to innovating SMEs and are 
transferable to the new Strategic Report.  It is the lengthiest patent information disclosure in 
the Business Review and this section has likely been prepared with the LQSXWRI*6.¶VGPG 
mentioned on p79.  The narrative patent information is still quite general and applies to any 
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 7KLVVSHFLILFµULVNIDFWRU¶LVUHSRUWHGLQPRUHGHWDLOIROORZLQJWKH)LQDQFLDO5HYLHZLQDVHSDUDWHVHFWLRQRI
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large pharmaceutical company that operates internationally.  Nevertheless, it concisely 
KLJKOLJKWVNH\ULVNVDVVRFLDWHGZLWK*6.¶VSDWHQWULJKWV7KLV type of patent information 
disclosure could be emulated by innovating SMEs. 
 The corporate reporting regulations for listed companies are set out in the )6$¶V 
Disclosure and Transparency Rules585 and the UK Corporate Governance Code586 which 
require a discussion of the ³mitigating activities´ a company takes to address the risks and 
uncertainties identified above.  7KH³0LWLJDWLQJ$FWLYLWLHV´ section on p79 is the first time the 
GPGDNH\SDUWRI*6.¶VLQWHUQDOSDWHQWPDQDJement strategy, is mentioned and 
demonstrates that GSK recognises the need to coordinate patent management strategy.    
 
 Mitigating activities include 
 The Group is supported by a global patents organisation within the legal group whose 
focus is to seek to ensure and protect the intellectual property rights of the  Group. 
Beginning in 2011 and continuing through 2012, the GPG sought to implement 
improvements to certain time-driven processes and controls in order to better manage 
its ability to obtain and maintain patent protection for the *URXS¶VNH\DVVHWVDQGWR
minimize risk of invalidity or unenforceability of its patents. These processes relate to 
(1) implementing a new review process designed to  help with obtaining and 
maintaining appropriate patent protection for key assets; (2) identifying opportunities 
for and obtaining patent term extensions; (3) ensuring timely payment of required 
renewal fees; and (4) ensuring appropriate listing of patents in the Orange Book587. 
The enhanced processes seek to ensure that all key patent applications are reviewed 
by senior management prior to worldwide filing and prior to grant and that senior 
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management approval is obtained prior to listing of  patents in the Orange Book or the 
initiation of Abbreviated New Drug Application litigation. In addition, the Group has 
initiated a post approval patent review process to ensure ongoing review of the quality 
of patents after grant. The GPG maintains internal litigation processes designed to 
ensure successful enforcement and defence of patent with the goal of maintaining 
exclusive rights to market major products. The GPG monitors new developments in 
patent law in the major markets in which the Group operates to seek to ensure 
DSSURSULDWHSURWHFWLRQRIWKH*URXS¶VDVVHWV7KH*roup (sometimes acting through 
trade associations) works with local  governments to seek to secure effective and 
balanced IP protection designed to meet the needs of patients and payers while 
supporting long-term investment in innovation. 
 
 This disclosure signposts that the GPG is actively responsible for coRUGLQDWLQJ*6.¶V
global patent management strategy including obtaining and maintaining patent protection for 
the GURXS¶VNH\DVVHWVDQG to minimise risk of invalidity or unenforceability of its patents.  
The existence of the GPG is noteworthy from a corporate governance perspective in terms of 
internal accountability and leadership.  However, this disclosure really only hints at how 
GSK manages is patent assets.  For example, there is no disclosure of: 
 
x representation within the GPG; 
x local patent strategy for key regions including the UK; 
x no designation of a Chief IP Officer or a key manager responsible for the global or 
regional patent portfolio(s); or  
x whether responsibility for patent strategy is divided by product or otherwise.   
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 To demonstrate leadership and accountability, a company should disclose who is 
responsible for coRUGLQDWLQJDQGPDQDJLQJWKHILUP¶VSDWHQWVWUDWHJ\DQGZKHWKHUH[WHUQDO
DGYLVRUV¶DGYLFHDQGH[SHUWLVHLVREWDLQHG(e.g. patent attorneys or IP solicitors).    
 
6.2.7 *6.¶VSDWHQWOLWLJDWLRQDFWXDODQGSRWHQWLDO 
 In the Financial Review, GSK mentions ³Legal and other disputes´ (Notes 29 and 44) 
at p64 which refers to patent litigation.  Patent litigation presents a financial risk for GSK as 
significant company revenue is endangered when a patent is challenged.  This is so even if 
the legal proceeding is brought to enforce the patent against an infringer because the 
GHIHQGDQW¶VUHVSRQVHXVXDOO\LQFOXGHVDEDUHGHQLDORILQIULQJHPHQWDQGDFRXQWHUFODLPWR
revoke the GSK patent on the grounds that it is invalid.  A typical patent case will last for 
over a year with the associated legal costs and the possibility of an appeal to extend the 
proceeding.  It is not unusual for a pharmaceutical company to be involved in a number of 
legal proceedings at any one time.  Thus, the validity of key corporate assets, namely patent 
rights, that are the result of substantial investment in R&D over the years, is at stake.  In 
Chapter 4 we saw that patents have the status of a cost centre for a company (a liability on the 
balance sheet) and as a minimum have an economic replacement value.  Patent litigation 
involves assessing a large number of uncertainties some of which are common to all litigation 
while others are unique to patent rights.  On p65 GSK disclosed the following legal risks: 
 
 Like many pharmaceutical companies, we are faced with various complex product 
liability, anti-trust and patent litigation, as well as investigations of our operations 
conducted by various governmental regulatory agencies. Throughout the year, the 
General Counsel of the Group, DVKHDGRIWKH*URXS¶VOHJDOIXQFWLRQDQGWKH6HQLRU
Vice President and Head of Global Litigation for the Group, who is responsible for all 
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litigation and government investigations, routinely brief the Chief Executive Officer, 
the Chief Financial Officer and the Board of Directors on the significant litigation 
pending against the Group and governmental investigations of the Group. 
 These meetings, as appropriate, detail the status of significant litigation and 
 governmental investigations and review matters such as the number of claims notified 
 to us, information on potential claims not yet notified, assessment of the validity of 
 claims, progress made in settling claims, recent settlement levels and potential 
 reimbursement by insurers.  
 
 The meetings also include an assessment of whether or not there is sufficient 
information available for us to be able to make a reliable estimate of the potential 
outcomes of the disputes. Often, external counsel assisting us with various litigation 
matters and investigations will also assist in the briefing of the Board and senior 
management.  Following these discussions, for those matters where it is possible to 
make a reliable estimate of the amount of a provision, if any, that may be required, the 
level of provision for legal and other disputes is reviewed and adjusted as appropriate. 
 
 Note 44 Legal Proceedings on pp210-217 XQGHUWKHKHDGLQJµIP¶GLVFORVHVVHYHUDO
patent litigation proceedings and the outcome to date.  The patent litigation disclosed relates 
to ten oI*6.¶VSKDUPDFHXWLFDOSURGXFWV.  In brief, the litigation involving GSK mainly 
concerns: (1) enforcement of patent rights against infringers; and (2) defending the validity of 
its patents.  This disclosure is the most detailed patent information in the Report, yet is 
succinct and informative. In the main, GSK states its involvement in the patent or licence-
related litigation and provides a brief background and description of each proceeding.  A 
VDPSOHRI*6.¶VVW\OHRISDWHQWGLVFORVXUHQDUUDWLve is set out below in Figure 30.   
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Figure 30 GSK Patent litigation proceedings as at 2012 
Product affected Type of litigation Disclosure 
 
 Benlysta 
 
 
Patent validity proceedings 
ongoing in the UK in 2013 
and in the CJEU in 2014. 
 
Biogen patent revoked by 
Technical Board of Appeal 
at the EPO with no effect 
RI*6.¶VPDUNHWLQJRI
Benlysta.  
 
In September, 2012, the UK Court of Appeal refused an appeal by Eli Lilly and Company 
µ(OL/LOO\¶DVVHUWLQJWKDW+XPDQ*HQRPH6FLHQFHV,QFµ+*6¶8.3DWHQW1R
EP0939804 for Benlysta was invalid on the grounds that it lacked the necessary 
information required to work the invention described in the claims which covered 
DQWLERGLHVWKHµDQWLERG\FODLPLQVXIILFLHQF\DUJXPHQW¶7KH8.High Court and  the UK 
Supreme Court previously had decided that the patent was valid on all other grounds. The 
initial revocation was brought by Eli Lilly in 2006 on the patent which claims the cytokine 
BLyS and any antibody that binds to BLyS, such as Benlysta (belimumab). Eli Lilly has 
petitioned the UK Supreme Court to hear an appeal on its antibody claim insufficiency 
argument. The decision of the UK Supreme Court whether to grant the appeal is pending. 
Eli Lilly has also requested a declaration that any Supplementary Protection Certificate 
µ63&¶ILOHG by HGS to extend its UK patent EDVHGXSRQ(OL/LOO\¶VDQWL-BLys mAb will 
be invalid. On 3 August2012, a decision was issued by the UK Court of Appeal to refer 
questions to the Court of Justice of the European Union µ&-(8¶relating to whether the 
product is protected by a basic patent in force. The judge ordered that the remaining issues, 
which are not included in the referral, should go to a fact-finding trial at the UK 
High Court. A trial date has been set for July 2013 at the UK High Court. The CJEU 
reference is likely to be heard in early 2014. 
 
  
 Litigation is fraught with uncertainty, which is inherent in situations where there is 
more than one possible outcome.588  A company must take care to ensure that their corporate 
disclosure of the risks involved in patent litigation provides D³IDLUVXPPDU\´ of the material 
information relied on by the board of directors in their decision-making.  The first step is to 
identify the uncertainties and be aware of what can happen.  Next, the company should assess 
the associated risks as to the likelihood or probability of each possible outcome occurring.589  
A company should also consider the settlement value of the litigation so that it can assess risk 
and cost of pursuing or defending an action weighed against the cost to settle the action.  Is 
the patent litigation worth the expense?  If patent rights are uncertain, pursuing settlement 
and negotiating a licence with the alleged infringer may be the best option in order to avoid 
the patent being invalidated.  Note that GSK does not specifically disclose how much it 
spends on legal fees nor do they quantify the potential damage in relation to each case. 
 1HOVRQDQG3ULWFKDUGLQWKHLUVWXG\FRQFHUQLQJILUPV¶YROXQWDU\disclosure of 
litigation risk examine the characteristics of narrative corporate disclosures.  They found that 
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 3ROWRUDN$DQG/HUQHU3µ,QWURGXFLQJOLWLJDWLRQULVNVDQDO\VLV¶0D\,VVXHManaging 
Intellectual Property, p1 
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firms subject to greater litigation risk (such as GSK and its patent litigation) disclose more 
cautionary language, update the language more from year to year, and use more readable 
language.590  However, they also found that firms should take care to remove cautionary 
language in their narrative disclosure when litigation risk decreases.591 
  In formulating a patent litigation risk disclosure strategy, an innovating SME must 
contend with uncertainty regarding the future.  Actual patent litigation should be voluntarily 
disclosed to provide a fair view.  However, if there is no actual litigation, the SME could 
carefully consider whether there is any need to disclose potential litigation and if so, use 
cautionary language in doing so.  Innovating SMEs should draft the disclosure using plain 
English and minimise the use of technical language and legal terms.592    
 Evaluating patent litigation risk inevitably leads a company to consider the quality of 
its patent portfolio.  Poor-quality patents, perhaps due to inadequacies in patent examination 
and issuance quality from patent offices (discussed in Chapter 2) leads to those patents being 
prone to litigation risk.  Lenders need to understand that poor-quality patent and careless 
patent-granting contributes to increased financial and legal risk.593   
 In summary, patent litigation risk has important implications for innovating SME 
corporate disclosure policies.594 Making decisions about patent litigation is about managing 
legal risk.  The costs of patent litigation can be disruptive and adversely impact normal 
business operations, especially in SMEs.595  As the cost of patent litigation is high and the 
outcome will have a financial impact on the business, SMEs should seriously consider all the 
effects of legal proceedings.  On the other hand, the rewards for well-organised and financed 
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patent enforcement action can be substantial.  In the long term, the strategic benefits of strong 
patent enforcement include a deterrent effect on other potential infringers of the patent in 
question and increase the likelihood that future patent disputes are settled out of court.596  An 
innovating SME should be sensitive to changes to their litigation risks.  Disclosure must be 
current and SMEs must update their disclosed litigation risks annually.  The innovating SME 
VKRXOGDYRLG³ERLOHUSODWH´ litigation risk disclosure which is a concern to corporate regulators 
and should strive to disclose information that is relevant to financial risk.  Ultimately, what is 
important for the innovating SME is to make the effort to disclose and demonstrate to the 
ILQDQFLHUWKHFRPSDQ\¶VDSSUHFLDWLRQRIWKHOHJDOULVNVWKDWPD\DULVHLQFRQQHFWLRQZLWK
patents and that it is actively managing those risks.    
  
6.2.8 *6.¶Vconfidential information 
 The possible disclosure of confidential information is a hidden risk of patent 
litigation.  As part of the discovery process, the parties may be required to divulge sensitive 
product development, manufacturing, marketing or pricing information to defendants and 
potentially to the public, although court procedures may be implemented to preserve 
confidentiality.  Whereas GSK discloses actual litigation to which it is a party, GSK reports 
two further specific business risks including ³Potential LiWLJDWLRQ´DQG³Protecting our 
,QIRUPDWLRQ´ on pp84 and 85 respectively.  The latter focuses on how GSK protects its 
confidential information.  This is an important component of patent strategy, as in order to be 
patentable, the legal requirement under the PA 1977 is that the invention must be ³new´.  
Section 2(1) PA 1977 provides that an invention shall be taken to be ³new´ if it does not form 
part of the state of the art.  An invention lacks novelty if the specified combination of features 
has already been anticipated in a disclosure.  In 6PLWK.OLQH%HHFKDP3OF¶V3DUR[HWine 
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Methanesulfonate) Patent,597 the House of Lords held there were two requirements for 
anticipation: prior disclosure and enablement.  These are distinct concepts each of which has 
to be satisfied and each of which has its own rules.  If any features of GS.¶VSRWHntially 
patentable inventions are made public before a patent application has been filed, the 
opportunity to be granted a patent will be lost.  This is a serious risk for a company that relies 
on patent-protected products.  *6.¶VGLVFORVXUHUHJDUGLng its confidential information on p85 
is set out below: 
 
 Protecting our information 
 Risk description: Risk of exposing business critical or sensitive data due to inadequate data 
 governance or information systems security. 
  The Group relies on critical and sensitive data, such as corporate strategic plans, 
 personally identifiable information, trade secrets and IP, to drive planning and 
 operations. Security of this type of data is exposed to escalating external threats that 
 are increasing in sophistication and changing from a goal of disruption to being 
 financially or politically motivated. Failure to implement appropriate safeguards to 
 adequately protect against any unauthorised or unintentional access, acquisition, use, 
 modification, loss or  disclosure of this critical or sensitive data may adversely 
 LPSDFWWKH*URXS¶VDELOLW\to maintain patent rights and competitive advantages and 
 may result in legal non-compliance resulting in fines and penalties or inability to sell 
 product in a particular market. 
 
 Mitigating activities include 
 The Group assesses changes in our risk environment through briefings by government 
 agencies, subscription to commercial threat intelligence services and security 
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 information sharing with other companies - both in our industry and beyond. The 
 *URXS¶VSROLFLHVDQGFRQWUROVRQLQIRUPDWLRQSURtection are regularly reviewed and 
 employees are routinely trained. The Group has dedicated information security 
 expertise and resources. In response to the changing external risk environment, the 
 Group has implemented a global programme to further increase business awareness 
 of information protection requirements, further define minimum information security 
 expectations for third-party agreements, implement additional technical controls to 
 SURWHFWGDWDDQGLPSURYHLWVVHFXULW\HYHQWPRQLWRULQJ« 
 
 *6.¶V disclosure is general and concise, signifying that the company recognises the 
issue and has a programme in place however, it does not disclose who is responsible for 
managing its confidential information.   
 
6.2.9 *6.¶VLQIRUPDWLRQIRULQYHVWRUVSURGXFWVFRPSHWLWLRQDQGIP 
 
 GSK provides an Investor Information section on pp224-HQWLWOHG³Products, 
Competition and IP´ beginning at p229 with a table containing 42 entries setting out the 
relevant patent expiry dates in the USA and EU.  A sample of the first entry of patent expiry 
information is set out below in Figure 31.    
 
Figure 31     Extract from GSK Investor Information, Products, Competition & IP table 
Products, Competition and IP 
Products Compounds Indicator(s) Major Competitor 
Brands 
Patent Expiry 
Dates 
USA 
Patent Expiry 
Dates 
EU 
Respiratory 
 
Veramist 
 
fluticansone 
propionate 
 
rhinitis 
 
Nasonex 
 
2021 
 
2023 
 
Flixotide/Flovent 
 
fluticansone 
propionate 
 
asthma/COPD 
 
Qvar, Singulair 
 
Expired compound 
(2016)  
(Diskus device) 
2013-2025 
(HFA-
device/formulation) 
 
Expired 
(compound) 
(Diskus device) 
2017 
(HFS-
device/formulation) 
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 7KHLPSDFWRISDWHQWH[SLU\RQ*6.¶VSKDUPDFHXWLFDOEXVLQHVVLVFULWLFDOLQIRUPDWLRQ
for investors.  Once a pharmaceutical enters the market, patent protection can result in high 
profits, with gross profit margins exceeding 90%.  When a patent that covers a product 
expires, generic manufacturers offer the products at prices reported to average about 30% of 
the price of the brand-name originals.  Once a pharmaceutical product loses patent protection, 
lower-price generics quickly siphon off as much as 90% of sales.598 The pharmaceutical 
industry is now experiencing the long-expected and much-discussed patent cliff.599  A notable 
2012 patent expiration for GSK is the patent covering the diabetes drug Avandia 
(rosiglitazone).  )XUWKHUDVDUHVXOWRI*6.¶VSDVWFRUSorate disclosures, industry analysts 
confirm that over the next few years GSK will lose patent protection on its anti-triglyceride 
product Lovaza (omega-3-acid esters), the benign prostatic hyperplasia drug Avodart 
(dutasteride),  the HIV/AIDS product Combivir and asthma medication Advair.  In 2010 
these drugs combined accounted for over $1 billion USD in earnings in the United States 
alone.  A generic form of Combivir is already available in the United States.600  This is a 
VLJQLILFDQW³patent cOLII´ that will result in additional generic competition for GSK, 
potentially eroding millions of pounds of turnover in the near future.  Disclosure of patent 
expiry dates is critically important for GSK shareholders and potential investors (equity 
financiers).  In terms of the type of information contained in Figure 31 above*6.¶V
disclosure lacks detailed information as to how they will optimise earnings before a 
significant patent expires.  There is no column in the table or commentary addressing this 
issue (e.g. through raising prices, enhanced advertising, a complementary pipeline product or 
outsourcing to lower cost regions of the world).  A OHQJWK\³Pharmaceuticals and Vaccines 
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SURGXFWGHYHORSPHQWSLSHOLQH´ table is set out in pp225-288.  This discloses investment in 
new pharmaceutical inventions that GSK believes will address unmet pharmaceutical needs 
and that are also profitable and UHSUHVHQWV*6.¶VVWUDWHJ\IRUPLQLPLVLQJWKHLPSDFWRIWKH
revenue loss attributable to patent expiry in the near future and to maintain profitability. The 
table headings and column structure is set out in Figure 32 below.  
 
Figure 32 Pipeline Pharmaceuticals and Vaccines 
Compound Type Indication Phase Marketing 
Authorisation  
Application (Europe) 
Achieved Regulatory Review Progress 
New Drug Application (NDA) USA / 
Biological Licence Application (BLA) 
 
 There is no additional narraWLYHGLVFORVXUHDSDUWIURPWKH³3LSHOLQHWDEOH´ which 
provides certain limited information concerning future actions, prospective products or 
product approvals which are intended to enhance future performance.  Nor is there any 
narrative disclosure of pipeline pharmaceuticals with the profit potential of Lovaza, Avodart, 
Combivir and Advair emerging in the near future.  There is no discussion of patent 
DSSOLFDWLRQVDWDOO,QFUHGLEO\*6.¶VERDUGKDVLQYHVWHGELOOLRQ GBP in its R&D pipeline 
but has refrained from making any express forward looking statement regarding its pipeline 
in this section.601  However, much earlier, on pLQWKH&(2¶V5HYLHZ6LU$QGUHZ:LWW\
VXPPDULVHVWKH*6.¶V5	'SLSHOLQHDV follows: 
 
 In R&D, the Group made significant progress in 2012. We now have six key 
 new products under regulatory review and expect Phase III data on 14 assets 
 in 2013 and 2014. In total, over the next three years, GSK has the potential to 
 launch around 15 new medicines and vaccines globally. 
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)XUWKHURQSXQGHUWKHKHDGLQJ³,QQRYDWLRQ´ GSK discloses:   
 
 In 2012, we invested £3.5 billion in core research and development of new 
 medicines, vaccines and consumer products, and we are currently evaluating 
 around 50 investigational medicines for diseases such as cancer, diabetes, 
 heart disease and respiratory illnesses. Over the next three years, we have 
 the potential to bring around 15 new medicines to patients. 
 
 One has to carefully analyse the table and then draw inferences and make independent 
conclusions from the information presented at either end of the Report.  This is time-
consuming and unhelpful.  *6.GRHVQRW³MRLQWKHGRWV´ for the reader and expressly explain 
with specificity how it will replace blockbuster pharmaceuticals whose patents are expiring 
with new pharmaceutical products that have the potential to become big sellers.   
 This weakness narrative patent information disclosure is echoed by auditing firm 
.30*,QWHUQDWLRQDOZKLFKFRQILUPVWKDWLQJHQHUDO³'LVFORVXUHRI5	'SLSHOLQHVUHPDLQ
relatively limited, influenced by the problems and lack of success of recent years, and 
FRPSHWLWLYHSUHVVXUH´DQG³:HGRQRWVHHthe issue of scientific risk yet being embraced: 
FRPSDQLHV¶GLVFORVXUHLVLQJHQHUDOOLPLWHGDQGWKHJRYHUQDQFHRI5	'PHULWVDKLJKHU
SURILOH´602   )XUWKHUDFFRUGLQJWR(G*LQLDW*OREDO&KDLU.30*¶V3KDUPDFHXWLFDO3UDFWLFH
US, as significant revenue is at risk when a patent is litigated or expired, replacing these 
revenue streams magnifies the need for successful R&D.603  For instance, GSK could make it 
more explicit that its strategy is to focus on growth in emerging markets to mitigate patent 
losses in developed markets or to acquire new patent portfolios with earlier product launch 
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 An Overview of Risk and Disclosure (April 2012) KPMG, pp2-3  
603
 Ibid, p7 
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schedules from other companies.604  On the other hand, adopting a selective or restrictive 
approach to R&D pipeline disclosure, by limiting detailed discussion of early stage R&D, 
arguably is sensible given the high failure rate.  Nevertheless, many investors and financiers 
hold the view that increased transparency is useful for assessing the relative attractiveness 
and competitive positioning of the R&D pipeline.605  Ultimately, from a corporate 
governance point of view, additional relevant and genuinely useful information would assist 
with an assessment of the GLUHFWRUV¶ stewardship of GSK¶VIP assets.   
 GSK does not disclose information about discontinued R&D projects or patents it has 
let lapse. According to KPMG, disclosure of discontinued projects remains rare and that in 
highly scrutinised industry, success and failure will be readily apparent to interested investors 
and financiers; it should enhance the reputation of companies to disclose failures.606  Bearing 
in mind that R&D is crucial to the future of the business and accounts for a high percentage 
RIDFRPSDQ\¶VDQQXDOH[SHQGLWXUHPRUHGHWDLOHG³MRLQHGXS´ disclosure of R&D, relevant 
IP and patent information is warranted.  
 
6.2.10 *6.¶VERDUGRIGirectors 
 The board of directors is collectively responsible for the long-term success of the 
company.607  GSK has a competent and well-qualified Board, and while Moncrief Slaoui is 
*6.¶V&hairman of R&D, there does not appear to be a director (executive or non-executive) 
who is a qualified patent attorney or IP law specialist.  According to the International IP 
6WUDWHJLVWV¶$VVRFLDWLRQ,17,36$LWLVQRORQJHUDGHTXDWHWRVLPSO\UHO\RQWKHWUDGLWLRQDO
role of the Chief Legal Officer or Chief Technology Officer to assume leadership and 
responsibility for IP and patent matters.  In certain medium and large companies, especially 
                                                 
604
 µ*OD[RVPLWKNOLQHXQGHUYDOXHGVD\DQDO\VWV¶'HFHPEHUDW
http://www.morningstar.co.uk/uk/news/114764/glaxosmithkline-undervalued-say-analysts.aspx 
605
 Supra [603] p16  
606Ibid p18 
607
 UK Corporate Governance Code, p8 
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in the US, responsibility for IP matters now rests with the Chief IP Officer (CIPO) or the 
Director of IP operating at the intersection of IP, technology and business.  The IP Director 
needs to understand where IP fits into the business and overall commercial reality.608  
INTIPSA advises that: 
 
 There is a direct parallel between the CIPO role and that of the CTO, both having a 
 strong emphasis on advising and influencing. The CIPO must be able to identify 
 strategic IP issues, trends, and industry sector issues plus be able to lobby internally 
 and externally if and when required. The CIPO should be a leader in IP strategic 
 thinking, including in such key areas as the acquisition of IP, IP portfolio 
 optimisation, setting goals for IP exploitation and understanding IP risk mitigation. 
 This will include litigation and settlements. Understanding the business environment 
 from an IP perspective, interpreting that for the business and providing foresight is 
 also crucial. Being able to communicate IP thinking to the company's other executives 
 as well as externally is a key  responsibility.609 
 
 GSK, or any firm with a business model that relies heavily on patent protection, 
should consider appointing a director with patent expertise (e.g. either a patent attorney or an 
IP solicitor RULGHDOO\ERWKWRVXSSRUWWKH%RDUG¶VGHFLVLRQ-making with respect to these 
valuable corporate intangible assets.  A cost-benefit analysis would be helpful here in relation 
to innovating SMEs with limited resources who could engage the services of competent IP 
professionals or consultants as needed.  
 
 
                                                 
608
 µ7KH5ROHRIWKH&KLHI,QWHOOHFWXDO3URSHUW\2IILFHU¶,17,36$SDWhttp://www.intipsa.com/wp-
content/uploads/2013/01/INTIPSA-Tips-The-role-of-the-CIPO1.pdf, 
609
 Ibid, p3 
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6.2.11  Increased transparency  
 In addition to the matters discussed above, increased transparency is needed in the 
following two areas:   
 
Depth of patent portfolio 
 Despite its patent assets having growing strategic importance, GSK does not report 
specifically on the depth of its patent portfolio (number of patents, patents per jurisdiction 
etc.), patent families, the strength of particular patent pools or sales and acquisitions of 
patents.  A search of Esp@cenet, the EPO¶VZorld-wide patent database confirms that 6147 
results were found for GSK as the applicant.610  Patents have also been filed by several of 
*6.¶VLQWHUQDWLRQDOVXEVLGLDULHVZLWKin the corporate group.  The size and quality of a 
FRPSDQ\¶VSDWHQWSRUWIROLRZLOOKDYHDGLUHFWLPSDFWRQLWVUHSXWDWLRQUHWXUQRQLQYHVWPHQWV
and access to the market.  All patents are not equal in value or importance and potential 
investors or financiers will need to use additional qualitative information to rank the expected 
value of the patents.  But the narrative corporative reporting provides little insight into the 
³big picture´RI*6.¶VSDWHQWSRUWIROLRWith respect to innovation, patent assets are seen as 
a clear signal of a FRPSDQ\¶VFRPSHWLWLYHQHVVDQGPRUHWUDQVSDUHQF\Ls this area would be 
welcome.  Indeed, reports suggest that GSK is undervalued.611   
 
Key researchHUVWHDPV	LQYHQWRU¶VULJKWV 
 GSK does not present any information about the expertise and performance of key 
prolific and influential R&D employees and/or those named as inventors in GSK patents.  
The IC of this important group of GSK staff does not feature.  The role of key R&D 
personnel is critical not only to innovation but they may also act as witnesses in patent 
                                                 
610
 Search carried out on 11 February 2014. 
611
 Supra [603] 
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litigation.  $ULVNWR*6.¶VILQDQFLDOUHVXOWVLVSRWHQWLDOO\WKDWSHUVRQQHOQDPHGDVLQYHQWRUV
or co-inventors may be entitled to compensation under s.40 PA 1977 (as amended) if the 
SDWHQWZDVRI³RXWVWDQGLQJEHQHILW´ to GSK (the employer).  In Kelly & Chiu v GE 
Healthcare Ltd612 two employee medical researcher/inventors were awarded µ´DLUVKDUH´ 
compensation, QDPHO\DFRPELQHGDPRXQWRIRI*(¶VPLOOLRQGBP profit.  Whether 
or not this type of issue LVDUHSRUWDEOH³SULQFLSDO´ risk warranting disclosure is an issue for 
*6.¶VBoard.  In the UK post-Kelly, the Board may also need to consider whether and how it 
should implement an appropriate inventor compensation scheme.  
 
6.2.12 *6.¶V patent value story 
 As a listed company, GSK¶VSDWHQWGLVFORVXUHLVH[WHQVLYH when compared to other 
companies.  However, one must comb through the entire 2012 Annual Report in order to 
collate patent-related information.  The ³patent value story´ is not assembled into one section 
for ease of reference, largely because GSK follows the Business Review structure and must 
report on a myriad of matters in addition to patent information, thus the structure could be 
improved in this regard.    
 In several instances detailed patent information e.g. expiry and litigation is presented 
in simple tables that arrange patent information in rows and columns with a prominent header 
row and typically using a wide format (as opposed to a narrow format).  As a communication 
tool a table enables a form of generalisation of patent information whilst providing a familiar 
way to communicate data.  GSK does not appear to use any other visuals to illustrate or 
disclose its patent information. 
 Although the Index to the Report lists IP, one suggestion is to simply include a 
³3DWHQW,QIRUPDWLRQ´ heading and reference to the relevant page numbers in which 
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 [2009] EWHC 191 (Pat) 
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disclosures occur.  Another suggHVWLRQLVWRKDYHDVWDQGDORQH³3DWHQW,QIRUPDWLRQ´ section in 
WKH³,QYHVWRU,QIRUPDWLRQ´ part of the report.     
 From a corporate governance point of view, more narrative information is needed on 
the effect of patent expiry on GSK and what the company is doing to escape the patent cliff 
and potential declining revenue.  This is needed to assess the current Board of Directors 
stewardship of its patent assets and strategy.  The new Strategic Report should enable GSK 
and other patent-owning firms to present their business models, strategy and objectives, 
principle risks and future outlook reliant, less generally and more completely, together with a 
higher degree of detailed patent information.   
 
6.3 Corporate disclosure: Evaluating the findings of the Banking on IP? Report and 
 the Final Report from the Expert Group on Intellectual Property Valuation  
 
 The Banking on IP? report only briefly touches on corporate disclosure of IP or 
patents under the CA 2006 VWDWLQJ³Calculation of estimates [of value] for micro, SMEs is 
further complicated by the ILOLQJRIDEEUHYLDWHGDFFRXQWV´.613  This point is not developed 
further in the remainder of the report.  Recommendation 5 does however suggest a more 
transparent marketplace will transform IP and intangibles as an asset class.   
 The EC IP Valuation Report published in March 2014614 takes up the point of 
corporate narrative reporting more diUHFWO\LQVHFWLRQµ3RVVLELOLWLHVIRUFRPSOHPHQWDry 
UHSRUWLQJRI,3DQG,35V¶It suggests that disclosure might include: 
 
  Examples of useful information on IP/IPRs can be the number of patents, the 
description and the number of patents actively employed in firm activities, the time to 
                                                 
613
 Supra Banking on IP? [18] p25 
614
 The March 2014 IP Valuation Report does not reference the 2013 Banking on IP? Report or refer to it in the 
bibliography.  
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expiration for the major IPRs, the description and number of patent submissions and 
the associated degree of success and the like.  Sometimes non-financial indicators are 
mixed with financial data to create new insightful information.  Examples of such 
indicators for the IPO/IPRs and research area are sales per patent (or family of 
patents) or revenue from the products/services introduced from R&D in the last 3-5 
years.615   
 
 The IP Valuation report also acknowledges the poor situation as to the recognition, 
measures and disclosure of IP and concludes that the present reporting and information 
frameworks are in urgent need of updating 616 that WKHILOLQJRID³PDQDJHPHQWUHSRUW´, 
detailing IP and IP value in addition to financial statements is recommended.617  The Expert 
Panel proposes: 
 
 «WKHLQWURGXFWLRQRIDQDGGLWLRQDO,3UHSRUWLQJVHFWLRQLQ corporate information and 
data aERXW,3DQG,35VDVDVHFWLRQRIDFRPSDQ\¶VILQDQFLDOVWDWHPHQW7KH
enrichment of the management report by more information about IP and/or a separate 
VWDWHPHQWDERXW,3DUHRWKHUSRVVLEOHDFWLRQV«<HWZHQHHGWRFRQVLGHUWKHIDFWWKDW
small companies (small in terms of Article 3 paragraph 2 of the EU Accounting 
Directive) are not required to publish a Management Report.  However it could be 
seen as a first move in the right direction for collecting more and better information 
about IP/IPR in Europe.618   
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 Supra IP Valuation Report [20] p41 
616
 Ibid, p44 
617
 Supra IP Valuation Report [20] pp45 and 65 
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 Supra IP Valuation Report [20] pp65-66 
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 These conclusions and recommendations directly support the approach taken in this 
thesis with respect to innovating SMEs - disclosure of their patent information and strategy is 
recommended to supplement the traditional financial statements.  The Expert Panel has not, 
however, fully considered in detail how companies, especially SMEs who are typically 
exempt from corporate narrative reporting, should make such disclosure.  This thesis further 
develops and advances these precise issues with respect to UK SMEs and the UK patent 
ecosystem.  Chapter 7 considers whether such disclosure should be legally mandatory or 
voluntary.  
 
6.4 Conclusion 
 The corporate financial reporting space has been dominated by a focus on a 
FRPSDQ\¶VWDQJLEOHDVVHWVWRVXFKDQH[WHQWWKDWHTXLW\LQYHVWRUVIRFXVRQDVLQJOHPHWULF± 
the ³earnings-per-share´ number.  The narrow and incomplete focus on short-term financial 
performance is only of interest to short-term equity investors who focus on the regulatory 
disclosure requirements for shareholders, as opposed to the type of information of interest to 
other stakeholders such as financiers and lenders.  There is a new and more holistic view, as 
well as an unmistakable movement for companies to disclose IP and patent information, that 
escapes the accounting lens, but can be captured by the corporate governance lens.  This is 
why company law should take the lead to provLGHD³WUXHDQGIDLU´ view of DFRPSDQ\¶V
internally generated patent assets.  
 Relatively little research has been done in the field of narrative corporate reporting 
and specifically, patent information and strategy disclosure.  There is a great demand for 
high-quality interpretative research which is able to build knowledge from observation of 
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phenomenon within a contextually rich environment.619  The GSK case study considered the 
FRQWHQWDQGVWUXFWXUH*6.¶VGLVFORVXUe of patent information in its 2012 annual report and 
was designed as an inductive qualitative research to provide insight into corporate narrative 
reporting practice.  ,WGRHVQRWHQWDLODFODLPIRU³DSSOLFDELOLW\´WKDWZRXOGZDUUDQWFRXUWVWR
apply the results directly in litigation. 620  GSK was selected to enable us to analyse a high 
level of patent information disclosure in terms of breadth, depth and scope.  $V*6.¶VSDWHQW
information disclosure is thought to be of a very high standard, given the FRPSDQ\¶VDFFHVVWR
best expert advice in preparing its annual report, it provides us with some knowledge as to 
best practice in terms of disclosure in the UK typical in the pharma sector.  Relevant aspects 
*6.¶VSDWHQWLQIRUPDWLRQGLVFORVXUHFRXOGEHHPXOated by innovating SMEs on a voluntary 
corporate reporting basis, dependant on the cost to produce such information as discussed in 
Chapter 5.  The case study found that GSK disclosed the following types of patent 
information in narrative form: 
 
x generalised patent information contextualised to signpost the value of patent 
protection and patent monopolies to the pharmaceutical business; 
x a summary of how the Internal Rate of Return on R&D investment is calculated; 
x NH\ULVNVDULVLQJLQFRQQHFWLRQZLWK*6.¶VSDtent rights: 
(i) securing and protection patent rights;  
(ii) patent life (duration and expiration of the legal monopoly) 
(iii) challenges to the validity of granted patents and legal proceedings;  
(iv) patent enforcement activities; 
(v) competition from generic medicine manufacturers; 
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 6FKHOO&µ7KH9DOXHRIWKH&DVH6WXG\DVD5HVHDUFK6WUDWHJ\¶Manchester Business School p14 at 
http://www.finance-mba.com/Case%20Method.pdf 
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 +ZDLGL0µ:K\DQG+RZ(PSLULFDO6WXG\LQ&RPPHUFLDO/DZ"¶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Study Association at Robert Gordon University, p3. 
268 
 
(vi) confidential information; and 
x patent management information including its GPg. 
 
 As a form of research, the case study is skill-intensive on the part of the researcher, 
and unparalleled for its ability to consider a single research question within an environment 
rich with contextual variables.621  The GSK 2012 Annual Report case study serves as 
exploratory research, but the scope for application of the evidence-based patent information 
disclosures is much greater as the findings are transferable to innovating SMEs and other 
corporates.  This research helps provides a new understanding of how narrative corporate 
disclosure of certain types of patent information may increase transparency and reduce 
asymmetric information regarding the financial accounting metric currently used to value key 
corporate patent assets and investment in R&D.  The knowledge gained from the exploratory 
case study and other literature in earlier chapters will be applied in Chapter 7, where such 
knowledge is comprehensively used as the foundation for constructing a streamlined (or 
simplified) patent information disclosure model for innovating UK SMEs.    
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7 Voluntary corporate narrative IP information and strategy disclosure  
 
 
7KHFRPPRQZLVGRPLVWKDW³\RXPDQDJHZKDW\RXPHDVXUH´7KHFRUROODU\LVRIFRXUVH
³RXWRIsight, RXWRIPLQG´ 
 
      Mr W. Richard Frederick, 
      Principal Administrator, Organization of  
      Economic Cooperation and Development  
      (OECD) 
 
Introduction 
 
 In Chapter 2 we saw that the patent ecosystem, both globally and in the UK, has 
undergone important changes in the past few years.  Changes have been set in motion by the 
advent of ever-increasing technological innovation, resulting in more granted patents and the 
ensuing economic value attributed to intangible corporate assets which remain largely hidden 
in traditional accounting statement formats.  Applying for and being granted patents 
positively affects perceptions of innovating SMEs and improves valuation estimates in early 
financing rounds (the more patents owned, the higher the likelihood of attracting finance).622  
Large publicly listed firms are also shedding some light via patent information disclosure in 
their statutory corporate narrative reports.  Chapter 6 presented a case study involving 
GlaxoSmithKline (GSK), a global firm with a sizeable patent portfolio,  that critically 
analysed the nature and content of the narrative patent information disclosures made in the 
FRPSDQ\¶V2012 annual report.  The goal of this Chapter is to build on the narrative content 
and style of the Danish and German ICS method and drafting mechanics, the GSK patent 
information disclosure, and other relevant literature, to derive a new bespoke model and 
specific guidance for innovating SMEs as to the type of patent information they may wish to 
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voluntaril\UHSRUWLQWKH6WUDWHJLF5HSRUWRIFRPSDQ\¶VDQQXDOUHWXUQ623  The thesis put 
forward that disclosing narrative qualitative (non-financial) patent information ensures that 
the value of the innovating 60(¶VSDWHQWSRUWIROLRLVQHLWKHU³RXWVLJKW´QRU³RXWRIPLQG´ 
and this will assist stakeholders such as lenders to identify patent assets and link them to the 
value and growth of the business.  However, as explained in Chapter 5, if a company is 
entitled to rely on the small companies exemption, delivery of a Directors¶ Report to 
Companies House is optional.624  In many private SMEs, the only member is a sole 
director625 and to date, from a corporate governance perspective, it has been seen as a 
completely unnecessary administrative burden to require such directors to prepare a 
Directors¶ Report for themselves which no one else sees.  As we also know, from an 
innovation perspective, a significant problem for both  investors and financiers is that patent 
assets lack transparency LQWKHFRPSDQ\¶VDQQXDODFFRXQWVDQGZLWKRXWUHOHYDQWXVHIXO
information finance decisions falter.  On a positive note, according to Frederick:  
 
 There appears to be a trend to report beyond the limits of what traditional accounting 
 standards require, and include a broader set of important value drivers. The question 
 has moved from whether this information is important and whether it needs to be 
 reported, to how to best report it.626 
 
 In the modern patent ecosystem, the need for increased voluntary disclosure of patent 
information by SMEs is acute.  What is less clear is how and what patent information 
                                                 
623
 Once every year, every company must deliver a return to Companies House containing relevant information 
DERXWOHJDOO\PDQGDWHGIHDWXUHVRIWKHFRPSDQ\¶VDIIDLUV: s854(1) CA 2006. Refer also Chapters 5 & 6. See also 
supra [478] 
624
 Sections 444(1) and 444(a) CA 2006.  See also supra [478].  
625
 7KH³RQH-PDQ´FRPSDQ\$OWHUQDWLYHO\WKHVROHPHPEHURIWKHFRPSDQ\PD\EHthe nominee of the 
director. 
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 )UHGHULFN:5µ5HFHQW'HYHORSPHQWVLQIC 5HSRUWLQJDQGWKHLU3ROLF\,PSOLFDWLRQV¶OECD 
Education Working Papers, No. 17, OCED Publishing. This paper touches on the UK Operating and Business 
Review on pp32-36 and predates the new Strategic Review. 
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innovating SMEs should voluntarily disclose.  Chapter 7 examines how to uniformly, 
succinctly and cost-efficiently disclose relevant patent information and strategy that has been 
subject to director-level review.  This requires the development of a conceptual framework 
leading to a new model for voluntary patent information reporting.  
 Section 7.1 summarises the views on solving the intangibles reporting problem 
DGGUHVVHGLQHDUOLHUFKDSWHUVDQGVHWVRXWWKHUDWLRQDOHIRUWKHDXWKRU¶VSUHIHUUHGDSSURDFK
Arguments are made in favour of voluntary patent information and strategy disclosure as 
opposed to mandatory disclosure.   
 Section 7.2 presents an original user-friendly Essential, Desirable & Optional Patent 
Information and Strategy model, the foundation for a coherent shape for SMEs to voluntarily 
UHSRUWWKH³SDWHQWDVVHWYDOXHVWRU\´in narrative form in the Strategic Report using key 
qualitative (non-financial) patent information indicators.  7KHQHZ³EXVLQHVVWULDJHVW\OH´627 
three-tier model is compared and contrasted with the Danish and German ICS models, the 
GSK patent disclosures and other literature.  
 Section 7.3 considers potential criticism of enhanced voluntary patent information 
disclosures by innovating SMEs.     
 Finally, while the new disclosure model is a starting point, it begs the question:  How 
should patent information and strategy disclosure be facilitated?  In section 7.4 we identify 
the relevant stakeholders that need to be involved in assisting and advising innovating SMEs 
to prepare their corporate narrative disclosures.   
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 Using the same triage categories employed by military medical and disaster medical services, business 
processes are categorized as essential/critical (red) important/urgent (yellow), or optional/supportive (green). 
6HH=LFK-µ%XVLQHVV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7ULDJHIRU7U\LQJ7LPHV¶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7.1 Views on solving the intangibles reporting problem 
 
       
 This thesis has explored the three approaches to solving the hidden intangibles and 
corporate reporting problem which are summarised below. 
 
7.1.1 Overhauling the fundamental accounting treatment of intangibles  
 Chapter 4 argued that it is necessary to implement fundamental changes to the 
traditional accounting system to address the shortcomings of IAS 38 Intangibles.  In short, 
traditional financial statements do not reveal what drives patent value due to the requirements 
of IAS 38 accounting standard for intangibles. This approach situates the problem and the 
solution within the domain of traditional financial reporting, and specifically, as a task for the 
accounting and valuing professions.  However, we have seen in Chapters 4 and 5 that reform 
of IAS 38 Intangibles is unlikely to take place in the short-to-medium term due to the need 
for a regulated patent market to provide accountants with historical transaction financial data.  
 
7.1.2 Supplemental reporting outside of the existing accounting framework via the 
 ICS or other reporting formats 
 The second approach holds that fundamentally changing the IAS 38 accounting 
standard is not feasible or desirable.  It is undesirable because the existing system of 
accounting and financial reporting functions with relative certainty internationally.  It 
provides a certain group of users with adequate information.  As a result, this view holds that 
an entirely new form of corporate reporting is needed, designed specifically for the needs of 
new/other users and should be separate from traditional accounts.628  As discussed in Chapter 
5, new forms of reporting are emerging such as the ICS, a separate management report, which 
covers a broader range of intangibles and IC than patent information and strategy.  In relation 
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to patent-backed lending, since 2010, five Hong Kong banks629  have offered more 
favourable financial and/or service privileges to successful business loan applicants who have 
voluntarily prepared their own ICS.630  The Hong Kong IP Department (HKIPD) worked 
closely with the banks to facilitate this.  HKIPD have also produced a helpful Guide to IC 
Management.631  
 
 
7.1.3 Better disclosure via the existing corporate reporting framework 
 
 Alternatively, the third approach recommends that accounting standards for intangible 
assets should be supplemented through the narrative disclosure of better and more detailed 
information.  This additional information can appear in traditional financial statements as 
notes to the accounts, or, as recommended in this thesis, in existing corporate annual 
narrative reporting.  Additional qualitative disclosures concerning intangible assets would 
have to comply with existing corporate reporting regulations thus, the limitations of IAS 38 
are overcome within the traditional financial statements and corporate reports.  However, the 
question is: what type of disclosure and where?  In 2013, Frey recommended the introduction 
RIDQHZW\SHRI³*URZWK5HSRUW´.632  In same year, the UKIPO¶VBanking on IP? Report 
confirmed that the level of awareness of IP by lenders is low and that IP needs to become 
more visible in public accounts.633  Although this report did not make any specific 
recommendation regarding supplementary narrative reports, it recommended that IP and 
intangibles must be identified during the financing process.  How can lenders do this easily 
and efficiently?  In 2014, the Final Report from the Expert Group on IP Valuation 
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 Bank of China (Hong Kong) Limited, Chon Hing Bank Limited, Citi Commercial Bank, Hang Seng Bank 
Limited and the Bank of East Asia.   
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 µ+RQJ.RQJ%DQNVVLJQXSWRJURXQG-breaking IC LQLWLDWLYH¶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633
 Supra Banking on IP [18] p15 
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recommended supplementary reporting of non-financial information on IP.  The group 
recommended tKDWFRPSDQLHVILOHDPDQGDWRU\³PDQDJHPHQW,3UHSRUW´ detailing IP and IP 
value.634  The author contacted Jackie Maguire, a UK representative of the EC Expert Group 
via LinkedIn, to elucidate the decision to recommend mandatory over voluntary corporate 
reporting.  She advised that a mandatory vs voluntary corporate reporting obligation was: 
 
 ³«DVXEWOHSRLQWEXWFRPSDQLHV have a tendency to follow the hard rules when it 
comes to financial reporting and do little more than is necessary.  For instance, there 
is nothing stopping PLCs from making an IP statement in their annual report now ± 
however very few do!  We wanted to see a step change in encouraging companies to 
think regularly about their intangible assets and the value that they provide for their 
business.´635   
 
 The author of this thesis is not convinFHGWKDWWKHSRLQWLVPHUHO\D³VXEWOHRQH´for 
important corporate law reasons that shall be more fully explored in the next section.  
8QIRUWXQDWHO\WKH([SHUW*URXS¶VUHSRUWGRHVQRWDUWLFXODWHDQ\IXUWKHUFRQVLGHUDWLRQRIWKH
dilemma between voluntary or mandatory reporting from a company law or corporate 
governance perspective.   
  In any event, all three approaches are being advanced.  Imperative changes are 
occurring in the accounting field in the treatment of certain intangibles, namely, the financial 
valuation of trademarks via the adoption of the new ISO 10668 Monetary Brand Valuation.636 
An ISO standard for patent valuation does not yet exist.  In summary, while there is a 
                                                 
634
 Supra IP Valuation Report [20] p45 
635http://www.linkedin.com/groups?gid=2991669&goback=%2Ebzo_*1_*1_*1_*1_*1_*1_*1_intipsa&trk=rr_
grp_name  
636
 International Organization for Standardization released ISO 10668 in 2010 setting out principles to be used 
when valuing a brand and may be used for the purpose of corporate finance and fundraising.  ISO 10668 
requires three types of analysis before arriving at a valuation:  legal, behavioural and financial.   
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convergence to a line of thinking that more information on patents, IP and intangibles is 
generally warranted, there is not yet a consensus as to how and where to report such 
information and whether reporting should be voluntary or mandatory.  This thesis argued in 
Chapters 5 and 6 that the appropriate method for supplementary patent and strategy 
information LVYLDWKHFRPSDQ\¶VDQQXDOFRUSRUDWHnarrative reporting.  As part of their 
lending policy,  more favourable financial and/or service privileges were offered to 
innovating SMES who voluntarily prepare and file their own Strategic Report for example, 
then this is a pragmatic win-win situation.  Lenders  would have access to important non-
financial information to help them to identify solid borrowers that in theory, should meet 
legal corporate reporting standards. The next section advances further legal arguments as to 
why disclosure of patent information and strategy should remain voluntary in the UK.   
 
7.1.4 Voluntary or mandatory disclosure and GLUHFWRUV¶OLDELOLW\DWUXHDQGIDLUYLHZ 
 
 Making IP reporting mandatory is equivalent to requiring accountability.  This is a 
difficult issue, politically as much as technically. 7KHDXWKRU¶VYLHZLVWKDWLWLVSUHPDWXUH
to impose a legal duty on company directors to report on IP and strategy without providing 
them with more detailed guidance on how to do so appropriately.  This is due to the severe 
legal consequences under the CA 2006 for failure to report ³IDLUO\´ so as not to mislead.637  
7KH³WUXHDQGIDLU´ view concept remains pivotal in the corporate reporting of accounting 
information and central to accounting practice.638  As such, any narrative patent information 
disclosed as part RIDFRPSDQ\¶VDQQXDOcorporate reporting will need to be verifiable and 
capable of substantiation to ensure the information disclosed is not false or misleading.  This 
                                                 
637Under s414A a person is guilty of a criminal offence and liable for a fine of up to £5000 for failure to comply 
with the legal requirement to prepare a strategic report or to take all reasonable steps for securing compliance 
with the requirement. CA 6WUDWHJLF5HSRUWDQG'LUHFWRUV¶5HSRUW5HJXODWLRQV1R   
638
 Parker, R. H. and Nobes, C. An International View of True and Fair Accounting (International Accounting) 
(1994) Cengage Learning EMEA 
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is the price companies pay in return for the benefits of separate corporate personality and 
especially, limited liability.639     
 Equally, disclosing patent information and strategy, whether voluntarily or mandated 
within the legal framework of the CA 2006, substantially increases its legitimacy and 
authority.640  This is so because s463 CA 2006 sets out a strong statement of the liability of 
company directors who make false and misleading statements in their corporate reports.  A 
director is liable to compensate the company for any loss it suffers as a result of:  
 
(a) any untrue or misleading statement; or  
(b) the omission of anything legislatively required to be included in it.641      
 
 This provision may worry inexperienced directors, however crucially to reassure 
them, there is a safe harbour.642  A director will only be liable under s 463 if he knew that the 
statement was untrue or misleading, or was reckless as to whether it was untrue or 
misleading, or knew the omission was a dishonest concealment of material fact: s463(3).    
The safe harbour provisions were included in the CA 2006 as the government felt that too 
strict a liability would encourage directors to make heavily qualified statements in their 
narrative reports which would reduce their usefulness.  Therefore directors¶OLDELOLW\ is limited 
to the company itself and does not extend to shareholders, investors or other third parties such 
as lenders.  This does not affect any civil penalty or criminal liability, but should reassure 
company directors as their exposure is limited and in particular, negligence claims cannot be 
brought against them. 
                                                 
639
 Mason, S. French, D. and Ryan C. Company Law (2013-2014) Oxford University Press, p108 
640
 If the report was prepared under the small companies  regime, that fact must be stated in a prominent position 
DERYHWKHGLUHFWRUV¶VLJQDWXUH s419(2) CA 2006 
641
 Section 463(2) CA 2006 
642
 A safe harbour is a legal provision of a statute to reduce or eliminate liability in respect of certain conduct as 
long as one, in this case the company director, is able to demonstrate good faith.  
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 Thus a combination of factors has hindered company directors (even in large, well- 
resourced companies) from adequately reporting on their intangible assets, especially patents, 
in their narrative corporate reports: (1) the hidden value of intangibles in traditional financial 
statements; (2) coupled with a lack of corporate leadership to identify and manage intangibles 
internally, (3) together with the knowledge if and how to report. 
 Corporate reporting standards enhance the quality and reliability of the information 
presented because directors need to be satisfied that their reports show a ³true and fair´ view.  
Thus bearing in mind consequences of non-compliance with s463 CA2006, an innovating 
SME company director must make an informed decision as to whether or not to voluntarily 
disclose patent information and strategy.  Directors will have to carefully consider the 
benefits of disclosure, balanced against the risks, costs and administrative burden of doing so.  
For these reasons, the author holds the view that IP, or specifically patent information and 
strategy disclosure, should be voluntary ± to be decided on a case-by-case basis by directors 
who are in a position to evaluate the compan\¶VVSHFLILFFLUFXPVWDQFHVLWVsize, complexity, 
the nature of the risks and challenges it faces, coupled with the human and financial resources 
available for making disclosure that meets the legal standard required by the CA 2006.    
 After systematically considering and comparing the benefits and costs of preparing 
patent disclosure, the director should consider whether doing so would promote the success 
of the company under s172 CA 2006.  If the answer to this question is in the affirmative, the 
director(s) may determine to optionally file a Strategic Report (from which they are otherwise 
exempt).  In other words, the need to obtain finance may justify the voluntary disclosure.  
Moreover, LIWKHFRPSDQ\¶VGLUHFWRUVHOHFWWRGLVFORVHWKHEHQHILWs to the innovating SME 
firm are twofold:  
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(1) disclosure will improve corporate governance with respect to the transparency of the 
GLUHFWRUV¶VWHZDUGVKLSRIYDOXDEOHSDWHQWDVVHWV; and 
(2) disclosure raises awareness of the availability of those assets as potential security in 
debt finance transactions as well as to potential equity investors and others who may 
become interested in the innovating 60(¶VEXVLQHVV 
 
 In Chapter 3 we saw that lenders typically require copies of a FRUSRUDWHERUURZHU¶V 
annual returns when appraising commercial loan applications.  The availability patent 
information and strategyGHVLJQHGWRPHHWWKH³WUXHDQGIDLU´ standard, would be helpful for 
commercial lenders who evaluate the innovating SME as a potential borrower using both 
quantitative (traditional accounting statements) and qualitative (narrative corporate reports) 
measures, assisting them to triangulate intangibles financial data through cross verification 
with corporate narrative disclosure 
 To educate and promote voluntary disclosure should EHWKHILUVW³VWHSFKDQJH´ in 
encouraging companies to think regularly about their patent assets and the value they provide 
to the business.  The first tier of the original model is introduced below. 
 
7.2 A new model to voluntarily communicate patent information and strategy  
 
 
 The original Essential, Desirable & Optional Patent Information and Strategy 
corporate narrative model has been devised as a new bespoke model to facilitate disclosure 
by innovating SMEs.  It builds on the narrative content and style of the Danish and German 
ICS method and draws on the GSK patent information disclosure, and other relevant 
literature, as a foundation DGRSWLQJ³EXVLQHVVWULDJHVW\OH´approach to provide innovating 
SMEs with specific guidance as to the type of patent information they may wish to 
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voluntarily report in the Strategic Report of the FRPSDQ\¶VDQQXDOUHWXUQ.  To begin, at the 
early stage of the innovating SME patent innovation lifecycle, a firm is trying to achieve 
several things, including to:  
 
x HQVXUHWKDW5	'VWDIIKDYH³IUHHGRPWRRSHUDWH´643 
x generate quality patents for their portfolio; 
x ensure that their core business is adequately protected; and 
x initiate managerial processes to facilitate patent generation, maintenance monitoring 
competition and enforcing patents. 
 
 Non-financial qualitative patent information value indicators address the relevance of 
patents to the 60(¶Vbusiness largely by determining the overall context and strategy of the 
patent portfolio.  These factors, RU³YDOXHLQGLFDWRUV´, may influence the value of the patent(s) 
both positively and negatively.  Similarly, by way of analogy, consider the example of a retail 
shop on any UK high street.  Factors such as location, frontage, size and retail traffic etc. 
affect the financial value of a building used as a retail shop.  But what of the threat of online 
shopping?  How does this impact on the valuation of the shop?  It may not ± it probably 
affects the value of the business carried out in the shop, but the effect of the online shopping 
may have little effect on the freehold value.  
  In the same way, the combination of patent-related qualitative factors determines the 
value of the patent portfolio and needs to be undertaken before contemplating mathematical 
or financial valuation, which is why the Strategic Report needs to highlight and evaluate the 
patent assets.  Patent protection will provide a business with multiple qualitative patent value 
                                                 
643
 5HLOO\5)µ$WWULEXWHV7KDW,QIOXHQFH,39DOXH¶6SULQJForensic Analysis Insights, p3 
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indicators that directly and indirectly relate to cash flow, information directly relevant to 
lenders, as illustrated in Figure 33 below.    
 
Figure 33 Patent information value indicators and cash flow 
DIRECTLY related to cash flow INDIRECTLY related to cash flow 
Earn licence revenue Protect new and improved features of products and 
services 
Earn sale revenue on legal transfer of the patent Exclusivity in the relevant market 
 Freedom to operate in the relevant market 
Ability to block product(s) of competitors 
Bargaining tool in cross-licensing deals or strengthen 
negotiation position 
Provide a defence in the event of legal patent 
infringement proceedings  
Prevent legal patent infringement proceedings  
Prevent copying of the product  
Enhance the ILUPV¶UHSXWDWLRQ in the field 
Source:  Sykes, J and King, K. Valuation and Exploitation of Intellectual Property and Intangible Assets (2002)   
 
 Narrative qualitative patent information aims to capture more of the value that 
indirectly contributes to cash flow, as illustrated in the right-hand column above.  The starting 
point is the relevant patent specifications.644  Internal management should evaluate the 
portfolio to categorise, rank and compare the individual patents or vis-à-vis comSHWLWRUV¶
portfolios, assessing the risks and opportunities created by the portfolio to formulate and 
                                                 
644
 This is a written description of tKHLQYHQWLRQZLWKGUDZLQJVDQG³FODLPV´7KH³DEVWUDFW´summarises the 
patent specification. Most successful patent applications have detailed descriptions in the specification that are 
several pages long, describe different versions of the invention and refer to a set of drawings showing these 
different versions. The exact style and content varies according to the subject matter. For instance, complicated 
machinery, electronic equipment and chemical processes need many more pages of description and drawings 
WKDQDVWUDLJKWIRUZDUGLWHPZLWKIHZSDUWV6HHWKH8.,32¶VPatent Applications Guide at: 
http://www.ipo.gov.uk/p-apply.pdf  
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document strategy to maximise the future value creation.  This is commonly known in the 
management discipline as a SWOT analysis.645   
 
7.2.1 Formulating and documenting patent information and strategy 
 Making a corporate disclosure, regardless of the format, forces a company to 
formulate and document its patent information.  This is an important step for an innovating 
SME as the process KDUQHVVHVWKH³SRZHURIIRFXV´ that can lead to critical management 
decisions in the short, medium and long-term.  For example, documenting patent strategy 
assists firms to focus on filing patents in the most important areas, or drop or license 
innovative projects in more marginal areas so that the quality of work in its core area of 
business increases.     
 )URPWKHOHQGHU¶VSRLQWRIYLHZWKHfirst step in the qualitative appraisal for security 
(collateral) purposes is to identify, define and describe the patent portfolio. This is akin to 
FDUU\LQJRXW³SDWHQWGXHGLOLJHQFH´Dprocess that primarily assesses three essential 
attributes: (1) the legal monopoly rights exist; the patent is properly registered and is still in 
force and; the remaining life of the patent; (2) that good legal title (ownership) of the patent 
can be established; and (3) the patent rights can be enforced to prevent third parties from 
using the invention without permission (thus generating revenues) in order to sustain cash 
flows derived from using or licensing the patent.  These attributes relate directly to the 
financial potential the patent(s) for the innovating SME.  However, qualitative patent 
appraisal by a lender for security purposes takes the assessment beyond standard legal due 
diligence by analysing additional information inputs.  This is necessary because the lender (a 
                                                 
645
 +XPSKUH\$µ6:27$QDO\VLVIRU0DQDJHPHQW&RQVXOWLQJ¶'HFHPEHUSRI Alumni Newsletter 
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future creditor) essentially wants to know the future sale value of the patent(s) should a 
default occur.  Qualitative patent appraisal assists with the latter objective.646   
   
7.2.2 Devising the Three-Tier model  
 A model is a simplification of the chosen part of reality that helps us to master a large 
and complex system, which cannot be easily understood in its entirety.  A model is intended 
to be easier to use for certain purposes than the complete system observed.  One of the main 
issues considered before devising the original Three Tier patent disclosure model was how it 
would fit into the existing legal corporate reporting framework, taking into account the 
guidance and consensus with respect to corporate governance and reporting contained in the 
UK Corporate Governance Code published by the FRC to facilitate effective, entrepreneurial 
and prudent management that can deliver the long-term success of a company.647  The Code 
is not a rigid set of rules rather it consists of principles of good disclosure as follows: 
 
x Leadership (Section A);  
x Effectiveness (Section B);  
x Accountability (Section C);  
x Remunerations (Section D); and  
x Relations with shareholders (Section E).   
 
                                                 
646
 In insolvency situations, ownership of the patent portfolio may pass to the lender under the terms of the loan 
agreement.  A company has a separate legal entity from those who run it (directors), those who work for it 
(employees) and those who own it (shareholders).  The lender should bear in mind these potential buyers for the 
SDWHQWSRUWIROLRLQDGGLWLRQWRFRPSHWLWRUVDQGRWKHUV\QHUJLVWLFILUPVZKHQDSSUDLVLQJWKH60(¶VORDQ
application.  Directors, key employees and shareholders may have substantial personal assets enabling them to 
acquire the patent portfolio if the event the innovating SME defaults on the loan, considerably reducing the risk 
of making a patent-backed loan.   
647
 September (2012) and applies to the reporting periods beginning on 1 October 2012 at 
https://www.frc.org.uk/Our-Work/Publications/Corporate-Governance/UK-Corporate-Governance-Code-
September-2012.pdf, p1.  
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 The standards of good practice with respect to corporate narrative disclosure apply to 
listed companies648 and are based on the underlying principles of good corporate governance:  
accountability, transparency, probity and focus on the sustainable success of an entity over 
the longer term.649  For the sake of simplicity and to reduce the administrative burden on 
innovating SMEs, the proposed model is envisaged to operate within the existing company 
law reporting regime with the principles espoused in sections A ± C of the Code.650 
 The first tier,  Essential Voluntary Patent Information and Strategy Disclosure Model 
(the Essential model), is designed WRDFWDVD³PHWDVWDQGDUG´ which succinctly identifies the 
specific patent-related information and strategy indicators to be disclosed in the Strategic 
Report in a simple ten step process.  The Essential model draws on the Danish and German 
ICS question method and intentionally avoids detailed methodological work steps and 
requirements.  However, in contrast to the Danish ICS which is based on four types of 
knowledge resources, namely, employees, customers, process and technologies (see 5.5.1 
above) and German ICS Fitness Check comprising 11 questions followed by six steps for 
drafting an ICS (see 5.6 above), the Essential model is streamlined and tailored to facilitate 
patent information and strategy disclosure.  Neither the Danish nor the German ICS provide 
bespoke IP asset disclosure guidance.  The Essential and the comprehensive Essential, 
Desirable & Optional business triage style models address this gap.  
 The Essential model is conceptualised for use by any innovating SME regardless of 
industry sector and promotes uniformity and comparability.  It makes use of the existing UK 
company law reporting principles espoused in sections A ± C of the Corporate Governance 
Code relating to leadership, effectiveness and accountability and the views of the Financial 
Reporting Council (see 6.1 above and Figure 35 below).  In Chapter 6, we found that GSK 
did not make a stand-alone patent information and strategy disclosure in its 2012 Annual 
                                                 
648
 Disclosure and Transparency Rules promulgated by FSA pursuant to the FSMA 2000, p2 
649
 Ibid, p1 
650
 Supra [646] 
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Report,  rather narrative disclosures were embedded throughout the entire 252 page document 
DQGRQHKDGWRSLHFHWRJHWKHUWKH³SDWHQWYDOXHVWRU\´ (see 6.2).  In contrast, both the 
Essential and the Essential, Desirable & Optional models contemplate a stand-alone patent 
information and strategy section.  
 The Essential model acts as a starting point to initiate discussion on the formulation 
and documentation of voluntary patent information disclosure to raise awareness of the 
FRPSDQ\¶VKLGGHQintangible patent assets.   This model addresses the lack of patent and 
other information concerning intangibles arising as a result of the shortcomings of traditional 
financial accounting statements prepared in accordance with IAS 38 Intangibles.  It does so 
by providing a set of qualitative non-financial patent information indicators to make visible 
the invisible and concurrently assist directors of innovating SMEs comply with their duty 
under s172 CA 2006 in the spirit of the Code.  The qualitative patent indicators are informed 
by the GSK case study, other reports and literature and the narrative format is inspired by the 
ICS concept discussed in Chapter 5.  
 
7.2.3 Principle qualitative patent indicators for disclosure 
 A useful and reliable patent information disclosure needs to be firmly anchored in 
fundamental qualitative non-financial indicators, accepted and endorsed by the relevant 
stakeholders.  The first issue to be addressed is to signpost the existence of valuable patents 
and patent applications and their central role within WKH60(¶VEXVLQHVVVWUDWHJ\³WKHSDWHQW
YDOXHVWRU\´This is not the same as carrying out a patent due diligence exercise (however 
the disclosure will assist with patent due diligence when the need arises).  Innovating SMEs 
need to become effective at translating their research and inventions into profits.  Lenders 
have no legal authority to tell an innovating SME borrower what to do to commercialise its 
patented innovations.  An equity financier will have more say depending on their percentage 
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of equity and whether it holds a managerial role in the business.  Lenders, however, can only 
observe and evaluate the choices and outcomes made by the innovating SME.    
 
7.2.4  The Essential Disclosure Model 
 
 A Strategic Report, tailored to meet a UK innovating 60(¶VEXVLQHVVREMHFWLYHV
should provide the information necessary for lenders to assess an innovating 60(¶V 
 
(a) development, performance and position; 
(b) future prospects; 
(c) strategy for achieving its objectives; 
(d) business model; and 
(e) governance. 
 
 
 The following qualitative non-financial indicators are regarded by the author as 
essential for disclosure, on the basis they are PDWHULDOWRSURYLGLQJD³WUXHDQGIDLU´ view of 
the business.  These are the recommended minimum level of disclosure for companies with 
small patent portfolios if they are to provide relevant, useful and reliable information to 
lenders, investors and stakeholders.    
 Figure 34 depicts the first tier of the disclosure model.  The Essential model is not 
used to give a detailed description of all possible real or theoretically real pieces of patent 
information and strategy, instead, it illustrates essential types of information.  
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Figure 34   ESSENTIAL Disclosure Model 
 
   
1. The Patent Value Story ± the business model as the platform for structuring the ensuing disclosure 
 
2. The Patent Portfolio ± development, performance and position, growth opportunities and time frame 
 
3. The Patent Strategy - strategy for achieving set objectives 
 
4. IPR & Patent Management ± governance,  stewardship and leadership 
 
5. Patent licensing and agreements (if any) ± commercial relationships and responsibilities 
 
6. Cost to commercialise ± finance requirements and objectives 
 
7. Patent life of key patents ± freedom to operate and duration of monopoly advantage 
 
8. Principal risks and uncertainties associated with key patents ±financier and investor information 
 
9. Financial status of the patent asset ± currently or previously used as security for debt 
 
10. Annual comparison of key patent asset performance indicators ± track performance over time 
 
 
 One should not overlook the importance of simplicity in terms of the application of 
the model.  The model attempts to elaborate clearly and unambiguously the minimum 
essential patent information indicators to be voluntarily disclosed.  The information can be 
presented in a relatively short form, a two-to-three page narrative report in a streamlined, 
succinct narrative style.  Those who rely on the disclosure need to have confidence that 
LQIRUPDWLRQDERXWWKHSDWHQWDVVHWVGLVFORVHGLV³WUXHDQGIDLU´ as well as the consequences of 
any risks involved.  The disclosure should be made in a consistent and uniform format, 
contributing to certainty and objectivity.  Nonetheless, there will be wide variation in how 
companies choose to disclose certain patent information and strategy indicators pertaining to 
their business.  The Essential model headings provide a useful framework for the disclosure 
and permits a free-form approach to the narrative style to enhance flexibility.  The FRC 
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report entitled, Louder than Words, provides general principles with respect to effective 
communication in corporate narrative reporting.651  These are reproduced in Figure 35 below.  
 
 
Figure 35   Principles for effective communication in narrative corporate reporting 
 
 
Focused  
Highlight important messages, transactions and accounting 
policies and avoid distracting readers with immaterial 
clutter. 
 
Open & Honest 
Provide a balanced explanation of the results ± the good 
news and the bad. 
 
Clear & Understandable 
Use plain language, only well-defined technical terms, 
consistent terminology and an easy-to-follow structure.  
 
Interesting & Engaging 
Get the point across with a report that holds the readers¶ 
attention.  
 Source: Louder than Words Appendix D   
 
  
 At the election of the innovating SME, the Essential model can be further elaborated 
upon to provide more detailed and comprehensive patent information and strategy disclosure 
as the company grows and acquires more resources.  Figure 36 sets out the DXWKRU¶Voriginal 
three-tier Essential, Desirable & Optional Patent Information and Strategy Disclosure 
Model.  This comprehensive model includes additional qualitative patent indicators that flow 
directly from the Essential indicators.     
 
 
 
 
 
 
 
 
 
 
 
  
                                                 
651
 Louder than Words: Principles and actions for making corporate reports less complex and more relevant  
(June 2009) FRC 
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Figure 36   Essential, Desirable & Optional Patent Information and Strategy  
  THREE TIER Disclosure Model  
 
NARRATIVE 
DICLOSURE 
Essential 
Tier 1 
 
 
 
Desirable 
Tier 2 
(consider on a cost -
benefit basis) 
 
Optional 
Tier 3 
(if low in cost to 
collate and produce) 
 
 
1. 7KH³3DWHQW9DOXH
6WRU\´ 
 
-the business model 
 
 
 
Describe the most value-creating 
patents in the reporting year and 
how those patents have created 
such a value for the business. 
 
One paragraph setting out 
business model. 
 
 
Contextualise how patent assets 
impact business strategy and 
highlight the critical value of 
patent monopolies to the 
business as a whole. 
 
Technology complexities 
HVSHFLDOO\µGLVSODFHPHQW¶
technology) 
 
Technology Readiness Level 
 
Activities performed by the 
entity to maintain the value 
capacity.  
 
Sustainability of the business 
model and patent value. 
 
Internally generated patent 
assets 
 
Acquired patent assets 
 
Sale of patents 
 
Independent valuation or 
European Patent Office 
IPScore  
 
Internally estimated value of 
the patents (e.g. GSK 
Internal Rate of Return 
methodology) 
 
Depth of its patent portfolio 
(number of patents, patents 
per jurisdiction), patent 
families, the strength of 
particular patent pools. 
 
 
 
2. The Patent 
Portfolio 
 
-development, performance and 
position 
 
 
 
 
 
 
 
 
-growth opportunities 
Link patents granted or pending 
to key products  
 
&RQILUPµIUHHGRPWRRSHUDWH¶LQ
key countries or regions. Note 
any material blocking patents.  
 
Whether the patent assets are in 
the R&D process or in the 
product development cycle.  
 
Product characteristics 
 
Future economic benefits to be 
derived from the patent assets 
and estimated timeframe.  
 
Future outlook 
 
Patent pools Patent citations 
 
3. Patent Strategy 
 
-strategy for achieving its objectives  
 
Set out objectives for achieving 
invention commercialisation. 
 
 
Information about potential 
uses of the patent assets. 
 
Information about the markets 
in which the patent assets might 
be used. 
 
Investment in R&D  
 
Further development, R&D 
pipeline 
 
Abandoned patents  
 
Abandoned projects 
 
Research and innovation 
management strategy ± 
structure for optimally 
progressing research and 
debt or equity finance 
raised.  
Patent renewal management 
and strategy  
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4. IPR & Patent 
Management 
 
-governance 
Patent management policy to 
confirm corporate governance, 
stewardship and leadership  of 
Patent Assets 
 
Corporate group structure ±Is 
there a subsidiary company that 
owns the patent assets to isolate 
risk? 
 
Managerial responsibility for 
co-ordinating and managing the 
ILUP¶VSDWHQWVWUDWHJ\ 
 
Patent or IP related 
qualifications of Board of 
Directors (executive and non-
executive) 
 
Chief IP Officer (CIPO) or IP 
Management Team  
 
Professional  advisors ± patent 
attorneys, legal, accounting etc.  
 
Detailed patent portfolio 
management strategy  
 
Education and training 
 
Patent searching  
 
Staff briefings (eg 
obligations owed to 
employer in respect of IP) 
Staff newsletters 
Profile key inventors/ 
researchers 
 
Invention disclosure policy 
 
Employee incentives and 
reward schemes 
 
Awards and prizes to 
demonstrate peer 
recognition 
Staff publications  
 
Business premises located 
within a technology park or 
the like 
 
 
5. Patent licensing and 
agreements 
 
-commercial relationships and 
responsibilities 
Principal patent licence 
agreements   
(licence-in or licence-out) 
 
Exclusivity 
 
Product distribution agreements 
 
Patent pool licences 
 
Sales information relating to 
patented products (actual and 
predicted)  
 
Collaboration agreements  (eg 
with a university or technology 
institute)  
 
 
 
Market size  (existing and 
expected)  
 
Market share (existing and 
expected)  
 
Trademark and other 
marketing rights 
 
Know how 
 
 
6. Cost to 
commercialise 
 
-finance requirements and objectives 
Costs incurred to develop the 
patent assets. 
Estimated R&D costs, and 
development phases. 
 
Costs envisaged to complete 
commercialisation of the 
patented invention.  
 
Financial resources available to 
apply for an renew patents.  
 
 
Patent Box or other tax 
incentives or tax relief 
 
 
 
7. Patent life of key 
patents  
 
 
Expiration and duration of key 
legal patent monopolies 
 
 Discontinued patents 
 
Discontinued R&D projects 
 
 
8. Principal risks and 
uncertainties 
associated with key 
patents 
 
-investor and financier information 
 
Securing and protecting patent 
rights and confidential 
information 
 
Loss of patent monopoly rights 
either due to expiry or successful 
challenges to the validity of 
granted patents, patent 
revocation, patent lapse due to 
non-payment of renewal fee.  
 
Legal proceedings:  patent 
validity; patent enforcement;  
patent infringement litigation; 
EUHDFKRIFRQILGHQFHLQYHQWRU¶V
remuneration rights (actual and 
potential) 
 
Competitors and competitive 
Risk management processes 
 
Consequences of failure to 
secure freedom to operate. 
 
µ0LWLJDWLQJDFWLYLWLHV¶WKH
company takes to address the 
risks and uncertainties. 
 
Standard of patent protection 
and enforcement in relevant 
international jurisdictions 
outside the UK and EU.  
 
General contextual information 
about the industry 
 
Monitoring the competition for 
patent infringement 
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landscape (products, competition 
and patents), availability of 
product substitutes. 
 
0RQLWRULQJFRPSHWLWRU¶V
patents and patent applications 
 
9. Financial status of 
the patent asset 
 
 
 
Is or has the patent asset been 
used as security against debt?   
  
 
10. Annual comparison 
of key patent asset 
performance 
indicators 
 
Systematically track and report 
the progress and growth of the 
patent portfolio throughout the 
business lifecycle 
 
Milestone achieved 
 
Performance and value-creation 
metrics 
 
 
    
 
 
 The three-tier Essential, Desirable & Optional model provides a straightforward yet 
flexible approach for a company to make additional voluntary patent information and strategy 
disclosure.  Beyond the Essential patent indicators, innovating SME company directors 
should consider whether to report the additional Desirable and Optional information on a 
cost-EHQHILWRU³ORZFRVWWRFROODWHDQGSURGXFH´ basis.  This is a crucial decision for 
financially-challenged innovating SMEs.  Thus the model FDQDFFRPPRGDWHWKH³JURZWK´ of 
the company enabling it to upgrade the patent information and strategy disclosed as it 
progresses through the business lifecycle without losing uniformity, reliability or 
comparability over time.  The model does not adopt the language of accountants and could be 
further enhanced through the use of visuals or graphics to complement the narrative.    
 The majority of the patent indicators in the model are self-explanatory and have 
already been discussed in Chapter 6 the GSK case study, or with respect to TRLs (section 
2.6.5).  However, those requiring further elaboration are discussed below. 
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7.2.5 Patent indicators used in the models 
7.2.5.1 7KH(32¶V,36FRUH3DWHQW9DOXDWLRQ6RIWZDUH 
 Item 1 Patent Value Story Option column refers to an indicator described as 
IPScore.652  7KH(32¶VIPScore patent valuation software is neither well-known nor widely 
used in the UK at present.  It is a useful online publicly available patent value assessment tool 
that can guide users to carry out their own free patent or patent portfolio valuation.  The EPO 
acquired, adopted and distributed the IPscore software to the national patent offices in its 
member states.653  The software enables users to carry out a basic qualitative patent 
evaluation for internal company management and provides a qualitative valuation of a single 
patent or development project and has a built-in financial model which, by producing a 
financial forecast, presents an order of magnitude for the value of the patented technology 
when put to use in the company.  IPscore creates a financial model that is able to provide a 
IRUHFDVWRIWKHSDWHQWHGWHFKQRORJ\¶VIRUHVHHDEOHFRQWULEXWLRQWROLTXLGLW\RYHr a 10-year 
period which is relevant to a leQGHU¶VHYDOXDWLRQRIIXWXUHFDVKIORZLQJWKURXJKWKHEXVLQHVV
and growth.  The calculation period is governed by the pre-determined life of the patented 
technology.  The net present value is a discounted foreseeable liquidity flow.654  Thus 
although IPScore does not evaluate the patent as a legal document, legal protection is the 
foundation of value which is why disclosure of the IPScore is optional supplementing 
traditional financial statements.  ,WLVFRPSDUDEOHWR*6.¶Vdisclosure of its ³Internal Rate of 
Return´ methodology discussed in Chapter 6.  The IPScore report is only as accurate as the 
information inputs and a lender could insist any such report be carried out by an independent 
valuer.  However, IPscore could be tremendously useful for innovating SMEs as it is a free 
online resource hosted by the EPO.   
                                                 
652
 IPScore®2.2 Manual (2009), p9  
653
 The author conducted a search of the UK IPO website at www.ipo.gov.uk and did not find any link to the 
IPScore webpage.   
654
 For a detailed explanation of the assumptions in the financial calculations, see IPScore 2.2.Manual (2009) 
Chapter 6.   
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7.2.5.2 Patent Citations 
 Item 2 Patent Portfolio Optional column sets out patent citations as an indicator.  
There is evidence to suggest that there is a strong correlation between patent value and patent 
citations observable in patent information documents.655  For example, the number of 
references to prior patents generated during the SDWHQWUHJLVWUDU¶Vsearch and examination 
process, and the number of citations a patent has received indicate its importance 
scientifically and therefore its relative value.  Further, certain patents will have many forward 
³QRQ-VHOI´ citations.  A forward citation is a reference to the patent to be evaluated in a later 
document.  Such citations are objective evidence that the patent has high value and is a 
seminal patent that protects major technical innovations within the particular field.  The 
number of citations can be empirically calculated and investigated, which is helpful and 
reliable as an information input.  The observable result is a network of links called a ³patent 
citations network´ which is a useful qualitative evaluation tool.656  In summary, the number 
of times a patent is cited tends to convey its scientific importance and therefore its value.  
Notwithstanding a simple citation count, it is important to consider how and why citations 
arise and the information they suggest.  Using a patent citation count as indicator of value is 
only as useful as the level of expertise of those who understand its significance.  This may be 
difficult for a lender to assess without the assistant of an experienced patent attorney.     
 
7.2.5.3 Freedom to operate:  the impact of neighbouring patent rights 
 Patent value is heavily influenced by the property rights that surround the patent 
monopoly.  Throughout this thesis, to keep the concepts as simple as possible, the author has 
tended to focus on small patent portfolios, given our focus on innovating SMEs at an early 
                                                 
655Hall, B. H., Jaffe, A. and Trajtenberg, M. µMarket value and patent citations¶JEL Classification: O31, 
O38 UC Berkeley at http://eml.berkeley.edu/~bhhall/papers/HallJaffeTrajtenberg_RJEjan04.pdf, p1. 
656
 Hand, J. and Lev, B. Intangible Assets: Values, Measures, and Risks (2003) Oxford University Press, pp208-
213; Michel, J. and Bettels B³3DWHQWFLWDWLRQDQDO\VLV´51 (1) Scientometrics pp185Ǧ201 
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developmental stage.  However, a single patent operating in isolation is rare, except for start-
ups and micro-firms.  In patent portfolios there may be blocking patents held by third parties 
that could significantly detract from the value of a FRPSDQ\¶VSDWHQWULJKWVA blocking 
patent is one that relates to a particular area of technology which prevents another patent 
from being used (without a licence from the first) because that other patent relies on 
technology covered by the first.657  Therefore owning a patent does not automatically provide 
the ownHUZLWKD³freedom to operatH´.  Another patent may block the desired use.  Where 
there are many separately owned blocking patents covering a particular product or process, a 
³pateQWWKLFNHW´658 is said to exist (discussed in Chapter 2).  It is recommended that the 
company (via a patent attorney) undertake a patent search to confirm whether blocking 
patents exist and make any appropriate disclosure on their impact.  This may be required to 
SURYLGHD³WUXHDQGIDLU´ view.  Dealing with any blocking patent incurs costs, either to 
license it or to work around it and such costs will need to be deducted from the future 
economic benefits that are projected from the blocked patent.   
7.2.5.4 Patent pools and synergistic patents 
 A patent pool is a consortium of two or more companies that agree to cross-license 
patents relating to a particular technology.659  In other words, companies join together to 
create a resource for their collective benefit.  Thus, the creation of a patent pool can save the 
innovating SME time and financial resources, and in the case of blocking patents, it may be 
the only reasonable way to commercialise the invention.  Within a portfolio there could also 
EHV\QHUJLVWLFSDWHQWVWKDWFRXOGHQKDQFHWKHYDOXHRIWKHFRPSDQ\¶VSDtent rights.  The 
                                                 
657
 *XHOOHF'0DUWLQH]&DQG=XQLJD3µ%ORFNLQJ3DWHQWV:KDW7KH\$UHDQG:KDW7KH\'R¶-XQH
2008) Preliminary Paper 
658
 Patent Thickets ± An Overview (25 November 2011) UK Intellectual Property Office Informatics Team 
659
 Patent Pools and Antitrust ± A Comparative Analysis (March 0214) Prepared by the WIPO Secretariat a p3 
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mirror image of a blocking patent is a synergistic patent portfolio comprising a group of 
related patent rights.660  These may be worth more in the aggregate when held in a single 
portfolio (or controlled in a single patent pool) than if held separately by different owners.  
This strategy may also have the effect of overcoming blocking patent problems and lead to an 
increase in value for each of the patents.  A patent forming part of a synergistic portfolio may 
have a higher value than if it is held in isolation.  In such a case, it will be important to 
consider the strength of the patent family.661     
7.2.5.5 Licences ± revenue that improves cash flow (relevant to lenders) 
 A patent can be licensed for use by several licensees simultaneously without 
decreasing its value.  This stands in sharp contrast to intangibles such as goodwill.  As such, 
there is a potential multiplying effect on future potential income streams which innovating 
SMEs need to highlight and information that potential lenders need to take on board.  
 
7.2.5.6 Financial resources to apply for and renew patents 
 The total cost of applying for and maintaining a UK patent over its lifetime, not 
including any enforcement of the patent rights, is made up of professional fees, official fees 
payable to the UK Patent Office and fees payable for professionally prepared patent 
drawings.  As discussed in Chapter 2, the lifetime cost of a typical patent over its complete 20 
year monopoly is of the order of £10,000-£20,000 GBP, (plus value added tax for UK 
companies and individuals).662  This cost range needs to be multiplied by the number of UK 
                                                 
660
 Murphy, W., Orcutt, J. and Remus, P. Patent Valuation Improving Decision Making through Analysis  
(2012) Wiley, p103 
661
 A patent family is a set of either patent applications or publications taken in multiple countries to protect a 
single invention by a common inventor(s) and then patent in more than one country. For example, an application 
is made in the UK and then extended to other offices. 
662
 )UDQNV	&Rµ,QFUHDVHLQ2IILFLDO8.,323DWHQW)HHV¶0D\DW 
http://www.franksco.com/news/2010/5/36-increase-in-official-ukipo-patent-fees 
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patents held by the company as well as similar figures for applying and maintaining patents 
in other countries which may be higher due to translation costs.   
 
7.2.5.7 Monitoring competition and SMEs 
 Innovating SMEs generally do not have significant financial resources to monitor 
competition or to detect potential patent infringement.663  7KHFRQFHSWRISROLFLQJRQH¶V
property is well-known in trademark law and trademark owners must patrol the marketplace 
for infringers or risk the dilution or loss of their trade marks, especially if the mark becomes 
generic.664  The duty of patent owners to police their patents is less clear-cut.  Innovating 
SME GLUHFWRUVKDYHVWHZDUGVKLSRIWKHSDWHQWDVVHWVDQGLQWKHDXWKRU¶VYLHZDVDPDWWHURI
good practice, there should be management procedures in place to patrol the marketplace for 
patent infringement appropriate to the FRPSDQ\¶VFLUFXPVWDQFHV.  If significant competition 
exists WKHQWKLVLV³PDWHULDO´ information that should be disclosed in order to provide a ³true 
and fair´ view of the business.  The innovating SME then needs to create a strategy to deal 
with the competition or to the avert infringement in order to preserve its place in the market.   
 The UKIPO provides training665 in patent searching and detecting infringement using 
publicly available patent databases and online resources, which could be accessed by 
innovating SMEs to police potential infringement.  Staff could be trained to be alert to 
infringing products and have policies in place for dealing with infringement or to carry out 
the watching briefs internally.  This function could also be outsourced to a firm with 
³ZDWFKLQJEULHI´ on the key patent journals published by patent granting offices.  
 
 
                                                 
663
 Rabinowitz, A. µ.HHS<RXU(\HRQ<RXU%DOO3DWHQW+ROGHUV¶(YROYLQJ'XW\WR3DWUROWKH0DUNHWSODFHIRU
,QIULQJHPHQW¶6SULQJ9RO$UW1RUWKZHVWHUQ-RXUQDORI7HFKQRORJ\DQGIP. 
664Ibid, p192 
665
 http://www.ipo.gov.uk/ipenforce/ipenforce-resources.htm  
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7.2.5.8 IP management  
 In many innovating SMEs, responsibility and accountability to shareholders for IP 
and patent matters is vague, often falling on the shoulders of the R&D director, chief 
technology executive, the company secretary or in-house lawyer if there is one.   In addition, 
corporate IP professionals are being asked to participate in internal IP management processes.  
However, in the evolving corporate environment there is a need for the Board of Directors to 
show leadership with respect to IP and patent management.  Increasingly, IP-rich large 
companies aSSRLQWD&KLHI,32IILFHUWKH³&,32´.666  Innovating SMEs should report who 
within the organisation is responsible and accountable for material decisions made about IP 
and patent assets.  If the board of directors is advised by external IP professionals to assist 
with such decisions, this is important information to disclose as it demonstrates prudent 
controls are in place to manage corporate patent assets and that the directors have effectively 
discharged their duties.   
 Further, the innovating SME may optionally disclose key innovation staff and 
inventors who have responsibility for driving the technical aspects of the innovation and 
patent strategy.  Staff with contributions to successful inventions, notable qualifications or 
other esteem factors such as academic or professional publications will enhance the 
perception that the innovating SME has the ability to achieve its innovation objectives.  New 
highly qualified staff may be attracted to work with the innovating SME.  IP management and 
leadership is important information for lenders who need reassurance that the patent assets 
over which they may take security are being look after.  
 
 
 
                                                 
666
 Harrison, S. and Sullivan, P. H. Einstein in the Boardroom (2006) Wiley, Chapter 2. 
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7.2.5.9  Incentives and/or reward schemes 
 In the model, it is optional to report whether incentives and/or reward schemes are 
offered to key researchers and inventors to align their interest with the FRPSDQ\¶V
commercial goals.  Research shows that monetary rewards are by far the most effective way 
to motivate employees who choose these by more than three to one over non-monetary 
recognitions.667    
 
7.2.5.10 Awards and prizes  
 
 The significance and impact on the innovating SME of winning industry awards and 
prizes should not be underestimated.  A company begins with a commercial purpose.  But not 
all that strive succeed.   An award or prize recognises excellence in the field and may carry a 
monetary award or other benefits and provides public and peer recognition which the 
company can use to distinguish itself and translate into support, financial and otherwise.  The 
more prestigious the award, the more positive reputational impact it has on the innovating 
SME¶Vability to successfully achieve its innovation and commercial objectives.  
 
7.2.6 Good practice in corporate reporting 
 7KHDVVXPSWLRQWKDWD³WUXHDQGIDLU´ Strategic Report implies full comprehensive 
disclosure is unrealistic.  The real purpose of narrative strategic report on patent information 
and strategy is to ensure fairness across the spectrum of information recipients.  The Strategic 
Report should disclose real-time insight on non-financial performance measures that could 
potentially inform decision-making by users of the information.  As a matter of good 
corporate governance, the company should hold documentary evidence to prove its patent 
information and strategy disclosures (whether direct or implied) that are capable of objective 
                                                 
667
 µ,QYHQWRU5HZDUGDQG5HFRJQLWLRQ3URJUDPV%HQFKPDUN¶ipPerformance Group, Napierville, Illinois 
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substantiation.  It is only if this standard is met that lenders and other external stakeholders 
are likely to have confidence in the narrative disclosures.  In the absence of adequate 
substantiation the courts may regard the disclosures as misleading.   
 BoilerplaWHDQGJHQHULFVWDWHPHQWVOLNH³our goal is deliver value from our patent 
portfolio WRRXUVKDUHKROGHUV´ should be avoided unless they are an introduction to company-
specific content setting out how this will be achieved.  Companies should not be over 
optimistic or exaggerate the value, accuracy, scientific validity or practical usefulness of the 
patents and patented products or processes.  If a comparison or comparative statement is 
made, companies must hold evidence that relates to both their own, DQGFRPSHWLWRUV¶SDWHQWV, 
that are the implicit or explicit subject of the comparison.    
 By definitionSDWHQWVDUHRQO\JUDQWHGIRU³nHZ´ inventions: s 1(1)(a) PA 1977.  The 
claims section of the patent provides the description of the property rights in the invention 
that are conveyed by the patent.  Section 14 PA 1977 provides that every application shall 
contain a patent specification containing a description, a claim and an abstract.  Section 14(5) 
requires a high degree of particularity in that the claims shall define the matter for which 
patent protection is sought, be clear and precise; be supported by the description and relate 
either to the invention or to a related group of inventions which are linked to form a single 
inventive concept.  The patent specification and the specific claims delimit the scope of the 
patent monopoly.  Any subsequent litigation, whether in relation to patentability, 
infringement or revocation, will be very closely concerned with what is the true basis of the 
invention as set out in the claims.  According to Lord Russell in Electric & Musical 
Industries Ltd v Lissen Ltd: 668  
                                                 
668
 (1939) 56 RPC 23  
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 The function of the claims is to define clearly and with precision the monopoly 
 claimed so that others may know the exact boundaries of the area in which, if they 
 venture therein, they will be trespassers.  
 Therefore, FRPSDQLHVZKRZLVKWRPDNH³QHZ´DQGHVSHFLDOO\³EUHDNWKURXJK´ claims 
are advised to collate sound research data to form a body of evidence to substantiate the 
strategic impact of the patent claims (e.g. properly controlled experimental studies).     
 Opinions expressed regarding the future value creation of the patent portfolio or 
individual patents should be supported with independent evidence of their accuracy.  An 
experienced patent attorney¶VRSLQLRQ as to the quality of a patent claims is a fundamental 
information input that feeds into the qualitative assessment of patent value.  If opinion on the 
future value creation of the patent assets is divided, the disclosure should not portray the 
future outlook as generally agreed.  The board of directors has a duty to ensure that its patent 
information and VWUDWHJ\GLVFORVXUHVSURYLGHD³WUXHDQGIDLU´ view.  In particular, if such 
disclosures have not been independently substantiated, the Board will need to determine that 
any patent information or strategy disclosure it makes is not untrue, unfair or misleading.    
 In summary, the original Essential, Desirable & Optional Patent Information and 
Strategy model creates a simple framework to collate and present WKH³3DWHQW9DOXH6WRU\´.  
The qualitative patent information value indicators used involves data that in many instances 
is already publicly available or capable of substantiation,  but is drafted to construct a 
narrative.  Once the relevant information has been researched it is relatively easy for a lender 
or investor to instruct an appropriately qualified patent attorney or patent lawyer to classify 
and evaluate the disclosure.  We have seen that a quantitative traditional financial valuation 
only gives an indication of the estimated monetary value of an innovating SME¶s patent 
portfolio and to date this approach has been insufficient in terms of the very limited number 
of patent-backed financing decisions made by lenders.  There is no logical reason why 
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lenders should restrict themselves to the financial statements.  The new Essential, Desirable 
& Optional Patent Information and Strategy model also facilitates a SWOT analysis of the 
60(¶VSDWHQWVDQGVWUDWHJ\)RUH[DPSOHtKHRXWFRPHRIDOHQGHUV¶UHYLHZRIWKH60(V
financial statements, corporate annual report and Strategic Review (based on the model) may 
or may not be that the innovating 60(¶V 
 
  «SDWHQWSRUWIROLRSURWHFWVDWHFKQRORJ\RIVWUDWHJLFLPSRUWDQFHIRUDQDWWUDFWLYH
 market; it can be enforced efficiently, but significant investment is still needed to 
 progress the development of product X.   The company will not be able to generate 
 the projected sales and hence profit, unless full finance is made available to it at the 
 beginning of the projected period.669 
 
 In another H[DPSOHWKHOHQGHUPD\DSSUDLVHWKHERUURZHU¶VSRVLWLRQE\FRQFOXGLQJ 
 
 It appears that the Xcel Innovation Company Ltd is an innovating SME in the process 
of consolidation.  It has made substantial investment in its biotechnology patents and 
renewal fees during the last three years as growth of assets during the period will 
reveal.  These investments are principally supported by a government research grant 
and the company is now seeking a long-term loan.  It might take a few more years to 
fully reap the benefits of these investments.  During this consolidation period, 
XcelInnovation has projected a moderate sales growth of approximately 7.5% per 
annum which is conservative but reasonable.  The operating structure of 
XcelInnovation is strong.  It has a stable growth-to-profit ratio.  
 
                                                 
669
 Bhattacharya, H. pp386-388  
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7.3 Criticism of narrative patent information and strategy disclosures  
 Despite the fact that they have been in existence for decades, the usefulness of 
corporate narrative disclosures generally has been subject to criticism.  Malone recognises the 
potential pitfalls of intangibles narrative reporting: 
 
 There are some good reasons for not attempting to measure the intangible assets, the 
 intellectual capital, of companies and other organizations. Such a measurement will 
 EHGLIILFXOWLPSUHFLVHDQGLWZLOORSHQWKH3DQGRUD¶V%R[RISROLWLFL]DWLRQDQGK\SH
 fad and fraud.670 
 
 There is no doubt that a high degree of judgement is necessary in assessing what and 
how to disclose.  This is the aim of the Essential, Desirable & Optional Patent Information 
and Strategy model ± to provide guidance for company directors and a basis for users to 
assess comparability.  Malone states further however that an attempt must nevertheless be 
made to describe intangibles.  Countries that have mandatory ICS regimes clearly accord the 
ICS the same level of official recognition as financial statements.  Similarly, in the UK, as the 
patent information and strategy disclosure will be presented in the Strategic Report, it also 
has official recognition.  Neilson studied the trends and issues in management commentary 
over the past two decades of attempts to create guidelines and regulation for corporate 
strategy narratives, concluding that: 
 
 A solution to making management commentary matter to the investment community 
is to emphasise the interconnectedness between parts of the narrative sections 
according to the logic of the business model.  Furthermore, regulation should be 
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 0DORQH6µ4XDQWLI\LQJWKH%UDYH1HZ:RUOG¶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concerned with creating guidance on how to structure management commentary and 
strengthen such narrative statements through relevant performance measures.671 
 
 This is precisely what the Essential, Desirable, Optional Patent Information & 
Strategy Model attempts to do, create a framework to demonstrate the role the patents assets 
play in future value creation for the business.  It is this interconnectedness that is key to 
providers of capital and debt finance.  Therefore, to address criticisms, voluntary disclosure 
of patent information should have a strategic focus and be communicated clearly, truthfully, 
fairly and unambiguously in compliance with the legal requirements of the CA 2006.  
Reporting patent information and strategy should be balanced and objective and enable 
comparisons over time by building on commonly accepted indicators, which fall outside 
obligatory disclosure by GAAP, and provide DEHWWHUXQGHUVWDQGLQJRIWKHFRPSDQ\¶VNH\
financial drivers beyond the figure for intangibles as recorded in the traditional financial 
statements.  The new model will assist users to evaluate management performance with 
respect to patent assets enabling them to differentiate between good, bad and ugly corporate 
stewardship, a central part of corporate governance.  A variety of problems that stem from the 
lack of transparency about material patent assets may be overcome including accountability, 
GLUHFWRUV¶DFWLQJLQWKHLURZQLQWHUHVWVVHOHFWLYHGLVFORVXUHVDQGLQVLGHUdealing.672  
 An important issue for directors is accountability versus confidentiality.    
Although there may be concerns about disclosure of confidential patent information, one 
needs to weigh this against the need for improved awareness of lenders and other 
stakeholders of patents asset value as a core part of the business.  Innovating SMEs should be 
alert to avoid public disclosure of information that may be conveyed in confidence directly to 
                                                 
671
 Neilson, C. µDilemmas in the usefulness of business reporting narratives towards investors and other 
professional decision-makers¶ Department of Business Studies, Aarlborg Universitet, p1  
672
 The latter applies only to publicly listed companies. Section 52 Criminal Justice Act 1993 creates three kinds 
of insider dealing offences involving the use of inside information and dealing in securities. 
 
303 
 
the lender.  A proper balance can be struck between the public interest of transparency, 
accountability and the private interest of confidentiality.   
 In conclusion, we have studied innovating SMEs whose competitive advantage rests 
largely on their ability to manage their strategic resources, which for our purposes are patent-
protected intangible assets, rather than tangible in shape and character.  We saw in Chapter 3 
that signalling effect of patent value is not being received by UK lenders contemplating 
making loans to innovating SME firms.  The value of an LQQRYDWLQJ60(¶VSDWHQWSRUWIROLR
value will change once applications are granted, and will change again, if and when a legal 
challenge, either offensive or defensive, has been successful.  The strength of the Essential, 
Desirable and Optional Patent Information and Strategy Disclosure Model for narrative 
corporate disclosure is its simplicity and that it provides a concrete solution for the lack of 
transparent patent information in traditional accounting statements and abbreviated corporate 
reports.  One can argue that if the patent information and strategy is important for the 
management of the company, then it is also relevant for external stakeholders to piece 
together sufficient relevant information to put the financial numbers with respect to 
intangibles in context.  The model facilitates access to debt finance by providing an effective 
method of communicating useful patent informatiRQDQGVWUDWHJ\WKDWPHHWVWKH³WUXHDQG
IDLU´ standard required by corporate disclosure laws to lenders and provides essential 
forward-looking information, crucial for lenders to estimate growth prospects.  The model 
directly supports and furthers the implementation of three key recommendations made in the 
Banking on IP? Report and could be included in a UKIPO resource toolkit and supporting 
services which when integrated will: 
x help old and new economy businesses identify and communicate their IP and its 
relationships to cash flows; 
x help companies and lenders understand the business value of IP; and 
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x improve efficiency in due diligence on IP assets.673  
 Implementing the model and the necessity for multi-disciplinary expertise is the 
subject of the next section.  
 
7.4 Implementation 
 
 The Essential, Desirable & Optional Patent Information and Strategy model initiates 
a new discourse and its reception depends on political consensus and wide acceptance by the 
innovating SMEs themselves.  Creating confidence in new types of patent information is a 
question of normalising company disclosure practice, being consistent so as to create user 
experience in understanding such performance measures.  
 The success of the model will only be possible if it receives government endorsement 
and support to encourage and promote its use by providing resources to educate innovating 
SMEs and commercial lenders.  At present,  neither the UKIPO, BIS, the FRC  nor 
Companies House work together to provide bespoke advice to innovating SMEs or other 
patent owning firms about IPR and patent information and strategy corporate narrative 
disclosure.  No official bespoke guidance exists to encourage innovating SMEs, who are 
otherwise exempt from providing a Strategic Report (formerly the Business Review) in their 
annual return, of the benefits of doing so.    
 Taking into account these points, voluntary adoption of the model would need to be 
recommended by BIS and UKIPO who could interact with the FRC and Companies House in 
terms of promotion and guidance to innovating SMEs.  A multi-agency approach is needed to 
coordinate the patent law, corporate and business finance advice that is contemplated by the 
model.    
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 In addition, within the private sector there is clearly an important role for both the 
accounting and patent attorney professions to play.  Turning firstly to the accounting 
profession, innovating SMEs at the early stage of their business lifecycle typically contact an 
accountant to establish the corporate entity and assist with filing of tax returns with HM 
Revenue & Customs and file corporate reports with Companies House.  Accountants are 
therefore the first port of call and WKH8.,32¶V,3)LQDQFHtoolkit will help to raise the level 
of awareness of accountants of the need to consider IP as corporate assets that should not 
only be accounted for as intangibles in traditional financial statements, but which warrant 
additional voluntary narrative corporate disclosure.  Similarly, the patent attorney who files 
the patent application on behalf of the innovating SME should also be in a position to 
highlight the benefits of voluntary disclosure of patent information and strategy in the 
innovating SME¶s annual return to facilitate access to finance.  The actual preparation of the 
disclosure could follow the three-tier business triage style model which may involve the input 
of the innovating 60(¶VDFFRXQWDQWVSDWHQWDWWRUQH\VDQGOHJDODGYLVRUVDVGHWHUPLQHGRQD
cost-benefit analysis.      
 In the future, it is predicted that multi-disciplinary accounting practices will need to 
employ or subcontract to IP or patent specialists to assist with preparation of patent 
information and strategy disclosures and the independent auditing of these.  Sophisticated 
accounting firms looking to the future will need more than just accounting, tax, consultancy 
and audit services to service their clients whether innovating SMEs or larger corporate 
entities.  A form of multi-disciplinary legal practice is already possible with the introduction 
of the Legal Services Act (2011) which introduced the Alternative Business Structure (ABS).  
This enables non-lawyer groups such as accountants to share the management and control 
and bring together lawyers and other professionals, potentially patent attorneys, to provide 
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services requiring a multi-disciplinary approach.  Similarly, commercial lenders will need to 
access IP and patent analysts to evaluate the assets of its IP-rich clients.  
 
7.5 Conclusion 
 The Essential, Desirable and Optional Patent Information & Strategy Disclosure 
Model provides guidance for a specialised type of narrative report that focuses on meeting the 
needs of a group of stakeholders that is broader than shareholders and investors, but which 
contemplates other capital providers such and commercial lenders and banks.  The innovating 
SME will then have a well-considered, coherent basis for ensuring connectivity between the 
various media and the message it communicates concerning its patent monopoly-based 
business model.  This will help to DOLJQWKH³3DWHQW9DOXH6WRU\´ across its company website, 
social media, brochures and product and services information.  A new disclosure structure 
will initiate a patent value revelation process.  The author is optimistic that the new model 
will be considered by innovating SMEs with consensus among stakeholders in the field 
because those with good news will begin to disclose, motivating others to join ranks as 
financiers will penalise silence on patent information and strategy.  Early innovating SME 
adopters who file a narrative corporate report as part of their communication strategy using 
the model could potentially build impetus and momentum for future mandatory IP 
management reporting regulation.   
 Chapter 8 sets RXWWKHDXWKRU¶VILQDOUHFRPPHQGDWLRQVDQGFRQFOXVLRQV.  
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8 Facilitating patent-backed lending decisions in the UK: Conclusions and 
 recommendations  
 
µ$FFRUGLQJWR'DUZLQ¶VOrigin of Species, it is not the most intellectual of the species that 
survives; it is not the strongest that survives; but the species that survives is the one that is 
able best to adapt and adjust to the changing environment in which it finds itself.¶ 
      Leon C. 0HJJLQVRQµ/HVVRQVIURP(XURSHIRU
      $PHULFDQ%XVLQHVV¶Southwestern Social  
      Science Quarterly (1963) 44(1): 3-13, at p4 
Introduction  
 
 Around the world several commercial lenders are  beginning to look with interest at 
patents as an asset class for security.  The way forward, in the author¶VRSLQLRQ, is to focus on 
what innovating SMEs want (money), what the commercial lenders want (security) and what 
corporate regulators want (accountability).  This chapter sets out a range of sharply pragmatic 
recommendations which can be grouped into three themes.  Section 8.1 recommends actions 
innovating SMEs can take to improve their position as borrower in a patent-backed lending 
transaction.  Section 8.2 considers the role of the commercial lenders in developing or 
upgrading existing strategies and policies to enhance their patent-backed lending business.  In 
section 8.3 the role of the government, as facilitator and policy coordinator, is re-examined 
and we derive policy recommendations on how to enhance information efficiency and 
improve the visibility of SME patent assets that will benefit external stakeholders such as 
lenders who are, and increasingly need to be, involved in the intangible economy.  Section 
8.4 sets out the author¶s final remarks regarding disclosure of patent information and strategy 
to overcome the effects of IAS38 Intangibles which hides the ³SDWHQWYDOXHVWRU\´.  This 
involves company law taking the lead using the Strategic Report format WRSURYLGHD³WUXH
and fair´ view of innovating SME patent assets.   
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8.1 Creating a level playing field for innovating SMEs 
 The playing field is far from level for innovating SMEs in several respects.  For this 
reason it is increasingly difficult to fund innovation, inspire inventors and protect the vital 
engine of the knowledge economy.674  Innovating SMEs are in a worse position than other 
SMEs due to: 
(1) large up-front costs required to obtain patents which are at the nucleus of the business 
strategy to protect innovations against copying by competitors and derive supra 
normal profits (Chapter 2);  
(2) the unlikelihood of commercial lenders to entertain the use of patent assets which they 
regard as poor-quality security under Basel III as security (chapter 3); 
(3) the difficultly valuing patents and the gap of several years before a patent application 
will be granted, thus becoming more valuable as a security (Chapter 3). 
 
 What actions can innovating SMEs take to improve their position as a borrower with 
patent assets?  The author makes the following recommendations. 
 
Recommendation 1 
UK innovating SMEs must ensure they benefit from the existing UKIPO and BIS freely 
available resources as set out in Chapter 2 to identify and manage their IP and patents 
(beyond their financial statements of expenditure).  This will enable them to build their 
narrative qualitative patent disclosure to inform prospective lenders and funders.   
 
                                                 
674
 :LOG-µ:K\GRQ¶WFRPSDQLHVZLWKKXJHFRPSOLDQFHGHSDUWPHQWVKDYHDQ\RQHORRNLQJDWSDWHQWV"¶
January 2014) Intellectual Asset Magazine  
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Recommendation 2 
Innovating SMEs should designate an Intellectual Property Officer (IPO) to manage the 
FRPSDQ\¶V,3IURPWKHRXWVHWWROHDGRQJRLQJ IP management as the company grows.  In a 
one-person company, the director should be aware of this aspect of his/her responsibilities to 
promote the success of the company under s172 CA 2006 (as seen in Chapter 7).  The IPO 
role feeds into business development, finance and marketing.   
 
Recommendation 3 
Innovating SMEs should consider making voluntary narrative disclosure of patent 
information and strategy in the Strategic Report of the annual return using the ³Essential, 
Desirable & Optional´ model presented in Chapter 7.  This should be updated annually to 
demonstrate, reliably and repeatedly, how their patents deliver value beyond the balance 
sheet which inadequately documents internally generated patents as an expense.  By using the 
UHJXODWRUV¶corporate reporting format, SMEs borrowers will avoid having to generate 
multiple sets of information e.g. management reports, ICS, growth statements.      
 
Recommendation 4 
In relation to the debt finance sought, the innovating SME borrower must be prepared to 
answer the lender¶s qXHVWLRQV³+RZPXFK"´³:K\"´DQG³:KHQ"´  The voluntary 
narrative patent information and strategy disclosure will assist to develop sensible 
commercially-oriented answers to these questions.  
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 These recommendations further develop the first and second recommendations of the 
Banking on IP? Report675 and will assist innovating SMEs to convince the finance 
community that patent value should be taken into consideration in commercial lending 
decisions.   The FRC recommends that all company narrative reports contain more 
information and focus on the area of IC which includes IP and more specifically, patent 
information (Chapter 6).  Providing the type and quality of information needed by lenders at 
the outset will reduce the cost of assessing creditworthiness, facilitating the patent-back loan 
appraisal process.    
 
8.2  The role of commercial lenders in developing and/or upgrading existing 
 strategies to enhance their patent-backed lending policies 
  
 This history of UK banking has been one of large shifts among assets in response to 
movements in differentials among rates of return and commercial banking (lending and retail 
deposit taking) ranks in third position behind investment banking and asset management.676  
More recently, we KDYHVHHQIURP%UDVVHOODQG.LQJV¶UHVHDUFKWKDW³UHFHQWEDQNLQJ
initiatives targeting growth businesses are finding that traditional fixed assets simply no 
ORQJHUH[LVW´677  In an age of financial innovation, Asia is setting the pace in IP-backed 
lending and UK lenders need to consider adjusting their mind-set and behaviour to profit 
from the changing environment by responding to the challenge of recognising patent assets in 
their future lending decisions, thus creating (or adapting) patent-backed lending policy to 
participate in a growing market (Chapter 2).   
  
                                                 
675
 Supra Banking on IP? [18] pp218-219 
676
 Supra Bhattacharya [408] p5 
677
 Supra Banking and IP? [18] p13 
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Recommendation 5 
Commercial lending banks urgently need to GHYHORSDFRQWHPSRUDU\ZULWWHQ³3DWHQW-Backed 
/HQGLQJ3ROLF\´ to provide a blueprint for lending decisions enabling the financial institution 
to self-regulate and carry out the required dynamic loan monitoring in respect of patent asset 
security against the background of the patent ecosystem (Chapter 2).   
 
 
 Howard Crosse, former Vice-President of the Federal Reserve Bank of New York, 
stated that ³WKHYHU\DFWRIIRUPXODWLQJDSROLF\DQGH[SUHVVLQJLWLQZRUGVWKDWDOODJUHHZLOO
VKDUSHQWKHLVVXHVDQGPDNHWKHHQGSURGXFWPRUHHIIHFWLYH´678  Commercial lending 
institutions should consider drafting patent-backed lending policies to attain the following 
broad objectives: 
 
(1) profit maximisation in the short and long term (taking into account the nature of the 
patented invention commercialisation cycle) based on its strategic plan; 
(2) conducting the patent-backed lending function within a managed risk framework; and 
(3) Basel III capital adequacy requirements.  
 
 Such policies need to align with the Lending Code (Chapter 4) which is monitored by 
the independent Lending Standards Board (LSB) to ensure that the standards are expected of 
banks in connection with the assessment of lending applications are met.  
 
                                                 
678
 Crosse, H. D. Management Policies for Commercial Banks (1962) Prentice-Hall Inc., Englewood, New 
Jersey 
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8.2.1 Profit maximisation 
 Profit maximisation remains the chief concern of bankers around the world.  Lenders 
will need to analyse how the decision to make patent-backed loans will impact on the 
profitability of the bank.  In modern commercial lending, as in any other enterprise, the 
strategic planning exercise must begin with a profit objective in view and other policy sub-
goals like credit-deposit ratio, portfolio-PL[³DFFHVVWROLTXLGLW\´WUDQVDFWLRQFRVWVORDQ
repayment norms, dynamic monitoring etc. will follow.679  This is important for the purpose 
of the bank implementing an appropriate appraisal system of the innovating SMEs patent 
assets.  Central to the development of a healthy patent-backed lending environment is the 
creditworthiness of both the patent-owning borrower and the lender.  Professional 
development for loan officers in terms of IP education, especially those dealing with 
innovating SMEs, will be necessary.  IP consultants could be engaged to advise on patent-
backed lending transactions.   
 
8.2.2 Managing patent-backed debt finance risk 
  
    Take calculated risks. That is quite different from being rash. 
      General George Patton (1885-1945), US Army  
Recommendation 6 
Commercial lenders need to develop a patent-backed lending policy that takes into account a 
³SDWHQW-ULVN´ profile and meets their own risk tolerance level.  This will impact on loan 
pricing and interest rates, which operationalises the profit target of the bank.   A policy 
stating the minimum Technology Readiness Level the bank requires is recommended.   
  
                                                 
679
 Supra Bhattacharya [408] p15 
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 A core function of the lender is gathering information to reduce uncertainty about the 
ERUURZHU¶V ability to repay the loan applied beginning with an evaluation of the traditional 
financial statements (Chapters 3 and 4).  However, we explained why this analysis is limited 
with respect to internally generated patent assets, because their value is hidden on the balance 
sheet (Chapter 4).  Yet credit appraisers identify the balance sheet as a crucial document in 
assessing creditworthiness, first as a tool for seeing if the value of the patents secures the 
loan, but also to see if the value of the business is growing.  It is at this point that patent-
backed lending policy should request the new qualitative patent information and strategy 
disclosure prepared by the innovating SME in the Strategic Report section of its annual return 
(Chapter 7).  This supplementary information will assist lenders to identify the patent assets 
and secondly, to take appropriate controls over registered patent applications and granted 
patents in a lending scenario (section 3.9 above) and determine whether the innovating SME 
business is growing.  ,QWKHDXWKRU¶VYLHZLWLVFUXFLDOWKDWWKHFUHGLWDSSUDLVHUKDYHERWKWKH
traditional financial statements and the voluntary narrative patent information and strategy 
disclosure to judge the financial and operating health of a borrower.     The lack adequate 
quantitative and qualitative information about corporate intellectual property (IP) assets, 
LPSHGHGOHQGHUV¶ability to assess strategic value of those assets.  They seek more relevant, 
accurate and timely information about corporate IP assets ± the type of information currently 
only known to internal management - to assist them to triangulate intangibles financial data 
through cross verification with corporate narrative disclosure.    
 We also noted the ground-breaking ICS initiative introduced in 2010 by five Hong 
Kong Banks who offer innovating SMEs more favourable financial and/or service privileges 
if they prepare their own ICS (Chapter 7).  UK patent-backed lending policy should adopt a 
similar approach with respect to the Strategic Report, to provide lenders with important 
qualitative non-financial patent information and strategy essential for credit appraisal.  
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Recommendation 7 
If lenders require a corporate narrative patent information and strategy report as part of their 
patent-backed lending policy, SMEs will likely devote the time, effort and resources to 
producing it and voluntarily ILOLQJLWDW&RPSDQLHV+RXVH7KLVIXOILOVERWKWKHOHQGHU¶V
objective, and promotes good corporate governance under the CA 2006.   
  
  It is well known the UK has some of the highest corporate governance standards in 
the world which should reassure lenders.  The UK the Strategic Report format must comply 
with the requirements of the CA 2006, even if made voluntarily, substantially increasing the 
legitimacy and authority of the information disclosed.  An original contribution of this thesis 
is the creation of the business triage style Essential, Desirable or Optional disclosure model 
for qualitative non-financial patent information, designed to fit within the existing corporate 
reporting regime.   
 
Recommendation 8 
A lender contemplating a patent-backed loan should take DFRPSOHWHYLHZRIWKH³SDWHQW
YDOXHVWRU\´ of the business.  This will enable it to better assess lending risk and provide a 
sensible level of finance that is not so low as to impede the SME¶s liquidity.    
 
Recommendation 9 
If a positive lending decision is made, the lender should register its security and implement a 
dynamic monitoring system to obtain periodic business forecasts and details of future outlook 
LQUHVSHFWRIWKHLQQRYDWLQJ60(¶Vevolving business, patent strategy and credit needs.    
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 It is expected that commercial lenders will update their credit appraisal methodology 
to include the qualitative patent information and strategy as an aspect of their forecasting 
techniques.  Actuarial science will lead to the creation of appropriate patent metrics and 
algorithms to deal with the financial impact of uncertainty and credit risk.    
 
8.2.2 Capital adequacy requirements and Basel III 
 The capital plan of a commercial lending bank is often regarded as a bridge between 
its strategic plan and its profit plan.  Bank capital supports confidence in banks.680  However, 
in Chapter 3 we saw that the argument that tighter restrictions on bank borrowing would 
UHVWULFWDEDQN¶VDELOLW\WRSURYLGHORDQVWRWKHUHVWRIWKHHFRQRP\LVQRWWHQDEOHDVDEO\
demonstrated by Admati and Hellwig.  Capital regulation does not force banks to reduce their 
capacity to make loans.  Viable banks can increase their reliance on un-borrowed funds 
without any reduction in lending. 
 
Recommendation 10 
Commercial lenders should consider adjusting their reaction to Basel III capital adequacy 
requirements and increase their risk tolerance for patent-backed lending transactions. 
 
 In conclusion, financial institutions are geared to serving the needs of customers for 
whom the volume of activity justifies the costs of acquiring information.  Currently the 
volume of patent-backed debt finance transactions is low.  Although commercial lenders 
already engage in IP finance to some degree, this is limited to large and public companies 
with significant patent portfolios and other assets that can be used together as loan security.  
This lending experience needs to flow downstream to lending officers who deal with 
                                                 
680
 Bhattacharya, H. p15 
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innovating SMEs.  The patent-backed debt finance transaction will become more efficient 
with frequency resulting in improvement to the credit appraisal process which will eventually 
become standardised (commoditised).  Therefore, the future success of a patent-backed loan 
policy lies not in its drafting, but in its implementation.   
 Is there a case for doing nothing?  Should lenders simply be left to their own devices?  
The difficulty with this argument is that if lenders are already averse to patent-backed lending 
the situation will simply become even more ingrained.  If all banks stepped up their patent-
backed lending, that would bolster patent asset values and support investment in innovation 
and the economy.    
 To achieve this, commercial lenders need to change the way they think and work.  
They need to think differently about the viability of patent-backed lending.  Better and more 
efficient techniques of appraising credit applications involving patent assets have been 
propounded in this thesis, but they must be embraced.  If more lenders take the initiative, 
following frontrunners (e.g. Clydesdale Bank, the London branch of the Silicon Valley Bank, 
Santander, the Brazilian Development Bank, the Jamaican Export-Import Bank, Credit-
Suisse, the five Hong Banks and China Development Bank), this will lead to financial sector 
reform.  These lenGHUVKDYHSURJUHVVHGWKURXJK³all four stages oIDFFHSWDQFH´identified by 
the British biologist, IBS Haldane: 
 
(1) this is worthless nonsense; 
(2) this is an interesting, but perverse, point of view; 
(3) this is true, but quite unimportant;  
(4) I always said so.681 
                                                 
681
 +DOGDQH,%6µ7KH7UXWKDERXW'HDWK¶Journal of Genetics 463-4 
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Haldane was referring to reactions to new ideas in science and not about lending or 
the law, but his words resonate in today¶V commercial lending market place.  There will be 
opportunities for innovative commercial lenders.  Just as research by the Oxford Internet 
Institute suggests that those who have the least experience of the Web are the most distrustful 
of it,682 so is there a similar situation with commercial lenders who lack experience dealing 
with and patents as security.  This thesis aims to increase OHQGHUV¶FRQILGHQFHLQSDWHQW-
backed lending and reduce one of their triad of concerns, namely, uncertainty as to patent 
value.  This is achieved by a legal solution to the transparency problem advocating company 
law take the lead and suggesting enhanced corporate disclosure of patent information and 
strategy in the Strategic Report is the way forward and increasingly essential for good 
corporate governance.  Lord Denning said: 
 
If we never do anything which has not been done before, we shall never get 
 anywhere.  The law will stand still whilst the rest of the world goes on and that will 
 be bad for both.683  
 
In the medium-term, it is predicted that as lending decisions become more efficient 
and accurate, the cost to the bank per pound (£) loaned to innovating SMEs will reduce.  In 
the longer term, it is envisaged that the evolutionary path for patent-backed lending strategy 
comprises three stages: EHVSRNH³one off transactions´; standardisation of process (avoiding 
duplication of effort or reinventing the wheel) and finally, systematisation of internal 
knowledge processes.684     
                                                 
682
 Dutton, W. and Helsper, E. The Internet in Britain (2007) Oxford Institute, Oxford 
683
 Packer v Packer [1954] at p22 
684
 Susskind OBE, R. The End of Lawyers? Rethinking the Nature of Legal Services (2008) Oxford University 
Press, p9 
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For the innovating SMEs, the aim is to enhance access to debt finance at an interest 
rate that is comparable to that offered to other SMEs who are not reliant on patent assets.  
This will be achiHYHGE\FODULI\LQJWKHKRZWKH³SDWHQWYDOXHVWRU\´ impacts on the SME¶s 
business model leads to future value creation.  
 In terms of future research, as the use of patent-backed debt finance is disseminated 
and reaches a wider audience of lenders and financial institutions, it will be of interest to 
analyse the uptake in the UK by innovating SMEs and lenders as well as other barriers to 
patent-backed debt finance. 
 
8.3  7KH*RYHUQPHQW¶VUROHDVIDFLOLWDWRUDQGSROLF\FRRUGLQDWRU 
 The public sector plays an important role in creating the environment for 
entrepreneurial innovating SMEs to be successful (Chapter 2).  The UK government has 
made substantial progress to improve the patent ecosystem in the past decade but must 
continue to respond creatively and forcefully to the challenge of patent-backed debt finance 
within the context of the patent ecosystem.  Nevertheless, the future for innovating SMEs 
could be prosperous or disastrous depending on whether they are able to secure the finance 
they need to grow and flourish.   
  We observed that the governments of Singapore, Malaysia and the PRC have been 
proactive in raising IP awareness to ensure that business and financiers in those jurisdictions 
understand the future value creating potential of all forms of IP which they support via 
government-OHG³,3ILQDQFLQJ´VFKHPHV&KDSWHU6LPLODUO\, we noted the proactive 
DSSURDFKWDNHQE\+RQJ.RQJ¶V,3'HSDUWPHQWLQHQJDJLQJZLWKEDQNVOHDGLQJWRDQ
agreement advantageous to loan applicants who prepare their own ICS (Chapter 4).   
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Recommendation 11 
The government should study the effectiveness and impact of the IP financing initiatives 
afoot in Singapore, Malaysia and the PRC and consider whether to implement an IP finance 
scheme in the UK.  
 
 (PSKDVLVLQJWKHEDQNV¶RZQVHOI-interest and how they will have the opportunity to 
profit from a new customer base by gaining early mover advantage, or fall behind their more 
innovative peers,  is likely to be the most successful strategy.   
 The research in Chapter 4 determined that company law should take the lead within 
the patent ecosystem, ahead of traditional accouQWLQJSULQFLSOHVWRSURYLGHD³WUXHDQGIDLU´ 
view of the future value creating potential of internally developed patent assets.  This is 
necessary in the absence of the regulated patent market the accountant needs to obtain an 
arms¶ length price for patent assets that is acceptable under IAS 38 for intangibles.  
Otherwise patent asVHWVZLOOUHPDLQLQYLVLEOHDQG³oXWRIVLJKW´DQG³RXWRIPLQG´.  There are 
further opportunities for the Government to make a positive impact on the progress of patent-
backed debt finance.   
 
Recommendation 12 
The government should acknowledge the lack of innovating SME patent information 
available to lenders, due to accounting practice with respect to intangibles, coupled with the 
unintended consequence of WKH³small FRPSDQLHVUHJLPH´.   
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Recommendation 13 
The government should develop a coherent approach at a national level (between UKIPO, 
BIS, Financial Reporting Council and Companies House) to encourage innovating SMEs to 
voluntarily disclose patent information and strategy in accordance with the corporate 
reporting requirements under the CA 2006. 
 
Recommendation 14 
The interaction between IP, personal property security law, company law and insolvency will 
need to be improved to ensure creditor protection if patent-backed debt finance is to flourish 
in an economically efficient manner.  The government should participate in the Secured 
Transactions Reform Project, ensuring that the UKIPO, BIS and Companies House are 
represented in the ³6ecurity Interests in IP´ working group to effectively co-ordinate the 
Company Register and specialist Patent (and other IP) Register rules.  
 
Recommendation 15 
The government should consider adopting the ³Essential, Desirable & Optional Model for 
Patent Information DQG6WUDWHJ\'LVFORVXUH´ developed in this thesis as a guide to enable 
innovating SMEs to further explain their patent assets how they will contribute value to the 
company, generate cash flow, income streams and growth.  
 
 At a broad policy level, the role of the corporate reporting for innovating companies, 
big or small, will become more important.  Company law and capital market regulators 
typically set out the minimum level of disclosure of corporate information.  However, 
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research by accounting firm Deloitte in 2009 indicated that the length of corporate annual 
reports increased by 48% during the period 2005-2009 and that a clear benefit of such 
enhanced disclosure is improved corporate valuation.685  ,QFUHDVHGGLVFORVXUHRIWKH³SDWHQW
YDOXHVWRU\´ should have a similar outcome: increased patent asset value.  It is highly likely 
that voluntary corporate reporting of patent information and strategy would positively impact 
those innovating SMEs seeking patent-backed debt finance secured by patent assets because 
lenders will need the same type of information that traditionally has been made available to 
equity financiers.  7KHYDOXHRIWKHLQQRYDWLQJ60(¶VSDWHQWDVVHWVZRXOGEHGHULYHGIURPDOO
available public information enabling banks to agree lending terms in alignment with more 
accurate risk levels.  ,IWKHFRPPHUFLDOOHQGLQJFRPPXQLW\¶VXQGHUVWDQGLng of patent assets 
improves and more positive patent-backed lending decisions are made, the bias against 
intangible patent assets will slowly reduce as lenders develop risk tolerance for, experience 
and familiarity correlating patent information with lending transactions and repayment terms.   
 
Recommendation 16 
The government should continue to make IP education and advice more accessible to 
innovating SMEs, but take this further to inform and demonstrate how to make patent 
information and strategy disclosure via annual corporate reporting, in consultation with the 
UKIPO, BIS, the FRC, Companies House; with the involvement of the professional bodies 
for accountants, patent attorneys (CIPA) and lenders (BBA). 
 
 At a political level in relation to the banking sector, the UK government should 
entreat and encourage commercial lending banks to evolve their own strategies for creating or 
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upgrading patent-backed debt finance policies via the co-ordinated efforts of the IP Minister 
and the Secretary of State for BIS.    
 
8.3.1 The UKIPO 
In relation to the UKIPO specifically, the author makes the following 
recommendations to progress patent-backed debt finance: 
 
x continue to support developments at an international level including WIPO and 
UNCITRAL (Chapter 1) 
x devote more resources to improving patent examining and reducing patent backlogs 
and to ensure innovating SMEs access advice to public funding opportunities 
LQFOXGLQJ+RUL]RQ7KH(8¶VVWUDWHJ\IRU5HVHDUFKDQG,QQRYDWion (Chapter 2) 
x replicate D8.YHUVLRQRI:,32¶VIP Advantage database to document the innovation 
finance funding environment and experience of innovating UK SMEs. (Chapter 3) 
x commission, together with the FRC, a legal opinion to ascertain whether the 
application of IAS 38 for Intangibles to internaOO\JHQHUDWHGSDWHQWDVVHWVLV³WUXHDQG
IDLU´ or requires revision (Chapter 4).   
x support the adaptation of traditional capital markets to facilitate the buying and selling 
of patents (or new IPR Exchange platforms) to enhance patent asset liquidity and 
SURYLGHDUPV¶OHQJWKSDWHQt transaction data (Chapter 4) 
x promote WKHXVHRIWKH(32¶VIPScore patent valuation software accessible via the 
UKIPO website (Chapter 7) 
x support the accreditation of specialist patent-backed debt finance lenders via UKIPO 
certification courses developed in conjunction with academic and professional 
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experts.  
 
In addition, the author recommends that future developments to the IP Finance Toolkit 
released in March 2015: 
 
x provide more specific advice and templates to capture the different types of IP e.g. 
patents, trade marks and copyright;  
x include case studies to illustrate real life examples of positive lending decisions 
(particularly to encourage lender confidence in IP-backed lending); 
x highlight the availability of the free interactive online IP Health Check Tool which 
can be used in tandem with the IP Finance Toolkit to produce a confidential IP asset 
report; 
x indicate that innovating SMEs may make a voluntary narrative report on their IP 
assets and IP strategy in the Strategic Report of their annual report to Companies 
House using the new Essential, Desirable and Optional model developed in Chapter 
7.   
 These measures will contribute to creating a level playing field in government IP 
policy enabling innovating SMEs to exploit their patents assets more easily and effectively, in 
line with owners of traditional tangible assets.  
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8.4 Final remarks 
 The present thesis focusses on a practical commercial problem within a legal context, 
namely how to improve access to patent-backed debt finance by innovating SMEs.  The 
central question, which directed the course of enquiry, was how to make patent assets more 
attractive to debt financiers as potential security for lending at the credit appraisal stage of  
patent-backed lending transaction.  To answer this question, a subset of questions was 
examined and analysed in the subsequent Chapters.  A vital question involved examining 
how to reduce the level of uncertainty perceived by lenders with respect to the value of 
patents as a form of security.  A key finding was that the information gap caused by 
traditional financial accounting principles and IAS 38 for intangibles in respect of internally 
generated patents was not the only information asymmetry problem for innovating SMEs.  In 
fact, standard information gathering during credit appraisal produced even less information 
about SME patent assets than originally thought, due to the unintended effects of the small 
companies regime and lack of narrative corporate report.  To UHFWLI\WKHSDWHQW³LQIRUPDWLRQ
JDS´, the author concluded that company law shoXOGWDNHWKHOHDGWRSURYLGHD³true DQGIDLU´ 
view of internally generated patent assets via voluntary disclosure of patent information and 
strategy in their narrative corporate report.  Corporate reporting standards enhance the quality 
and reliability of the patent information presented because directors need to be satisfied that 
their reports show a true and fair view.  This solution should reassure and LPSURYHOHQGHUV¶
appreciation of the value patent assets and how they contribute to an innovating SMEs 
business, while simultaneously promoting accountability and stewardship for corporate patent 
assets.  The analysis required joined-up thinking at an academic level adopting a legal 
approach to examine the barriers to patent-backed debt finance from the perspectives of the 
borrower and the lender.   
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 A case study of the content and structure of narrative disclosure in a multinational 
pharmaceutical company¶VDQQXDOUHSort was presented in Chapter 6.  The idea of studying 
the content of narrative disclosures in corporate annual reports is not new, what is new is 
considering corporate narrative, specifically of patent information and strategy disclosures, 
witKLQWKHFRQWH[WRIWKH8.¶VSDWHQWHFRV\VWHPDQGFRUSRUDWHUHJXODWLRQ.  
 7KHDXWKRU¶VUHVHDUFKFXWVVKDUSO\DFURVVacademic boundaries to make a synthesis 
regarding corporate disclosure of patent information and strategy by innovating SMEs in the 
UK that has not been made before.  The insights of this thesis provide an academic audience 
with a deeper level of legal analysis as to why patent-backed debt-finance for innovating 
SMEs is undeveloped and underused, namely, the absence of reliable patent information with 
which to determine the financial value of patent assets.  The research produced a pragmatic 
potential solution to simplify patent information disclosure via an original three-tier 
Essential, Desirable & Optional model for enhanced voluntary narrative corporate disclosure.  
The model goes beyond mere description of the pateQWDVVHWVDQGGHPRQVWUDWHVWKH³3DWHQW
9DOXH6WRU\´ ± the role the patents assets play in future value creation for the business.  It is 
this interconnectedness that is crucial information for providers of capital and debt finance. 
Ultimately, this thesis adds to the body of knowledge related to patent-backed and IP debt 
finance generally with a view to application within the UK.  While the work will further 
academic discourse, it is hoped that this research will have impact beyond the academic 
FRPPXQLW\DQGWKHDXWKRU¶VUHFRPPHQGDWLRQVZLOOEHadopted with the broadest possible 
participation by innovating SMEs, lenders and government policymakers, with consensus 
among stakeholders in the field.  However, if the research proves to serve the purpose of 
initiating debate in this multidisciplinary field, helping to reduce one of the barriers to the 
patent-backed debt lending process, it will have served an equally important purpose.   
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 In conclusion, patents are embedded in the economic foundation of the UK and 
managing corporate wealth is vital to the future.  However, there is a dearth of corporate 
financial and narrative information about which companies most effectively exploit patents 
and how they do it.  Voluntary narrative corporate disclosures made by innovating SMEs 
should be a powerful WRROIRUFRPPXQLFDWLQJWKH³SDWHQWYDOXHVWRU\´ and informing lenders 
and other stakeholders ZKRLQFUHDVLQJO\HYDOXDWHGLUHFWRUV¶ILGXFLDU\REOLJDWLRQVand risks 
associated with valuable corporate patent assets.      
         Janice Denoncourt  
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